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PROLOGUE
Whether or not a  thing is measurable is not something 
to be decided a  p rio ri bg thought atone but something 
to be decided) onlg bg experiment.
Ttegnam (1963)
SUMMARY
The a b i l i t y  of re tina derived antigens to induce a strong 
immunological response resu lt ing  in immunopathological a lte ra t ions  
in the retinae of experimentally immunised animals has been well 
established (reviewed by Faure, 1980). The photoreceptor spec if ic  
soluble prote in , known as S-antigen, has been implicated as one of 
the most uveitopathogenic components of the re tina (Wacker et a j . ,  
1977). There is a growing number of reports suggesting 
immunological a lte ra t ions  in human re t ina l degeneration, such as 
r e t i n i t i s  pigmentosa (RP), and chorio re tina l inflammatory diseases, 
e ithe r involv ing spec if ic  re t in a l autoimmunity or an imbalance in 
immunological control mechanisms (reviewed by Forrester et aj.., 
1986). This thesis has sought to fu r the r characterise S-antigen, 
and to examine the s p e c i f ic i t y  of autoimmunity in the RCS ra t 
re t ina l dystrophic model, human u v e i t is ,  and RP.
Sensitive ELISA assays were developed in order to investigate
humoral responses in RCS ra ts , and RP and u ve it is  patients to
p u r if ie d  S-antigen, and rod outer segment membranes. In the ra t
study, i t  was possible to measure the antibody responses of 
ind iv idual animals at d i f fe re n t  times during the degenerative 
process, and the animals were tested at the ages of 3, 6 and 9
weeks, ie. ea rly , middle and la te  stages. Four o f the ten Campbell 
RCS rats exhibited pos it ive  t i t r e s  to S-antigen, and weaker
reponses to ROS in the middle to la te  stages of the degeneration. 
The pigmented Hunter RCS rats did not demonstrate responses 
s ig n if ic a n t ly  d i f fe re n t  from the contro ls. One Wistar albino
control ra t was also s ig n if ic a n t ly  pos it ive  to S-antigen at the age
of 6 weeks. I t  was in te res ting  that the highest responses were 
obtained from the pink-eyed or albino animals, suggesting that 
l ig h t  induced re t in a l changes could have a ro le in the in i t ia t io n  
of autosensitisa tion . In immunoblots, two of the pos it ive  Campbell 
ra t  sera, and the one posit ive  Wistar serum, id e n t i f ie d  S-antigen, 
plus a 40K antigen in the crude re t in a l ex trac t. One Campbell ra t  
also appeared to recognise a 35K antigen. Autoantibodies to opsin 
were not re ad ily  demonstrated in immunoblots, perhaps due to 
denaturation of the relevant epitopes during the procedure.
Five of the six u ve it is  pa tien ts ' sera tested in the ELISA, 
demonstrated t i t r e s  raised above those of the con tro ls , e ith e r to 
S-antigen or to the ROS, but not to both antigens. The f iv e  RP 
patients tested, generated serum responses w ith in  the range o f the 
ten normal sera. A ll of the posit ive  sera, regardless of ELISA 
s p e c i f ic i t y ,  reacted with S-antigen and a 40K antigen in the crude 
re t ina l ex trac t. Human antibodies to opsin were not detected in the 
immunoblots.
The potentia l humoral autoimmune responses to re t in a l antigens was 
fu r the r examined by the temporary immortalisation o f the B 
lymphocytes of humans and ra ts . C ircu la ting  B lymphocytes from RP 
and u ve it is  patients were transformed by Epstein Barr v irus (EBV), 
cultured and assayed fo r  a n t i - re t in a l  antibody secretion. Using 
th is  technology, several clones of transformed B ce lls  producing 
antibody reactive against S-antigen and ROS could be detected in 
some RP and u ve it is  pa tients , but not in the healthy control 
subjects tested. The splenic lymphocytes o f both s tra ins  of 
dystrophic RCS rats and pigmented PVG control ra ts were 
immortalised using the hybridoma technology of Kohler and Mil s te in
(1975), and s im i la r ly  assayed. In the ra t system, 14 out of 249 
primary clones, derived from 5 fusions with RCS ra t B lymphocytes, 
demonstrated re a c t iv i ty  in ELISA to S-antigen and/or ROS. Sim ilar 
pos it ive  clones were not detected in the 3 control fusions.
Three Hunter RCS hybridoma lines secreting autoantibody to 
S-antigen and ROS were subcloned to a tta in  s t a b i l i t y  and 
monoclonality, before fu r th e r study. One of these clones, H9.1.C2, 
secreted antibody reactive with S-antigen. A second monoclonal 
autoantibody, H9.5.A4, was reactive against ROS in the ELISA but 
was unreactive in immunoblots, presumably due to the denaturation 
of the spec if ic  epitope upon binding to the n itro ce llu lo se  paper. 
The th ird  antibody, H10.1.C2, crossreacted with S-antigen and opsin 
in ELISA in immunoblotting. The crossreaction may have resulted 
from a shared ammino acid sequence or a common carbohydrate group, 
or perhaps more l i k e ly ,  from dual s p e c i f ic i t y  of the monoclonal 
antibody. A ll three monoclonal autoantibodies were of the IgM class 
and were of re la t iv e ly  low a f f i n i t y ,  demonstrating low antibody 
t i t r e s .
In addition to the a n t i - re t in a l  monoclonal autoantibodies, two 
monoclonal antibodies were produced from hyperimmunised DA ra ts . 
Monoclonal antibody, S2.4.C5 raised against S-antigen, indicated 
high s p e c i f ic i t y  in immunoblots against crude re t in a l antigens and 
ir re levan t antigens. This monoclonal antibody was shown to be of 
the IgGl isotype, and demonstrated a re la t iv e ly  high t i t r e  and high 
a f f i n i t y  in the ELISA. This antibody was used in the 
immunocytochemical lo ca lisa t io n  o f S-antigen at the u l t ra s tru c tu ra l  
level on human and pig photoreceptor ROS disc membranes visua lised 
by gold probes. Labelling of the outer segments was more intense
v
compared with the inner segments, although the perinuclear region 
of the rods was f a i r l y  in tensely stained. In addition the S-antigen 
was also localised on apparently newly phagocytosed ROS membranes 
w ith in  the re t in a l pigment e p ith e l ia l  (RPE) c e l ls .  IgM antibody, 
R1.2.D2, raised against ROS membranes, was reactive against an 
antigen with an apparent molecular weight of 39K in immunoblots. 
This antibody was also reactive at the electron microscopical 
le ve l,  s p e c i f ic a l ly  la b e l l in g  the disc membranes of the rod ce l ls  
in human and pig re tinae. In contrast to the lo ca lisa t io n  of 
S-antigen, the 39K antigen appeared to be v i r t u a l l y  absent from the 
inner segments.
In conclusion, certa in patients with uveoretinal diseases might 
become sensitised to th e ir  re t in a l antigens, although i t  was not 
possible to deduce the immunopathogenicity o f the response. This 
prelim inary study using B lymphocyte transformations, in 
conjunction with ELISA assays, has indicated the po ten tia l of the 
technique to dissect the humoral immune response o f patients 
without the complications of nonspecific antibody reactions present 
in low serum d i lu t io n s .  S im ilar re t in a l autoimmune responses appear 
to develop in RCS ra ts . However, humoral autoimminity was only 
detected in a re la t iv e ly  small number o f ind iv idua ls , in p a r t ic u la r  
the Campbell ra ts , suggesting tha t the phenomenon is  not general 
and is u n l ike ly  to be involved in the in i t ia t io n  of the disease. 
S-antigen appears to be one o f the dominant potentia l autoantigens 
in the re t in a , as indicated by the immunoblotting re su lts .  However, 
there seems to be at least one other important antigen, w ith an 
apparent molecular weight of 40K. This antigen may be the bearer of 
the epitope recognised by the IgM antibody, R1.2.D2.
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INTRODUCTION
Chapter 1 
INTRODUCTION
1.1 LOCATION, STRUCTURE AND FUNCTION OF THE RETINA
1.1.1 The Anatomy of the Eye
The basic structure o f the eye is  s im ila r  in a l l  classes of 
vertebrates (Figure 1.1). The outer coat of the eye is  a tough, 
collagenous layer known as the sclera. The sclera is  continuous 
with the transparent cornea. Adjacent to the sclera is  a second 
layer o f t issue , the uvea, which is  pigmented and re g ion a lly  
d if fe re n t ia te d  to form the choroid, the c i l i a r y  body and the i r i s .  
A pigmented monolayer o f c e l ls ,  the re t ina l pigment epithelium 
(RPE) is  intermediary between the vascular choroid and the neural 
re t ina . The neural re tina forms a complex layer o f c e l ls ,  including 
the photoreceptors, which l in e  the in te r io r  of the op tic  cup. The 
photoreceptor ce l ls  are c lose ly  associated with the RPE c e l ls .  The 
transparent vitreous body is  an in traocu la r t issue with a g e l- l ik e  
s truc tu re , which occupies fo u r - f i f t h s  o f the volume of the globe. 
The transparent aqueous humour, located behind the cornea, is  more 
f lu id  in form than the v itreous. The aqueous humour and vitreous 
ass is t in the maintenance of in traocu la r pressure. The corneal 
curvature and the lens are responsible fo r  focussing transmitted 
l ig h t  onto the re t ina .
1.1.2 The Neural Retina
The neural re tina  consists of a h igh ly organised layer o f s ix  
d i f fe re n t  kinds o f neurons, including the photoreceptor rod and 
cone ce lls  (Figure 1.2). The second order neurons, the horizontal 
and b ipo lar c e l ls ,  synapse w ith the photoreceptors. The b ipo la r
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Figure 1.2 Diagramatic Representation of the In te rre la t ionsh ips  of Cells 
in the Retina. Cell types: A=amicrine c e l l ;  B=bipolar c e l l ;  
G=ganglion c e l l ;  H=horizontal c e l l ;  PE=pigment e p ith e l ia l  c e l l ;  
CC=choriocapillaris; C=cone c e l l ;  R=rod c e l l .  Layers of re t in a :  
RPE=retinal pigment epithelium; 0SL=outer segment laye r;
ISL=inner segment layer; 0LM=outer l im i t in g  membrane; 0NL=outer 
nuclear layer; 0PL=outer plexiform layer; INL=inner nuclear layer 
IPL=inner plexiform layer; GCL=ganglion ce ll  laye r; NFL=nerve 
f ib e r  layer; ILM=inner l im i t in g  membrane. (Modified from 
Dowling and Boycott, 1966).
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ce l ls  form synapses with the ganglion c e l ls .  The amacrine ce l ls  are 
accessory c e l ls ,  and also synapse with the ganglion c e l ls .  The 
nuclei o f the c lose ly  spaced photoreceptor ce l l  bodies form the 
outer nuclear layer, and those o f the second order neurons form the 
inner nuclear layer. The outer and inner plexiform layers consist 
o f the axons and synapses between the ce lls  o f the neural re tina  
(Figure 1.2). Incident l ig h t  passes through these various layers 
before i t  reaches the l ig h t  sensitive photoreceptor outer segments.
The photoreceptor ce l ls  are separated by Muller ce l l  processes. The 
precise function o f the Muller ce l ls  is  unclear, although they may 
o f fe r  physical support to the re t ina . The t ig h t  junctions between 
the photoreceptor and the Muller ce l l  membranes, form the external 
l im i t in g  membrane which is  located below the photoreceptor nuclei 
(Figures 1.2 and 1.3). The photoreceptor ce l ls  and m ic r o v i l l i  o f 
the PRE do not completely f i l l  the subretinal space, but are 
surrounded by the interphotoreceptor matrix (IPM). The IPM contains 
proteins which are d is t in c t  from those o f the ce l ls  which i t  
surrounds (Adler and Severin, 1981; Adler and Klucznik, 1982). The 
IPM proteins are synthesised and secreted by the RPE and, in  
p a r t ic u la r ,  the re tina  (Adler and Severin, 1981) which is  
responsible fo r  the production o f interphotoreceptor re t in o l  
binding prote in (Bridges et aJL, 1984).
1.1.3 The Photoreceptor Cells
Vertebrates may possess two basic photoreceptor ce ll  types; the 
rods and the cones (Figure 1.3). These terms were o r ig in a l ly  coined 
by early  nineteenth century b io lo g is ts ,  to describe the 
morphological appearance o f the d is ta l t ip s  o f the c e l ls  at the 
level o f the l ig h t  microscope. However, the morphology o f the two
2
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photoreceptor types is  not always d is t in c t ,  fo r  example foveal 
cones are c y l in d r ic a l rather than tapered, and are d i f f i c u l t  to 
d is tingu ish  from rod c e l ls .  The rod c e l ls  are p r im a r i ly  responsible 
fo r  v is ion in low l ig h t  in te n s i t ie s ,  detecting d i f fe re n t
in te n s it ie s  of l i g h t ,  and are also involved in the perception of
shape. The rods generally form the dominant ce l l  type. A human
8 6 re tina  has approximately 1.2 x 10 rods and 6 x 10 cones
(0sterberg, 1935). The ra t io  of rods to cones is  greater in
nocturnal animals; fo r  example in the ra t  the ra t io  is  4000:1 and
in man i t  is  20:1 (La V a i l ,  1976c). The cone ce l ls  are the
mediators o f colour v is ion , and in mammals there appears to be
d is t in c t  cone receptors which discrim inate d iscrete bands of the
spectrum, red, blue and green. The fovea, in man, is  a region o f
the re t in a , 1.5mm in diameter, in the centre o f the visual ax is ,
which is  composed v i r t u a l l y  exc lus ive ly  o f cones (see Fein and
Szuts, 1982). Towards the periphery o f the visual f i e ld ,  the
frequency of the cones decreases.
The photoreceptor ce l ls  are h igh ly  d if fe re n t ia te d  (Figure 1.3). The 
main regions o f the photoreceptor ce lls  are the outer segments,
inner segments, nuclear regions, axons and synapses. The outer 
segments are modified non-motile c i l i a  which are outgrowths o f the 
inner segments. F inger- l ike  s tructures, known as calycal processes 
extend from the inner segments and l i e  pa ra l le l and in close 
proxim ity to the outer segments, and may have a supportive r o le . '  
The inner segments can be subdivided in to  specialised regions. The 
apical e l l ip s o id  regions, o f the inner segments contain large, 
densely packed mitochondria. Proximal to the e l l ip s o id  region is  
the paraboloid region which contains vacuoles and presumptive 
glycogen granules. Below the mitochondrial area is  the myoid
region, characterised by rough endoplasmic reticulum ( RER), Golgi 
apparatus and free polyribosomes. This region is  also r ich  in 
co n tra c t i le  prote ins, actin  and myosin, which are responsible fo r  
photomechanical movements in some species (see Fein and Szuts, 
1982). The photoreceptor ce ll  bodies house the nuc le i, and from 
th is  region, slender axons o f approximately 1pm in diameter, extend 
to the synaptic terminals. The rod synapse is  known as the 
spherule, and the larger cone synapse is  referred to as the 
pedicle. The dendrites of the horizontal and b ipo lar c e l ls ,  in se rt  
in to  the single deep invagination o f each spherule, and the 
numerous shallow invaginations of the pedicles.
The outer segments are packed with thousands of f la ttened  disc 
membranes (Figure 1 .3 ), containing a high concentration o f the 
visual pigments and the other proteins associated with the 
biochemistry of v is ion (Sections 1 .2 .1). The discs are orienta ted 
perpendicular to the long axis of the outer segments. The disc 
membranes are formed by invagination in the plasma membrane at the 
base of the outer segment. In typ ica l rod outer segments (ROS), the 
disc membranes are pinched o f f  and separated from the plasma 
membrane, and only the lower 10 to 20 discs are continuous with the 
plasma membrane. In contrast, typ ica l cone disc membranes remain 
continuous with the plasma membrane, and are f i l l e d  with 
e x tra c e l lu la r  m ateria l. The rims o f the discs are not 
f re e - f lo a t in g ,  but are attached to the plasma membrane by proteins 
which have recently  been p a r t ia l ly  characterised (Molday et a l . ,  
1986). Microtubules are also located w ith in  the outer segments.
1.1.4 Role o f the Retinal Pigment Epithelium
The apical membrane of the re t in a l pigment epithelium (RPE) is
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c lose ly  associated with the photoreceptor ce ll  laye r, and the two 
ce ll  types are embryologically re lated. The RPE ce l ls  are v i ta l  to 
the normal function ing and health o f the photoreceptor c e l ls .  The 
basal membrane surface o f the RPE has numerous in fo ld in g s , and 
forms one boundary of Bruch's membrane. The membranes o f the 
ch o r io ca p i l la r is  o f the choroid, form the other boundary to Bruch's 
membrane. The basal membrane o f the RPE is  specialised in the 
uptake o f nu tr ien ts , oxygen, and other metabolites from the 
ch o r io c a p i l la r is ,  fo r  the support of the photoreceptors as well as 
i t s e l f ;  both ce l l  types are m etabo lica lly  very active .
The apical surface o f the RPE is specialised in the phagocytosis o f 
shed rod outer segment (ROS) membranes and also in the exchange o f 
material from the interphotoreceptor matrix (IPM), including 
nutrien ts  and metabolites. Numerous m ic rov il lus  processes, which 
are important in phagocytosis, extend from the apical surface o f 
the RPE, fo r  a distance equal to at least twice the height o f the 
RPE c e l l .  The th icke r o f these processes, which may contain melanin 
granules, encase the t ip s  o f the photoreceptor ce ll  outer segments 
(Figure 1.2).
The RPE ce ll  are involved in the metabolism of r e t in o l ,  a vitamin A 
de riva tive . The RPE ce l ls  receive re t in o l from the c i r c u la t io n ,  
which is  transported t ig h t l y  complexed with serum re t in o l binding 
protdin (SRBP). The RPE monolayer forms a permeability  b a r r ie r ,  
s im ila r to tha t found in the bra in, which does not allow proteins 
and most low molecular weight substances, to cross to the 
in t e r s t i t i a l  space. Thus the apical surfaces o f the RPE c e l ls  have 
receptors fo r  SRBP (see H e lle r , 1976). The re t in o l is  transported 
through the cytoplasm of the RPE c e l ls  associated with a c e l lu la r
re t in o l binding prote in (H e lle r, 1976). In the photoreceptor c e l l ,  
the vitamin A de riva t ive , in the form of re t in a l ,  provides the 
chromophore 'group fo r  rhodopsin, the visual pigment. When rodopsin 
absorbs a photon o f l i g h t ,  the chromophore is  released in the form 
o f re t in o l (Dowling, 1960). The re t in o l is  transported through the 
interphotoreceptor m atr ix , associated with interphotoreceptor 
re t in o l binding proteins (IRBP) (Adler and Martin, 1982). The 
re t in o l is  transported to the RPE were i t  is  e s te r i f ie d  and stored 
(Berman et a j . ,  1979). These transport processes are reversed in 
the dark. In l ig h t  adapted re tinae, the m a jo r ity  o f re t in o l  is  
bound to IRBP, in the IPM (Adler and Martin, 1982).
The outer segments o f many vertebrates, including the ra t ,  are 
con tinua lly  renewed at th e i r  base and trimmed at th e i r  t ip s  by the 
RPE (Young, 1967, 1971, 1974). The considerable p ro l i fe ra t io n  o f
the rhodopsin containing membranes is  one o f the most 
cha rac te r is t ic  features o f the photoreceptor c e l ls .  New discs are 
formed at the base o f the outer segments, thus disp lacing the 
ex is ting  membranes. The renewal process was determined by the use 
of t r i t i a t e d  amino acids, eg. methionine, leucine, h is t id in e  and 
phenalalanine, in jected in to  l iv e  frogs, ra ts , mice and rhesus 
monkeys (Young, 1967; Young and Droz, 1968; Young and Bok, 1969; 
Bok and H a ll, 1971). The animals were k i l le d  at d i f fe re n t  time 
in te rva ls , th e ir  retinae f ixed and sectioned fo r  autoradiography. 
The resu lts  suggested tha t the precursors of the visual pigment, 
and other c e l lu la r  prote ins, were synthesised from the labe lled  
amino acids, p r im a r i ly  in the myoid region of the photoreceptors. 
The labelled proteins appeared to migrate through the inner 
segment, many via the Golgi apparatus, through the connecting 
c il ium  and subsequently incorporated in to  the newly forming disc
membranes (Young and Droz, 1968). The labelled band o f discs was 
displaced along the ROS as new, less in tensely labelled discs were 
formed. The la b e l l in g  of a band o f discs more l i k e l y  represented 
membrane prote ins, such as rhodopsin, rather than the soluble 
proteins which would not remain confined to d iscre te regions. The
older discs were discarded at the outer segment t ip s ,  and removed
by phagocytosis. Young (1971) reported tha t in the rhesus monkey, 
groups o f 8 to 30 discs were shed at a time. Electron 
m icroscopica lly, the edges of the discs appeared to curl upwards, 
displacing a small portion o f cytoplasm in to  the space thus formed 
(Young, 1971). The plasma membrane of the outer segment indents, 
separating the shed package o f discs and sealing the t ip  o f the
outer segment. Cytoplasmic extensions, o r ig ina t in g  from the RPE, 
surround the shed group of discs, and phagocytosis proceeds. Bok 
and Hall (1971) found tha t complete renewal o f disc membranes was 
achieved a f te r  8 days in ra ts , although the time varies with
species.
Phagosomes containing ROS membrane material undergoing lysosomal 
degradation are found w ith in  the RPE c e l ls  (Young and Bok, 1969; 
Young, 1971). I t  has been suggested tha t the lysosomes o f the RPE 
are specialised in th e i r  content o f hyd ro ly t ic  enzymes, fo r  the 
degradation o f ROS membranes (Zimmerman et _al., 1983). At leas t 
some protein epitopes, eg. o f S-antigen (Section 1 .2 ), may be 
detected w ith in  the RPE phagosomes p r io r  to complete d igestion 
(Section 8.5).
In the developing re t in a ,  the RPE a c t ive ly  phagocytoses ROS 
membranes before the ROS have reached th e i r  maximum length (Herron 
et a l ,  1969; Bok and H a ll,  1971; Tamai and Chader, 1979). The rate
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of disc production must exceed the disc shedding u n t i l  the maximum 
ROS length is  reached, and a balance achieved. The adult pattern of 
shedding in the ra t  is  reached at 3 to 4 weeks a f te r  b i r th .  Under 
normal circumstances, there is  a balance between synthesis and 
phagocytosis o f disc membranes. The RCS ra t model fo r  inherited  
re t in a l degeneration, possesses an RPE which demonstrates a fa i lu re  
to phagocytose shed ROS membranes (Section 1 .5 .5 ). I t  is  possible 
tha t some forms of human re t in a l degeneration have s im ila r  RPE 
abnormalities. Ripps e t a]_. (1978) suggest tha t in some forms o f 
human autosomal dominant r e t i n i t i s  pigmentosa (AD RP), there may be 
an imbalance in the renewal system such tha t the rate o f disc 
shedding and phagocytosis is  greater than th e ir  production, thus 
resu lt ing  in a progressive shortening o f the ROS. Further 
investiga tions, however, are required to establish th is .
Evidence suggests tha t the processes o f photoreceptor disc shedding 
and phagocytosis in ra ts are l ig h t  stimulated and fo l low  a 
circadian rhythm, such tha t the packets of discs are shed at
daybreak (La' V a i l ,  1976b). However, these processes w i l l  continue 
in an animal which has already been exposed to the l ig h t  cycle, i f  
the l ig h t  stimulus is  absent. Maximal disc shedding in the ra t ,  
however, occurs 1 to 2 hours a f te r  the onset of l ig h t  (La V a i l ,  
1976a,b). Tamai and Chader (1979) present evidence tha t circadian 
rhythm of disc shedding and phagocytosis, is  established a t a very
early  age in the development o f the ra t  re t in a , ie . when the eyes
open at about 14 to 15 days. In add it ion , no d iffe rence was 
observed in  the development of the ROS disc shedding and
phagocytosis, in rats raised under dim or b r ig h t l ig h t in g  
conditions.
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There is  a growing number of reports supporting the view tha t there 
exists spec if ic  receptor-1igand in te rac tions , which are involved in 
disc shedding and phagocytosis (see Colley and H a ll,  1986). Colley 
and Hall (1986) produced evidence suggesting tha t the ligands on 
ROS surfaces do not vary in the re la t ion  to the shedding cycle, or 
tha t i f  c yc l ic  a lte ra t ions  in components of the ROS surface do 
occur, they are not stable during the iso la t io n  procedure.
F in a l ly ,  the RPE has a ro le in the absorption o f 's t ra y ' l ig h t  
pa rt ic les  which escape absorption by the photoreceptors. The is  
achieved by the numerous l ig h t  absorbing pigment granules, 
containing melanin.
1.2 RETINAL S-ANTIGEN
1.2.1 Introduction
S-antigen is  a soluble prote in extractable from mammalian 
photoreceptor rod outer segments, with a molecular weight in the 
region of 50K. S-antigen is so called because o f i t s  high 
s o lu b i l i t y .  Since i t s  discovery (Wacker, 1973), S-antigen has 
stimulated much in te res t with respect to i t s  ro le in photoreceptor 
function and i t s  a b i l i t y  to induce re t in a l autoimmunity (Sections
1.2.3 and 1 .3 .3 ). The protein was o r ig in a l ly  id e n t if ie d -a s  a h igh ly  
uveitopathogenic fac to r present w ith in  the photorecepter rod outer 
segments (Wacker, 1973) (Section 1 .6 .2).
Some groups have reported the absence o f carbohydrate on S-antigen 
(Wacker et a l . ,  1977; Beneski et a l . ,  1984), however, the pro te in  
may have a small carbohydrate moiety, since i t  has been shown to 
sta in p o s i t iv e ly  with periodic a c id -S ch if f 's  (PAS) reagent in
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SDS-polyacrylamide gels (Borthwick and Forrester, 1983). Wacker et 
a l .  (1977) suggested tha t there may be a small amount of l i p id  
associated with the prote in . There has been some discrepancy of the 
molecular weight of S-antigen (reviewed by Broekhuyse and Bessems,
1985) (Section 8.1). Recently, i t  has been suggested tha t S-antigen 
is  the 48K pro te in , described by Kuhn (1978), although the precise 
molecular weight is  l i k e ly  to vary between species.
There have been re la t iv e ly  few reports on the properties o f human 
S-antigen, since the human tissue is  d i f f i c u l t  to obtain in 
quantity . Beneski et a l .  (1984), found that human S-antigen 
demonstrated s im ila r  properties to tha t of the bovine re t in a .  The 
molecular weight was found to be 52K by SDS-PAGE and 48K by high 
pressure l iq u id  chromatography (HPLC). The is o e le c tr ic  po int o f the 
human protein was 5.7, which is  s im ila r  to the value of 5.5 
reported fo r  bovine S-antigen (Borthwick and Forrester, 1983). The 
amino acid composition o f bovine and human S-antigens were s im i la r ,  
except tha t there was almost twice the amount o f glycine in the 
human protein (Beneski et a2-, 1984). In add it ion , the most common 
amino acids in the human S-antigen were aspartic acid and leucine, 
whereas in the bovine p ro te in , aspartic acid and glutamine were the 
most abundant. The human S-antigen was demonstrated to have a 
s im ila r  capacity fo r  the induction o f experimental autoimmune 
u ve it is  (EAU) in guinea pigs (Beneski et a l . ,  1984).
1.2.2 C e llu la r Localisation of S-Antigen and Species S pec if ic ty
S-antigen was f i r s t  loca lised by Wacker et al_., (1977) using 
antisera to p u r if ie d  S-antigen, throughout the photoreceptor rod 
ce l ls  in an immunofluorescence procedure. Using s im ila r  techniques, 
S-antigen has also been loca lised w ith in  the mammalian pineal gland
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(Kalsow and Wacker, 1977; Korf et al_., 1985), which is
phylogenetica lly  re la ted to the re tina (reviewed by Wiechmann,
1986). Furthermore, S-antigen has been id e n t i f ie d  w ith in  fixed 
sections of human photoreceptor derived retinoblastoma c e l ls ,  using 
a monoclonal antibody in an immunoperoxidase technique (Donoso et 
a l . ,  1985).
S-antigen appears to be well conserved; antibodies raised against 
the S-antigen from one species cross-reacts with the same protein 
of d i f fe re n t  species (Dorey and Faure, 1977; Wacker et , 1977; 
Tuyen et a l . ,  1982). Dorey and Faure (1977) obtained a reaction of 
id e n t i ty  in Ouchterloney immunodiffusion assays, with human, guinea 
p ig , ra b b it ,  bovine and possibly sheep, pig and horse S-antigens, 
using guinea pig antisera to homologous re t ina . Wacker et a | .  
(1977) found tha t p u r i f ie d  bovine S-antigen migrated as a doublet 
in SDS-PAGE, and tha t one o f these bands gave a reaction o f id e n ity  
with the guinea pig pro te in , and the other band gave a reaction of 
only p a r t ia l  id e n t i ty  with guinea pig S-antigen. De Kozak et a2-
(1981) found, tha t S-antigen extracted from d i f fe re n t  species 
demonstrated s im ila r  capacities to induce EAU in ra ts . Tuyen et aK
(1982) suggested tha t the conserved nature o f S-antigen is  not 
complete, since the sera o f rats immunised with S-antigens 
extracted from d i f fe re n t  mammalian species, reacted most s trong ly  
with the immunising S-antigen in the enzyme linked immunosorbent 
assay (ELISA). Faure et a l . ,  (1984), Mirshahi et a l . ,  (1984) and 
Mirshahi £ t  a l . ,  (1985) have studied the phylogenic d is t r ib u t io n  of 
d is t in c t  epitopes of S-antigen using mouse monoclonal antibodies. 
At least some epitopes seem to date back to the Cambrian period, 
being present in the c i l i a r y  type o f photoreceptors (Mirshahi et 
a l . ,  1984). These authors have detected epitopes o f S-antigen in
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the photoreceptors and pinealocytes o f species from every class of 
vertebrates, and in the photoreceptors of certa in  invertebrates, 
using mouse monoclonal antibodies and ra t polyclonal antisera to 
S-antigen, in immunofluorescence techniques. Epitopes of S-antigen 
could even be detected in annelids and molluscs, although not in 
the two species from the class of Arthropoda which were tested 
(Mirshahi _et a l . ,  1985). The photoreceptor outer segments o f the 
re tina and pineal organ were cons is ten tly  stained, and the inner 
segments and synapses were usually also stained (Mirshahi et a l . ,
1984). One o f the monoclonal antibodies was spe c if ic  fo r  bovine 
S-antigen, which fu r th e r  suggested a diversion between the 
mammalian proteins (Faure et a l . ,  1984).
At the level o f the electron microscope, the prote in has been 
loca lised p r im a r i ly  on the rod disc membranes (Broekhuyse et a2«, 
1984a; McKechnie et a j . ,  1986) using conventional polyclonal 
antisera with immunocytochemical techniques. The ul t ra s tru c tu ra l 
lo ca lisa t io n  of S-antigen is  fu r th e r  discussed in the context of 
the find ings o f  the present study (Section 8.5).
1.2.3 Physiological Role of S-antigen
The b io log ica l function of S-antigen remains obscure. Wacker et a l . 
(1977) f i r s t  suggested tha t i t  may be the 50K subunit o f ROS 
cytosol re t in o l binding prote in . Later, i t  was speculated tha t i t  
might be the photoreceptor phosphodiesterase (Faure, 1980). 
Nussenblatt et a l .  (1981c) presented immunological evidence which 
suggested tha t S-antigen might be rhodopsin kinase (RK), a 67K 
protein (Kuhn, 1978). The evidence was based on the c ro s s re a c t iv ity  
of antiserum to S-antigen with RK, the presence of RK a c t i v i t y  
w ith in  preparations of S-antigen, in h ib i t io n  of RK a c t i v i t y  w ith
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antiserum to S-antigen and the s im ila r  capacities of RK to induce 
EAU. The s ig n if ic a n t  d ifference in the molecular weights o f the two 
proteins was not discussed, and the experimental observations 
probably resulted from contaminating RK w ith in  the preparations of 
S-antigen, and vice versa.
At present, i t  is  generally accepted that S-antigen is  the soluble 
48K ROS protein described by Kuhn (1978). The 48K protein is  
characterised by i t s  light-dependent binding to photoactivated, 
phosphorylated rhodopsin (the visual pigment) on disc membranes 
(Kuhn, 1978; Kuhn e t ^ l . j  1984), and the in h ib i t io n  o f the l ig h t  
dependent a c t iv i t y  o f guanosine 3 ' , 5 1-monophosphate (cyc l ic  
GMP)-phosphodiesterase. The 48K protein is  p u r i f ie d  from ROS using 
a procedure based on i t s  a b i l i t y  to bind to i l lum inated disc 
membranes (Kuhn, 1982). Evidence fo r  the id e n t i ty  of S-antigen with 
the 48K pro te in , was based on th e ir  co-migration in SDS-PAGE with
apparent molecular weights in the region of 50K, the a b i l i t y  fo r
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both proteins to bind to il lum inated ROS disc membranes, the 
c ro ss re a c t iv ity  of monoclonal antibodies to S-antigen with the 48K
prote in , s im ila r  t i t r a t io n  curves of spec if ic  antisera in
radioimmunoassay (RIA) to both antigens, and the s im i la r i t y  in 
severity  of ocular inflammation in EAU experiments (P f is te r  et a j . ,
1985). The mechanism of in te rac tion  o f the 48K prote in  (or
S-antigen) suggested by Kuhn et al_., 1984) is  described below.
Rhodopsin, an in tegra l membrane p ro te in , has been extensive ly 
characterised (reviewed by Hargrave, 1982). The pigment is  
synthesised from a 39K glycoprote in, opsin, and the chromophore 
group 11-cis re t in o l ,  a vitamin A de riva t ive , which dissociates 
from the protein upon the absorption o f a photon, while rhodopsin
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undergoes a series of stereoscopic and conformational tra ns it ion s  
(see Kauppand Koch, 1986). This resu lts  in a chain of amplified 
biochemical * and e lectrophysio log ica l events in i t i a t in g  v is ion  
(reviewed by Stryer et a l . ,  1981 and Chabre, 1985). The a-subunit 
of transducin, the rod G pro te in , in te racts  with the photolysed 
rhodopsin intermediate, metarhodopsin I I ,  which forms w ith in  a few 
milliseconds, to form a complex. Rhodopsin acts as a ca ta lys t,  
causing the exchange o f GDP bound to transducin, fo r  GTP. A single 
molecule of rhodopsin, activated by one photon, has the capacity 
fo r  500 such conversions, th is  is  the f i r s t  stage in the 
am p lif ica t ion . The second step is not amplified. Each activa ted, 
GTP-transducin, then complexes with one phosphodiesterase (PDE), a 
peripheral membrane pro te in , which is  then activa ted, probably by 
the release of an in h ib i to ry  fa c to r ,  to ra p id ly  hydrolyse c yc l ic  
GMP (cGMP). The hydrolysis of cGMP is h igh ly am plif ied, since one 
activated PDE molecule is  capable of hydrolysing 2000 molecules of 
cGMP per second. The absorption of a single photon can be amplified 
by the enzyme cascade, by a fac to r of 106 .
The consequence of the decrease in the levels of cGMP is  the 
closure of the R0S plasma membrane sodium channels, which resu lts  
in the hyperpolarisation o f the membrane. This is  detected by the 
photoreceptor synapses, resu lt ing  in nerve signal f i r i n g  and 
v is ion . The precise mechanisms of channel opening and closing are 
not yet c lear. The l ig h t  dependent closing of the Na+ channels has 
also been found to be associated with a r ise  in the concentration 
of Ca2+ ions. Recent evidence suggests tha t the Ca2+ might have at 
least two e ffec ts  on light-dependent conductance, e ith e r by 
d i re c t ly  regulating ion permeability or by regulation o f cGMP 
concentration (see Kauppand Koch, 1986).
The photochemical reactions are in h ib ite d , or con tro lled , by 
hydrolysis o f GTP bound to a-transducin , to GDP, as a re su lt  of a 
slow in t r in s ic  GTPase a c t iv i t y  (see Kauppand Koch, 1986). At least 
two other proteins might be involved in the modulation o f the l ig h t  
ac t iva tion  o f PDE, rhodopsin kinase and the 48K prote in . Rhodopsin 
kinase (RK) phoshorylates photobleached rhodopsin, tra ns fe rr ing  up 
to 9 phosphate groups onto the cytoplasmic surface o f the protein 
(Wilden and Kuhn, 1982). Wilden et a j .  (1986) studied the e f fe c t  of 
ATP and the 48K pro te in , in the deactivation of the PDE system, 
using thoroughly washed disc membranes, whose rhodopsin had been 
previously phosphorylated and chromophore group regenerated. To 
th is  system, p u r i f ie d  PDE and transducin were reassociated. I t  was 
found that such phosphorylated membranes demonstrated a 
s ig n if ic a n t ly  lower capacity compared to unphosphorylated control 
membranes. The addition of the 48K protein to the phosphorylated 
membranes fu r the r suppressed the ac tiva t ion  of PDE. Depending on 
the concentration of the 48K protein and the in te n s ity  o f the l ig h t  
f lash , th is  suppression could be as high as 98%. The 48K prote in 
was not able to influence the ac tiva tion  or deactivation of PDE 
a c t iv i t y  on unphoshorlyated membranes (Wilden et a l . , ’ 1986).
The binding of the 48K protein to the disc membranes was thought to 
be through phoshorylated rhodopsin, and appeared to be slow, and 
involved in in h ib i t io n  of the in te rac tion  of transducin with 
rhodopsin, thus reducing the ac tiva t ion  o f PDE (Kuhn et a j . ,  1984; 
Wilden et a l . ,  1986). Thus, i f  S-antigen is  the 48K p ro te in , i t  may 
have an important ro le  in the regulation o f phototransduction, in 
many species of vertebrates and invertebrates. Further work, 
however, is  required in order to establish that S-antigen is ,  in
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fa c t ,  the 48K pro te in , and to c la r i f y  the nature of the binding of 
the 48K protein to phosphorylated disc membranes.
1.3 EXPERIMENTALLY INDUCED RETINAL AUTOIMMUNITY
1.3.1 Introduction
A theory o f ocular autoimmune reactions which might explain the 
observed histopathology was developed early  th is  century in 
re la t io n  to human sympathetic u ve it is  (see Vannas et al_., 1960).
Since th is  time the theory has been extended to other human ocular 
conditions. Sympathetic u ve it is  is a condition which can develop in 
a healthy eye, a few weeks or months a f te r  in ju ry  to the other eye. 
The uninjured eye develops granulomatous u v e i t is ,  apparently in 
sympathy with the traumatised eye. The pathophysiology o f th is  
condition is  unclear, although i t  is generally held tha t ce l l  
mediated immunity to uveal antigens is  responsible (reveiwed by 
Wakefield et a j . , 1982). However, there is  l i t t l e  evidence fo r  
autoimmunity to uveal rather than re t in a l antigens.
Hess and Romer (1906) f i r s t  discovered the a n t ig e n ic i ty  o f the ROS, 
and suggested that anti-ROS antibodies may be involved in human 
re t ina l disease. They fu r the r suggested that normally there ex is ts  
a b a rr ie r  at the level of the RPE or the c h o r io c a p i l la r is ,  which is  
now known as the b lood-re tina l b a rr ie r .  S-antigen has been 
implicated as one of the potentia l autoantigens (Section 1.3.3) 
since, when in jected in to  experimental animals i t  has the capacity 
to induce immunohistopathological changes s im ila r  to those seen in 
human sympathetic uve it is  (Wacker et a l . ,  1979).
1.3.2 Experimental Autoimmune Uveitis
Experimental a l le rg ic  (or autoimmune) u ve it is  (or u v e o re t in i t is )
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(EAU) has a long h is to ry  (reviewed by Faure, 1980). The term was
introduced by Wacker and Lipton (1965), to describe the autoimmune
experimental'disease in guinea pigs induced by immunisation with 
homologous re t ina . EAU generally resulted in inflammatory ce ll
i n f i l t r a t i o n  of the v itreous, choroid and re t in a , with the eventual 
destruction o f the photoreceptor ce ll layer. In 1968(a,b), Wacker 
and Lipton presented evidence fo r  the sup e r io r i ty  o f the re tina  in 
inducing u v e i t is ,  compared with the uvea and other ocular antigens. 
The f i r s t  evidence fo r  the immunopathogenicity of the iso lated ROS, 
in guinea pigs, was produced by Faure et , in 1973.
I t  is  important to id e n t i fy  and characterise the relevant ocular 
antigens in EAU, and to determine th e ir  involvement in human 
uve it is  and r e t i n i t i s  pigmentosa. Proteins which have been
p a r t ia l ly  characterised, eg. S-antigen and more recently ,
interphotoreceptor binding pro te in , have been found to be capable 
of inducing EAU (Sections 1.3.3 to 1.3.4) and provide models fo r  
human uve it is  (Section 1 .4 .4). The s im i la r i t ie s  in the
immunopathology and immune response of animals with EAU and human
patients w ith*certa in  diseases o f the uvea and re t in a ,  imply tha t
EAU may provide a useful model fo r  research in to  the pathogenesis 
and therapy of such human conditions.
1.3.3 S-antigen induced EAU
S-antigen was f i r s t  id e n t i f ie d  by Wacker in 1973, as the primary 
ae tio log ica l agent in EAU, being h igh ly  antigenic and capable o f 
inducing the condition in microgram doses (Wacker, 1973; Wacker et 
a l . ,  1977). There was a s t r ik in g  increase in immunopathogenicity 
with increasing p u r i ty  o f the S-antigen preparation, on a weight 
basis. An incidence of 100% EAU of mild to moderate seve r ity  was
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obtained in guinea pigs immunised with as l i t t l e  as l-5pg o f the 
pu r i f ie d  protein (Wacker et aj_., 1977). Several other laboratories 
have reported s im ila r  find ings (Dorey and Faure, 1977; Faure et 
aH., 1981; Forrester et a l . ,  1985). This is in contrast to the much 
greater quantit ies (1 to 4mg) required to induce EAU with ROS, in 
guinea pigs (Faure et a l . ,  1973; Meyers and P e t t i t ,  1975; Meyers, 
1976).
Forrester et ja l . (1985) describe the morphological changes at the 
ul t ra s truc tu ra l level in the guinea pig re tina induced by 
immunisation with p u r if ie d  bovine S-antigen. Single in jec t io ns  of 
S-antigen in adjuvant, 17 or lOOpg o f p ro te in , resulted in focal 
c h o r io re t in i t is ,  characterised by the selective destruction of the 
outer re t in a l layers. The inflammation observed in the choroid and 
re tina consisted almost e n t i re ly  of monocytes. Although each focal 
lesion ra p id ly  progressed to the end stage a f te r  2 to 3 weeks, new 
lesions continued to appear and the inflammatory a c t i v i t y  in the 
vitreous became chronic. Forrester et a j .  (1985) supported the view 
tha t the ROS are the immune target tissue in EAU, which appeared 
swollen with the loss of discrete discs. Large macrophages were 
id e n t i f ie d  w ith in  the subretinal space and appeared to phagocytose 
the ROS debris. EAU provides a useful model fo r  ce rta in  human 
ocular conditions, fo r  example uve it is  (Brinkman e_t al_., 1980a;
Newsome and Nussenblatt, 1984; Chant et al_., 1985) (Section 1 .4 .4 ). 
The pathology o f S-antigen induced EAU is focal in rats and guinea 
pigs (Broekhuyse et a j . ,  1986; Forrester et al_., 1985), as are many 
posterio r human u ve it is  conditions, and human RP may also be focal 
in i t s  ea rly  stages.
1.3.4 Other Uveitopathogenic Antigens
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1.3.4.1 Rhodopsin
Early reports on the uveitopathogenic a c t iv i t y  of rhodopsin (or 
opsin) was based on experiments with isolated ROS (Hong et a l . ,  
1975; Faure et a K ,  1973). However, although these antigen 
preparations may represent over 80% opsin, recent evidence suggests 
tha t S-antigen, a h igh ly  uveitopathogenic agent (Section 1 .3 .2 ) , is 
not re ad ily  removed form the ROS (Broekhuyse et a K ,  1986). More 
recently , the a b i l i t y  of p u r i f ie d  rhodopsin or opsin, to induce EAU 
has been investigated. Marak et al_. (1980), reported 
c h o r io re t in i t is  and inflammation in guinea pigs immunised with lmg 
of rhodopsin in adjuvant. The inflammation extended in to  the outer 
re tina only in the most severe cases, sparing the inner re t in a . The 
a b i l i t ie s  of rhodopsin and opsin, to induce EAU, were compared and 
no s ig n if ic a n t  difference was found (Marak et al.-, 1980).
Meyers-El i o t t  et a j . (1983), reported s im ila r  find ings in guinea 
pigs in jected with smaller doses of p u r i f ie d  rhodopsin (250 or 
500pg, in adjuvant). The outer re t in a l layer was destroyed, without 
substantial inflammation of the re t ina .
Broekhuyse j i t  _al. (1984), investigated the ra t as a model fo r  
rhodopsin induced EAU, since th is  animal, l ik e  man, has a vascular 
re t ina . In Lewis ra ts , high doses, 250pg o f rhodopsin, were found 
to induce moderate to severe disease, with r e t i n i t i s  predominating 
a f te r  2 weeks. Within a few days, the photoreceptor ce l l  layer was 
destroyed. Lymphocytes obtained from these animals, generated high 
responses in the lymphocyte transformation assay in the presence of 
rhodopsin. Lower doses o f rhodopsin seldom induced severe r e t i n i t i s  
(Broekhuyse et a] . , 1984). The authors also pointed out tha t the 
method of so lu b i l is a t io n  of the rhodopsin could be important in 
uveitopathogenesis, since they found l i th ium  dodecyl sulphate
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so lub il ised  rhodopsin to be less antigenic and immunopathogenic 
compared with T riton X-100 so lub il ised  m ateria l.
The morphology of S-antigen and rhodopsin induced EAU, described by 
d i f fe re n t  groups varies in some respects, perhaps due to 
differences in the animal species or s t ra in ,  anatomy of the re t in a , 
preparations o f S-antigen or the immunisation schedules (see 
Broekhuyse _et , 1984; . Forrester et al_., 1985; Broekhuyse et
a l . ,  1986).
1.3.4.2 Rhodopsin kinase
There is  evidence that rhodopsin kinase (RK) may have a s im ila r  
uveitopathogenic capacity to tha t of S-antigen (Nussenblatt e t a K ,  
1981c). The s im i la r i t ie s  between the histopathological p ic tures of 
EAU induced by RK and S-antigen led the authors to suggest tha t 
they are one and the same protein (see also Section 1 .2 .3 ). Both 
antigens induced a focal degeneration of the photoreceptor ce l l  
layer when 30pg of p ro te in , in adjuvant, was in jected in to  Lewis 
ra ts . However, since no evidence fo r  the p u r i ty  o f these 
preparations was presented, and given tha t S-antigen has been found 
to be capable of inducing EAU with as l i t t l e  1 to 5pg (Wacker et 
a l . ,  1977), fu r th e r work is  required to estab lish the
uveitopathogenicity of RK.
Broekhuyse £ t  al_. (1986) found Lewis rats to be more susceptible to 
the interphotoreceptor re t in a l binding protein (IRBP) induced 
disease, compared with Wistar, PVG, and BN ra ts . Thus, i t  is  
possible tha t d i f fe re n t  s tra ins of ra t  may be more or less 
sensitive to EAU induction by RK and S-antigen, thus 
d i f fe re n t ia t in g  between the two antigens.
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1.3.4.3 Interphotoreceptor re t in o l binding protein
Interphotoreceptor re t in o l binding protein (IRBP) (see Section
1 .1 .4 ), derived from the matrix surrounding the photoreceptor 
c e l ls ,  has recently  been found to have a capacity to induce EAU in 
Lewis ra ts ,  in microgram quan t it ies , s im ila r  to S-antigen 
(Broekhuyse et a j . ,  1986). Doses of 15 to 80pg of protein in 
complete Fruend's adjuvant, induced moderate to severe inflammation 
in almost a l l  rats a f te r  9 days. The disease induced by IRBP 
demonstrated an e a r l ie r  onset, progressed more ra p id ly ,  and 
appeared s l ig h ly  more severe than S-antigen induced EAU. Like 
S-antigen, IRBP induced EAU affected the an te r io r segment of the 
eye i n i t i a l l y ,  followed by severe inflammation o f the poste rio r 
segment, 1 to 2 days la te r .  In opsin induced disease, where very 
much larger doses are required (Section 1 .3 .4 .1 ),  m ilder reactions 
occurred in the an te r io r segment, and r e t i n i t i s  was the predominant 
feature (Broekhuyse et a l . ,  1986). The common feature in S-antigen, 
rhodopsin and IRBP induced EAU was the to ta l destruction o f the 
photoreceptor ce l l  layer.
1.3.5 Evidence fo r  T Cell involvement in EAU
There is  strong evidence tha t EAU, whether induced by S-antigen or 
other re t in a l antigens, is  dependent on T ce ll mediated mechanisms 
(Nussenblatt et al_., 1980c; Nussenblatt et al_., 1983b; Nussenblatt 
and Chan, 1985). In the presence o f re t in a l antigens, macrophage 
migration in h ib i t io n  and pos it ive  lymphocyte s tim u la tion  indices 
have been found in animals with EAU (de Kozak et _al., 1974;
Nussenblatt et a_K, 1980c), in addition to serum antibody. 
Moreover, EAU can be adoptively transferred to naive guinea p igs, 
by the in traperitonea l in je c t io n  o f peripheral blood lymphocytes or
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spleen ce lls  from donors immunised with S-antigen, providing tha t 
these in vivo sensitised ce l ls  were stimulated in v i t r o  with 
S-antigen or concanavalin A (Mochizuki et a K , 1985). Passive 
trans fe r of ROS induced EAU, has been successfully obtained in 
guinea pigs in jected with f re sh ly  harvested lymphoid c e l ls  (Aronson 
et a l . ,  1971; Meyers, 1976). Adoptive trans fe r o f EAU, with 
hyperimmune serum has been la rg e ly  unsuccessful (Quinby and Wacker, 
1967; Aronson et a l . , 1971).
Cyclosporin A, an immunosuppressive drug derived from a fungal 
product, has been found to be e f fe c t ive  in the prevention o f EAU in 
ra ts , fu r th e r  supporting the importance of T ce l l  mediated 
mechanisms (Nussenblatt et al_., 1981b; Nussenblatt e t al_., 1982;
Nussenblatt et al_., 1983b). A large amount o f in form ation,
sometimes c o n f l ic t in g ,  has accumulated over the la s t  decade, on the 
mechanisms of action o f CsA (reviewed by Shevach, 1985). The most 
dramatic e f fe c t  ot the drug is  the prevention o f T ce ll  
p ro l i fe ra t io n  in the presence of mitogens and a l1oantigens. The 
drug probably acts on T-helper ce l ls  by preventing the induction o f 
ce ll-su rface  receptors fo r  IL2, or by the in h ib i t io n  o f i t s  
secretion (see Shevach, 1985).
Further evidence tha t the induction of EAU requires T ce l l  mediated 
mechanisms comes from studies with the athymic nude ra t  
(Salinas-Carmona et a j . ,  1982). These animals were incapable o f 
producing humoral antibody or cel 1-mediated responses to S-antigen 
a f te r  immunisation, and were re frac to ry  to the induction o f EAU. 
However, the athymic rats developed EAU when in jec ted  with 
sensitised, in v i t r o  stimulated lymphocytes. The disease could not
be transferred by serum alone (Sal inas-Carmona et al_., 1982).
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1.4 OCULAR AUTOIMMUNITY IN HUMAN EYE DISEASE
There is  evidence tha t the immune system may be involved in human 
re t in a l inflammtory and degenerative diseases (Sections 1.4.3.3 to
1.4 .4 ). L i t t l e  is  known of the precise e ffec to r  mechanisms involved 
in re t in a l degeneration, such as RP, and inflammatory eye diseases, 
and autoimmune mechanisms have been implicated, p a r t ic u la r ly  in 
u v e it is .
1.4.1 Aetiology of Autoimmunity
Autoimmune disease is  thought to arise from defective mechanisms of 
tolerance to se lf-antigens. Since the immune system has access to 
the m a jo r ity  o f s e l f  prote ins, and other potentia l autoantigens, 
there must e x is t  a mechanism fo r  the prevention of 
au tosensitisation . Burnett's  clonal deletion theory has, fo r  
several years, been central to discussion of autoimmune disease. 
During development a f te r  b i r th ,  a state of tolerance or 
unresponsiveness to s e l f  antigens is  achieved, in p a r t ic u la r  to the 
major common antigens. This theory holds that certa in  tissue 
spec if ic  antigens, such as thyrog lobu lin , and lens, re t ina  and 
brain prote ins, are sequestered early  during development and escape 
to le r is a t io n .  These antigens, i f  exposed to the immune system in 
the adu lt, are not recognised as s e l f ,  but are treated as fo re ign . 
The destruction of certa in  c e l ls ,  such as the photoreceptors, and 
the release of th e i r  antigens, may stimulate the immune system. For 
example, Gregerson et £ l . (1982) detected a raised serum antibody 
response to bovine S-antigen in some diabetic  retinopathy patients 
a f te r  argon laser photocoagulation treatment. The p ro l i fe ra t io n  of 
the Toxoplasma gondii protozoons w ith in  re t in a l c e l ls ,  and th e i r  
subsequent rupture releasing the organisms, has also been found to
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raise serum responses to S-antigen, the P-antigen, and the P59 
antigen in the ELISA (Abrahams and Gregerson, 1982). These f ind ings 
support the view that nonspecific re t in a l damage can in i t i a t e  
humoral immune resonses. The immunopathological s ign if icance of 
such autoantibodies is  not known.
The concept of clonal deletion has been found to be too simple, 
since there is  evidence tha t s e l f  reactive T and B lymphocytes 
normally ex is t  w ith in  the adu lt. This is  shown by the induction of 
experimental autoimmune disease in animal in jected with 
autoantigens, fo r  example thyroglobulin  or re t in a l antigens in 
adjuvant. Furthermore, many autoantigens are 'seen' by c irc u la t in g  
immunocompetent c e l ls .  For instance, thyroglobulin  c ircu la tes  in 
concentrations of 10 to lOOpg per ml (R o it t ,  1984).
Smith and Steinberg (1983) have emphasised the importance of a 
number of key observations in re la t ion  to autoimmune disease, 
namely, that s e l f  re a c t iv i ty  is  normal, and tha t both normal immune 
responsiveness and normal immune regulation are based on s e l f  
recognition. The general acceptance o f  the network theory o f immune 
regulation (Jerne, 1974) has lead to the concept o f homeostatic 
mechanisms which prevent the tr ig ge r in g  of the normally present 
autoreactive T and B c e l ls .  The key to th is  system is  the helper T 
ce ll (Th c e l l ) ,  which is  activated by spec if ic  antigen presented, 
in the context o f s e l f  h is to co m p a tib i l i ty  Class I I  antigens, on the 
surface of antigen presenting ce l ls  (APC) (Unanne, 1984). APCs make 
up a group o f ce l l  types, and are p r im a r i ly  located in the skin 
epidermis, lymph nodes, spleen and thymus, where they are known as 
Langerhan's ce l ls  (sk in ) ,  macrophages (lymph nodes and other 
tissues) and in te rd ig i ta t in g  ce l ls  and f o l l i c u la r  de n d r it ic  ce l ls
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(lymphoid tissues) (see R o itt  et a K ,  1985). The Th ce l ls  are 
stimulated by the APCs to help or induce T -e ffec to r or cyto toxic 
ce lls  and B 'ce lls  to p ro l i fe ra te .  This requires the in te rac t io n  of 
two leukocyte growth fac to rs , macrophage derived in te r le u k in  I 
which induces Th ce ll  p ro l i fe ra t io n ,  and in te r leu k in  I I ,  secreted 
by Th c e l ls ,  which stimulates the T -e ffec to r and B c e l ls  to 
d iv ide . These mechanisms re su lt  in antibody production and/or
autoaggressive c y to ly t ic  reactions, i f  the o r ig ina l antigen was an 
autoantigen.
The a n t i - s e l f  lymphocytes, which are normally present, are 
quiescent due to a lack of recognition of the autoantigens by 
spec if ic  helper T c e l ls ,  ie .  the helper ce l ls  are fu n c t io n a l ly  
absent, e ith e r due to clonal deletion or to ac t iva t ion  o f 
suppressor T ce l ls  (Ts c e l ls ) .  The Ts ce lls  are activated 
simultaneously by the APGs, and probably prevent autoimmune disease 
by active suppression of p o te n t ia l ly  autoreactive T and B c e l ls ,  
and are e ithe r spec if ic  fo r  antigen or id io type , or they may also 
be nonspecific. Lack o f T suppression leads to severe autoimmune 
disease, and- defects in stem ce ll  T precursors sp e c if ic  fo r  Ts
ce lls  have been reported in certa in  animal models. Autoimmunity 
arises when th is  complex regulatory mechanism is circumvented, 
e ith e r as a defect in one or more Ts ce ll  types, eg. antigen or 
id io ty p ic  spec if ic  (Delves and R o it t ,  1984), by d ire c t  a c t iva t io n  
o f T -e ffec to r or Th ce lls  by autoantigen, or by ac t iva t ion  o f T 
contrasuppressor ce ll  (Tcs c e l l ) ,  which render the autoreactive Th 
ce l ls  res is tan t to suppression or by acting on the Ts c e l ls  (Roitt 
et a l . ,  1985 ). However, the existence of Tcs c e l ls  is  s t i l l
equivocal (R o itt  et al_., 1985). Several mechanisms have been
suggested in which the to le r ised  Th ce l ls  could be bypassed (see
R o itt  et al^., 1985). A foreign antigen or organism might bear an 
epitope which crossreacts with host antigen. Under these
circumstances, Th ce lls  recognising the foreign epitopes could
supply help to the p o te n t ia l ly  autoreactive T and B lymphocytes, 
which recognise the crossreactive determinants. In another
s itu a t io n , drugs or other haptens can bind to autoantigens, forming 
a foreign determinant recognisable by Th c e l ls ,  which may then 
provide help, inappropria te ly  to lymphocytes reactive with the s e l f  
antigen. S im ila r ly ,  an a lte ra t io n  in the ammino acid sequence or 
structure of a s e l f  protein might in i t ia t e  autoimmunity. Polyclonal 
ac t iva to rs , such as 1ipopolysaccharide (LPS) or the Epstein Barr 
v irus (EBV) are able to stimulate lymphocytes d i r e c t ly  and 
nonspec if ica lly , bypassing T ce ll  help. Although the la t te r  
phenomena are u t i l is e d  experimently in v i t r o ,  there is  l i t t l e
evidence fo r  the importance o f such mechanisms in vivo.
F in a l ly ,  inappropriate expression of MHC Class I I  antigens (HLA-DR 
in humans or la in certa in  rodents) on a ce ll  carry ing an 
autoantigen could convert tha t ce l l  in to  an antigen presenting 
c e l l ,  and enable i t  to stimulate autoreactive T -e ffec to r and Th 
c e l ls .  Recently, such a mechanism has been implicated in S-antigen 
induced EAU (Chan et al_., 1986) where an inappropriate expression 
of la antigens was induced on the surface of the RPE c e l ls .
Autoimmunity can re su lt  from quantita tive  imbalance in these 
homeostatic regulatory mechanisms, fo r  example the amount o f
antibody produced or the degree of p ro l i fe ra t io n  o f an autoantigen. 
An autoimmune disease, however, is  u n l ik e ly  to re su lt  from a sing le 
' f a c to r 1, eg. c l in i c a l l y  unaffected re la t ives  of systemic lupus 
erythromatosis (SLE) pa tien ts , share with the patients a defect in
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the generation o f nonspecific Ts ce l ls  (see R o itt et a l . ,  1985). 
Some of these factors  may be nonimmunolgical, eg. genetic, 
environmental and even hormonal. This c le a r ly  has p a r t ic u la r  
relevance in RP.
1.4.2 Tests of Immune Function
A wide va r ie ty  of tests are available fo r  the c l in ic a l  assessment 
o f immune function in disease states. These are c la s s if ie d  as 
assays of humoral (B c e l l )  or c e l lu la r  (T ce l ls  and macrophages)
immunity. However, i t  is  c lear tha t since immune responses involve
the in teractions o f several ce l l  types, making th is  c la s s i f ic a t io n  
too simple. Most tests o f humoral immunity involve the assay of 
serum fo r  autoreactive antibody, e ith e r in tissue sections 
(immunocytochemistry) or against p u r if ie d  antigens in complement 
f ix a t io n  or so lid  phase immunoassays, eg. the enzyme linked
immunosorbent assay (ELISA). In immunohistochemical assays, id e a l ly  
the sera should be tested against the p a t ie n t 's  own t issue , 
otherwise there may be nonspecific reactions due to differences in 
h is to com p a tib i l i ty  o f the non-self antigens (Leopold, 1973).
Testing fo r  a n t i - re t in a l  antibody, fo r  example, is  hindered because 
of the low t i t r e s  o f the patients tested, and the need fo r  a h igh ly  
sensitive assay (Rahi, 1973). The ELISA o ffe rs  exquis ite  
s e n s i t iv i ty .  However, low a f f i n i t y  autoantibodies may be 
discouraged from binding due to the washing steps necessary in th is  
assay.
The most frequently  used assays fo r  ce ll mediated immunity te s t 
T -e ffec to r ce ll functions, eg. the secretion of lymphokines by 
e ffe c to r  T ce l ls  (macrophage migration in h ib i t io n  fa c to r ,  
chemotactic fa c to r ,  procoagulant a c t iv i t y ,  e tc . ) ;  the a b i l i t y  of
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lymphocytes to p ro l i fe ra te  in the presence of autoantigen or 
nonspecific mitogens, and the a c t iv i t y  o f cytotoxic T (Tc) c e l ls .  
The detection o f p ro l i fe ra t io n  of lymphocytes to antigens does not 
give precise information about the type of ce l l  responding, ie . T 
or B c e l ls .  Assays fo r  Th or Ts ce ll a c t iv i t ie s  have not been 
widely applied to c l in ic a l  studies although in d ire c t  information 
regarding spec if ic  T ce l l  functions has been extrapolated from data 
on T ce ll  subset counts in peripheral blood.
Although the ce ll  mediated immunity assays might be useful in 
detecting c e l lu la r  hype rsens it iv i ty  in ocular diseases, th e i r  
diagnostic and prognostic value have yet to be proved, and the 
re la tionsh ip  between the i_n_ v i t r o  lymphocyte reactions and immunity 
i_n vivo is  yet to be established (Meyers, 1975). The relevance of 
f ind ing  sensitised ce l ls  i j i  v i t r o  can not be accurately in terpreted 
u n t i l  the nature of the ce l l  re la t iv e  to the disease under study 
and in which i_n v i t ro  assay best re f le c ts  the function o f the ce ll  
is  known (Meyers, 1975).
1.4.3 Autoimmunity in R e t in i t is  Pigmentosa
1.4.3.1 R e t in i t is  Pigmentosa
R e t in i t is  pigmentosa (RP) is  a term which encompasses a group of 
hereditary progressive degenerations o f the re t in a ,  characterised 
by night blindness, early  loss of visual f ie ld  eventually including 
the central v is ion , and typ ica l pigmentary (bone-spicule) fundus 
changes with la te  attenuation of re t in a l a r te r io le s  and op tic  
atrophy. Marmor et a l .  (1983) have defined RP as a set of 
progressive hereditary disorders tha t d i f fu s e ly  and p r im a r i ly  
e f fe c t  photoreceptor and pigment e p ith e l ia l  function . The 
electroretinogram is abnormal from an early  stage and is  eventua lly
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lo s t .  Expression of RP has been found to be extremely diverse in 
both c l in ic a l  course and mode of inheritance. RP is the most
frequently  * encountered inherited eye disease, a ffec t ing  
approximately 1 to 2 persons in every 5 thousand of the general 
population (Boughman et a j . ,  1980).
RP is  c la ss if ie d  by generic type, topography and re t in a l
involvement and severity  o f disease. The m a jo rity  o f cases are 
sporadic (simplex), without known affected re la t ive s .  However, 
almost 50% of cases show a marked fa m il ia l  tendency, although only 
a few cases are c le a r ly  dominant, recessive or X-linked recessive 
(Fishman, 1978; Berson et a j . ,  1980; Jay, 1982; Hu, 1982). When a 
profound, progressive hearing loss is  associated with RP, the 
condition is  known as Usher's syndrome, and is  usually  a recessive 
condition. As more c l in ic a l  and biochemical studies on RP are made, 
fu r the r subsets of the disease emerge and the c la s s i f ic a t io n
becomes more complex (Fishman et a j . ,  1985). The considerable
heterogeneity of RP renders comparisons of laboratory studies 
d i f f i c u l t ,  and resu lts  often appear to c o n f l ic t ,  fo r  example in 
investigations of the immune mechanisms (Newsome and Fishman, 
1986).
Although the modes of inheritance and c l in ic a l  features o f the 
disease are quite well known, the pathophysiology o f the disease 
remains obscure. Pathological studies of human RP have been 
re la t iv e ly  infrequent, and fo r  obvious reasons, the cases studied 
have usually demonstrated advanced disease (Mizumo and Nishida, 
1967; Kolb and Gouras, 1974; Szamier et a l . ,  1979; Goebel et a l . ,
1985). These studies have shown extensive loss of the photoreceptor 
rod and cone c e l ls ,  with changes in the RPE. The inner nuclear, and
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outer plexiform layers also show disorganisation, and large 
pigment-laden macrophages are present in the areas corresponding to 
the bone-spicule pigmentation seen ophthalmoscopically. In these
areas, the pigment e p ith e l ia l  ce l ls  appear devoid of melanin
granules. Ep ire tina l membrane formation is  also a constant feature 
o f RP pathology (Szamier, 1981), and appears to develop at an early  
stage. Such membranes have a high content o f laminin (Newsome and 
Hewitt, 1985) possibly la id  down by migrating re t in a l g l ia l  c e l ls .
1.4.3.2 Physiological a l te ra t ions  in RP
I t  is possible tha t the re t in a l degeneration is  a re su lt  o f a 
primary metabolic defect or physiological disorder to which the 
re tina  is  p a r t ic u la r ly  sens it ive . Useful information has been 
gained by studies on more accessible tissues such as blood. For 
example, some groups of RP patients have been found to have 
subnormal concentrations o f plasma taurine (Uma et a2-, 1983), a
sulphonated amino acid, which exists in the re tina  in high
concentrations, and has been found to be essential fo r  i t s
v ia b i l i t y  (Voaden, 1982). Furthermore, several forms of RP are
associated with known metabolic diseases such as 
abetalipoproteinemia, Rafsum's disease (disorder of phytanic acid
metabolism). In add it ion , i t  has been reported tha t the m a jo r ity  o f
RP men over the age of 35 years and also X-linked RP males, are
hyperlipidaemic, compared to the unaffected spouses and s ib l ings  
(Converse et a j . ,  1983; Converse et al_., 1985). In add it ion , serum 
docosahexaenoic acid (C22:6), thought to be s p e c i f ic a l ly  required 
by the photoreceptors, has been reported to be reduced in two
X-linked and one autosomal dominant RP patient from three fam ilies  
(Converse et a j . ,  1983). In view o f these f ind ings , i t  is
in te res ting  that photoreceptor degeneration in the RCS ra t  can be
s ig n i f ic a n t ly  retarded by spec if ic  control of the d ie t ,  feeding 
with a mixture containing corn starch and 4% corn o i l  ra ther than 
with commercial lab chow (Pautler and Ennis, 1984).
Hussain and Voaden (1985) have reported that there may be an 
increase in erythrocyte osmotic f r a g i l i t y  in the recessive forms of 
RP, and also certa in forms of autosomal dominant RP. This may be a 
re f le c t io n  o f a defect in l i p id  metabolism as suggested by Converse 
et a l .  (1985), or an abnormality in a cytoskeletal prote in such as 
spectrin . Both these factors are relevant to the visual c e l ls ,  
which have a spec if ic  membrane l ip id  composition, and also possess 
a s p e c tr in - l ike  cytoskeleta l p ro te in , thought to be involved in the 
maintenance o f the normal photoreceptor outer segment s tructure 
(Wong and Molday, 1986). Thus, defects in e ithe r l i p id  metabolism 
or the synthesis of spec if ic  re t in a l proteins could produce 
defective visual ce l l  function .
Recent studies on isolated Bruch's membrane have indicated another 
possible dimension to the RP problem (Hewitt and Newsome, 1985). 
Hewitt and Newsome (1985) found tha t the proteoglycans extracted 
from autosomal dominant RP Bruch's membrane were la rger in s ize, 
than from aged matched con tro ls . In add it ion , there was a dramatic 
increase in the proportion of heparan sulphate proteoglycan in the 
RP Bruch's membrane. Considering the s truc tura l and f i l t r a t i o n  
properties of the proteoglycans, a lte ra t ions  such as these could 
a f fe c t  the transport of nu trien ts  and metabolites from the 
ch o r io ca p i l la r is  to the RPE, and thus a f fe c t  the whole re tina  
(Hewitt and Newsome, 1985). Although the a lte ra t ions  in the Bruch's 
membrane may be secondary, such changes could exacerbate the 
re t in a l degeneration.
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Much of the research in to  RP involves the in v i t r o  cu ltu re  of 
normal and dystrophic human or animal RPE c e l ls ,  in order to 
investigate th e ir  behaviour. In view o f the d i f f i c u l t i e s  involved 
in d i f fe re n t ia t in g  between primary and secondary defects, and the 
infrequent a v a i la b i l i t y  of re tina  undergoing the ea r ly  stages of 
degeneration, in v i t ro  tissue cultu re systems, such as tha t 
described by Boulton et a l .  (1983), provide a valuable model system 
fo r  both RP and normal RPE c e l ls ,  and those derived from re t in a l 
dystrophic animal models. However, even in these systems data must 
be c a re fu l ly  in terpreted since the cultu re environment may a l te r  
the ce ll to ce ll in te rac tions . In add it ion , important factors  and 
nu tr ien ts  present i_n v ivo , may be absent.
I t  has been suggested tha t the re t in a l damage might have an 
autoimmune component, although th is  is  more l i k e ly  to be secondary 
to biochemical or physiological cause. At present, the evidence fo r  
re t in a l autoimmunity in RP is  somewhat tenuous (Newsome and 
Fishman, 1986), however there is  evidence that abnormal immune 
regulation may play a ro le in certa in  forms o f RP (Sections 1.4 .3 .4  
to 1 .4 .3 .6 ).
1.4.3.3 Evidence fo r  Retinal Autoimmunity in RP
The hypothesis tha t there may be some immunological and/or 
inflammatory basis to RP is  not new. Indeed, RP was o r ig in a l ly  
thought to be post-inflammatory (hence i t s  name) since i t  showed 
strong s im i la r i t y  to other post inflammatory or traumatic re t in a l 
pigmentary disturbances (otherwise known as pseudo re t in it is  
pigmentosa). Vitreous ce l ls  are a constant feature o f RP (Marmor et 
a l . ,  1983), and there is  frequent evidence of peripheral vascular
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sheathing, suggestive o f re t in a l v a s c u l i t is .  Recent studies have 
shown that there is  breakdown of the blood re t ina l b a rr ie r  in RP, 
with inward transport o f f luorescein (Mai l i c k  et a j . ,  1984). 
Retinal vascular leakage in RP and other re t ina l/ch o ro ida l 
diseases, which could re su lt  form low grade inflammatory changes, 
w i l l  permit communication between re t in a l tissue and c irc u la t in g
immunocompetent c e l ls .  Thus, the chances o f s t im ula ting the
normally present autoreactive c e l ls  to previously iso la ted 
antigens, w i l l  be increased. ROS antigens could break a possible 
state of immune tolerance, although the resu lt ing  immune response 
may not necessarily have a pathogenic ro le .
Yamamoto and Yamori, (1966), were among the f i r s t  to discuss the
p o s s ib i l i t y  tha t autoimmune phenomena may play a ro le  in the
pathogenesis of RP. They suggest tha t opsin might enter the
bloodstream of the patients and act as an autoantigen s tim u la ting  
the production o f an ti-ops in  antibody. The antibodies could then 
bind with opsin of the ROS and the resu lt ing  immune complexes could 
i n i t i a t e  inflammation.
1.4.3.4 Evidence fo r  a ltered humoral immunity in RP
Total serum IgM and IgG in RP patients has been estimated in 
several studies. Raised serum IgM in some RP patients has been 
reported (Fessel, 1962; Rahi, 1973; and Spalton et a l . ,  1978a,b). 
More recently , Garcia-Calderon et al_. (1984), reported raised 
levels o f IgM in only 2 out o f 46 RP pa tien ts , and rheumatoid 
fac to r in 3 patients . In add it ion , Galbraith and Fundenberg (1984) 
reported a high frequency of raised serum antibody to human IgG 
(rheumatoid fa c to r ) ,  which seemed confined to a subgroup o f 
patients and was unrelated to mode of inheritance of the RP or to
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severity  of the disease. A r ise  in the level of serum IgM is 
ind ica tive  o f chronic in fe c t ion  (Ganfors, 1979), and may suggest 
tha t the aetio logy of RP may be associated with in fec tious/chron ic  
inflammation. However, la rger studies have not confirmed these 
find ings (Newsome, 1985; and Spiro et al_., 1984). The range of 
values fo r  serum immunoglobulin concentrations, among the normal 
population, is  probably too wide to id e n t i fy  subtle changes.
The presence o f c irc u la t in g  immune complexes (CIC) in RP patients 
was investigated in a single study reported by Heredia et a l .
(1984) and Garcia-Calderon (1984). CIC were found in approximately 
20 of 46 RP pa tien ts , but not in 100 control subjects. Furthermore, 
i t  was reported tha t there was a f a l l  in the levels of c irc u la t in g  
complement components C3 and C4. However, Spalton e t a]_. (1978a,b) 
in e a r l ie r  work, did not detect the breakdown products o f 
complement in the serum of RP patients . I t  was suggested tha t the 
complexes could lodge in the ocular tissues and ac tiva te  the 
complement system, thus resu lt ing  in ce ll ly s is  and also an 
increase in vascular permeability, which may serve to exacerbate 
the disease (Heredia et a l ,  1984). I t  is  possible tha t in some 
cases, small amounts o f immune complexes are formed and deposited 
lo c a l ly  and would only be detected in tissue studies (Spalton et 
1978a,b). However, CIC could have a protective ro le  in the 
sequestering o f p o te n t ia l ly  l y t i c  antibodies. The CIC id e n t i f ie d  by 
Heredia _et a l .  (1984) were measured by polyethylene glycol (PEG), a 
method which has many inherent flaws. In add it ion , CIC can be 
demonstrated in the normal population, therefore s t r i c t  a tten t io n  
must therefore be paid to the adequacy o f controls in such studies.
Autoantibodies to re t in a l antigens in the sera of RP patients  has
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been sought by several investiga to rs . Spalton et aK (1978a) 
observed tha t the sera of RP patients can react, at a 1 in 5 
d i lu t io n ,  with ra t  photoreceptors, in an in d ire c t  fluorescent 
antibody assay on frozen, f ixed ra t photoreceptors. Chant e t a2-
(1985) report tha t the undiluted sera o f 43 out o f 116 (37%) RP
patients demonstrated reaction in the immunofluorescence assay, 
with the photoreceptor c e l ls ,  or more frequently  the whole re t ina . 
This was compared with 21 pos it ive  fluorescence reactions out o f 64 
(33%) non-RP ocular patients and 1 out o f 40 contro ls (2%). There 
were, however, several experimental variables which the authors did 
not investiga te , in p a r t ic u la r  serum d i lu t io n .  The in te rp re ta t io n  
o f these resu lts  is  d i f f i c u l t  since sera from some normal, healthy 
adults contains low t i t r e s  of anti-smooth muscle antibody, and also 
fluoresces with ra t  photoreceptors due to crossreactions with the 
actin  and myosin w ith in  the myoid region of the photoreceptors. 
Thus, i t  is  d i f f i c u l t  to d is t ingu ish  autoantibody to re t in a l 
antigens from non-tissue spec if ic  antibody.
The complement f ix a t io n  assay has also been used to investiga te  the 
humoral immune responses of RP patients to the soluble and 
insoluble frac tions  o f human and bovine re tinae , but no s ig n i f ic a n t  
d ifference was found in comparison to controls (Brinkman e t a l . ,  
1980). More precise information may be derived from antibody 
assays, using p u r i f ie d  re t in a l antigens. Antibodies to re t in a l 
S-antigen (Section 1.2) have been found by some authors (reviewed 
by Newsome and Fishman, 1986). However, s ig n if ic a n t  numbers of 
normal people have also been found to secrete antibody which reacts 
(or crossreacts) with S-antigen (Forrester, personal communication,
1986).
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1.4.3.5 Evidence fo r  a ltered ce ll  mediated immunity in RP
There have been several studies o f the c e l lu la r  immune response in 
RP. Char et a]_. (1974), found a n t i - re t in a l  ce ll mediated immunity 
in 17 of 20 patients with pigmentary re t in a l degenerations,
including RP pa tien ts , using a - ^ I - i o d o d e o x y u r i d i n e  j 1 2 5 j _udR)
c y to to x ic i ty  assay against a long term tissue cu ltu re  l in e  derived 
from human retinoblastoma. However, no fu r the r work on th is  system 
has since been reported.
Lymphocyte p ro l i fe ra t iv e  responses of some RP patients to crude 
re t in a l extracts (Brinkman et a]_., 1980), and to S-antigen,
p a r t ic u la r ly  in Usher's patients (Newsome and Nussenblatt, 1984) 
have been reported. The lymphocytes of some RP patients were 
s ig n i f ic a n t ly  stimulated when incubated in the presence o f human 
soluble antigens and bovine ROS, but not to human insoluble 
antigens and bovine uveal antigens (Brinkman et _al., 1980). In 
macrophage migration in h ib i t io n  assays, the migration of leukocytes 
from patients with non-recordable ERGs were s ig n i f ic a n t ly  more 
inh ib ited  with p u r i f ie d  rhodopsin than those from patients with 
subnormal ERGs and the controls (Brinkman et al_., 1980). I t  is
in te res ting  that no s ig n if ic a n t  difference between the patients  and 
controls was obtained fo r  e ith e r assay when bovine ROS, which 
contains mainly opsin, and human crude re t in a l insoluble antigens. 
Newsome and Nussenblatt (1984) reported that the lymphocytes from 
only 1 of 15 RP and 1 of 6 Usher's patient responded to crude human 
re t in a l antigen, and that a second Usher's pa tient responded to 
crude human choroid antigen. The choroid, however, contains many 
antigens with which any type of serum might react, fo r  example 
h is to com p a tib i l i ty  antigens. When the responses to p u r i f ie d  
S-antigen were tested, 5 RP and 2 Usher's patients appeared
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p o s it ive . However, others have been unable to confirm these resu lts  
using p u r i f ie d  bovine S-antigen (Hendricks and Fishman, 1985) and 
bovine ROS or human crude re t in a l extract (Chant et a l . ,  1985).
There are two reports suggesting tha t the lymphocyte responsiveness 
to nonspecific mitotgens, such as phytohaemaglutinin, may be 
diminished in RP (Heredia et a K , 1981; Galbraith and Fundenberg,
1984). These resu lts  have not been confirmed in a study invo lv ing 
12 RP patients (see Forrester et cH., 1986). S ig n if ica n t 
discrepancies were observed between tests performed on samples from 
the same ind iv id ua ls , taken on d i f fe re n t  days (Hendricks and 
Fishman, 1985), which rather casts doubt on the f ind ings of 
previous studies. These authors do not support the hypothesis tha t 
re t in a l autoimmunity is  associated with RP. Very s im ila r  
observations were made by BenEzra et aj_. (1984), who performed 
lymphocyte stim ulation assays using bovine re t in a l S-100 antigen in 
addition to S-antigen.
1.4.3.6 Lymphocyte subsets and lymphokines production in RP
There are recent reports re la t in g  an imbalance in the 
helper/suppressor T ce ll subsets, and also abnormal lymphokine 
production and Class I I  antigen expression in RP. These reports , 
however, have been contrad ic tory . I t  has been suggested tha t there 
might be a subset of RP patients with a subnormal level o f 
c irc u la t in g  T lymphocytes, and a reduction in T ce ll  function 
(Galbraith and Fundenberg, 1984). In add it ion , Galbraith e t a l . 
1984 reported a decrease in the a b i l i t y  of helper T c e l ls ,  derived 
from RP pa tien ts , to form rosettes with transformed human B c e l ls .
Hooks et a l . (1983) reported normal levels of T and B lymphocytes
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in RP and Usher's syndrome pa tien ts , but subnormal levels o f y-INF 
were detected in 11 out of 12 RP pa tien ts , although normal values 
were obtained fo r  the Usher's pa tients . I t  was suggested tha t there 
may be a reduced number of y-INF producing ce lls  in RP or tha t 
there was a defect in i t s  production. A lte rn a t ive ly  there may be a 
fa u l t  in the population of macrophages, which are involved in the 
production of Y-INF by T c e l ls .  However, others have been unable to 
repeat these re su lts ,  using a s im ila r  b io log ica l assay (BenEzra et 
a l . ,  1984) or a sensitive RIA method fo r  measuring y-INF (Hendricks 
and Fishman, 1986). In add it ion , the production of IL-1 and IL-2, 
by RP pa tien ts ' lymphocytes, was not obviously d i f fe re n t  from tha t 
of the lymphocytes from the controls (BenEzra jet al_., 1984).
Furthermore, there was a marked v a r ib i l i t y  in the production of the 
lymphokines between the d i f fe re n t  ind iv idua ls  tested, and also 
w ith in  ind iv id ua ls , evident upon re -tes t in g  (BenEzra et al_., 1984;
Hendricks and Fishman, 1986). BenEzra et al_. (1984) made 
recommendations fo r  a large double masked longitud inal study of 
lymphokine production in patients and contro ls . However, even in 
such a study the resu lts  may s t i l l  be equivocal, since these tests  
have such a large inherent v a r ia b i l i t y ,  and are of l im ited  value in 
studies involv ing heterogeneous populations.
The T lymphocyte subsets and Y-INF production were investigated by 
Hendricks and Fishman (1985; 1986). In th e ir  i n i t i a l  study they 
report a s ig n if ic a n t  decrease in the number o f helper T c e l ls ,  
using the Leu series of mouse monoclonal antibodies with 
s p e c i f ic i t ie s  fo r  human lymphocyte ce l l  types, and the fluorescence 
activated ce ll sorter (FACS). However, the data suggested tha t 
although the mean of the RP group was below that o f the con tro ls , 
the m a jo r ity  of the points appeared w ith in  the normal range.
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However, la te r  Hendricks and Fishman (1986) reported the absolute 
number o f the helper T ce l ls  per ml o f blood in RP patients was 
normal in 33-RP and 16 Usher's patients . In add it ion , the natural 
k i l l e r  (NK) ce ll a c t i v i t y  in the patients was evaluated and found 
not to be s ig n i f ic a n t ly  d i f fe re n t  from the controls (Hendricks and 
Fishman, 1986). I t  was concluded tha t there were no s ig n if ic a n t  
immunological abnormalities in RP and Usher's patients .
Detrick ert a j .  (1985) have reported fo r  the f i r s t  time, the 
presence of Class I I  antigens (HLA-DR) on the surfaces of cultured 
normal human RPE ce lls  (derived from 4 in d iv id u a ls ) .  This 
expression appeared diminished on the surfaces of RPE ce l ls  derived 
from 4 RP post mortem eyes. Furthermore, the expression of HLA-DR 
antigens on the surfaces o f c irc u la t in g  monocytes was diminished in 
a l l  19 RP patients tested, compared to 22 control subjects. This 
was correlated to a subnormal production o f y-INF, a potent 
regulator of HLA-DR antigen expression, since the expression o f 
HLA-DR on the monocytes and RPE ce l ls  o f RP patients could be 
raised to normal levels by incubation in the presence of exogenous 
Y-INF. Detric'k et al_. (1985) suggested tha t the genetic d isorder o f 
RP may be linked with a defect in y-INF production. Further 
studies, however, have fa i le d  to v e r i f y  these resu lts  (Detrick et 
a l . ,  1986).
Thus, i t  is  thus c lear tha t the data from immunological studies in 
RP are c o n f l ic t in g ,  and the relevance o f pos it ive  responses to the 
aetio logy of RP is  unclear. The evidence in support o f re t in a l 
autoimmunity in RP is  somewhat tenuous at present, not leas t due to 
the paucity o f subjects and contro ls involved in the studies. Many 
of the contradictions in the published work arise form the
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heterogeneity among the patient group, and inconsistency in the 
techniques between laboratories (Newsome and Fishman, 1986).
1.4.4 Autoimmunity in Uveitis
1.4.4.1 Uveitis
The term uve it is  refers to the inflammation of the uveal t ra c t .  
Uveitis is  a heterogeneous group of diseases c la s s if ie d  according 
to the major s i te  of involvement. Anterior u ve it is  is  frequently  
u n ila te ra l (a ffec t ing  only one eye) and involves the i r i s  and/or 
c i l i a r y  body. Anterior u ve it is  is  associated with pain, blurred 
v is ion and other symptoms. The disease is  usually re la t iv e ly  short 
l ive d , 2 to 4 weeks, with a tendency to recur. Posterior u v e it is  is 
usually b i la te ra l ,  involves an inflammation of the choroid, re tina  
and v itreous, and tends to form a chronic disease. The annual 
incidence of uve it is  is  15 new cases per 100,000 o f the general 
population. Thus, uve it is  is  a re la t iv e ly  common condition (see 
review by Wakefield et , 1982).
Uveitis may be associated with in fec tious agents such as v iruses, 
bacteria , fung i, Toxoplasma gondii (protozoon) and toxocara canis 
(dog round worm larvae), or with systemic diseases, fo r  example 
sarcoidosis. However, 50% of cases are of unknown aetio logy 
(Wakefield et a l . ,  1982). The inflammatory i n f i l t r a t e  in to  the 
uveal tissues and vitreous humour, consists o f macrophages and 
lymphocytes, perhaps predominantly T lymphocytes (Kaplan e t a l . ,  
1982; De Abreu e t a l . ,  1984). The means by which the inflammatory 
responses loca lise  in the eye are not f u l l y  understood, and the 
ro le of autoimmune mechanisms are often investigated. Healing o f
the inflammatory lesions can re su lt  in scarring and a decrease in
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visual acu ity , i f  the central macular/foveal region is  involved.
Associations* with the major h istocom patability  antigens, the human 
leucocyte antigens (HLA) may determine s u s c e p t ib i l i ty  to disease. 
There have been several reports o f an association between the 
HLA-B27 antigen and s u s c e p t ib i l i ty  to d i f fe re n t  forms o f the 
disease, including an te r io r  u ve it is  (Andrews et a l . ,  1979; Saari et 
a l . ,  1981; Wakefield et aH., 1982; Kahn et_ al_., 1983; and McCoy et 
a l . ,  1984). Wakefield et aK (1982), report tha t 37% of patients 
with u ve it is  were HLA-B27 p o s it ive , in an Australian population. 
Crews et a l .  (1979) reported an association between Bechet's 
disease, a form of u v e i t is ,  and HLA-B5.
Over the la s t  20 years, there have been several reports which have 
examined the potentia l autoimmune mechanisms involved in u v e i t is .  
C learly the immune system is  involved, although the s p e c i f ic i t y  o f 
the responses are yet to be established. The possible immune 
mechanisms include (1) exposure to an antigen, exogenous or 
endogenous, tha t causes p ro l i fe ra t io n  of autoimmune e f fe c to r  c e l ls ,  
(2) an altered suppressor ce l l  modulation, eg. a defect in 
suppressor ce ll a c t iv i t y ,  or a non-reponsiveness o f the e f fe c to r  
ce l ls  to th e i r  signals or, (3) the production of inducer c e l ls  tha t 
are not modulated (Nussenblatt et al_., 1985). Research, e i th e r
invo lv ing the experimental disease in animals, or the immune 
responsiveness of pa tien ts ' lymphoid c e l ls  or serum antibody, has 
sought to dissect the nature of the immune mechanisms o f u v e i t is .  
The s t r ik in g  success of immunosuppressive therapy with cyclosporin 
A (CsA) in preventing the development o f EAU (Section 1 .3 .5 ) ,  
prompted pre lim inary use of the drug in human ocular inflammatory 
disease, and CsA has been used to t re a t uve it is  patients  with
41
varying success (Nussenblatt et a l . ,  1983a; Karjalainen, 1984). The 
responses however, are l i k e ly  to be complex, and perhaps variable 
due to the’ diverse nature of the disease (Nussenblatt et a l . ,
1985). The present evidence suggests tha t the immune mechanisms 
involved in an te rio r and posterio r uve it is  may be d i f fe re n t  
(reviewed by Nussenblatt e t al_., 1985). In general, however,
evidence fo r  altered immune mechanisms, and/or spe c if ic  ocular 
autoimmunity, is  somewhat con trad ic tory , probably due to the great 
d iv e rs i ty  of uve it is  syndromes and also differences in the 
immunological methodology between laboratories.
1.4.4.2 A lte ra tions in c irc u la t in g  immunoglobulins and autoantibody
Uveitis  patients may demonstrate raised serum IgM, but the 
s ign if icance o f th is  remains unknown, and may re f le c t  a substantia l 
systemic immune response (Kahn et a l . ,  1983). Kahn et aj_. (1983), 
found that 62% of 975 u v e it is  patients demonstrate s ig n if ic a n t  
raised immunoglobulin leve ls , of e ith e r IgM (43.8% of cases), IgA 
(34%) or IgG (11.9%). L ite ra tu re  concerning the existence o f raised 
Ig levels is  con trad ic tory , and the studies l im ited  (see Kahn et 
a l . ,  1983).
In seeking ocular autoimmunity, ea rly  investigators concentrated 
p r im a r i ly  on crude uveal antigen, which included choroid, RPE c e l ls  
and re t ina . Later, a f te r  the establishment of the superior 
a n t ig e n ic i ty  of the re t in a ,  and in p a r t icu la r  certa in  ind iv idua l 
antigens (Sections 1 .3 .2 -4), the potentia l humoral, and ce l l  
mediated immune responses of the patients could be dissected in 
greater d e ta i l .  Using crude uveal antigen and a simple, but 
r e la t iv e ly  insens it ive , Ouchterlony immunodiffusion technique,
Aronson e t a l . (1964) reported tha t 52% of patients possessed
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anti-uveal serum antibody. This seemed to be re lated to the 
severity  and duration of the disease. However, 22% of patients with 
ocular diseases not involv ing the re tina  (contro ls) also had such 
antibodies (Aronson et a l . ,  1964; Aronson et a l . , 1966). Thus, the 
antibodies could be re la t iv e ly  nonspecific, and could be 
recognising non-tissue spec if ic  antigens. Using immunofluorescence, 
Audain et a | .  (1977) found tha t 4 out o f 23 patients had anti-uveal 
antibody a c t iv i t y ,  and one had an ti-nuc lear a c t iv i t y ,  and a second 
anti-smooth muscle a c t iv i t y ,  and three anti-m itochondrial a c t iv i t y .  
Thus, the apparent anti-uveal antibody response could have been 
nonspecific. I t  was not c lear i f  control sera were tested, or the 
serum d i lu t io n ,  i f  any, employed.
Recently a useful study has been made on the re a c t iv i ty  of 893 
u v e i t i ts  pa tien ts ' sera to non-ocular antigens (Murray, 1986). Out 
o f the whole group, over 40% had detectable levels o f serum
autoantibody. Antibodies to smooth muscle antigens were found in 
23.1% of pa tien ts , 12.7% had autoantibody to nuclear m a te r ia l,  3% 
demonstrated antibody to gas tr ic  pa rie ta l c e l ls ,  1.8% had antibody 
to re t ic u l in  and 0.2% had serum re a c t iv i ty  to mitochondria. When 
the patients were categorised in to  9 groups, only one c l in ic a l
e n t i ty ,  patients with u ve it is  associated with juven ile  chronic
a r t h r i t i s ,  showed reactions s ig n i f ic a n t ly  d i f fe re n t  from the 
con tro ls . Anti-nuclear antibody was detected in 77% of these 
pa tien ts . These find ings have relevance to studies invo lv ing the 
tes t ing  of pa tien ts ' sera on sections of re t ina  in
immunohistochemical assays since the photoreceptor c e l ls  contain 
nuclear and mitochondrial antigens, and also elements s im i la r  to 
those found in smooth muscle.
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Better defined antigens have also been studied, using more 
sensitive techniques (Gregerson et a l . ,  1981). C ircu la t ing  
antibody, reactive against ROS antigen, the pa rt icu la te  (P), both 
of which contain rhodopsin, the previously unreported P59 antigen, 
and S-antigen were detected in the sera of certa in  u v e it is  patients 
using the ELISA assay. However, although 91 patients were involved
in the study, there were only 13 controls which probably was an
in s u f f ic ie n t  number to cover the wide v a r ia b i l i t y  in the normal 
population. In add it ion , the pa tien ts ' responses were h igh ly  
var iab le , and the data rather open to in te rp re ta t io n . The m a jo r ity  
o f the pa tien ts ' responses appear to l i e  well w ith in  the normal 
range.
The s p e c i f ic i t y  of serum antibody from u ve it is  patients with 
re a c t iv i ty  to re t in a l antigens has also been studied by means o f 
immune p re c ip ita t io n  techniques (Gregerson and Abrahams, 1983). The 
authors found tha t the sera were capable of recognising a t least 2 
other antigens, in addition to S-antigen. However, only 6 patients 
and 3 controls were studied, rendering the data ra ther 
unconvincing/ In add it ion , there were a few problems with the 
methodology employed, espec ia lly  the use of crude human choroid and 
re t in a ,  which were heavily cross-contaminated containing large 
amounts o f human immunoglobulin, which could also react w ith the 
rabb it anti-human IgG antibody employed to detect the patients
antibody, a f te r  the addition of the labelled protein A.
1.4.4.3 Immune complexes
Immune complex mediated ocular tissue in ju ry  has been reported in 
rabbits  with EAU (Howes and McKay, 1975). Char e t_a j. (1979), have 
demonstrated a s ig n if ic a n t  increase in immune complexes (o f the IgM
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type) in 10 of 12 patients with d if fuse  u v e it is ,  most of whom did 
not have detectable autoantibody. Andrews et a l . (1979) reported 
the presence’ o f c irc u la t in g  immune complexes in 49% of a l l  acute 
an te r io r u ve it is  pa tients . Immune complexes have been found in the 
sera and aqueous humour in a number o f u v e it is  conditions 
(Dernouchamps et ji]_ ., 1977). Depositions o f Ig and C3, as well as 
Ig containing inflammatory c e l ls ,  have been id e n t i f ie d  in i r i s  
biopsies (Audain et a2., 1977). Although i r i s  biopsies can be
taken, and also samples of v itreous and aqueous humour removed, 
choroidal biopsies are more hazardous, and the s itu a t io n  in the 
choroid and re tina  may not re f le c t  tha t in the v itreous. Further 
work, however, is  required before the s ign if icance of immune 
complexes in the human eye can be determined.
1.4.4.4 Cell mediated immune mechanisms
In posterio r u v e i t is ,  i t  is possible tha t mast ce l l  factors  induce 
an increase in vascular permeability  o f the choroidal blood vessels 
and c h o r io c a p i l la r is ,  thus f a c i l i t a t in g  the en try  of 
immunocompetent c e l ls .  Under these circumstances the ROS antigens 
could break a possible state of immunological to lerance. I t  is  
perhaps s ig n if ic a n t  tha t in ra ts with S-antigen induced u v e i t is ,  
mast ce l ls  accumulate in the choroid, and degranulate, re su lt in g  in 
the in f lu x  of lymphocytes (de Kozak et _al., 1981). Certain u v e it is  
patients have been found to possess ce ll  mediated immunity to 
p u r i f ie d  bovine and human S-antigen and crude human re t in a l  
antigens, but not human choroid (Nussenblatt et a l . ,  1980b). Out o f 
31 posterio r u ve it is  pa tien ts , only 7 (22%) responded to S-antigen. 
This group had e ith e r active or inactive  lesions, also suggesting 
tha t they might become sensitised to re t in a l antigens. However, 
only 9 control subjects were included (patients with a n te r io r
u v e it is )  which renders the data re la t iv e ly  in v a lid .  A larger 
control group is necessary before the sign ificance o f these resu lts  
can be evaluated.
I t  has been suggested tha t there may be an altered suppressor ce ll 
function in uve it is  pa tien ts , including an increase in the 
suppressor ce ll  population (Nussenblatt et a2*s 1980a; Nussenblatt 
et a2*, 1983a; Nussenblatt et a K , 1985) or a decrease in the
helper T ce l ls  (de Abreu et a l . ,  1984). However, Ts c e l ls  can be 
antigen spec if ic  (see R o itt  et 1985) and these assays only 
involved the estimation of the quantity  of Ts ce l ls  and T ce ll  
ra t io s .  In add it ion , the population of c irc u la t in g  lymphocytes can 
vary on d i f fe re n t  days and also according to the physiological 
state of the subject. Several samples should be taken from each of 
a large number o f well c la s s if ie d  cases of u v e it is ,  and age matched 
healthy contro ls , in order to establish these observations.
C learly , fu r the r well con tro lled  studies are required to answer 
many o f the questions with respect to autoimmunity in u v e i t is .
1.5 RCS RAT MODEL FOR RETINITIS PIGMENTOSA
1.5.1 Value of Natural Animal Models fo r  R e t in i t is  Pigmentosa
Several potentia l animal models fo r  human re t ina l degeneration have 
been discovered during the la s t  25 years (reviewed by Matuk, 1984). 
The RCS ra t and the various mouse models fo r  human re t in a l  
degeneration, have been extensively studied, o ffe r ing  the advantage 
o f easy animal husbandry and short periods between generations. Two 
other, less well studied, forms of re t in a l degeneration in ra ts 
have been described (Lai et aH., 1979; Lai e t al_., 1980). The
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degeneration in the RCS ra t ,  l ik e  RP, extends from the an te r io r  
re t ina . The peripheral re t in a l degeneration in aging Fisher 344
rats might also provide a suitable model fo r  human RP (Lai et a l . ,
1979). Progressive re t in a l atrophy (PRA) in the dog (Setter) was 
f i r s t  described in 1911 (Magnusson, 1911). Since th is  time, PRA has 
been described in many breeds of dog throughout the world.
Recently, progressive re t in a l degeneration, or atrophy, has been 
described in the Abyssinian cat (Narfstrom, 1983; Barnett and
C urt is , 1985), a breed of Friesian cows (Bradley et jQ . ,  1982) and 
in the Rhode Island chicken (Ulshafer and A llen, 1985).
I t  is  d i f f i c u l t  to determine how relevant the RCS ra t  model, or any 
other animal re t in a l degenerations, is  fo r  human RP, since only 
very ra re ly  are the early  stages of the human disease ava ilab le  fo r  
h istopathological inves tiga tion , and most studies have been made on 
the la te  stages. RP appears to present a variable c l in ic a l  course, 
although th is  could be re lated to other genetic or environmental 
fac to rs , whereas re t in a l dystrophic rats and mice are inbred, and 
therefore gene tica lly  f a i r l y  homogeneous. The s im i la r i t ie s  between 
human RP and animal progressive re t in a l degeneration, or dysplasia, 
include th e i r  genetic transmission, b i la te ra l  expression, re t in a l 
blood vessel attenuation, depigmentation of the RPE, s im ila r  end
stage h is to log ic  p icture and progressive loss o f ERG and v is ion . 
However, at the electron microscopical le v e l,  the various re t in a l 
dystrophies may d i f f e r  (Matuk, 1984), and could develop from
completely d i f fe re n t  pathophysiological courses. I t  is  possible
tha t in RP the fa u l t  l ie s  with the RPE, or photoreceptors or both. 
The photoreceptor ce ll is  morphologically, p h ys io log ica l ly  and 
biochemically unique and complex, and a large number o f genes are 
expected to maintain such a c e l l .  There are l i k e ly  to be several
avenues along which re t in a l in s ta b i l i t y  and degeneration could
proceed. There is  a l im ited  number o f reactions which a given
tissue can undergo in response to harmful genotypic changes. Thus, 
a common phenotype could develop from d i f fe re n t  mutations or 
environmental fac to rs . As an example, severe vitamin A defic iency 
looks l ik e  the end stages of inherited  re t in a l dystrophy of man,
ra ts , mice and dogs (Dowling and Sidman, 1962).
During the la s t  decade, with the aid of technical advances in 
molecular biology and physiology, much has been learned about the 
underlying mechanisms of photoreceptor degeneration. The use of 
animal models has also enabled a be tte r understanding of the normal 
physiological processess of healthy re t in a l t issue. In add it ion , i t  
is  possible tha t research invo lv ing animal models, which may not be 
iden tica l to the human condition , may reveal methods o f c o n tro l l in g  
secondary pathological changes, possibly including re t in a l 
autoimmunity, which might be common to several forms o f re t in a l 
degeneration, and thus slow the disease process.
The RCS ra t  model was u t i l is e d  in the present study, in order to 
investigate fu r the r the p o s s ib l i ty  of associated re t in a l 
autoimmunity (Sections 1.5.6 and 4 .1 ).
1.5.2 The RCS Retinal Dystrophic Rat
Hereditary degeneration of the re tina  in the Royal College of 
Surgeons (RCS) ra t  was f i r s t  described by Bourne et aj_. (1938a), 
although the s tra in  was i n i t i a l l y  developed as a model fo r  
cataract. The degeneration is  a recessive condition re su lt in g  in 
the progressive destruction of the photoreceptor ce l l  layer 
(Section 1.5 .3). The histopathology tha t develops in the RCS ra t
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is  s im ila r  to tha t which develops in human r e t i n i t i s  pigmentosa 
(Bourne et al_.5 1938b). The o r ig ina l RCS ra t  is  known as the
Campbell s tra in  and is  a tan-hooded animal with pink eyes and a
non-pigmented RPE. Since 1938, pigmented stra ins o f the RCS ra t 
have been developed (Herron et a l . ,  1974; Yates et_ al_., 1974; La
Vail et aJ_-9 1975). The pigmented ra t  is  perhaps a more useful
model fo r  human RP, since humans normally have a pigmented RPE.
Several studies have been conducted in the search fo r  the s i te  of 
action o f the recessive mutant gene causing re t in a l dystrophy in 
the RCS ra t .
1.5.3 Retinal Degeneration in the RCS Rat
Rats, l ik e  other rodents, are born b lind  and v is ion  develops when 
they are 9 to 19 days old (Dowling and Sidman, 1962). At 9 days, 
the nuclear layers of the re tina  are formed, and small inner 
segments pro ject beyond the l im i t in g  membrane. The connecting c i l i a  
extend in the d irec t ion  o f the RPE, but there is l i t t l e  or no outer 
segment material u n t i l  day 10. The outer segments ra p id ly  develop, 
reaching the adult length o f 23.5pm by day 39 (Dowling and Sidman, 
1962). The normal re la tionsh ip  between the photoreceptors and the 
RPE ce lls  is  described in Section 1.1.4. The importance o f the RPE 
ce l ls  in the health of the visual ce l ls  has been fu r th e r  
exemplified by the investigations of the RCS ra t  RPE. The RCS ra t  
demonstrates an almost absolute in a b i l i t y  to phagocytose shed ROS 
t ip s  (Dowling and Sidman, 1962; Herron, et a l . ,  1969; Bok and H a ll,  
1971; Edwards and Szamier, 1977). The s ite  of action fo r  the 
defective gene causing re t in a l dystrophy in the RCS ra t  is  now 
known to be expressed w ith in  the RPE (Mullen and La V a i l ,  1976; 
Edwards and Szamier, 1977).
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Visual ce l l  development in the RCS ra t is  normal u n t i l  day 12, when 
the shed ROS membrane material begins to accumulate between the 
outer segments and the RPE. The accumulated material causes the 
re tina to thicken. At day 22, when some inner segments and visual 
ce l l  nuclei degenerate, and the ERG decreases in s e n s i t iv i t y  
(Dowling and Sidman, 1962). By day 32, the inner segments have 
almost e n t i re ly  disappeared and thus the a b i l i t y  to synthesise ROS 
proteins is  lo s t ,  and the rhodopsin content markedly decreases. The 
RPE ce l ls  have been reported to break away from the Bruch's 
membrane by day 40, and migrate through the ROS debris (Dowling and 
Sidman, 1962). However, others suggest tha t these c e l ls  are more 
l i k e ly  to be macrophages (Essner and Gorrin, 1979). Cytoplasmic 
processes, emanating from the wandering RPE-like c e l ls ,  extend 
through the debris. However, at no time has phagocytosis of the 
shed ROS t ip s  been seen, e ithe r by the RPE c e l ls  in s i tu ,  or 
wandering RPE-cells seen in la te  stages of the degeneration 
(Dowling and Sidman, 1962; Herron, et a l . ,  1969; Bok and H a l l ,  
1971; Essner and Gorrin, 1979).
Through the second month of l i f e ,  degeneration of nuclei and 
synapses occurs with complete loss of ERG, no normal photoreceptors 
can be seen, and the ra t  becomes completely b l in d . (Dow!ing and 
Sidman, 1962; Herron et a jk ,  1969). The eventual cause o f 
photoreceptor ce l l  death might, at least in pa rt,  re s u lt  from a 
poor n u tr i t io n a l supply, since the presence of the photoreceptor 
material blocks the flow o f nu tr ien ts  from the c h o r io c a p i l la r is  
(Dowling and Sidman, 1962). A fte r one year, the ROS debris zone' 
almost disappears and there is  the complete absence o f a visual 
ce l l  layer, although the RPE and layers of nerve c e l ls  showed no 
s ig n if ic a n t  change (Dowling and Sidman, 1962; E isenfeld, et a l . ,
50
1984).
1.5.4 Defective RPE Cells in the RCS Rat
The elegant work of Mullen and La Vail (1976), using experimental 
chimeras o f albino RCS and pigmented normal ra ts ,  c le a r ly  suggests 
tha t the mutant gene is  expressed in the RPE c e l ls ,  and not in the 
visual c e l ls .  The d ifference in pigmentation allowed the 
id e n t i f ic a t io n  o f the two genotypes of the RPE c e l ls .  The retinae 
o f the chimeras were a mosaic o f mutant and gene t ica l ly  normal 
c e l ls ,  and degenerating photoreceptors only occurred opposite the 
non-pigmented RPE. Patches of non-pigmented RPE greater than two 
c e l ls ,  always had degenerating photoreceptors opposite them, 
although there was less disorganisation and death of photoreceptors 
opposite areas of only one mutant RPE c e l l .
Additional evidence tha t the mutant RCS gene is  expressed in the 
RPE was obtained from i_n v i t r o  phagocytic studies (Edwards and 
Szamier, 1977). Normal RPE began phagocytosing ROS one hour a f te r  
incubation, irrespective  o f th e ir  o r ig in .  In contrast, most o f the 
RCS RPE c e l ls  did not phagocytose the ROS fragments, even a f te r  18 
hours incubation.
1.5.5 Speculation on the Expression of the Dystrophic Gene
The mode of expression of the mutant gene, w ith in  the RCS RPE, has 
not yet been determined. Although the RCS RPE ra re ly  phagocytoses 
ROS m ateria l, the ce l ls  appear to recognise i t  by extending 
m ic ro v i l lu s  processes in vivo (Dowling and Sidman, 1962; Herron et 
a l . ,  1969; and Bok and H a ll,  1971) and in v i t r o  (Edwards and 
Szamier, 1977). There are probably d i f fe re n t  genes fo r  recogn it ion , 
attachment and ingestion, the RCS ra t  lacking the la t t e r  gene (see
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Colley and H a ll,  1986). Edwards and Szamier, (1977) have shown that 
the mutant RCS RPE ce lls  do not have a general defect in
phagocytosis* since they are capable o f phagocytosing polystyrene 
spheres when cultured in v i t r o , at a rate s im ila r  to tha t o f normal 
RPE c e l ls .
Early workers suggested that the in a b i l i t y  to phagocytose may be a 
re su lt  from the lack of a d i f fu s ib le  substance, or an enzyme 
defic iency (Herron et al_., 1969; Young, 1971; Mullen and La V a i l ,  
1976). The presence of acid phosphatase has been demonstrated 
w ith in  the interphotoreceptor matrix (IPM), the a c t iv i t y  being 
greatest near the RPE surface, suggesting that some predigestion of 
the ROS membranes, exposing new determinants, may be required fo r  
phagocytosis (Alder and Martin, 1983). There is  evidence tha t the 
acid phosphatase pos it ive  lysosomes o f RCS ra t RPE, are fewer in 
number compared to normal, and tha t th is  enzyme may be 
inappropria te ly  shunted to e ith e r the RPE m ic r o v i l l i  or
melanosomes, instead o f the phagosomes (Seyfried-Williams and 
McLauchlin, 1984).
I t  has also been suggested tha t the ra t  re t in a l dystrophy might be 
in i t ia te d  by the presence of l y t i c  enzymes o r ig ina t in g  from the RPE 
(Burden et al_., 1971). An increase in the a c t iv i t y  of the alb ino 
RCS ra t RPE lysosomal enzymes was detected, beginning a f te r  4 weeks 
and progressing with degeneration. In rats as young as one week 
old, the lysosomes of the RCS RPE were less stable than those o f
control animals, and th is  in s ta b i l i t y  appeared to increase with'
disease progression.
Recent evidence suggests tha t there may be an a lte ra t io n  in a
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1igand-receptor mechanism involv ing mannose, con tr ibu ting  to the 
RCS ra t  RPE phagocytic defect, since cultured RCS RPE c e l ls  
phagocytose ‘ fewer mannose coated la tex beads than the contro ls 
(Seyfr ied-W il1iams and McLaughlin, 1983). In add it ion , the RCS RPE 
ce l ls  phagocytosed greater numbers of la tex beads coated in le c t in s  
spec if ic  fo r  mannose, suggesting tha t more mannosyl residues are 
accessible on the RCS RPE m ic ro v i l l i  than normal RPE m ic ro v i l l i  
(McLauchlin et a j . , 1984).
1.5.6 Retinal Autoimmunity in the RCS Rat
The a n t ig e n ic i ty  of the re t in a l ROS has been well established 
(Section 1.3). In view of the accumulation of the shed 
photoreceptor t ip s  in the RCS ra t ,  i t  seems possible tha t the 
antigens released could stimulate the immune system in these 
animals. In add it ion , there may be a breakdown in the. t ig h t  
junctions between the RCS RPE ce lls  (Caldwell and McLaughlin, 1984; 
Caldwell et al_., 1984)), which may predispose the rats to a
breaching o f the b lood-re tina l b a r r ie r .  There has been c o n f l ic t in g  
evidence, however, fo r  the sens it isa t ion  o f these rats to re t in a l  
pro te ins, and there is  l i t t l e  evidence fo r  an inflammatory reaction 
in the RCS ra t  re t in a .
IgM autoantibodies in RCS ra t  sera were detected using 
immunofluorescence techniques, from day 8 and throughout the 
degenerative process, but not in animals older than 7 to 12 months 
where degeneration is  complete (Chant and M eye rs -E ll io t t ,  1982). 
The autoantibodies appeared to sta in mainly the photoreceptor c e l l '  
bodies, and not the ROS, perhaps recognising precursors o f the ROS 
structures or certa in  cytoplasmic prote ins. Furthermore, po s it ive  
stimulation indices to bovine ROS and rhodopsin, were obtained with
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RCS ra t  lymphocytes, in comparison with congenic controls (Chant 
and M e yers -E ll io tt ,  1982). However, there are several problems in 
the in te rp re ta t io n  of these re su lts ,  fo r  example the use of 
undiluted sera, which maximises the opportunity fo r  nonspecific 
antibody in te ractions in immunocytochemistry. In add it ion , studies 
involv ing lymphocyte assay have been found to have a wide inherent 
v a r ia b i l i t y ,  and in a study involv ing splenic lymphocytes, large 
numbers of animals would have to be employed, even in an inbred 
s tra in .
In contrast to these f ind ings , Brinkman and Broekhuyse (1981), were 
unable to detect autoantibody to re t in a l antigens in neat sera from 
pink eyed RCS ra ts , using s im ila r  techniques. In add it ion , no 
difference was found between the dystrophic and control ra ts ,  when 
ce ll mediated immunity to rhodopsin, uveal pigment granules and 
soluble re t in a l pro te ins, was measured by a radiometric ear assay. 
The RCS rats were shown to be capable of responding to bovine 
rhodopsin when immunised (Brinkman and Broekhuyse, 1981). However, 
the radiometric ear assay was not compared with the more commonly 
used lymphocyte stim ulation assay, and only 2 animals were tested 
from each selected age grouping (15, 40, 65, and 120 days).
S im ila r ly ,  no evidence has been found fo r  a humoral autoimmune 
response to the RPE, in RCS rats (Reich-D' Almeido and Rahi, 1974). 
However, th is  study was very l im ite d , since only animals o f 3 weeks 
and 1.5 to 2 months old were investigated, and i t  was not c lear how 
many rats in each group were studied, nor the d i lu t io n ,  i f  any, o f 
the RCS ra t  sera used.
The concept of re t in a l autoimmunity in the RCS is  fu r th e r discussed 
in Sections 4.9 and 8.4, in the context o f the find ings of the 
present study.
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EXPERIMENTAL OBJECTIVES
This study was undertaken in order to fu r the r investigate  the 
association of re t in a l autoimmunity with ocular disease. S-antigen 
is  one of the most potent mediators o f EAU, and has been implicated 
in human ocular disease (Sections 1.3 and 1.4). In add it ion , there 
is  evidence tha t the RCS re t in a l dystrophic ra t  might present 
a n t i - re t in a l  immune re a c t iv i ty  (Section 1.5 .6). However, the data 
concerning spec if ic  re t in a l autoimmune reactions in ocular 
pa tien ts , and RCS ra ts , is  generally unconvincing and often 
contrad ictory.
In order to shed more l ig h t  on the problem of humoral autoimmunity 
in the RCS ra t ,  a detailed serum study was made, invo lv ing 
p r im a r i ly  a sensitive ELISA assay and immunoblotting, to te s t  fo r  
antibodies to S-antigen and crude re t in a l antigens. The pink-eyed 
and pigmented stra ins o f RCS ra t  involved in the inves tiga tion  were 
inbred and therefore gene t ica lly  f a i r l y  homogeneous. Thus, in the 
ra t  study i t  was more feas ib le  to make comparisons between 
ind iv id ua ls , than in a heterogeneous human population. The RCS ra t  
study also sought to iso la te  and p a r t ia l l y  characterise monoclonal 
autoantibodies with s p e c i f ic i t y  fo r  re t in a l antigens, from the
p o te n t ia l ly  autoimmune animals.
This study also sought to investigate the value of techniques fo r  
the immortalisation of c irc u la t in g  B lymphocytes derived from
u ve it is  and RP pa tien ts , in the analysis o f th e i r  antibody
s p e c i f ic i ty .  The number o f patients involved in th is  p re lim inary  
study was small, and thus the additional analysis o f th e i r  ELSIA
t i t r e s  to re t ina l antigens was much more l im ited  in comparison to
the ra t study.
A fu r the r aspect o f th is  work involved the development and 
characterisation o f a spec if ic  ra t  monoclonal to S-antigen, fo r  use 
in the fu r th e r  analysis o f th is  p ro te in , including i t s  
u l t ra s tru c tu ra l lo ca lisa t io n .  The e f fe c t  o f the p u r i f ie d  monoclonal 
antibody on the progress o f S-antigen induced EAU has also been 
studied. A second antibody, to a 39K re t in a l antigen was also 
produced, and used in electron immunocytochemical lo ca lisa t io n  
studies.
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CHAPTER TWO
MATERIALS AND METHODS
Chapter 2
MATERIALS AND METHODS
The materials and methods employed during the course o f th is  study 
are described below.
2.1 MATERIALS
2.1.1 Major Suppliers
B.D.H. Chemicals L td . ,  Poole, Dorset, England 
Becton Dickinson Co. L td . ,  Dublin.
Boehringer-Mannhein, Sussex, England
Costar In c . ,  Northumbria B io log ica ls L td . ,  Northumbria, England
DIFCO Laboratories, Surrey, England
Dynatech Laboratories L td . ,  Sussex, England
Fisons S c ie n t i f ic  Apparatus, Loughborough, England
Flow Laboratories L td .,  I rv in e , Scotland
Gibco Europe L td .,  Paisley, Scotland.
Koch-Light Laboratories L td .,  H ave rh il l ,  Suffo lk , England
May and Baker L td .,  Dagenham, England
Miles S c ie n t i f ic  L td . ,  Slough, England
Nunc, Trident House, Paisley, Scotland
Pharmacia Fine Chemicals, Hounslow, Middlesex, England
Polaron Equipment L td .,  Watford, Hertfordshire , England
Sigma Chemical Company L td .,  Dorset, England
S te r i l in  L td . ,  Teddington, Middlesex, England
2.1.2 Bovine Eyes
Cattle eyes were supplied by Sandyford Abatto ir Accessories, 
Paisley, Scotland.
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2.1.3 Protein P u r i f ica t io n  Materials
DEAE-Sephacel ancPalso Chromatofocusing m ateria ls , in the form of a 
k i t  containing Polybuffer Exchanger 94 and Polybuffer 74, were 
obtained from Pharmacia Fine Chemicals. PD10 Sephadex, G25, 
prepacked columns, 9ml bed volume, were also supplied by Pharmacia. 
QAE-Sephadex was supplied by Sigma Chemical Co.
D ia lys is tubing was obtained from Visking Tubing, S c ie n t i f ic  
Instruments L td . ,  London.
2.1.4 Electrophoretic Materials
Acrylamide, N, N' -methylene bis acrylamide, N,N,N'N'-Tetramethylene 
diamine (TEMED) and ammonium persulphate were obtained from B.D.H. 
Chemicals. Koch-Light Laboratories supplied the 2-mercaptoethanol, 
and the low molecular weight protein markers were supplied by 
Pharmacia Fine Chemicals. Schleicher and Schuell, Surrey, England, 
supplied the 0.45pm n itroce llu lo se  membrane f i l t e r  paper.
2.1.5 Stains and Staining Reagents
Coomassie BTue (G and R forms) and Naphthol Blue black were 
obtained from Sigma Chemical Co. S c h if f 's  reagent was also supplied 
by the same company. Johnson Matthey Chemicals, U.K. supplied the 
s i lv e r  n i t ra te .  Polaron Equipment Ltd. supplied the uranyl acetate, 
and the lead c i t ra te  was supplied by TAAB Laboratories, Reading, 
England.
2.1.6 Enzymes
Electrophoretical l y  pure bovine tryps in  and chymotrypsin were
obtained from Worthington Biochemical Corporation, Freehold, New
Jersey, USA. Staphylococcus aureus V8 protease was supplied by 
Sigma Chemical Co.
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2.1.7 Radiochemicals
125The Western’ In firm ary, Glasgow, Scotland, supplied the I-N a l, 
with a spec if ic  a c t iv i t y  o f 7.5PBq/pmole. The iodogen was supplied 
by Pierce-Warriner, Chester, England.
2.1.8 Tissue f ix in g ,  Embedding and Mounting Materials
2.1.8.1 Fixatives
Paraformaldehyde, Sychemica grade, was obtained from Hopkin and 
Williams, Chadwell Heath, Essex, England. Gluteraldehyde, EM grade, 
was supplied by Sigma. Johnson Matthey Chemicals L td . ,  UK, supplied 
the osmium te trox ide .
2.1.8.2 Materials fo r  L ight Microscopy
Xylene and D.P.X. mounting medium were supplied by BDH Chemicals 
Ltd.
2.1.8.3 Materials fo r  Electron Microscopy (EM)
Lowicryl K4M, Dimethylformamide (D.M.F), A ra ld ite  CY212, dodecenyl 
succinic anhydride (D.D.S.A.), D i lu ty l  phthalate, 
benzyl dimethyl amine (B.D.M.A.), and nickel g r ids , G300 mesh s ize, 
were obtained from Polaron Equipment Ltd. LR White was supplied by 
Agar Aids, Hampshire, England. Propylene oxide (1,2-Epoxypropane) 
was obtained from Koch-Light Ltd.
2.1.9 Acids
C i t r ic  acid was obtained from BDH Chemicals Ltd. Glacial ace tic
acid and hydrochloric acid were supplied by May and Baker Ltd.
Periodic acid was obtained from Sigma Chemical Co. Ltd. Phosphoric
acid was supplied by BDH Chemicals Ltd. Sulphuric acid was obtained 
from Riedel-De Haen AG, Seelze-Hannover.
2.1.10 Detergents
Tween 20 (polyoxyethelene sorbiton monolaurate 20) was obtained 
from Sigma Chemical Co. Triton-X 100, ce ty ltr im e thy l ammonium 
bromide (CTAB) and sodium dodecyl sulphate (SDS) were supplied by 
BDH Chemicals Ltd.
2.1.11 Enzyme Substrates
Ortho-phenylenediamine (0PD), diaminobenzidine (DAB), and
ortho-d ian is id ine  were supplied by Sigma Chemical Co. Hydrogen 
peroxide was supplied by Fisons.
2.1.12 General Chemicals
Agarose (gel electrophoresis grade) was supplied by Bethesda 
Research Laboratories Ltd. 2-amminoethylisothiouronium bromide
(AET), bovine serum albumin (BSA), h is t id in e  and po ly -L - lys ine  
(molecular weight 70K to 150K) were obtained from Sigma Chemical 
Co. Butan-2-ol was supplied by BDH chemicals Ltd. Complete Freund's 
adjuvant (H37 Ra) was supplied by DIFC0. EDTA 
(ethylenediaminetetra-acetic acid) was supplied by BDH Chemicals 
Ltd. Ammonia, ammonium sulphate (low in heavy metals), ammonium 
chloride and EDTA were obtained from BDH Chemicals Ltd.
Formaldehyde, acetone and glycerol were obtained from May and Baker 
Ltd. Glycine was obtained from BDH Chemicals Ltd. Gold c o l lo id ,  
lOnm p a r t ic le  s ize, was obtained from Janssen Pharmaceutica L td . ,  
Beerse, Belgium. Hydrogen peroxide was obtained from Fisons. 
Ovalbumin was obtained from Pharmacia Fine Chemicals Ltd.
Polyethylene glycol (PEG) 6000 was obtained from Serva Laboratories 
Ltd. Protein A (Cowan s tra in )  was supplied by Sigma Chemical Co.,
and Miles S c ie n t i f ic  Ltd. Formachem, Strathaven, Scotland, supplied 
the sucrose. T r is  (hydroxymethyl) ami nomethane (trizma base) was
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obtained from Boehringer-Mannhein.
2.1.13 Preservatives
Benzamidine hydrochloride hydrate was supplied by A ldrich Chemical 
Company Ltd. PMSF (phenylmethylsulphonyl f lu o r id e )  was supplied by 
Boehringer-Mannhein. Sodium azide was obtained from Sigma Chemical 
Co.
2.1.14 Sodium Salts
Sodium chloride was obtained from Research Internationa l L td .,  
Strathaven, Scotland. Fisons S c ie n t i f ic  Apparatus supplied the 
sodium carbonate and sodium bicarbonate. Sodium di-hydrogen 
phosphate and di-sodium hydrogen phosphate were supplied by 
Riedel-De Haen AG, Seelze-Hannover. Sodium hydroxide was obtained 
from Koch-Light Ltd. May and Baker Ltd. supplied the sodium 
metabisulphite. Sodium periodate was obtained from BDH chemicals 
Ltd.
2.1.15 Materials fo r  Immunological Assays
The m ic ro t i t ra t io n  ELISA plates . were supplied by Dynatech 
Laboratories Ltd. The BSA blocking agent was obtained from Sigma 
Chemicals Ltd. Automatic m icro-pipettes and multichannel 
m icro-pipettes were obtained from Gilson Anachem L td . ,  Luton, 
England, and from Flow Laboratories L td . ,  respective ly.
2.1.16 Immunological Reagents
Goat anti-human IgG(H+L) horseradish peroxidase conjugate, ra bb it
anti-human IgG(H+L), rabb it anti-human IgG+IgM+IgA, ra bb it  a n t i - r a t
IgG(H+L), rabb it a n t i - ra t  IgG(H+L) horseradish peroxidase and
fluorescein conjugates, rabb it a n t i - r a t  IgM (p chain s p e c i f ic ) ,  
rabb it a n t i - ra t  IgG (y  chain spe c if ic )  sheep a n t i - r a t  IgGl, goat
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a n t i - ra t  IgG2a, rabb it a n t i - ra t  IgG2b, goat a n t i - ra t  IgG2c, were 
supplied by Miles S c ie n t i f ic  Ltd.
Gold adsorbed protein A and goat a n t i - ra t  IgG(H+L), 5 and lOnm gold 
p a r t ic le  sizes, were obtained from Janssen Pharmaceutica L td . ,  
Beerse, Belgium.
Normal goat and normal rabb it sera were obtained from the Scottish 
Antibody Production U nit, Wishaw, Scotland
2.1.17 Animals
S ib ling pairs o f DA ra ts were obtained from OLAC L td . ,  Blackthorn, 
B icester, U.K., in 1982, and propagated by s ib l in g  mating. Piebald 
V iro l Glaxo (PVG) ra ts , and the pink-eyed Campbell and pigmented 
Hunter s tra ins  of RCS ra t ,  were supplied by Mrs Jean Hunter o f the 
Pharmacology Department, Edinburgh Univers ity , Scotland. Wistar 
rats and Balb C mice were obtained from colonies propagated in the 
Univers ity  o f Glasgow. Experimental work generally required animals 
no younger than 3 weeks of age.
2.1.18 Cell Lines
The ra t  myeloma ce ll  l in e ,  Y3-Ag.l.2.3 (Galfre e t a l . ,  1979), was 
obtained from Professor C. Mil s te in , MRC, Cambridge, England The 
KR4 human plasmacytoma ce ll l in e  (Kozbor e t_ a l . ,  1982), and the EBV 
secreting marmosette ce l l  l in e ,  B95-8 (M il le r  and Lipman, 1973), 
were obtained from Dr Dorothy Crawford, Hammersmith Hosp ita l, 
London.
2.1.19 Disposable Cell Culture Plasticware
Cell cu ltu re  plates of both 24 and 96-wells, and s te r i le  p e tr i  
dishes were supplied by Costar In c . ,  Northumbria B io log ica ls .
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Screwcap p la s t ic  ampoules (capacity 1.8ml) were also obtained from 
Costar Inc. Tissue cultu re flasks o f 50, 250 and 500ml were
obtained from Nunc. S te r i le  universals and disposable pipettes o f 1 
and 5m1 in capacity were obtained from S te r i l in  Ltd. S te r i le  10 ml 
p ipettes were obtained from Costar Inc. S te r i le  V-bottom tubes, 
50ml capacity, were supplied by Becton Dickinson. The s te r i le  o.2pm 
s te r i le  f i l t e r s  were supplied by Flow. Northumbria B io log ica ls Ltd. 
S te r i le  p la s t ic  syringes of 1 , 2 ,  5, 10 and 20ml in volume, and 
s te r i le  needles gauge size 21, were obtained from Becton Dickinson 
Co. The gauge 25 needles were supplied by G i l le t te  Surgical, 
Middlesex, England. A m icroaliquoter and f i t t i n g  5ml s te r i le  
syringes were obtained from SMI S c ie n t i f ic  Manufacturing Industries 
Inc. Lithium heparin tubes were supplied by S te r i l in  Ltd.
2.1.20 Cell Culture Media and other Materials
Flow Laboratories, supplied the RPMI-1640 medium (constituents 
shown in Table 2.1). Gentamycin was obtained from Sigma Chemical 
Co. Foetal c a l f  serum (v irus and mycoplasma negative), the sheep 
red blood c e l ls ,  p e n ic i l l in  and streptomycin, glutamine were 
supplied by ' Gibco Ltd. Ficoll-Paque and Percoll was supplied by 
Pharmacia Fine Chemicals.
2.1.21 Cell Culture Chemicals
Ami nopterin was obtained from Flow laboratories Ltd. 
Dimethylsulphoxide (DMS0) was supplied by Koch-Light Laboratories. 
Hypoxanthine, thymidine and ouabain-octahydrate were obtained from 
Sigma Chemical Co. Cyclosporin A was obtained from Sandoz 
In te rn a tion a l, Switzerland. Polyethylene glycol (PEG) 1500 and 4000 
were obtained from Serva, Heidelberg, Germany.
2.1.22 Photographic Materials
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Table 2.1 Composition of RPMI 1640 medium
Amino acids
L-Arginine
L-Aspargine H2 O
L-Aspartic acid
L-Cystine disodium s a lt
L-Glutamic acid
L-Glutamine
Glycine
L-H is tid ine
L-Hydroxyprol ine
L-Isoleucine
L-Leucine
L-Lycine HC1
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
Vitamins
B io tin
D-Calcium pantothenate 
Choline Chloride 
Folic acid 
i - In o s i to l  
Nicotinamide 
p-Aminobenzoic acid 
Pyridoxine HC1 
Riboflavin 
Thiamin HC1 
Vitamin B 12
Inorganic sa lts
MgS04 . 7H20
NaCl
NaHC03
Na2 HP04
Other compounds
Glucose 
Glutathione 
Sodium phenol red
Ca(N03)2
KC1
mg/1itre
200.00
56.82
20.00
59.15
20.00
300.00
10.00
15.00
20.00
50.00
50.00
40.00
15.00
15.00
20.00
30.00
20.00 
5.00
20.00
20.00
0.20
0.25
3.00
1.00 
35.00
1.00
1.00
1.00
0.20
1.00
0.005
69.49
400.00
100.00 
6000.00 
2000.00
800.70
2000.00
1.00
5.00
X-ray f i lm  (Kodak X-omats), SX-80 developer, FX-40 X-ray l iq u id  
f i x e r ,  and Kodak Ektachrome (ASA 160 and 400, fo r  tungsten l ig h t )  
were supplied by Kodak L td . ,  Hemel Hempstead, England.
2.1.23 Miscellaneous
Precision op tic  quartz c e l ls  were obtained from Thermal Syndicate 
L td . ,  England. P las tic  disposable cuvettes were supplied by 
Sastedt, Germany. Eppendorf tubes (capacity 1.5ml) were supplied by 
Geratebau, Netheler and Hinz, U.K. Scalpel blades were supplied by 
Swann Morton, She ff ie ld , England. The haemocytometer was obtained 
from Weber S c ie n t i f ic  In ternational L td . ,  Sussex, England.
A ll other reagents were o f ana ly tica l grade or o f the highest 
available p u r i ty .
2.2 STANDARD BUFFERS AND SOLUTIONS
The solutions and buffers required fo r  antigen is o la t io n ,  prote in 
p u r i f ic a t io n ,  e lectrophoretic  techniques immunological procedures 
and ce ll  cu ltu re  are specified below.
2.2.1 Retinal S-Antigen P u r i f ica t io n  Buffers
2.2.1.1 Hypotonic extraction bu ffe r 
2.5mM Tris
0.01% (w/v) Sodium azide 
2mM Benzamidine 
0 .5mM PMSF 
HC1 to pH 7.9
2.2.1.2 Column s ta r te r  buffer 
20mM Tris
0.01% (w/v) Sodium azide
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HC1 to pH 7.5
2.2.1.3 Histidine/HCl 
25mM H is tid ine  
HC1 to pH 6.2
2.2.2 Column Buffer fo r  IgG P u r i f ica t io n  
1M Tris
HC1 to pH 6.4
. /
2.2.3 Solution fo r  iso la t io n  o f Rod Outer Segments
2.2.3.1 42% Sucrose so lu tion
42% (w/v) Sucrose in d is t i l l e d  H 0
2.2.3.2 Tris  acetate bu ffer 
1.0M Tris
Acetic acid to pH 7.4
2.2.3.3 Sucrose homogenising solu tion 
1.14M sucrose
5mM Tris  acetate bu ffe r , pH 7.4 
0.2mM MgCl 
65mM NaCl
2.2.4 ELISA Buffers
2.2.4.1 PBS
145mM NaCl 
9.0mM Na2HP04 
1.3mM NaH£P04 
D is t i l le d  H^ O to 11
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pH 7.6 for  ELISA
pH 7.2 to 7.4 fo r  immunocytochemistry
2.2.4.2 PBS-Tween wash bu ffe r
PBS pH 7.6, with 0.05% (v /v) Tween 20
2.2.4.3 Mcllvaines bu ffe r ,  pH 6.0 
Stock 0.1M C i t r ic  acid 17.9ml 
Stock 0.2M Na2HP04 32.1ml 
D is t i l le d  H^ O to 100.0ml
2.2.4.4 ELISA peroxidase substrate 
Mcllvaines b u ffe r ;  lOml/ELISA plate 
Orthophenyl diamine 4.0mg/10ml 
Stock 30% Hydrogen peroxide 3.2pl/10ml 
(Make up immediately p r io r  to use)
2.2.5 Electrophoresis Buffers and solutions
2.2.5.1 30% Acrylamide
30% (w/v) Acrylamide 
0.8% (w/v) Bisacrylamide 
D is t i l le d  H^ O to 100ml
2.2.5.2 Resolving gel bu ffe r 
Stock so lu tion
3.0M Tris  
HC1 to pH 8.8
2.2.5.3 Stacking gel bu ffer 
0.5M Tris
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HC1 to pH 6.8
2.2.5.4 Reservoir bu ffe r 
0.25M Tris  
1.92M Glycine
1% (w/v) SDS 
pH 8
2.2.5.5 Sample bu ffer 
0.0625M Tris  
2% (w/v) SDS
10% (v/v) glycerol 
5% (v /v) 2-mercaptoethanol
0.001% (w/v) Bromophenol blue 
HC1 to pH 6.8
2.2.5.6 Coomassie Blue sta in and destain 
Stain
0.1% (w/v) Coomassie Blue G250
25% (v /v) Methanol
10% (v/v) Glacial acetic acid
Destain
5% (v /v) Methanol, 7% (v /v ) acetic acid in d i s t i l l e d  H2O
2.2.6 Immunoblotting Buffers
2.2.6.1 E lec tro -trans fe r bu ffer
25mM Tris  
0.19M Glycine 
0.03% (w/v) SDS
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20% (v /v )  Methanol
HC1 to pH 8.6
D is t i l le d  H2O to 3 l i t r e s
2.2.6.2 Wash bu ffe r 
20mM Tris  
0.015M NaCl
0.05 or 0.5% (v /v) Tween 20 
HC1 to pH 7.2
2.2.7 Cell Culture Media
2.2.7.1 Complete medium
Foetal c a l f  serum (FCS) (Section 2.1.20) was heat inactivated at 
56°C fo r  30 minutes, and stored froozen at -20°C. Frequent freezing 
and thawing was avoided. FCS 2, 5, 10 or 20% (v/v) was added to
RPMI (Section 2.1.20). The medium was usually supplemented with 
glutamine (Section 2.1 .20), to give a f in a l  concentration of 
50pg/ml of medium. P e n ic i l l in  and streptomycin were also usually  
added to routine cu ltu re  medium, to give a f in a l  concentration o f 
102I . U. /ml and lOOpg/ml, respective ly.
2.2.7.2 HAT medium
The concentrations of hypoxanthine (H), thymine (T) and aminopterin 
(A) (Section 2.1.21) in the complete medium (Section 2 .2 .7 .1) were 
as described by L i t t l e f i e l d  (1964). 100 fo ld  concentrated stocks o f 
HT were made by dissolv ing 135.lmg o f H, and 38.7mg of T in 100ml 
d is t i l l e d  H2O. H was dissolved by s t i r r in g  the mixture at 50°C fo r  
60 minutes. The solu tion was f i l t e r  s te r i l is e d  through 0.2p s te r i le  
f i l t e r s  (Section 2.1.19), and stored at -20°C in the dark. 1ml o f 
the HT stock was added to 100ml o f complete medium to give a f in a l
concentration o f 1 x 10"3M of H and 1.6 x 10“ 4M of T. HAT medium 
was made by adding 0.4ml o f A stock to give a f in a l  concentration 4 
x 10"^M.
2.2.7.3 Freezing medium
20% (v/v) FCS, 15% (v/v) DMSO in RPMI
2.2.7.4 PEG medium
Polyethylene glycol (PEG) (Section 2.1.21) was s te r i l is e d  by 
autoclaving at 151b /sq .in . fo r  15 minutes. While i t  was s t i l l  
l iq u id ,  the PEG was mixed with warm RPMI to give a f in a l  
concentration o f 45 to 50%. Aliquots o f 2ml were stored at -20°C.
2.2.8 Immunocytochemistry Buffers
2.2.8.1 Tris/HCl buffers
Wash bu ffe r : 20mM Tris/HCl, pH 7.4
Incubation bu ffe rs : 20mm Tris/HCl 0.1% BSA, pH7.4
20mM Tris/HCl 1.0% BSA, pH8.4
2.2.8.2 Cacodylate buffer
0.2M Sodium cacodylate 33.0ml 
2.0M Sucrose 12.5ml
HC1 to pH 7.2
D is t i l le d  H^ O to 100.0ml
2.2.8.3 Reynolds lead c i t ra te
1.76g of sodium c i t r a te ,  and 1.33g of lead n i t ra te  were each 
dissolved separately in 15ml of d is t i l l e d  water and then combined. 
A white p rec ip ita te  was formed. The mixture was agitated fo r  20 to
30 minutes, before the addition of 8ml o f IN NaOH. The volume was
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then made up to 50ml with d is t i l le d  ^ 0 .  To minimise the formation 
o f carbonated, the so lu tion was passed through a m il l ip o re  f i l t e r  
(Section 2.1.19).
2.2.8.4 DAB peroxidase substrate
3,3'-Diaminobenzidine te tra  hydrochloride (Section 2.1.11) was 
dissolved in 20mM Tris/HCl, pH 7.6 to give a concentration o f
0.75mg/ml. H^ O was added give a concenration of 0.01%.
2.3 GENERAL METHODS
2.3.1 Measurement of Total Protein by Reading Absorbances at 280nm
To give an approximate estimation of the to ta l prote in 
concentration, the samples were placed in quartz ce l ls  (Section 
2.1.23) and th e i r  absorbances read at 280nm in a spectrophotometer. 
A reading of 1 absorbance u n it  at 280nm (A280) is  approximately 
equivalent to a protein concentration o f lmg/ml. When the prote in 
concentration o f column frac tions  was measured, the column bu ffe r 
served as a blank fo r  the readings. Several substances are known to 
in te r fe re  with the absorbance at 280nm, fo r  example detergents such 
as T riton X-100 (2.1.14) and chemicals l ik e  Benzamidine (Section 
2.1.13).
2.3.2 Bradford's Protein Assay
The Bradford microprotein assay (Bradford, 1976) was employed to 
assess to ta l prote in during the p u r i f ic a t io n  of S-antigen and o f 
monoclonal antibodies.
2.3.2.1 Solutions
1. Coomassie Blue in alcohol
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Coomassie B r i l l i a n t  Blue (G250), O.lg in 50ml 95% (v /v )  Ethanol
2. Phosphoric acid 85% (w/v), in d is t i l l e d  water
3. Protein reagent
The two solutions were mixed in a ra t io  o f one part o f so lu tion 1 
to two parts solution 2, and f i l t e r e d .  The volume was made up with 
d is t i l l e d  water to give the proportions o f 5% solu tion 1 and 10% 
solu tion 2.
4. BSA protein standards
lmg/ml BSA in the appropriate bu ffe r
2.3.2.2 Procedure
The protein standards were prepared in te s t  tubes, in the same
buffer as that o f the sample, fo r  e ith e r the mg or pg prote in
assay. For the mg assay, the d i lu t io n s  were made from lmg/ml to
0 . lmg/ml, in volumes o f lOOpl. 5ml o f the protein reagent was added 
to each tube and mixed by inversion or vortexing. lOOpl o f the 
protein samples were added to 5m1 volumes of the protein reagent.
The absorbances at 595nm were read in a spectrophotometer, and a 
standard curve was p lo tted in order to determine the prote in
concentration of the samples.
The procedure fo r  the pg prote in assay was s im ila r ;  the standards 
were made up to give 0.1 to 0.01 mg/ml, and 2ml of prote in reagent 
were added to each tube.
2.3.3 The Lowry Assay
The Lowry prote in assay (Lowry et _al., 1951) was u t i l i s e d  to
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estimate the to ta l prote in content of p u r if ie d  re t in a l ROS (Section
3.6).
2.3.3.1 Solutions
1. 2% (w/v) NaC03 in 0.1M NaOH
2. 0.5% (w/v) CuSO .^BH^O in 1% potassium ta r ta ra te
3. Reagent A: 1ml o f so lu tion 2 mixed with 50ml of so lu tion 1. This 
reagent was made up fresh before use.
4. F o lin 's  reagent
5. BSA standard so lu tion (lmg/ml)
2.3.3.2 Procedure
Tests tubes were set up in duplicate , containing lOOpl volumes 
containing 10 to lOOpg o f BSA, in the appropriate bu ffe r . 1ml o f 
reagent A (Section 2.3.3.1) was added to each tube, followed by a 
10 minute incubation. Then 0.1ml o f F o lin 's  reagent was added, the 
tubes mixed w e ll,  and incubated fo r  a fu r th e r 30 minutes. lOOpl o f 
bu ffe r containing no p ro te in , s im i la r ly  treated served as a reagent 
blank. The optica l densities were read at 750nm, and a standard 
curve p lo tted . The te s t samples were treated in the same manner and 
th e ir  protein concentrations determined from the standard curve.
2.3.4 SDS-Polyacrylamide Gel Electrophoresis
Protein samples were resolved according to th e i r  molecular weights, 
under the denaturing conditions of SDS-PAGE, with a discontinuous 
gel bu ffe r system (Table 2 .2 ), as described by Laemmli (1970). The
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Table 2.2 Recipe fo r  gel preparation
Stock Solutions Stacking
gel
3.3%
Final
15%
acrylamide concentration in 
resolving gel*
12.5% 10% 8.5%
Acrylamide-bisacrylamide+ 
(30:0.8) ml
2.5 15.0 12.5 10.0 8.5
Stacking gel bu ffer stock+ ml 5.0 - - - -
Resolving gel bu ffer stock+ ml - 3.75 3.75 3.75 3.75
10% SDS ml 200 300 300 300 300
15% ammonium persulphate jul 100 150 150 150 150
D is t i l le d  water ml 12.3 10.45 12.95 15.45 16.95
TEMED jul 15 15 15 15 15
Total Volume ml 20 30 30 30 30
* Final concentration o f buffers: Stacking ge l; 0.125M Tris-HCl, pH 6.8
Resolving ge l; 0.375M Tris-HCl, pH 8.8
+ Section 2.2.5
chemicals and reagents required fo r  electrophoresis are l is te d  in 
Sections 2.1.4 and 2.1.12. This system of protein detection 
provided a c r i te r io n  fo r  p u r i ty  in the p u r i f ic a t io n  o f S-antigen 
(Section 3.4.2) and one of the monoclonal antibodies (Section 6 .5 ). 
The procedure is  a prerequis ite  to the immunoblotting o f antigens 
described in Section 2.3.9. Preparative gels were also employed fo r  
the excision o f spec if ic  bands fo r  Cleveland gel experiments 
(Section 2 .3 .8 ). Variations in the technique described below 
involve only the change in poros ity  o f the gel matrix or in the 
size o f the gel slab.
2.3.4.1 Gel and sample preparation and electrophoresis
The stock solutions fo r  the preparation o f SDS polyacrylamide gels 
are described in Section 2.2.5. The recipes fo r  the various gel 
poros it ies employed fo r  the experiments described in th is  work are 
described in Table 2.2, and are c la s s if ie d  according to th e i r  
percentages o f acrylamide composing the gel. The gels were cast 
between glass gel plates at room temperature, or 40°C. Samples to 
be electrophoresed were mixed with sample bu ffe r (Section 2 .2 .5 .5) 
in a ra t io  o f  4:1 and boiled fo r  2 minutes to so lu b i l ise  w ith SDS.
The gels were assembled onto the e lectrophoretic  apparatus and the 
reservo ir bu ffe r (Section 2.2.5.4) was added. F in a l ly ,  the samples 
were applied to the wells o f the upper stacking gel. 
Electrophoresis was achieved at 40 mamps per ge l, at a constant 
voltage o f 200, at room temperature.
2.3.4.2 Drying of gels
A fte r electrophoresis as described above, and sta in ing (see below), 
selected gels were photographed and dried between f i l t e r  paper and
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c ling  f i lm  under a vacuum at 80°C. To avoid gel cracking the gels 
were pre-soaked in the destain to which glycerol (Section 2.1.12) 
had been added to give a f in a l  concentration o f 5% (v /v ) .  th is
increased the drying time from 1 hour to 3 hours. The s i lv e r
stained gels (Section 2.3.6) were soaked in a more aqueous so lu tion 
before drying, eg. 10% methanol.
2.3.5 Coomassie Blue Staining of SDS-PA6E Gels
Routine protein sta in ing was achieved by sta in ing with Coomassie 
Blue 6250 (Section 2 .2 .5 .6 ) ,  followed by destaining (Section
2 .2 .5 .6 ). When resu lts  were required qu ick ly  (eg. fo r  obtaining gel 
chips fo r  Cleveland experiments; Section 2 .3 .8 ) , the gels were 
stained fo r  30 to 60 minutes at 40°C, followed by destaining with 
gentle continuous ag ita t ion . Generally, however, the gels were 
stained fo r  4 hours or l e f t  to sta in  overnight, before destaining.
2.3.6 S ilve r Staining fo r  Protein
The s i lv e r  sta in ing method described below was employed when a more 
sensitive detection procedure was required. The method is
esse n t ia l ly  the same as tha t described by Wray et j f L  (1981). This 
sta in ing technique was used to assess the p u r i ty  o f fra c t ions  
obtained during protein p u r i f ic a t io n  procedures, and also to detect 
low concentrations of protein in Cleveland gels (Section 2 .3 .8 ).
2.3.6.1 Solutions and reagents
The solutions and reagents required fo r  the s i lv e r  s ta in ing were 
made up in deionised water which had been f i l t e r  s te r i l is e d .  
Solution A
S ilve r n i t ra te ,  0.8g in 4ml deionised H^ O 
Solution B
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0.36% (w/v) NaOH 21ml 
14.8M Ammonia 1.4ml 
Solution C ’
Solution A was added dropwise to so lu tion B, while s t i r r in g  
v igorously. The volume was made up to 100ml with deionised water. 
Developer
1% (w/v) C i t r ic  acid 2.5ml 
38% Formaldehyde 250pl
Deionised H^ O to 500ml
2.3.6.2 Staining procedure
The gels were placed in so lu tion C and stained fo r  15 minutes with 
constant gentle ag ita t ion . High percentage gels, eg. 15%, required 
a few minutes longer in the s ta in . The gels were rinsed in 
deionised water fo r  approximately 5 minutes, with 3 changes. The 
bands were visualised with the developer, again with constant, 
gentle ag ita t ion  fo r  up to 15 to 20 minutes. The reaction was 
terminated a f te r  placing the gel in to  50% methanol, although th is  
did not stop the reaction immediately. The destain used fo r  
Coomassie Blue stained gels was used to l igh ten overstained gels.
Stain C was collected in a bo tt le  and the s i lv e r  was p rec ip ita ted  
as AgCl by the addition o f NaCl. Once the p rec ip ita te  had s e tt le d , 
the supernatant was poured o f f  to avoid the formation o f explosive 
compounds.
2.3.7 PAS Staining fo r  Carbohydrate Groups
The periodic acid S c h if f 's  (PAS) s ta in  (Section 2.1.5) is  used to 
id e n t i fy  glycoproteins, g lyco lip id s , polysaccharides and other 
materials which are high in carbohydrate.
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2.3.7.1 Solutions and reagents
1. 7.5% (v/v) Acetic acid
2. 10% (v /v ) ’ Acetic acid
3. 0.2% (w/v) Periodic acid
4. S c h if f 's  reagent
5. Destain: Na metabisulphite 5.0g
1M HC1 50.0ml
D is t i l le d  F^ O to 1 l i t e r
2.3.7.2 Procedure
A ll incubations were at room temperature unless otherwise stated. 
The samples were electrophoresed in the normal fashion (Section 
2 .3 .4 .1 ) ,  and the gel slab placed in 7.5% acetic acid (Sections
2.1.9 and 2.3 .7.1) fo r  1 hour. The gels were then placed in to  0.2% 
periodic acid (Sections 2.1.9 and 2.3.7.1) and incubated a t 4°C fo r  
45 minutes. The gels were removed and placed immediately, w ithout 
r in s in g , in to  the S c h if f 's  reagent and re fr ige ra ted  fo r  a fu r th e r  
45 minutes. The gels were destained in two or three changes o f 10% 
acetic acid, or fo r  more rapid destaining, the destain recipe 
described above was used, and care taken not to bleach the bands.
The gels were stored at 4°C fo r  a longer preservation o f bands.
2.3.8 Cleveland Gels
Peptide maps o f S-antigen were produced by enzymatic p ro teo lys is  
and separation by SDS-PAGE employing the method o f Cleveland et 
a l . ,  (1977). Three p ro teo ly t ic  enzymes were u t i l i s e d ;  t ry p s in ,  
chymotripsin and Staphalococcus aureus V8 protease (Section 2 .1 .6 ) .
2.3.8.1 Preparation o f samples
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The S-antigen sample to be subjected to peptide mapping was
prepared fo r  SDS-PAGE as usual (Section 2 .3 .4 .1 ). The samples were 
resolved in 8% SDS-polyacrylamide gels without the use o f a comb in 
the stacking gel. A fte r e lectrophoresis, the gels were b r ie f l y  
stained and destained (Section 2 .3 .5 ). The stained band o f 
S-antigen was excised using scalpel blades and cut in to  pieces of 
dimensions 2 x 3mm. These gel chips were rinsed in 0.125M Tris/HCl 
bu ffe r , pH 6.8, with 0.1% SDS; 4 changes in 30 minutes, with 
occasional sw ir l in g . The chips could be stored frozen at th is
stage.
2.3.8.2 Method of digestion
Peptide mapping requires gels o f small poros ity  in order to 
v isua lise  the small fragments of pro te in . 15% SDS-polyacrylamide 
slab gels were cast (Table 2 .2 ), with a 5cm 3% stacking gel using 
the buffers described in Section 2.2.5.
The stock solutions o f tryp s in , chymotrypsin and V8 protease were
at a concentration o f lmg/ml. These were d ilu ted  to 0.25 to 
2.5pg/ml in ' th e  chip wash bu ffe r (Section 2 .3 .8 .1 ) ,  to which 
glycerol had been added to 10%, and bromophenol blue to 0.01%.
The S-antigen gel chips were loaded to the s lo ts  in the stacker o f 
the 15% gels with the aid o f a small spatula. The chips were 
overlaid with chip wash bu ffer containing 20% g lyce ro l.  F in a l ly  
20pl, containing 5 to 50ng o f the enzyme samples were applied above 
the glycerol layer. The gels were electrophoresed at 10 to 45 mamps 
ju s t  u n t i l  the band o f bromophenol blue had almost reached the base 
of the stacking gel. At th is  time the current was switched o f f  fo r  
30 to 60 minutes, before running again to approximately 1cm from
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the bottom of the main gel. Electrophoresis and digestion were 
carried out at room temperature.
The gels were e ith e r s i lv e r  stained fo r  to ta l prote in (Section
2 .3 .6 ) , since th is  method is  more sensitive compared with Coomassie 
Blue, or e lecrophore tica lly  transferred to n itro ce llu lo se  paper fo r  
use in immunoblotting experiments (Section 2 .3 .9 .9 ).
2.3.9 Immunoblotting
1 pc
During the course o f th is  work, both enzyme and the I prote in A 
immunoblotting procedures were employed. The technique followed was 
essen tia l ly  tha t of Batte iger et al_. (1982).
2.3.9.1 E lectro transfer of proteins
The protein samples were electrophoresed in the normal manner 
(Section 2 .3 .4 .1 ). The gels were handled with gloves and placed 
c a re fu l ly  on f i l t e r  paper, avoiding a i r  bubbles, soaked in the 
trans fe r bu ffer (Section 2 .2 .6 .1 ) ,  which was in turn ly in g  upon a 
gauze square soaked in the same bu ffe r. The gel was wetted with 
transfe r bu ffe r and over la id  with a piece of n it ro ce llu lo se  paper, 
soaked in the bu ffe r , avoiding a i r  bubbles. The n it ro ce l lu lo se
paper was f i n a l l y  covered over with a second piece o f f i l t e r  paper 
and then the second gauze square, both soaked in the trans fe r 
bu ffe r. The described assembly was then encased w ith in  the p la s t ic  
cassette and qu ick ly  f i t t e d  in to  the trans fe r tank containing 3 
l i t r e s  o f the trans fe r bu ffe r , in such a way tha t the
n itroce llu lo se  paper was nearest to the pos it ive  electrode.
E lec tro -transfe r was achieved at room temperature a f te r  4 hours at
350 mamps, or overnight at 35 mamps, followed by 1 hour a t 350
mamps.
A fte r e le c tro - tra n s fe r  and dissassembly of the apparatus, the 
n itro ce llu lo se  s tr ip s  were trimmed to the size of the o r ig ina l gel 
and the o r ien ta tion  was marked by the cu tt ing  o f one corner. The 
s tr ip s  were then e ith e r stained with Amido black (Section 2.3 .9.2) 
fo r  to ta l prote in or immunoblotted as described below (Section 
2 .3 . 9 .6 ).
2.3.9.2 Staining fo r  to ta l protein
The Amido black s tr ip s  were stained fo r  to ta l prote in with 0.1% 
Naphthol Blue-black (Amido black) (Section 2.1.5) in 40% methanol, 
10% acetic acid in d is t i l l e d  water. Staining was achieved a f te r  a 2 
minute incubation in the s ta in , and the s tr ip s  were destained in 
40% methanol, 10% acetic acid in water. The n it ro ce l lu lo se  s tr ip s  
were dried f l a t  between f i l t e r  paper.
2.3.9.3 Primary antibodies
The d i lu t io n s  o f the primary antibodies used was dependent upon 
th e i r  t i t r e s  in ELISA. Generally the ra t  antisera to bovine 
S-antigen and R0S demonstrated a t i t r e  o f several thousand to th e i r  
appropriate antigens in ELISA (Section 3 .8 .5 -6 ), and were used at 
d i lu t io n s  of 1:200 to 1:1000 in immunoblotting experiments.
When autoantibodies were sought using the immunoblotting technique, 
higher concentrations were required (eg. 1:80) due to the low serum 
t i t r e s  in ELISA. Sera from RCS rats (Section 4 .1 .8 ) ,  and u v e it is  
and RP patients (Section 4 .2 .7 ) ,  were tested by th is  method, fo r  
autoantibodies. Controls included normal human and normal ra t  sera, 
in addition to the omission of primary and/or secondary antibodies.
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2.3.9.4 Secondary antibodies
Primary ra t  or human antibody was detected by means o f rabb it
a n t i - ra t  IgG(H+L) and rabb it anti-human IgG(H+L) respective ly
IPS(Section 2.1.16) d ilu ted  1:200. The I protein A (Section 2.1.12)
detection system allowed the omission of the second antibody in the
case o f the ra t  IgG monoclonal antibody S2.4.C5 (Chapter 6). Almost 
a l l  the nonspecific reactions observed were a tt r ib u te d  to the
second antibody (Section 6 .3 .3 ). The second antibody was retained, 
however, fo r  prote in A detection in Cleveland b lo ts (Section 
2.3 .9.9) since i t  may increase the s e n s i t iv i t y ,  and no nonspecific 
reaction was observed betweeen the S-antigen and the second
antibody (Section 3.8.1, Figure 3.9).
2.3.9.5 Iodination o f prote in A
lmg of iodogen (Section 2.1.7) was dissolved in 0.5g of chloroform
in a v ia l .  The v ia l was coated with the iodogen by slowly blowing
o f f  the chloroform, lmg of the protein A was dissolved in 0.5ml of
the b lo t wash bu ffe r (Section 2 .2 .6 .2 ) ,  and transferred to the
125iodogen coated v ia l .  27MBq of Na I in lOOpl, was added to the 
prote in A and allowed to stand fo r  15 minutes at room temperature. 
The solu tion was then transferred to a separate clean v ia l .  The 
iodinated protein A was passed through a 10ml G50 column (Section 
2 .1 .3 ) , previously equ ilib ra ted with the b lo t  wash bu ffe r and 1ml 
frac t ions  were co llected. lOpl samples of each f ra c t io n  were 
counted in an LKB 1275 Minigamma counter, and the fra c t ions  
containing the f i r s t  peak were pooled, aliquoted to give 10 counts 
per a l iq u o t,  and stored at -20°C under lead.
2.3.9.6 Immunoblotting methodology
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125The methodologies fo r  the enzyme and I immunoblotting were 
almost id e n t ic a l.  The Tris/HCl, pH7.2, blocking and wash bu ffe r 
contained 0.5% Tween 20 (Section 2.1.10). Blocking was achieved 
ater a 1 hour incubation at 40°C or overnight at 4°C. Further 
incubations were fo r  60 to 90 minutes at room temperature. To 
conserve reagents, the incubations were made in sealed p la s t ic  bags 
in volumes of 2.5 to 10ml, depending on the size of the 
n itroce llu lo se  s t r ip s .  Washing was carried out with 5 x 200ml o f 
bu ffe r (Section 2 .2 .6 .2 ) ;  each wash was incubated on a shaker fo r  5 
to 10 minutes. Monoclonal antibodies were applied as c e l l - f re e  
hybridoma cu ltu re  supernatant. A fte r fu r th e r washing, the 
n itroce llu lo se  s tr ip s  were incubated with the second antibody, 
which was conjugated to horseradish peroxidase in the case of the 
enzyme method. In the prote in A system, the labelled prote in A was 
able to bind to the IgGl ra t  monoclonal antibody S2.4.C5, allowing 
the omission o f the second antibody (Section 2 .3 .9 .4 ) .  Monoclonal 
antibodies of the IgM class and a l l  sera involved the incubation
with a second antibody, before washing and the f in a l  incubation
with the prote in A. A fte r the f in a l  incubation with e ith e r the 
labelled prote in A, or the peroxidase conjugate, the n i t ro ce l lu lo se  
s tr ip s  were f i n a l l y  washed in the washing bu ffe r.
2.3.9.7 Development o f the reaction
125Blots treated according to the I labe lled prote in A methodology 
were developed on X-Omat f i lm  (Kodak) (Section 2.1.22). The length 
o f time necessary to develop the bands varied with the stock o f the
labelled prote in A. For th is  reason, a l l  b lo ts which were to be
compared, were treated with the same preparation. At the end o f the 
reaction detection the n itroce llu lo se  s tr ip s  could be stained with 
Amido black (Section 2 .3 .9 .2 ),  allowing the overlay o f the
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developed f i lm  on stained s tr ip s  and thus the id e n t i f ic a t io n  o f the 
antigenic bands was fa c i l i ta te d .
Blots treated according to the peroxidase enzyme system were 
incubated with f re sh ly  made peroxidase substrate, described below. 
The reaction was almost instantaneous when spec if ic  antibodies had 
been used in the f i r s t  antibody incubation. The reaction was 
terminated by washing in running deionised water. Washing was 
continued fo r  several minutes before drying between f i l t e r  paper. 
The bands tended to fade with time, thus important b lo ts  were 
photographed promptly.
Stock Solutions
1. 1% (w/v) O-dianisidine (Section 2.1.10) in methanol
2. lOmM Tris /HCl, pH7.4
3. H20 , o.2% (v/v)
Peroxidase Enzyme Substrate, 20ml 
O-dianisidine stock 0.5ml 
H20 stock 1.0ml
Tris/HCl 18.5ml
2.3.9.8 B lo tt ing  with Cleveland gels
Only the prote in A technique was used fo r  the Cleveland b lo t t in g  
experiments, since varying the exposure to the f i lm  fa c i l i t a te d  the 
id e n t i f ic a t io n  of epitope bearing bands. Shorter exposure times 
were required to v isua lise  the higher molecular weight bands than 
the smaller peptides. The methodology fo r  the e le c tro - tra n s fe r  and 
b lo t t in g  of Cleveland gels was almost identica l to tha t of 
conventional gels. S im ilar trans fe r times were used since, although
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the gels were o f a higher percentage of acrylamide (15% instead of 
8 or 10%), the molecular weights involved were a l l  below 50K (not 
including the prote in standard markers). A fte r t ra n s fe r ,  the 
n itroce llu lo se  papers were blocked with 0.5% Tween 20 (Section
2.2.6.2) as usual. However, the concentration of Tween was reduced 
to 0.05% fo r  a l l  subsequent washing since th is  was found to reduce 
the loss of the lower molecular weight peptides during the 
immunoblotting procedure. When antiserum was used in place o f a 
monoclonal antibody, the reduced Tween concentration sometimes 
resulted in an increase in background reaction, probably due to the 
immunoglobulins nonspec if ica lly  in te rac ting  with the n itro ce l lo lo se  
paper. The second antibody step (Section 2.3.9.4) was preferred fo r  
the Cleveland gels since i t  could amplify the reaction.
2.4 IMMUN0CYT0CHEMISTRY AT THE LIGHT MICROSCOPE LEVEL
2.4.1 Tissue Fixation
Rat eyes were dissected and the an te r io r segments removed together 
with the v itreous. Some eyes were fixed overnight in pre-cooled 
(4°C) 70% alcohol and embedded in pa ra ff in  wax fo r  l ig h t  microscopy 
e ith e r according to conventional procedures or to the method of 
Sainte-Marie (1962). Other eyes were f ixed  in 4% gluteraldehyde 
(Section 2.1.8.1) in PBS (Section 2.2 .4.1) and processed fo r  l ig h t  
microscopy according to conventional methods.
2.4.2 Conventional Para ffin  Embedding
Fixed tissue was dehydrated through a graded series o f alcohols in 
d is t i l le d  water to xylene and f i n a l l y  pa ra ff in  wax, in a 
H istokinette automatic tissue processor, as described below.
1. 8% phenol in 50% (v/v) alcohol 2 hours
2. 8% phenol in 70% (v/v) alcohol 2 hours
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3. 8% phenol in 90% (v /v) alcohol 2 hours
4. Methanol I 1 hour
5. Methanol l l 1 hour
6. Absolute alcohol I 1 hour
7. Absolute alcohol I I 1 hour
8. Absolute alcohol: chloroform (1:1) 1 hour
9. Chloroform I 1 hour
10. Chloroform I I 2 hours
11. Wax I (Paraplast) 2 hours
12. Wax I I  (Paraplast) 4 hours
2.4.3 Cold Embedding Method
The alcohol f ixed tissue (Section 2.4.1) was dehydrated in 4 
changes of pre-cooled absolute a lcohol, 1 hour each incubation. The 
tissue was cleared by passing through consecutive baths of 
pre-cooled xylene fo r  1-2 hours each, at 4°C. The t issue , in 
xylene, was allowed to come up to room temperature and taken 
through consecutive baths of f i l t e r e d  pa ra ff in  at 56°C fo r  1-2 
hours each. The blocks were stored at 4°C, and sectioned at room 
temperature.
2.4.4 Immunoperoxidase Staining Procedure
Wax sections were cut on a ro ta ry  microtome at 5pm, co llected on 
poly lysine (Section 2.1.12) (lOpg/ml) coated ( fo r  h istochemistry 
only) s l ides. The sections were dewaxed in xylene and hydrated 
through a graded series of ethanol d i lu t io n s ,  to water.
The endogenous peroxidase was exhausted by incubation w ith 0.03% 
hydrogen peroxide in methanol fo r  30 minutes. A fte r blocking with 
10% normal rabb it serum in PBS, the sections were incubated fo r  60
.84
minutes with antiserum (d ilu ted  1:200 in the blocking bu ffe r) or 
monoclonal antibodies to re t in a l antigens, in the form of ce l l  free 
cu ltu re supernatants. Negative controls consisted of pre-immune 
serum (d ilu ted  1:200) and ir re le va n t ra t  monoclonal antibodies. 
The sections were washed in PBS before a 30 minute incubation with 
fresh rabb it a n t i - ra t  peroxidase conjugate (Section 2.1 .16), 
d ilu ted  1:100 in the blocking bu ffe r. A fte r washing, the sections 
were incubated with the diaminobenzidine substrate (Sections 2.1.11 
and 2.2 .8.4) fo r  5 minutes.
The sections were washed and counterstained with haematoxylin to 
v isua lise  nucle i. The sections were then dehydrated through a 
graded series o f alcohols (ethanol) to xylene. The sections were
mounted with DPX (Section 2.1 .8.2) and coverslips. The resu lts  were
recorded by photography a t the 1igh t microscopical level using 
Kodak Ektachrome colour f i lm  fo r  tungsten l ig h t ,  ASA 160 or 400 
(section 2.1.22).
2.4.5 Immunofluorescence Staining Procedure
Immunofluorescence was performed on frozen sections o f ra t  eye and 
whole of mounts fresh ra t re t ina . Whole albino ra t  eyes were 
enucleated and snap frozen in l iq u id  nitrogen, and embedded in 
Tissue Tek O.C.T. (Raymond Lamb, London). Sections were cut at 8pm 
in a cryosta t, and stored at -20°C before use.
The sta in ing procedure was the same fo r  the whole mounts and the
frozen sections. A ll steps were carried out a t room temperature. 
The sections were b r ie f ly  f ixed in acetone or 95% alcohol fo r  2 
minutes and a i r  dried before blocking fo r  10 minutes in 20% normal 
rabb it serum in PBS (Section 2 .2 .4 .1 ). The sections were drained
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and the primary antibody samples applied and incubated in a humid 
chamber fo r  1 to 3 hours. The sections were then gently  washed 4 
times with PBS, before incubation with the FITC conjugated second 
antibody (Section 2.1 .16), d ilu ted  1:20 in PBS, fo r  1 hour in the 
humid chamber. The sections were f i n a l l y  gently rinsed 4 times in 
PBS and once in water, and mounted in  the f lu id  specified below. 
The sections were v isualised in a Le itz  Orthoplan fluorescence 
microscope equiped with a Le itz  MPV compact photometer.
Mounting F lu id , pH 8-9 
NaHCOg 71.5mg
Na^ COg 16.0mg
D is t i l le d  H^ O 10.0ml 
Glycerol 90.0ml
2.5 IMMUNOCYTOCHEMISTRY AT THE ELECTRON MICROSCOPE LEVEL
2.5.1 A ra ld ite  Embedding
2.5.1.1 Tissue f ix a t io n
Rat eyes were dissected as described in Section 2.4.1 and f ixed 
fo r  1 hour in 0.75% gluteraldehyde and 3% formaldehyde, fre sh ly  
prepared from paraformaldehyde (Section 2.1.8.1) in PBS (Section
2 .2 .4 .1 ). A fte r f ix a t io n  the tissue was washed in 3 changes o f 
PBS and 3 changes o f cacodylate bu ffe r (Section 2.2 .8.2) over the 
period of an hour. The fixed tissue was cut in to  pieces o f 1mm by 
2mm using a razor blade.
2.5.1.2 A ra ld ite  embedding mixture
i )  A ra ld ite  CY212 10.0ml
i i )  D.D.S.A. 10.0ml
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i i i )  D i lu ty l  phthalate 1.0ml
iv )  B.D.M.A. 0.5ml (accurate)
Substances i ) ,  i i )  and i i i )  (Section 2.1 .8.3) were mixed 
thoroughly, yet gently to avoid bubbles, before iv )  was added.
2.5.1.3 Embedding procedure
The pieces o f fixed re tina  were placed in 25% ethanol (Burrough's 
absolute alcohol) fo r  10 minutes. This was exchanged fo r  50% 
ethanol fo r  a fu r th e r  10 minutes, and followed by th i rd  10 minute 
incubation with 75% ethanol. Then the tissue samples were 
incubated with absolute alcohol fo r  20 to 30 minutes. The 
absolute alcohol was changed 3 more times before 2 incubations 
with propylene oxide fo r  10 minutes each. The samples were then 
incubated overnight in an A ra ld ite  propylene oxide 50:50 mixture. 
Then the pieces o f tissue were incubated with a mixture of 
A ra ld ite  and propylene oxide in a ra t io  of 75:25 fo r  2 to 6 hours 
on a spinning device. F in a l ly  the pieces o f re tina were placed in 
fresh A ra ld ite  in rubber moulds and cured at 60°C fo r  24 to 48 
hours.
2.5.2 Gold Conjugation o f Antibodies and Protein A
Rabbit a n t i - ra t  IgG(H+L) (Section 2.1.16) and protein A (M iles, 
Section 2.1.12) were conjugated to lOnm co llo id a l gold p a r t ic le s  
(Section 2.1 .12), according to the method o f Roth (1982).
2.5.2.1 Preparation of the reagents
The rabb it a n t i - ra t  sera was d i lu ted  1:5 in  20mM Tris  HC1, pH 
8.4; the optimal pH fo r  the s ta b i l is a t io n  of immunogold (De Mey,
1983). A stock solu tion o f 2mg/ml protein A was made in d i s t i l l e d
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water. An 800pl volume o f d is t i l le d  water was added to 20pl of 
the stock so lu tion to obtain a concentration of 50pg/ml.
2.5.2.2 T i t ra t io n  to determine concentrations o f reagents
The gold c o l lo id  was the colour of red wine. Upon de s tab il isa t ion  
in the presence o f s a l t ,  the gold pa rt ic le s  p re c ip ita te ,  assuming 
a mauve to blue colour. Protein has the a b i l i t y  to s ta b i l is e  the 
co llo id a l gold p a rt ic le s  in  the presence of sodium ch lo ride. The 
optimal concentrations o f the antibodies and protein A required 
to s ta b i l is e  the gold was determined as fo llows:
For each reagent, prote in A or rabb it a n t i - ra t  IgG(H+L), to be 
conjugated to gold, 10 wells o f a -96 well tissue cu ltu re  p late 
(Section 2.1.19) were f i l l e d  with 200pl o f gold c o l lo id .  From the 
f i r s t  to the tenth w e l l ,  5 to 90pl o f the 50pg/ml prote in  A 
solu tion or 5 to 90pl o f 1/100 d i lu t io n  o f an tisera , was added. 
In the case of the 1:5 d ilu ted  rabb it a n t i - ra t  IgG(H+L) ,  5 to
90pl samples were applied, one to each o f the 10 wells o f gold. 
For the p u r i f ie d  monoclonal antibody, 5 to 90pl were added to the 
10 wells . F in a l ly ,  50pl o f 10% NaCl was added to every well
containing gold and the d i f fe r in g  amounts of s ta b i l is in g
proteins.
The blue p rec ip ita te  indicated d e s ta b il isa t io n , and the mauve
colour indicated p a r t ia l  d e s ta b il isa t io n ,  while the wine colour 
s ig n if ie d  s ta b i l is a t io n .  The quantity  of the antibody or prote in  
A taken to be optimal in s ta b i l is a t io n ,  was tha t amount, 2 wells 
away from the mauve coloured w e ll.
Generally, 20pl of protein A (50pg/ml) s tab il ise d  200ul of
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co llo id a l gold. Thus 50|jg (30pl of 2mg/ml stock) o f protein A was
used to s ta b i l is e  12ml gold c o l lo id .  In the case o f antisera ,
20pl (1/100 d i lu t io n )  s tab il ised  200pl of co l lo id a l gold, or 60pl 
of 1/5 d i lu t io n ,  s tab il ise d  12ml of gold.
2.5.2.3 Gold conjuation procedure
25pl o f protein A (2mg/ml), or 60ul of rabb it an ti-ra t(H+L) (1/5 
d i lu t io n ) ,  was added in drops around the edge of a tube fo r  a
T i60 ro to r ,  containing 12ml o f co l lo id a l gold. The tube was then
spin mixed and l e f t  fo r  2-3 minutes. Then 1ml o f \% PEG 
(molecular weight 20,000) in d is t i l le d  water, was added. This 
mixture was then centrifuged at 48,000g fo r  60 minutes, at 4°C. 
The supernatant was discarded and the dark red p e l le t  of protein 
A-gold or immunogold complexes, resuspended in 1% PEG-H^O, and
centrifuged as before. The p e l le t  was resuspended in 1.5ml o f 1%
PEG in PBS and stored at 4°C, fo r  up to 1 year. Before use, the
protein A gold suspension was d i lu ted  to give an absorbance
reading o f 0.2 at 520nm, and passed through a 0.2pm membrane 
f i l t e r  (Section 2.1.19).
2.5.3 Immunostaining Procedures
Sections were cut a t 800A and mounted on 300 mesh nickel grids 
(Section 2 .1 .8 .3 ). The grids were floa ted on droplets o f the 
reagents, on sheets o f dental wax or Nescofilm and incubated in a 
moist chamber. A ll procedures were carried out at room 
temperature. A ll grids were pre-incubated on PBS fo r  10 minutes 
and then blocked with 5% normal goat serum (immunogold method), 
or 1% ovalbumin (prote in A technique), in  PBS fo r  30 minutes. The 
grids were drained and incubated fo r  one hour on the ra t  
monoclonal antibodies (hybridoma supernatants) or ra t  primary
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antisera , d ilu ted  1:200 in PBS with 5% normal goat serum. The 
protein A sta in ing method yielded best resu lts  when a second 
antibody step was included, th is  involved the incubation o f the 
grids with rabb it a n t i - ra t  IgG(H+L) (Section 2.1.16) d ilu ted  
1:100, fo r  1 hour. The grids were then j e t  washed in  PBS (Section
2.2.4.1) followed by incubations through droplets o f Tris/HCl
bu ffe r pH 7.2 (Section 2.2.8.1) 5 changes, 4 minutes each. This
was followed by two, 5 minute incubations in the T r is  bu ffe r with
0 .1 . BSA. Then the grids were transferred to T ris  b u ffe r ,  pH 8.4,
with 1% BSA, fo r  5 minutes. The grids were then transferred to 
droplets o f gold adsorbed goat a n t i - ra t  immunoglobulin or gold 
labelled prote in A (Section 2.1.16) d ilu ted  to give an optica l 
density reading of 0.2 at 520nm, in Tris/HCl w ith 1% BSA, pH 8.4, 
and incubated fo r  one hour. The grids were then transferred to 
Tris  bu ffe r with 0.1% BSA, two changes, 4 minutes each. This was 
followed by washing through droplets o f Tr is  b u ffe r ,  e ight 
changes, 3 to 4 minutes each. F in a l ly ,  the grids were rinsed in 
d is t i l l e d  water, three changes, 3 to 4 minutes each and 
counterstained w ith f i l t e r  s te r i l is e d  solutions o f uranyl acetate 
(saturated in 50% ethanol) (Section 2.1.5) and lead c i t ra te  
(Section 2 .2 .8 .3 ).
The fo llowing control experiments were performed:
1. Omission o f the primary antibody, to control fo r  non-specific  
binding of secondary antibody or gold conjugate to the sections.
2. Incubation with preimmune ra t  serum, d ilu ted  1:200 or 1:100, 
instead of the primary antibody.
3. Incubation of grids with an ir re le va n t ra t  IgG monoclonal 
antibody, e ith e r as hybridoma supernatant or as a 5 to 10 fo ld  
concentrate.
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4. Incubation o f grids with antisera or monoclonal antibody which 
had been pre-incubated with saturating amounts of p u r i f ie d  bovine 
S-antigen.
5. Antiserum from a ra t  immunised with bovine opsin (p u r i f ie d  by 
SDS polyacrylamide gel electrophoresis) d ilu ted  1:200 was included 
as a disc s ta in ing control since opsin is  known to be located on 
the disc membranes.
The grids were viewed in a transmission electron microscope 
(P h i l l ip s )  and a photographic record was made of the re su lts .
2.6 PRODUCTION OF RAT MONOCLONAL ANTIBODIES
2.6.1 Immunisation o f Experimental Animals
The DA s tra in  o f ra t  (Section 2.1.17) was chosen fo r  the production 
of ra t monoclonal antibodies. Although the fusion partner fo r  the 
ra t B lymphocytes, was o r ig in a l ly  derived from a Lou ra t  (Galfre et 
a l . ,  1979), the DA s tra in  has been found to be su itab le , and these 
rats produce a good immune response upon immunisation. Rats were 
immunised with bovine re t in a l S-antigen (Section 3.2-3) or 
photoreceptor rod outer segment (ROS) membranes (Section 3.6). 
Generally 10 to 50pg o f prote in (according to the Bradford's assay, 
Section 2.3.2) in a volume o f 0.5ml, was homogenised with an equal 
volume o f complete Freunds adjuvant (CFA) (Section 2.1.12) 
immediately p r io r  to immunisation. The animals were anaesthetised 
with ether and in jected subcutaneously in the neck and one or both 
hip regions. Usually the animals received two or three such 
immunisations in CFA, with a minimum period o f one week between 
in jec t io ns . I t  is  generally considered desirable to administer an 
in traperitoneal or intravenous ( t a i l  vein) boost of the antigen in
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buffer or sa line , 4 days p r io r  to the day o f fusion (see Campbell,
1984). The protein content of these boosts was approximately 1 to 
lOpg in volumes o f 0.1 to 0.4ml.
2.6.2 Assay o f Sera and Hybridoma Supernatants
2.6.2.1 Bleeding and assessment o f serum t i t r e
The animals were anaesthetised with ether p r io r  to the t a i l  bleed. 
Using a fresh scalpel blade fo r  every second animal, the t a i l s  were 
cut at minimum distance from the t a i l  t ip .  A few drops o f blood 
were collected in Eppendorf tubes (Section 2.1.23). The blood was 
allowed to c lo t  at room temperature fo r  an hour, and then kept at 
4°C overnight. The serum was removed a f te r  cen tr ifuga tion  and 
stored at -20°C.
The sera were d ilu ted  1:100 in PBS Tween 20 bu ffe r (Section
2.2.4.2) with 0.05% (w/v) BSA (Section 2.1 .12), fo r  t i t r e
determination by ELISA. The ELISA plates (Section 2.1.15) were 
coated with Ipg/ml o f S-antigen and blocked with 50mg/ml BSA. 
Doubling d i lu t io n s  o f the sera were made across or along the 
p la tes, beginning with a d i lu t io n  of 1:100. The plates were 
incubated fo r  30 minutes at room temperature before completion of 
the ELISA protoco l, as described in Section 3.8.3.
Animals demonstrating a serum t i t r e  in ELISA of greater than 1:2000 
were considered to be suitable fo r  fusion purposes.
2.6.2.2 Assay o f fusion hybridoma supernatants
The ELISA system was selected fo r  the screening of fusion 
supernatants since i t  is  rapid, and convenient to use. I t  also 
tends to select fo r  re la t iv e ly  high a f f i n i t y  antibodies since i t
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involves washing steps.
Samples of hybridoma supernatant were removed by means of s te r i le  
t ip s  and a m icropipette, set at a volume of lOOpl, and applied 
d i re c t ly  to coated and blocked ELISA plates. The plates were 
incubated fo r  2 hours at room temperature or kept at 4°C overnight. 
The resu lts  were developed in the usual manner (Section 3 .8 .3).
2.6.3 Rat Parent Cell Line and i t s  Care
The ra t myeloma ce ll l in e  Y3-Ag.l.2.3 (Y3) (Section 2.1.18) (Figure
2.1) was employed as the fusion partner fo r  the ra t  splenic 
lymphocytes (Galfre et ^ 1 . ,  1979). The ra t  hybridoma system was
selected because o f the greater s t a b i l i t y  of both uncloned and 
cloned hybrids, in terms of continual antibody secretion, compared 
with the mouse system. The fusion methodology and treatment o f the 
c e l ls  is  almost identica l to tha t of the mouse system. The Y3 ce l ls  
were maintained on 10% FCS in RPMI (Table 2.1) (Section 2 .2 .7 .1 ) ,  
and were usually grown in a spinner f lask  fo r  three or four days
p r io r  to fusion. Care was taken not to allow the Y3 c e l ls  to
overgrow or become too crowded in the few days before fus ion, and 
the ce l ls  were taken to a low ce ll  density about 24 hours p r io r  to 
the time o f the fusion.
2.6.4 Dissection of Spleen and Removal of Blood
The rats were k i l le d  by over-anaesthetising in ether. The abdomens 
were soaked in iso-propanol before inc is ion . A transverse lower 
abdominal cutaneous inc is ion  was made exposing the an te r io r  
abdominal muscles, which were cut with the parie ta l peritoneum. The 
in testines were l i f t e d  aside and any fa t  cut away to expose the 
dorsal aorta. Blood was withdrawn from the aorta by means o f a
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gauge 21 (G21) needle and a 5ml syringe (Section 2.1.19). Volumes
obtained in th is  manner ranged from 1 to 5ml. The serum was 
isolated and stored as described in Section 2.6.2.1 .
The spleens were dissected out, leaving minimal f a t t y  tissue 
adhering to the organ, and placed immediately in to  a s te r i le  
p la s t ic  universal container (Section 2.1.19).
2.6.5 Method of Cell Counting
An estimate of ce l l  density was obtained by counting the c e l ls  on 
grids w ith in  the haemocytometer chamber. Cells growing in flasks 
usually required d i lu t in g  1:10 or 1:20 before they could be 
counted. A 50pl sample o f the d ilu ted  spleen ce lls  was added to a 
300ul volume of 0.9% (w/v) ammonium chloride (Section 2.1.12) in 
d is t i l le d  water, and incubated at room temperature fo r  5 minutes. 
This procedure lysed the red blood ce l ls  present in the rodent 
spleen ce ll  suspension, thus f a c i l i t a t in g  counting o f the 
lymphocytes. The value of the mean o f two counts, taken from 
d i f fe re n t  regions o f the g r id , was m u lt ip l ied  by 10 to obtain the 
number of ce lls  per ml w ith in  the sample. This number was 
m u lt ip l ied  by the d i lu t io n  fac to r in order to obtain the density  of 
ce l ls  w ith in  the o r ig ina l ce ll suspension.
2.6.6 Fusion Protocol
The fusion protocol employed was e sse n tia l ly  tha t of Kohler and 
M ils te in  (1975).
2.6.6.1 Preparation of the spleen ce lls
The spleen was rinsed in approximately 5m1 o f RPMI in a small p e tr i
dish and transferred to a fresh pe tr i  dish (Section 2 .1 .19 ), to
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which a fu r th e r 5ml of RPMI had been added. The spleen tissue was 
teased to form as f ine  a suspension as possible using s te r i le  G21 
needles (Section 2.1.19). The p e tr i  dish was t i l t e d  and the spleen 
ce ll  suspension drawn in to  a 5ml syringe. The syringe contents were 
then passed in to  a fresh p e tr i  dish. The spleen ce ll  suspension was 
again taken up in to  the syringe and re-expelled. This syringe 
passage was repeated at least four times. Then the spleen ce ll  
suspension was passed through f in e  gauge 25 (G25) needles, a t least 
three times, and f i n a l l y  expelled in to  a s te r i le  universal 
container. The universal was topped up with RPMI and centrifuged 
fo r  5 minutes at approximately 500g. The supernatant was discarded 
and the p e l le t  resuspended in RPMI and centrifuged as before. The 
ce ll  p e l le t  was resuspended in 10ml RPMI and the ce l ls  counted as
o
described in Section 2.6.5. I t  was shown that approximately 1 x 10 
ce l ls  can be obtained by th is  method.
2.6.6.2 Preparation o f the Y3 ce lls
Universals of Y3 myeloma ce l ls  were centrifuged fo r  5 minutes at 
500g, and the ce ll pe lle ts  resuspended in RPMI. The c e l ls  were 
re-centrifuged and resuspended in 10ml o f RPMI fo r  counting 
(Section 2 .6 .5 ). Approximately h a lf  the number of Y3 c e l ls  to
o
splenic lymphocytes was required, ie . usually  0.5 x 10 c e l ls .
2.6.6.3 Cell fusion
Suspensions o f Y3 and spleen ce l ls  were mixed, ensuring tha t a 
small sample o f each was retained to provide spleen and Y3 ce ll  
con tro ls . The Y3 ce ll  control wells were included, to ensure tha t 
these ce l ls  were k i l le d  in the HAT medium (Section 2 .2 .7 .2 ). Spleen 
ce ll  control wells were included since the spleen ce l ls  may secrete
antibody fo r  several days, and th is  could re su lt  in the detection
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of fa lse  pos it ives , unless the hybridoma medium was changed at 
least twice before assay. The ce ll  mixture was pelle ted in the 
usual manner, and the supernatant discarded.
Over a period of 30 seconds, 2ml of warm (37°C) 45-50% PEG 
(molecular weight 1500 or 4000) in RPMI (Section 2 .2 .7 .4 ) ,  was 
added dropwise to the ce l l  p e l le t ,  with constant a g ita t ing  of the 
tube to disperse the ce lls  in the PEG medium. The mechanism of ce l l  
fusion is  complex and, as ye t, not f u l l y  understood. The PEG is 
hydrophilic  in nature and is  thought to occupy the 'physical free 
water' space, leading to ce ll  agg lu tina tion . The ce l ls  were gently 
resuspended fo r  30 seconds, and allowed to res t fo r  another 30 
seconds. Then 5ml o f RPMI was added over a period o f 90 seconds, 
while the tube was agitated to mix the media. A fu r th e r  5ml o f RPMI 
was then added over 2 seconds, while the tube was rotated. F in a l ly ,  
the universal was allowed to stand fo r  2 to 3 minutes before 
cen tr ifuga tion  in the usual manner.
The supernatant was tipped and the p e l le t  gently resuspended in a 
few ml o f HAT medium (Section 2 .2 .7 .2 ) ,  and transferred to a 100ml 
volume of the same medium. The ce ll  suspension was seeded at 
approximately 1ml per w e ll ,  in to  four 24-well Costar plates 
(Section 2.1.19), apart from those reserved fo r  the spleen and Y3 
ce ll contro ls. The fusion plates were then placed in a 37°C 
incubator with 5% CO^ . The plates were b r ie f ly  inspected a f te r  
approximately 24 hours to ensure tha t no contamination had 
occurred.
The HAT medium allowed the growth of the hybridoma c e l ls ,  while the 
Y3 ce lls  did not survive. The drug aminopterin, in h ib i ts  the enzyme
96
dihydrofo late reductase, which is  essential to the main pathways o f 
purine and pyrimidine de novo biosynthesis. However, salvage 
pathways e x is t ,  where exogenous nucleotides are used; the purine 
pathways involve exogenous hypoxanthine with the enzyme, 
hypoxanthine phosphoribosyl transferase (HPRT). The pyrimidine 
pathway u t i l is e s  exogenous thymidine and thymidine kinase (TK). The 
Y3 ce l ls  cannot survive in HAT medium unless they have acquired the 
HPRT gene by fusion with the antibody secreting spleen c e l ls .
2.6.7 Care o f Fusions and Observations o f Wells
2.6.7.1 Feeding
The fusion plates were fed a f te r  four to seven days with HAT 
medium, 0.5ml per w e ll.  The fusion plates were fed a second time
a f te r  approximately 10 days post fusion. At the second feed, 0.5ml
of medium was removed to be replaced with 0.5ml of fresh medium. By 
th is  time the Y3 ce lls  had died, and aminopterin was no longer 
required in the medium. The HT was retained at th is  stage, however, 
since residual aminopterin w i l l  remain with the emerging
hybridomas. Subsequent feeding depended on the emergence o f clones.
2.6.7.2 Characteristics of a fusion well
A fte r three or four days the Y3 ce lls  appeared dead, having become 
granular and tending to clump together. Several types o f spleen 
ce ll remained a l ive  fo r  some time, in  p a r t ic u la r  the f ib ro b la s ts  
which would occasionally take over the well and cause the medium 
to turn ac id ic  (indicated by the yellow co loura tion). Over a few 
days post fusion, the background population o f c e l ls ,  dying Y3s, 
red blood c e l ls ,  and other spleen ce l ls  began to c lear away and 
tended to form a large mass o f ce l l  debris at the well centres. 
Such a c learing process fa c i l i ta te d  detection of the emerging
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Figure 2.1 High Magnification of the Rat Myeloma Cells
Figure 2.2 High Magnification of Rat Hybridoma Cells
Arrows indicate ce ll  blebs

hybridomas.
2.6.7.3 The emergence o f the hybridomas
The ra t  hybridomas appeared v i r t u a l l y  ind istingu ishable  from th e ir  
Y3 parent c e l ls ;  they were re la t iv e ly  large c e l ls  with variable and 
ir re g u la r  shapes and were non-gregarious in behaviour (Figure 2.2).
The hybrids generally emerged by 14 days post fusion. In 'good1 
fusions, the hybrids were detected as early  as 6 days a f te r  fusion. 
Such early  emergence o f clones was generally ind ica t ive  o f a high 
fusion frequency, and conversely when clones were slow to appear, 
there tended to be fewer wells with growth. I f  no hybrids appeared 
by the th i rd  or fourth week post fus ion, the plates were discarded.
2.6.7.4 Assay and expansion of clones
Once a well became approximately 70-80% confluent w ith the 
hybridomas, i t  was assayed by the asceptic removal o f lOOpl o f 
supernatant, and d i re c t ly  applied to ELISA p la tes, which had 
previously been coated with antigen. The ELISA assay procedure is  
described in Section 3.8.3. Positive clones were expanded in to  25ml 
flasks and fed with approximately 3m1 o f complete medium. The 
flasks were generally l e f t  upright overnight to allow the c e l ls  to 
fu r th e r expand before feeding with 3 to 5ml of medium and then 
being placed horizon ta l. The ce l ls  were fed every 24 to 48 hours 
u n t i l  enough ce l ls  were obtained to make a frozen stock (Section 
2 . 6 .8 ).
2.6.8 Cell Freezing
Aliquots o f p o s it ive , but as yet uncloned c e l ls ,  were frozen and 
stored in l iq u id  nitrogen as insurance against loss o f cu ltu res .
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Suspensions o f the ce lls  to be frozen in l iq u id  nitrogen were
counted (Section 2.6.5) and centrifuged at 500g fo r  5 minutes and
the ce ll  pe l le ts  resuspended in a volume of freezing medium 
(section 2.2 .7.3) to give 5-10 x 10^ ce l ls  per ml. 1 to 1.5ml of 
the ce l l  suspensions were placed in to  screw cap p la s t ic  Costar
ampoules o f 1.8ml capacity (Section 2.1.19). The ampoules 
containing the ce l ls  were frozen fo r  24 to 48 hours at -70°C,
before trans fe r to l iq u id  or gas phase nitrogen storage f a c i l i t i e s .
2.6.9 Subcloning to Establish Monoclonality
Monoclonality is  achieved by successive subcloning a t 0.5 or 0.25 
ce l ls  per w e ll,  in the presence o f  spleen feeder c e l ls .  
Monoclonality may be assumed a f te r  the th i rd  subcloning at such 
ce l l  densities.
2.6.9.1 Procedure
Suspensions o f spleen ce lls  were obtained from an unimmunised ra t  
or Balb C mouse (Section 2.1.17) as described in the fusion 
protocol in Section 2.6 .6.1 . These ce l ls  act as feeders fo r  c e l ls  
cloned at very low densities, or fo r  ce l ls  exh ib it ing  poor growth. 
These spleen ce l ls  probably a f fe c t  the hybrids by providing growth 
factors and physical support.
The feeders were resuspended in complete medium (Section 2 .2 .7 .1 ) 
and seeded at 1 x 10^ ce l ls /w e l l  in lOOpl volumes, in to  the 
wells of two Costar 96-well plates (Section 2.1 .19), per ce l l  l in e  
to be subcloned. The hybrid ce l ls  to be cloned were washed and
r
counted (Section 2 .6 .5 ) , and d ilu ted  to give 1 x 10 ce l ls  per ml. 
Consecutive 1:10 d i lu t io n s  o f the ce l ls  were made through 
universals containing 5ml volumes of RPMI to achieve a
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2concentration o f 1 x 10 ce l ls  per ml. This ce ll  suspension was 
d ilu ted  1:10 in complete medium to obtain 10 ce lls  per ml. This was 
then d ilu ted  1:2 in complete medium to give 5 ce l ls  per ml, and 
d ilu ted  1:2 again, to give 2.5 ce l ls  per ml. Using a m icroaliquoter 
or a one ml p ipette  (Section 2.1 .19), 0.1ml o f the 10 c e l ls  per ml 
suspension was applied to the wells of one 96-p la te, in which 
feeders had been la id  down. To the second 96-well p la te , the 5 
ce l ls  per ml suspension was added to h a lf  o f the plate and the 2.5 
ce l ls  per ml to the other h a lf .  Thus, there was one plate with 1 
ce l l  per w e l l ,  and another p late with 0.5 and 0.25 ce l ls  per w e ll.
The plates were b r ie f l y  inspected approximately 24 hours a f te r  
subcloning, to ensure no contamination had occurred. The plates 
were incubated fo r  10 to 14 days at 37°C to allow the clones to 
develop. The wells were considered ready fo r  assay once the ce l ls  
covered h a lf  or more of the well f lo o r .  Generally, a p late seeded 
a t 1 ce l l  per well was not assayed i f  there were enough wells with 
growth in the plate seeded at the lower ce l l  densities. The wells 
were assayed in the same manner as the fusion w e lls , described in 
Section 2.6 .7.4 .
2.6.10 Bulk Culture o f Monoclonal Hybridomas
Once monoclonality had been achieved through subcloning procedures, 
unlim ited quantit ies o f antibody could be generated fo r  fu r th e r  
analysis and experimentation. For the purposes of th is  study, up to 
1 l i t r e  volumes were generated as required.
The hybrids were usually expanded to the normal volume o f one or 
two 250ml f lasks , p r io r  to trans fe r in to  a 1 l i t r e ,  s i l ic o n is e d ,  
s te r i le  glass spinner cu ltu re f la sk .  The flasks were incubated at
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37°C over a magnetic s t i r r in g  device e ith e r in a 37°C water bath or 
in a 37°C hot room. The hybrids usually  grew exponentia lly  and 
required sub-culturing on a d a i ly  basis.
2.6.11 Determination o f Monoclonal Antibody Isotype
The immunoglobulin classes and subclasses o f monoclonal antibodies
were determined by means of Ouchterlony immunodiffusion assays in
agarose (Section 2.1 .12), against antisera with s p e c if ic ty  fo r  ra t 
immunoglobulin isotypes.
2.6.11.1 Solutions
1. 1% agarose (w/v) in PBS (Section 2.2 .4.1) 
with 0.02% sodium azide
2. 0.9% (w/v) NaCl, 0.02% sodium azide 
in d i s t i l  1ied h^ O
3. 0.025% (w/v) Coomassie Blue R (Section 2.1.5) 
in destain solution
4. Destain
Acetic acid 25ml 
Methanol 25ml 
H20 350ml
2.6.11.2 Preparation of Ouchterlony slides
The agarose was dissolved in PBS by b o i l in g ,  and while hot 3ml 
applied to clean glass microscope slides using a pre-heated 5ml 
glass p ipe tte . When cool, 1mm diameter wells were made using a 
template, consisting o f a central and 6 surrounding w e lls . The 
prepared slides were stored in a moist chamber at 4°C, i f  not 
immediately used.
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2.6.11.3 Procedure
The ra t monoclonal antibodies were assayed with rabb it a n t i - ra t  
IgM, and IgG, sheep a n t i - ra t  IgGl, goat a n t i - ra t  IgG2a, rabb it 
a n t i - ra t  IgG2b and goat a n t i - ra t  IgG2c (Section 2.1.16). Serial 
d i lu t io n s  (1:1 to 1:32) o f the hybridoma supernatant, in volumes o f 
5 p l , were applied to the wells surrounding the central w e l l ,  to 
which 5pl of 1:10 d i lu t io n  o f the a n t i - ra t  Ig class spec if ic  sera 
was added. In add it ion , the undiluted hybridoma supernatant was 
applied to the centre well o f separate s lides , and assayed with 
seria l d i lu t io n s  (1:10 to 1:320) o f the d i f fe re n t  antisera to the 
ra t  immunoglobulin isotypes, in the outside'wel 1 s. The slides were 
then incubated in a moist chamber, fo r  18 to 24 hours at 4°C. The 
immunoprecipitation reaction were v is ib le  between the centre well 
and the outer wells containing the higher concentrations o f 
antibody.
2.6.11.4 Staining o f the immunoprecipitates
The Ouchterlony slides were washed in at least 3 changes of 
100-200ml saline solution (Section 2 .6 .11 .1), at 4°C, to remove 
excess proteins. The slides were then dried between f i l t e r  paper, 
under a weight fo r  24 to 48 hours. The prec ip ita tes  were stained 
with Coomassie blue fo r  up to 10 minutes, and destained as 
necessary (Section 2.6 .11.1). The slides were a i r  dried and stored.
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2.7 THE HUMAN TRANSFORMATION AND HYBRIDOMA SYSTEM
2.7.1 Production o f the Transforming Virus
The Epstein-Barr v irus (EBV) u t i l is e d  fo r  the transformation of 
human peripheral blood lymphocytes was obtained from the marmoset 
ce ll  l in e ,  B95-8 (M il le r  and Lipman, 1973) (Section 2.1.18). The 
virus has been c la s s if ie d  as a category 3 pathogen, by the B r i t is h  
Medical Research Council, thus routine m icrobiological practice was 
taken during handling.
The B95-8 ce l ls  were grown in 5% FCS in RPMI (Section 2.2 .7 .1) at a
6 * density o f 1x10 ce lls /m l.  For v irus secretion, the c e l ls  were
d ilu ted  to a density o f 0.2 x 10  ^ ce lls /m l in RPMI with the FCS
reduced to 2%. In add it ion , the temperature at which the c e l ls  were
incubated was dropped to 33°C. The c e l ls  were cultured under these
conditions fo r  2 weeks before the v irus pa rt ic les  were harvested.
The B95-8 ce lls  were allowed to s e tt le  at 4°C and then the
supernatant containing the v irus was collected a f te r  cen tr ifuga tion
at 200g. The supernatant was f i l t e r  s te r i l is e d  and aliquoted at
volumes o f 1ml in 1.8ml capacity p la s t ic  screw cap freezing
ampoules (Section 2.1.19) and stored in l iq u id  nitrogen u n t i l
required.
2.7.2 Preparation o f Peripheral Blood Lymphocytes
Heparinised (Section 2.1.19) human blood samples, o f 10 to 40ml, 
were d ilu ted  1:1 with warm (37°C) 2% FCS in RPMI, and gently
layered onto equal volumes o f Ficoll-Paque (Section 2.1.20) in  50ml 
Falcon tubes (Section 21.1.19). The tubes were centrifuged at 500g 
fo r  15 minutes. The lymphocyte layer was removed a t the in te r fa ce , 
and the pelleted red ce lls  were discarded. The lymphocytes were
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washed tw ice, in un iversals, in the 2% FCS in RPMI. The c e l ls  were 
counted as described in Section 2 .6 .5 , and recentrifuged and
resuspended in RPMI to give a ce ll density o f 10^ ce lls /m l.
2.7.3 Separation o f the B Lymphocytes
2.7.3.1 AET-treatment o f sheep red blood ce lls
Human T lymphocytes are able to bind to sheep red blood ce l ls  
(SRBCs), and th is  c a p a b i l i ty  can be exploited fo r  the removal o f 
these ce l ls  from the B c e l ls .  The SRBCs (Section 2.1.20) were 
washed three times with RPMI. 1ml o f the red ce ll  p e l le t  was 
removed and placed in to  4ml o f a f i l t e r  s te r i l is e d  so lu tion o f 
2-aminoethylisothiouronium (AET) (Section 2.1 .12); 102mg in 10ml
water, adjusted to exactly pH 9.0, with sodium hydroxide so lu tion . 
This pre-treatment was used in order to improve the re p ro d u c ib i l i ty  
o f the technique (Kaplan and Clark, 1974). The ce lls  were incubated 
at 37°C fo r  20 minutes with occasional mixing, then washed 5 times 
with RPMI (Section 2.1.20) and made up to a concentration o f 10%,
i .e .  to 1ml of packed ce ll volume 9ml o f RPMI was added.
2.7.3.2 Preparation of Percoll
The human peripheral B lymphocytes were separated from the rosetted 
T ce lls  by means of f lo a ta t io n  on a Percoll (Section 2.1.20) 
cushion (Section 2 .7 .3 .3 ). The Percoll was prepared as fo llow s : 
10ml of f i l t e r  s te r i l is e d  PBS was added to 90ml of s te r i le  P e rco ll;  
6.3ml of the Percoll-PBS was mixed with 3.7ml of RPMI p r io r  to use, 
to a tta in  a density of 1.08 fo r  the B ce ll  separation.
2.7.3.3 Procedure fo r  the iso la t io n  of B lymphocytes
The PBLs, prepared as described above, were d ilu ted  to obtain 10^
ce lls  per ml. An equal volume of 2 % AET-SRBCs was added to the
ce ll  suspension. Then a volume o f FCS, equal to tha t of the
or ig ina l volume of the ce ll  suspension was added. This combination 
was l i g h t l y  centrifuged at 200g fo r  10 minutes. The tube was placed 
on ice fo r  1 to 2 hours, without the removal o f the supernatant. 
A fte r th is  time, the tube was inverted or rocked gently and a 
sample removed fo r  examination by haemocytometer to check fo r  the 
presence o f the T ce l l  rosettes.
The sample was then gently layered over Percoll and centrifuged at 
500g fo r  10 minutes. The B lymphocytes were collected from the
in terface and washed twice in  RPMI-2% FCS.
2.7.4 Transformation o f Human Peripheral Blood B Lymphocytes 
Procedure
The pe lle ted B lymphocytes, separated from the rosetted T ce l ls  
(Section 2 .7 .3 .3 ) ,  were resuspended in 1ml of v irus stock 
supernatant (per 20ml blood sample). The ce l ls  were incubated with 
the v iru s ,  at 37°C fo r  1 hour. F in a l ly ,  the ce l ls  were washed once 
and resuspended in complete medium with 20% FCS (approximately 12ml 
per 20ml blood sample). The c e l ls  were seeded in to  the inside wells 
of one 96 well p late (Section 2.1.19) per 20ml blood sample, at 
approximately 200pl/well. The peripheral wells were f i l l e d  with
200pl each of RPMI; th is  was to protect the inside wells containing
the c e l ls ,  from evaporation.
2.7.5 The Cyclosporin A Method
Cyclosporin A (CsA) is  a drug which is  thought to s p e c i f ic a l ly  
in h ib i t  the a c t iv i t y  o f T lymphocytes (reviewed by Shevach, 1985). 
The drug in h ib i ts  the potentia l a c t iv i t y  of T c e l ls  against in
v i t ro  transformed B lymphocytes (Bird et al_., 1981). In th is  study
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the rosett ing  and CsA methods of removing the T ce ll  influence were 
compared in some samples.
The procedure fo r  the CsA technique was e sse n tia l ly  the same, with 
the omission o f the rosett ing  steps to remove the T c e l ls ,  and the 
inclusion of CsA at 1 to 2pg/ml in the complete medium in which the 
ce ll  were f i n a l l y  resuspended and seeded in to  96-well p lates. The 
CsA method, reduced the time o f  the transformation procedure by at 
least 4 hours.
2.7.6 Care and Appearance o f Emerging Transformed Cells
The transformed ce l ls  were f i r s t  fed a f te r  7 days, by the removal 
of approximately 50pl o f the o r ig ina l medium, and replacing w ith 
fresh complete medium (Section 2 .2 .7 .1 ). The CsA treated 
transformants were treated in the same manner. The c e l ls  were fed 
weekly fo r  up to 3 or 4 weeks, by which time the ce l ls  were well 
established w ith in  the wells and ready fo r  assay (Section 2 .7 .7 ).
The transformed ce lls  appeared much la rger than the o r ig in a l B 
lymphocytes. The ce l ls  tended to be asymmetrical; rounded at one 
end, with cytoplasmic protrusions at the other (Figure 2 .3 ). The 
ce lls  tended to be gregarious in behaviour, forming discrete clumps 
ranging from two ce l ls  to co llec t ions  up to 1mm in diameter. These 
clumps were not clones since the ce l ls  could be separated by gentle 
shaking; w ith in  an hour the clumps would reform.
2.7.7 Assay and Expansion of Positives
The transformations were usually  ready fo r  assay when they were 
approximately three weeks old. The wells were assayed in a s im ila r  
manner to the ra t  hybridomas (Section 2 .6 .4 .7 ) ,  however, genera lly
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only 70pl o f supernatant was removed fo r  assay due to the small 
amount ava ilab le , and the need to assay against both S-antigen and 
ROS. The medium was replaced by feeding, a f te r  removal fo r  assay. 
Positive clones were expanded in to  24-well plates (Section 2 .1 .19), 
reassayed and expanded in to  50ml f lasks (Section 2.1 .19), i f  they 
remained pos it ive . The ce l ls  could be fu r th e r expanded in to  250ml 
f lasks. Fusions were performed with transformed ce l ls  grown in 
e ithe r 50 or 250ml flasks (Section 2 .7 .8 ).
2.7.8 Human Fusion Protocol
2.7.8.1 Preparation o f parent ce l ls
The pa tien ts ' EBV transformed c e l ls  which remained p o s it ive ,  a lb e i t  
weakly, a f te r  expansion in 50 or 250ml f lasks , were harvested and 
washed 3 times in serum-free RPMI. The ce lls  were resuspened in 
10ml o f RPMI and counted as described in Section 2.6.5. The fusion 
partner employed was the KR-4 human lymphoblastoma c e l l  l in e  
(Kozbor et aj_., 1982) (Section 2.1.18). These ce l ls  were also 
harvested, washed and counted. Equal numbers, eg. 1 x 10?, o f each 
ce ll  type was required.
2.7.8.2 Fusion procedure
The transformed ce l ls  and the KR-4 c e l ls ,  prepared as above were 
pooled and centrifuged together in a s te r i le  universal conta iner, 
at 500g fo r  5 minutes. The supernatant was discarded and 0.5mT of 
warm (37°C) 50% PEG in RPMI was added dropwise over 1 minute, while 
gently ag ita t ing  the tube. The ce l ls  were gently mixed with the PEG 
fo r  90 seconds, and 5ml of warm RPMI was added over a period o f 6 
to 10 minutes. The f i r s t  1ml o f RPMI was believed to be the most 
c r i t i c a l  and was added over 3 minutes. The universal container was 
then capped and incubated at 37°C fo r  20 to 60 minutes, during
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which time more fusions could be made.
The c e l ls  were then centrifuged and washed twice in RPMI, before
f i n a l l y  being resuspended in HAT medium (Section 2.2 .7 .2) to which
oubain (Section 2.1.21) has been added to give a f in a l
-5concentration o f 1x10 M. This medium was also supplemented with 
spleen feeder ce l ls  from a young Balb C mouse (Section 2.1.17) 
prepared as described in Sections 2.6.6.1 and 2 .6 .9 .1 . The ce l ls  
were seeded in to  one 96 well p late per fus ion, at lOOpl/well. 
Approximately 10 wells were reserved fo r  the con tro ls , these 
consisted o f 5 wells of the unfused transformed c e l ls  and 5 wells 
of the unfused KR-4 c e l ls .  Generally, a f te r  8 to 10 days, the 
parent ce l ls  were dead. The fusion plates were maintained at 37°C.
2.7.8.3 Care of human fusions and appearance o f hybrids
The wells of the fusion plates were fed a f te r  24 hours with lOOpl 
o f complete medium containing twice the usual concentration of HAT 
(Section 2 .2 .7 .2 ) ,  although the concentration of oubain remained 
the same. Three days a f te r  fusion, approximately 150pl o f the 
medium was aspirated and replaced with lOOpl of HAT-oubain medium, 
at the o r ig ina l concentrations. The ce l ls  were fed every 4 to 6 
days depending on the growth rate o f the c e l ls .  The oubain was 
omitted from the medium a f te r  about 2 weeks and the HAT was omitted 
a f te r  3 weeks.
The hybrids could f i r s t  be detected a f te r  as early  as 4 days in one 
fus ion, although 6 to 12 days was more usual. The hybrids appeared 
about 1.5 times larger than the parent c e l ls ,  and were also 
gregarious. These ce lls  tended to be rounded at one end, tapering 
at the other and often f ish  l ik e  in appearance (Figure 2 .4 ).
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Figure 2.3 High Magnification of Transformed Human B Lymphocytes
Figure 2.4 High Magnification of Human Hybrid Cells
Arrows ind ica te ce l l  protrusions

2 .7 .8 .4  Assay of human hybrids
The human fusion plates were ready fo r  assay by ELISA, a f te r  3 to 4 
weeks when the hybrids has grown to a number tha t could be expanded 
in to  the wells o f a 24 well p la te . Positive human hybrids can be 
expanded and subcloned to achieve monoclonality, as in the ra t  
system (Section 2 .6 .9 ). However, in th is  study no suitable 
positives were detected a f te r  fusion.
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CHAPTER THREE
PREPARATION OF ANTIGENS AND DEVELOPMENT OF 
IMMUNOASSAY SYSTEMS
Chapter 3
PREPARATION OF ANTIGENS AND DEVELOPMENT OF IMMUNOASSAY SYSTEMS
The methods fo r  the preparation o f S-antigen and ROS are described 
below. The development of the ELISA assay systems invo lv ing these 
antigens, is also described.
3.1 PREPARATION OF RETINAL ANTIGENS
The princ ipa l re t in a l antigens investigated in th is  study were the
rod photoreceptor outer segment (ROS) membrane proteins and the
soluble p ro te in , S-antigen, extractable from the ROS. Bovine 
retinae were u t i l is e d  since the eyes were read ily  obtained in large 
quan tit ies , and common inter-species determinants have been found 
fo r  re tina  spec if ic  proteins (Brinkman et j i l_ ., 1979; Brinkman et
a l . ,  1980), including S-antigen (Dorey and Faure, 1977).
I t  is  known tha t ROS membranes consist of 80 to 90% opsin; other 
membrane or membrane associated proteins account fo r  the remainder 
(Heitzmann, 1972; Papermaster and Dreyer, 1974) (Figure 3.8). 
Although a mixture of po tentia l antigens, the ROS antigens w i l l  be 
referred to as the ROS antigen.
The ROS were prepared according to the method of Papermaster and 
Dreyer (1974) with minor a lte ra t io n s , and the S-antigen was 
p u r if ie d  by a modification o f the method o f Borthwick and Forrester 
(1983). The procedures involved in the preparation and p u r i f ic a t io n  
of the re t in a l antigens are described below.
3.1.1 Eye Dissection
The sclera was incised with a scalpel blade and the an te r io r
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portion o f the eye (containing cornea, lens, and i r i s )  together 
with the vitreous was removed. The posterio r eye cup was everted 
and the re tina gently detached from the RPE using a pasteur 
p ipette . The re tina  was suspended from i t s  attachment at the optic  
nerve head and rinsed with the hypotonic bu ffe r , in to  a beaker 
containing the appropriate bu ffe r (Section 2.2.1.1 and 3 .6 .1 ). The 
re tina  was then removed with scissors and dropped in to  the beaker. 
A ll procedures were carried out on ice.
3.2 PURIFICATION OF RETINAL S-ANTIGEN BY ION EXCHANGE 
CHROMATOGRAPHY
3.2.1 Preparation of Crude Retinal Extract
I t  has been shown tha t hypotonic bu ffe r aids the extraction  of 
soluble proteins from the ROS (Godchaux and Zimmerman, 1979). The 
retinae were dissected in to  the 2.5mM Tris/HCl hypotonic b u ffe r ,  pH 
7.5 (Section 2 .2 .1 .1 ), on ice. Approximately 5 to 10ml o f bu ffe r 
were used fo r  each re t ina . The suspension was homogenised by hand 
with a glass homogeniser, with about 5 or 6 passes, followed by 
u ltra ce n tr i fu g a t io n  at 80,000g fo r  60 minutes, at 4 °C. The 
supernatant containing the soluble material was collected and the 
p e l le t  discarded.
An equal volume o f cold saturated ammonium sulphate so lu t ion , 
adjusted to approximately pH 7.5 with ammonia, was slowly added to 
the supernatant, with constant s t i r r in g .  The p re c ip ita te  was 
allowed to s e tt le  overnight. The suspension was centrifuged a t 
12,000g fo r  30 minutes and the an t igen ica l ly  r ich  p e l le t  was 
dissolved in water. The sample was then dialysed against 0.15M 
saline to remove the ammonium sulphate, followed by d ia ly s is
against the 20mM Tris/HCl column s ta r te r  bu ffe r , pH 7.5 (Section
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2 .2 .1 .2 ) .  All procedures were performed at 4°C.
Prior to ion exchange chromatography, the crude soluble ex trac t was 
centrifuged at 80,000g fo r  60 minutes to remove aggregated prote in .
3.2.2 Preparation o f Column
DEAE-Sephacel (Section 2.1.3) was selected since i t  o ffe rs  
volumetric s ta b i1i t y  over the ion ic  concentrations employed, and 
also allows re la t iv e ly  high flow rates to be used. The column was 
assembled in an upright pos it ion at 4°C. A s lu r ry  of the Sephacel 
gel in s ta r te r  bu ffe r , was poured in to  the column and allowed to 
s e tt le  under g rav ity . The column was then equ il ib ra ted with at 
least 5 column volumes of the s ta r te r  bu ffe r (Section 2.2.1.2) a t a 
flow rate o f 50ml per hour.
3.2.3 Sample Application and Elution
Crude re t in a l ex trac t, prepared as described above, was applied to 
the column. The column capacity was 160mg/ml of ge l, and generally 
lOOmg of crude protein was applied to a 10ml column. The column 
was then washed through with at least 5 column volumes o f s ta r te r  
bu ffer to remove unbound m ateria l. A gradient consisting o f 250ml 
o f s ta r te r  bu ffe r and 250ml of 1.5M NaCl in s ta r te r  bu ffe r  was 
pumped through the column at the same rate as before. Fractions o f 
3 to 5m1 volumes were collected.
Total prote in concentration in the frac tions  was estimated by 
reading the absorbance at 280nm and the Bradford's prote in assay 
(Section 2 .3 .2 ). S-antigen was detected in the column fra c t ions  by 
use of an ELISA system developed fo r  S-antigen (Figure 3 .1 ). 
SDS-PAGE was used to tes t the p u r i ty  o f the frac tions  co llec ted .
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Figure 3.1 Detection of S-Antigen in Fractions of DEAE-Sephacel Column
The absorbance o f the eluent o f the DEAE-Sephacel ion 
exchange column, was measured at 280nm (A280), during the
p u r i f ic a t io n  o f S-antigen. The antigen was detected in most
column fra c t io n s , using the ELISA assay, with the ra t
monoclonal antibody S2.4.C5, spec if ic  for-S-antigen. The 
m a jo r ity  o f the S-antigen, however, was obtained in the
protein peak (A280) in the region o f 0.05M NaCl as 
demonstrated by ELISA, and also in SDS-PAGE (Figure 3.3).
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3.3 CHROMATOFOCUSING
When h ig h ly ’p u r if ie d  S-antigen was required fo r  immunisation o f DA 
rats fo r  monoclonal antibody production (Section 2 .6 .1 ) , fu r th e r 
p u r i f ic a t io n  was achieved by a means of a second, chromatofocusing 
column (Borthwick and Forrester, 1983). Chromatofocusing is  a 
chromatography technique which separates proteins according to 
th e ir  is o e le c tr ic  points (p i ) .  The technique was f i r s t  described by 
Sluyterman and Wijdenes (1977), who demonstrated tha t a pH gradient 
could be produced on an ion exchanger by taking advantage of the 
buffering capacity o f the exchanger's charged group. A pH gradient 
is  formed w ith in  a column when a bu ffe r , adjusted to a spe c if ic  pH, 
is  applied to an ion exchanger, equ ilib ra ted to a d i f fe re n t  pH. 
This pH gradient can be used to e lute proteins in order o f th e i r  
is o e le c tr ic  points.
In the present study, Polybuffer Exchanger 94 (PBE 94) and 
Polybuffer 74 (Pharmacia, Section 2.1.3) were u t i l is e d .  The pH 
range in th is  system is 7 to 4, which was suitable fo r  the 
p u r i f ic a t io n  'o f  S-antigen with i t s  pi of 5.5 (Borthwick and 
Forrester, 1983). The PBE 94 was equ ilib ra ted  to pH ‘6.2 and the 
S-antigen sample to be fu r th e r p u r i f ie d  was dialysed against the 
column bu ffer a t the same pH. The sample containing S-antigen was 
loaded onto the column, and at the s ta r t in g  pH of 6.2 the S-antigen 
was negatively charged and bound to the exchanger. During the 
application o f the eluent (PB 74) pH 4, a pH gradient was created. 
As the pH of the bu ffer surrounding the S-antigen decreased to a 
value below the pi o f the pro te in , S-antigen became p o s i t iv e ly  
charged and was repelled from the exchanger and migrated ra p id ly  
through the column u n t i l  i t  reached a position where the pH o f the
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buffer was above i t s  pi and the prote in became bound once more. 
This process occurred fo r  a l l  proteins present in the sample. The 
a tt ra c t io n  afid repulsion processes were repeated u n t i l  the proteins 
were eluted from the column in order o f th e ir  is o e le c tr ic  points.
3.3.1 Preparation o f Column
The gel was dispersed in the 25mM h is tid ine /H C l, pH 6.2 s ta r te r  
bu ffe r (Section 2.2 .1.3) to make a s lu rry .  The s lu r ry  was degassed 
p r io r  to packing. A column o f dimensions 1 x 13cm was used. The 
s lu r ry  was applied dropwise to keep the column f u l l  to the brim 
with bu ffe r , while the gel was packing. Packing was continued at a 
l inea r flow rate of 100ml/hour u n t i l  the gel bed had completely 
se tt le d , with a f in a l  bed volume of 10ml. I t  was convenient to 
equ il ib ra te  overnight with a reservo ir o f excess b u ffe r ,  over n ight 
at 4°C. The column was equ ilib ra ted when the pH o f the eluent 
matched tha t o f the s ta r te r  bu ffer.
3.3.2 Preparation of Sample
A sample of S-antigen p u r i f ie d  by ion exchange chromatography, was 
dialysed against the h is tid ine /H C l, pH 6.2 bu ffer (Section 2 .2 .1 .3) 
at 4°C. The d ia lys is  also removed the NaCl, present in the 
S-antigen eluted from DEAE-Sephacel columns (Section 3 .2 ) ,  which 
would in te r fe re  with the chromatofocusing.
3.3.3 Sample Application and Elution
A 5ml volume o f PB 74 (Section 2.1.3) eluent, pH 4.0, d i lu ted  1:8 
was applied to the equ il ib ra ted column, p r io r  to the app lica tion  of 
the sample in order to avoid exposure to extremes o f pH. 
Approximately lOmg o f S-antigen was applied in a volume o f 10ml. 
The sample was eluted with 12.5 column volumes o f the d ilu ted  PB 74
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Figure 3.2 Detection of Chromatofocusing P urif ied  S-Antigen
S-antigen, p u r i f ie d  by Chromatofocusing, was detected in the 
ELISA assay using a 1:1000 d i lu t io n  of ra t antisera, with 
s p e c i f ic i t y  fo r  S-antigen. The m a jo r ity  of S-antigen was 
detected in the pH range o f 4.8 to 5.6.
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at a flow rate o f 30 to 40ml per hour and 1ml frac t ions  were 
collected. During the e lu tion  procedure the pH of the column 
frac tions wfere measured (Figure 3.2). A ll procedures were carried 
out at 4°C.
The chromatofocusing PBE 94 was regenerated by the passage of two 
to three bed volumes of the s ta r te r  bu ffe r through the column, and 
was stored in 20% ethanol at 4°C, when not in use.
3.4 DETECTION OF S-ANTIGEN, YIELD AND PURITY
3.4.1 Detection of S-Antigen
S-antigen, p u r i f ie d  by ion-exchange chromatography and 
chromatofocusing, was detected immunologically in  ELISA (Sections
3.8.2 and 3 .8 .3 ) , by applying d i re c t ly  to the p la te , 50jj1 o f each 
o f the column frac tions  to be tested, or a 10 fo ld  d i lu t io n  o f the 
fra c t ions . I n i t i a l l y ,  S-antigen was detected using the rabb it 
anti sera of Borthwick and Forrester (1983), raised against bovine 
S-antigen. In subsequent preparations, the protein was detected by 
means of antibody raised in rats against S-antigen, e ith e r 
polyclonal antiserum (Section 3.8.1) or monoclonal antibody S2.4.C5 
(Chapter 6), when i t  became ava ilab le. The monoclonal antibody was 
preferable since i t  has been shown to be spec if ic  to S-antigen in 
immunoblotting experiments, against crude re t in a l proteins and 
ir re levan t proteins (Figures 6.7 and 6.11).
Immunologically S-antigen could be detected in most column 
frac tions  a f te r  ion exchange chromatography, although i t  tended to 
remain bound to the column during the wash p r io r  to the app lica tion  
of the gradient, providing tha t the column had not been overloaded 
with the crude m ateria l. The most intense reactions in ELISA were
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obtained fo r  the frac tions  around the peak absorbance a t 280nm, in 
the region 0.05M NaCl (Figure 3 .1 ), and showing S-antigen to form 
the major band a f te r  SDS-PAGE (Figures 3.3 to 3.5). The detection 
o f S-antigen in the ELISA over such a wide range o f frac t ions  was a 
re f le c t io n  o f the s e n s i t iv i t y  o f the assay system, which is  capable 
of the detection of antigen at nanogram quan tit ies . Minute 
quantit ies o f S-antigen d issocia ting from the column before the 
major peak, were thus e a s ily  detected.
The m a jo r ity  o f the S-antigen, p u r i f ie d  by chromatofocusing, was 
detected by ELISA in the column frac tions  w ith in  the pH range of 
4.8 to 5.6 (Figure 3.2). The is o e le c tr ic  point of S-antigen is  
known to be 5.5 (Borthwick and Forrester, 1983), thus, th is  is  the 
pH region in which i t  is  l i k e ly  to be eluted.
3.4.2 Electrophoretic Id e n t i f ic a t io n  o f S-Antigen
Column frac tions  were subjected to SDS-PAGE (Section 2.3.4) as a 
c r i te r io n  fo r  p u r i ty .  Both Coomassie Blue (Section 2.3.5) and 
s i lv e r  sta in ing (Section 2.3.6) methods were u t i l is e d .  S-antigen 
p u r i f ie d  by ion exchange chromatography (Section 3 .2 ), was 
id e n t i f ie d  as the major band with an apparent molecular weight in 
the region o f 50K, a f te r  SDS-PAGE (Figures 3.3 to 3.5). Figure 3.3 
shows a Coomassie Blue stained gel o f column frac tions obtained 
from the protein peak in the region o f 0.05M NaCl, which gave 
intense readings in the ELISA assay (Figure 3.1). Due to the high 
prote in concentration in th is  region, the contaminating proteins 
are more e a s ily  seen. Some of these contaminants might represent 
breakdown products o f S-antigen, and micro-aggregates o f these. 
This was shown by the reaction o f several minor bands in 
immunoblots (Section 2.9) o f the S-antigen containing column
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Figure 3.3 SDS-PAGE of S-Antigen Purif ied  on a DEAE-S'ephacel Column
Column fra c t io n s , o f volume 5ml, containing S-antigen 
p u r i f ie d  by ion-exchange chromatography on a DEAE-Sephacel 
column, were subjected to SDS-PAGE as c r i te r io n  o f p u r i ty .  
The p u r i ty  o f 15jul samples o f fra c t io n s , obtained from the 
S-antigen containing peak (Figure 3 .1 ), was shown in a 12.5% 
gel stained with Coomassie Blue.
LANES
1 to 4, 7 to 9. Consecutive column frac tions
5. Pharmacia low molecular weight standard proteins
6. S-antigen from a previous preparation
9 4 . 0 0 0
67 . 0 0 0
43 . 0 0 0
3 0 . 0 0 0
21,100
1 2  3 4  5 6 7 8 9
Figure 3 .4  SDS-PAGE of S-Antigen Purif ied  on a DEAE-Sephacel Column
Column fra c t io n s , o f volume 5ml, containing S-antigen 
p u r i f ie d  by ion-exchange chromatography on a DEAE-Sephacel 
column, were subjected to SDS-PAGE as c r i te r io n  o f p u r i ty .  
The p u r i ty  o f 5jul samples o f fra c t io n s , obtained from the 
S-antigen peak, was shown in a 12.5% gel stained with 
Coomassie Blue.
The S-antigen was the only band detected in the Coomassie 
Blue s ta in , however, s i lv e r  sta in ing of s im ila r  frac tions  on 
the same gel, revealed a few contaminating bands (Figure 
3 .5).
LANES
1. Pharmacia low molecular weight standard proteins 
2 to 5. Consecutive column frac tions
6. Crude re t in a l extract
I94 ,000 --------
*
67,000
'
-------------  m
4 3 ,0 0 0 --------
3 0 ,0 0 0 -------- ■—
2 0 ,1 0 0 -------
1 2 3 4 5 6
Figure 3.5 P urity  of S-Antigen in a S i lv e r  Stained Gel
Samples of 5j l i 1 were obtained from frac tions  containing 
S-antigen p u r i f ie d  on a DEAE-Sephacel column, and 
electrophoresed in a 12.5% ge l, followed by sensitive s i lv e r  
sta in ing (Wray et a l . ,  1981).
The S-antigen was the major band detected a f te r  s i lv e r  
s ta in ing , however, a few contaminating bands were evident, 
compared with the less sensitive Coomassie Blue stain 
(Figure 3.4).
LANES
1. Crude re t in a l extract
2. Pharmacia low molecular weight standard proteins
3. 4 and 5. Consecutive column frac tions
9 4 .0 0 0
6 7 .0 0 0
4 3 .0 0 0
3 0 .0 0 0
20,100
1 2
Figure 3.6 SDS-PAGE of S-Antigen Purif ied  by Chromatofocusing
Samples o f lO^ ul were obtained from chromatofocusing 
frac tions  which generated the most intense reactions fo r  
S-antigen in the ELISA, and electrophoresed in a 12.5% gel, 
and stained with a sensitive s i lv e r  s ta in .
LANES
1 to 8. Consecutive chromatofocusing trac tions
LMW: Pharmacia low molecular weight standard proteins 
S: S-antigen, used as a marker
 96,000
—    67,000
 43,000
 30,000
LMW S
/
frac tions  with the IgG monoclonal antibody, S2.4.C5 (Chapter 6). 
Figures 3.4 and 3.5, compare s im ila r  gels o f S-antigen, p u r i f ie d  by 
ion-exchange’ chromatography, stained with Coomassie Blue and by a 
s i lv e r  s ta in ing technique. The s i lv e r  sta in o f the p u r i f ie d  
S-antigen showed tha t i t  was about 90% pure.
The m a jo r ity  o f the S-antigen, p u r i f ie d  by chromatofocusing, was 
recovered in the column frac tions  w ith in  the pH range o f 4.8 to 5.6 
(Section 3.4.1 and Figure 3.2). Figure 3.6 shows a Coomassie Blue 
stained gel o f S-antigen obtained from th is  region. The presence o f 
the e lu t ion  Polybuffer, which contains a mixture of s a l ts ,  caused 
d if fu s io n  o f the samples during the i n i t i a l  stages of SDS-PAGE. The 
resolution was apparently unaffected by the i n i t i a l  d i f fu s io n  
(Figure 3.6). The major prote in detected a f te r  SDS-PAGE had a 
molecular weight in the region o f 50K (Figure 3.6).
The column frac t ions  were pooled according to th e i r  p u r i ty  and 
protein content evident in SDS-PAGE.
3.4.3 Protein Estimation
During ion-exchange chromatography, an estimate o f protein content 
was given by measuring the absorbances o f the column fra c t ions  a t 
280nm (Figure 3.1). Unbound material was eluted during the wash o f 
the column p r io r  to the application o f the gradient. As the s a l t  
gradient progressed, S-antigen was eluted in a peak in the region 
of 0.05M NaCl (Figure 3.1).
Pooled column frac tions  of both ion exchange and chromatofocusing 
columns were subjected to the Bradford's protein assay (Section 
2.3.2) fo r  a more accurate value o f prote in concentration. When
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Figure 3.7a SDS-PAGE of Purif ied  S-Antigen stained with PAS Reagent
The PAS reaction was determined fo r  approximately 20pg 
S-antigen, in an 8.5% SDS gel (Section 2 .3 .7 ).
The reaction was very weak, and sharply contrasted to tha t 
obtained fo r  opsin (Figure 3.7b).
S-ant igen
Figure 3.7b SDS-PAGE of Bovine ROS Membranes stained with PAS Reagent
The PAS reaction o f bovine ROS (Section 3 .6 .1 ), 
electrophoresed in an 8.5% gel and stained as described in 
Section 2.3.7.
An intense reaction was obtained fo r  opsin, which provided a 
pos it ive  sta in ing control fo r  tes t ing  o f S-antigen (Figure 
3.7a). The reaction observed below the dye f ro n t ,  may 
represent g ly c o lip id  material which was not v is ib le  in the 
Coomassie Blue sta in fo r  prote in (Figure 3.8).
Opsin
Dye front
lOOmg of crude protein was applied to a 10ml column o f 
DEAE-Sephacel, approximately 3.4mg of S-antigen could be obtained, 
giv ing a y ie ld  o f 3.4%. The preparation was reasonably pure, 
forming the only one major band in SDS-PAGE, even when the h igh ly  
sensitive  s i lv e r  sta in  (Wray et al_., 1981) (Section 2.3.6) was 
employed (Figure 3.5).
When lOmg of S-antigen was applied to the chromatofocusing column, 
s l ig h t ly  less than lOmg were recovered in the pooled fra c t io n s . 
This was presumably due to the loss o f protein during the 
procedure, in addition to the removal o f contaminating pro te in .
3.5 CHARACTERISTICS OF PURIFIED S-ANTIGEN
3.5.1 Periodic Acid S c h if f 's  Staining o f S-Antigen
Purif ied  S-antigen was tested fo r  carbohydrate content by the 
periodic acid S c h if f 's  (PAS) reaction (Section 2 .3 .7 ) ,  a f te r  
SDS-PAGE. A very fa in t  sta in ing was obtained fo r  S-antigen, even 
when 20jjg of the prote in was applied to the gel (Figure 3.7a), 
which may indicate the presence o f a small carbohydrate moiety. The 
PAS . reaction obtained fo r  S-antigen contrasted with the intense 
reaction observed fo r  opsin (Figure 3.7b). The ROS provided a 
pos it ive  sta in ing control since the N-terminal of opsin is  known to 
be r ich  in carbohydrate residues (H e lle r, 1968).
3.5.2 Uveitopathogenicity o f S-Antigen
The uveitopathogenic a c t iv i t y  o f bovine S-antigen p u r i f ie d  
according to the procedures described above was v e r i f ie d  by the 
induction o f EAU in Duncan-Hartley guinea pigs, fo llow ing the 
in je c t io n  o f S-antigen (Section 6.6).
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3.6 ISOLATION OF PHOTORECEPTOR ROD OUTER SEGMENTS
The re t in a l photoreceptor rod outer segments (ROS), o f c a t t le  and 
ra ts ,  were prepared on a discontinuous sucrose gradient, 
e sse n tia l ly  by the method o f Papermaster and Dreyer (1974), w ith 
minor modifications.
3.6.1 Procedure
The re tina  were dissected out (Section 3.1.1) in to  the 34% sucrose 
solu tion (Section 2 .2 .3 .3 ) ,  in order to f lo a t  the ROS (eg. from 50 
bovine eyes). The retinae were gently s t i r re d  and sw irled. The 
suspension was centrifuged a t l,600g fo r  5 minutes in a Sorvall SS34 
ro to r and the supernatant containing the ROS was retained. The 
pe lle ts  were resuspended together in about 25ml o f the 34% sucrose 
so lu tion . Smaller volumes were required fo r  preparing ra t  eyes. The 
suspension was centrifuged fo r  approximately 8 minutes a t l£00g and 
the supernatant was co llected, and added to the f i r s t  supernatant. 
Twice the volume of lOmM Tris  acetate (pH 7.4) (Section 2 .2 .3 .2 ) 
was then added to the pooled supernatants. The mixture was then 
centrifuged in a Beckman T i60 ro to r  at 21,000g fo r  approximately 30 
minutes. The supernatant was collected and frozen at -70°C fo r  
subsequent use in the preparation o f S-antigen (Section 3 .2 ). The 
pe lle ts  containing the ROS membranes were resuspended in  18ml o f 
density 1.10 sucrose solu tion (Table 3 .1 ). Aggregates o f the crude 
ROS material were dispersed by passage through f in e  gauge G21 
needles (Section 2.1.19).
Sucrose solutions fo r  density gradients are displayed in Table 3.1. 
The sucrose gradients were made in s ix  tubes according to the 
capacity of the SW40 ro to r.  The layers o f sucrose solutions were 
applied using a pasteur p ipe tte , in volumes of 3ml. The ROS samples
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Table 3.1 Solutions required fo r  the preparation of sucrose gradients*
Sucrose solutions fo r  density gradients 
Stock Density Density Density Density
solutions 1.15 1.13 1.11 1.10
42% sucrose solution 93.OOg 81.40g 68.40g 62.40g
1.0M Tris  acetate, pH7.4 lOOpl lOOpl lOOpl lOOpl
0.1M MgCl lOOpl lOOpl lOOpl - lOOpl
To f in a l  weight
with d is t i l l e d  l^O 115.OOg 113.OOg lll.OOg 110.OOg
*Papermaster and Dreyer (1974)
were applied to the top o f the gradients in volumes o f 3ml. The 
tubes were topped up and balanced using e ith e r additional crude ROS 
in density 1.10 sucrose, or the density 1.10 sucrose so lu tion 
alone. The tubes were u ltracen tr ifuged at 95,000g fo r  2 hours. The 
p u r i f ie d  ROS forming bands between density 1.11 and density 1.13 
sucrose layers, were collected. The samples were d ilu ted  with lOmM 
Tris  acetate bu ffe r at twice the sample volume. The suspensions 
were centrifuged in a Beckman centr ifuge, fo r  30 minutes at
21,000g. The pe lle ts  were resuspended in the T r is  bu ffe r ,  and
centrifuged as before. This washing procedure was repeated several 
times when required. The pe lle ted ROS were stored in  Eppendorf 
tubes (Section 2.1.23) a t -20°C or -70°C.
3.6.2 Reduction o f S-Antigen Content
Some experiments performed during the course of th is  study required 
a reduction in the S-antigen content o f the ROS so tha t antibody 
responses to rhodopsin and other insoluble proteins could be more 
read ily  induced or measured. The f in a l  step in the method o f 
Papermaster and Dreyer (1974) involved two washes o f the ROS. The
soluble proteins of the ROS may be reduced by repeated washing o f
the p u r i f ie d  membranes (Section 3 .6 .1 ) , especia lly  a f te r  ly s is  by 
freezing and thawing. Membrane associated prote ins, such as 
S-antigen, may be more res is tan t to removal by washing, espec ia lly  
under il lum inated working conditions. The supernatants from the 
repeated washing o f the ROS were therefore tested fo r  S-antigen in 
ELISA using i n i t i a l l y  antisera and subsequently monoclonal antibody
S2.4.C5 (Chapter 6 ), raised against bovine S-antigen, to determine 
the degree o f contamination o f the ROS antigen w ith soluble 
proteins.
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Figure 3 .8  SDS-PAGE of isolated ROS Membranes
Bovine ROS were prepared according to a method based on that 
o f Papermaster and Dreyer (1974) (Secton 3.6 .1). A fte r 
washing the ROS membranes 5 times, in 1'OmM Tris  acetate 
bu ffe r ,  pH7.4, very l i t t l e  S-antigen could be detected in 
the Coomassie Blue stained 8.5% gels a f te r  SDS-PAGE. Opsin 
appeared to represent over 80% of the prote in (Lane 2).
LANES
1. Pharmacia low molecular weight standard proteins
2. Bovine so lub il ised  ROS membranes
9 4 .0 0 0
6 7 .0 0 0
4 3 .0 0 0
3 0 ,000
20,100
S-antigen was found to pe rs is t a t low levels in the supernatants 
a f te r  as many as 25 washes in 15ml volumes o f the ROS (1ml p e l le t ) ,  
by the application of supernatant to ELISA plates and use o f 
spec if ic  antisera fo r  the detection. Figure 3.8 shows an SDS 
polyacrylamide gel o f ROS which were washed 5 times. In Coomassie 
Blue stained gels, no S-antigen could be detected in ROS which had 
been washed 10 times. Generally, 5 washes o f the ROS p e l le t  were 
found to remove most of the S-antigen, although i t  could s t i l l  be 
detected in immunoblotting procedures using the monoclonal antibody
S2.4.C5 (Chapter 6).
3 . 7 STABILITY OF STORED RETINAL ANTIGENS
Puified S-antigen frozen at -70°C remained stable fo r  long periods. 
Stocks in  routine use, stored a t -20°C, were found to degrade upon 
re-freezing and thawing; degradation products were observed upon 
SDS-PAGE and the major band decreased in molecular weight. In 
add it ion , the prote in concentration decreased, especia lly  when the 
o r ig ina l amount o f protein was low, presumably due to the prote in 
forming insoluble p rec ip ita tes , or adhering to the walls o f the 
vessels. Consequently, repeated freeze-thawing was avoided.
The ROS membranes stored at -70°C were s im i la r ly  stable. The ROS, 
when subjected to repeated freeze-thawing, was apparently more 
stable than the S-antigen, probably due to the higher prote in  
content o f the preparation o f ROS. The ROS in sample bu ffe r  
(Section 2 .2 .5 .5 ) ,  however, tended to aggregate during storage a t 4 
°C.
3.8 DEVELOPMENT OF THE ELISA ASSAY SYSTEMS
The ELISA assay, f i r s t  described by Engvall and Perlman (1971), was
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employed throughout the course o f th is  study fo r  the screening of 
column frac tions  a f te r  the p u r i f ic a t io n  o f S-antigen (Section
3.4.1) and o f the monoclonal antibody, S2.4.C5 (Section 6.5.2) and 
also fo r  the screening o f human and ra t  sera and ce ll  cu ltu re  
supernatants against S-antigen and ROS (Chapters 4, 5 and 6). The 
ELISA assay was selected because o f i t s  high s e n s i t iv i t y  and
re p ro d u c ib i l i ty .  I t  also provided a rapid and convenient assay, 
enabling large numbers o f samples to be screened simultaneously. 
The methodology was s im ila r  to tha t o f Tuyen _et aj_. (1982), with 
modifications.
3.8.1 S p e c if ic i ty  o f Antisera
Rat polyclonal an tisera , raised against bovine S-antigen and ROS, 
were obtained upon the s a c r if ice  o f immunised animals (Section
2.6.1) fo r  the purposes of fusions (Section 2 .6 .4 ). The an tisera , 
with s p e c i f ic i t y  to S-antigen, was used in the screening of column 
fra c t io n s , in  the ELISA assay (Sections 3 .8 .3 ) , during the
p u r i f ic a t io n  o f the prote in . Rat antisera to S-antigen and ROS 
insoluble prote ins, were also used as pos it ive  ELISA reaction 
con tro ls , fo r  the screening o f ra t  and human sera, and ce l l  cu ltu re  
supernatants (Chapters 4, 5 and 6).
A ll  antisera obtained demonstrated a serum t i t r e  in ELISA o f at
least 2000 (eg. Figure 3.10). The s p e c i f ic i t ie s  o f antisera to
S-antigen and ROS were confirmed in immunoblotting experiments
(Section 2 .3 .7 ). Figure 3.9 shows the s p e c i f ic i t y  o f one ra t
polyclonal antiserum to S-antigen, when immunoblotted against crude
125re t in a l proteins and p u r i f ie d  S-antigen using the I prote in  A 
(Sections 2.1.7,12) detection system (Sections 2 .3 .7 .6 ,7 ) .  In th is  
experiment i t  was shown tha t the second antibody employed, ra bb it
122
Figure 3.9 S p e c if ic i ty  of a Rat Anti serum to S-Antigen in Protein A
Immunoblots
The s p e c i f ic i t y  o f the one anti serum used in the ELISA
assays, was tested by immunoblotting. In the experiment
125shown in th is  Figure, the I prote in A detection system 
was u t i l is e d  (Section 2 .3 .9 .6 ,7 ) . This involved the use o f a 
second antibody; rabb it a n t i - ra t  IgG(H+L).
Neither the prote in A (a) or the second antibody, rabb it 
a n t i - ra t  IgG(H+L) * (b ), nonspec if ica lly  interacted with the 
re t in a l pro te ins, when the primary antibody was omitted. No 
reaction could be detected with the ra t  anti serum, raised 
against S-antigen, when the second antibody was omitted (c). 
The use o f the ra bb it  second antibody enabled the reaction 
o f the ra t  antiserum to be detected (d).
The ra t  antiserum was f a i r l y  spec if ic  to S-antigen. The 
contaminating bands might ind icate the presence of 
antibodies to proteins which contam inated  the immunising 
antigen, or they may represent breakdown products of 
S-antigen and micro-aggregates o f these.
An Amido black stained bl.ot is  shown at (e).
LANES
1. Pharmacia low molecular weight standard proteins
2. Solub ilised ROS membranes
3. Crude re t in a l extract
4. S-antigen
a b c d • e
1 2 3 4  1 2 3 4  1 2 3 4 1  2 3 4  1 2  3 4
a n t i - ra t  IgG(H+L) (Section 2.3 .7.4) and the prote in A, did not 
react with the re t in a l antigens or the standard marker prote ins.
The antisera employed in the experiment, shown in Figure 3.9, 
reacted in tensely with the p u r i f ie d  S-antigen and the S-antigen 
w ith in  the crude re t in a l ex trac t. S-antigen was also detected 
w ith in  the resolved ROS prote ins, which had been washed 5 times in 
order to remove most of the soluble antigens (Section 3 .6 .2 ) . A few 
bands, in  addition to the S-antigen band, were apparent in the 
autoradiograph. This may have indicated the presence o f antibodies 
raised against minor contaminants present w ith in  the immunising 
antigen, or the bands could be breakdown products o f S-antigen, and 
microaggregates o f these.
3.8.2 Antigen Coating
Dynatech m ic ro t i t ra t io n  plates (Section 2.1.19) were pre-rinsed in 
d is t i l l e d  water and dried before use. The plates were then coated 
with S-antigen d ilu ted  in the column s ta r t  bu ffe r (20mM Tris /HC l, 
pH 7.5, Section 2.2 .1.2) since th is  was the bu ffe r o f the stock 
prote in . Where bovine ROS were used as the antigen, the plates were 
pre-treated with po ly-L-lys ine (Section 2.1 .12), lOjjg/ml in PBS 
(Section 2 .2 .4 .1 ) ,  100/j1 per w e l l ,  fo r  one hour. The plates were
then rinsed in PBS and dried before coating with ROS so lu b il ised  as 
described in  Section 3.8.6. Generally the plates were coated with 
50 to lOOpl per well o f a so lu tion containing lpg/ml o f S-antigen 
or 5pg/ml of ROS pro te in . Antigen coating was achieved a f te r  an 
incubation o f one hour at room temperature, or 18 hours a t 4°C.
A high pH o f coating bu ffe r was not used to increase antigen 
binding (Engvall and Perlman, 1971) since the neutral pH o f the
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res t o f the ELISA procedure may f a c i l i t a t e  leaching o f antigen.
3.8.3 The ELISA Procedure
The antigen coated ELISA plates were rinsed three times in the wash 
b u ffe r , and dried by vigorous application o f the plates onto 
tow e lling . The plates were then blocked with 100/jI per well o f the 
BSA blocking bu ffe r with e ith e r normal rabb it serum ( fo r  ELISA 
assays with ra t  serum samples) or normal goat serum ( fo r  assay o f 
human serum). The plates were washed and dried as before. The 
antibodies to be tested were d ilu ted  in PBS with 0.05% Tween 20 and
0.5% BSA (Section 2.2 .4.2) and applied to the plates at lOOjul per 
w e ll .  The plates were then incubated at room temperature fo r  30 to 
60 minutes, or overnight at 4°C. The plates were washed thoroughly 
in  the PBS-Tween bu ffe r and dried in the usual manner. A 1:1000 
d i lu t io n  o f the rabb it anti-species ( ra t  or human) IgG(H+L) 
peroxidase conjugate (Section 2.1 .16), in the d i lu t in g  b u ffe r ,  was 
applied a t IOO^ jI per w e l l ,  and incubated at room temperature fo r  30 
minutes. They were washed thoroughly, and dried. The plates were 
then incubated in  the dark with lOOpl per well the substrate, fo r  
approximately 10 minutes, with occasional but b r ie f  inspection. The 
reaction was terminated by the addition o f 50jj1 per well o f 4N H^ SO^  
(Section 2 .1 .9 ) , including the f i r s t  column of the p late which 
served as a blank on which to read the absorbances at 492nm, in a 
T ite r t re k  Multiskan spectrophotometer. The resu lts  were obtained in 
the form o f a numerical p r in tou t o f the absorbances.
3.8.4 The ELISA Chequerboard
Suitable antigen concentrations fo r  ELISA plate coating were 
determined using a chequerboard system. Doubling d i lu t io n s  of the 
antigen concerned were made e ithe r across or down the p la te , and
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incubated as described in Section 3.8.3. A fte r washing and blocking 
the plates (Section 3 .8 .2 ) , the plates were treated with doubling 
d i lu t io n s  o f the appropriate antibody made in the opposite 
d irec t ion  to tha t o f the antigen. The ELISA protocol was continued, 
as described in  Section 3.8 .3, and the resu lts  examined in order to 
select a concentraton of antigen su itable fo r  detecting antibody at 
a chosen d i lu t io n .  Figure 3.10 shows the resu lts  obtained fo r  a 
chequerboard experiment with S-antigen and a ra t an ti serum raised 
against th is  prote in (see below).
3.8.5 The S-Antigen ELISA
In th is  system, a useful concentration o f S-antigen fo r  the coating 
o f ELISA p la tes, was determined using chequerboard systems (Figure 
3.10) (Section 3 .8 .4 ). Figure 3.10 shows the e f fe c t  o f decreasing 
antigen concentration on the ELISA reaction at constant antibody 
concentration, and also the e f fe c t  o f increasing antibody d i lu t io n  
while the concentration o f antigen remained constant. Generally 
m ic ro t i t re  plates are coated with a so lu tion o f 1 to 10/jg/ml o f 
soluble prote in . A useful concentration of S-antigen was found to 
be in the region o f l j jg /m l, when the plates were coated w ith 50 to 
100/il volumes o f antigen. At th is  concentration, ra t  antiserum 
t i t r e s  o f several thousand could be detected, above the same 
d ilu t io n s  o f pre-immune serum (Figure 3.10). In Figure 3.10 the 
ELISA reaction is  shown to decline f a i r l y  ra p id ly ,  as the 
concentration o f the coating antigen is  reduced, while the serum 
d i lu t io n  remains constant at 1:200. th is  suggests tha t antigen 
concentrations below l^ig/ml, might be less su itab le  fo r  the 
detection o f low antibody concentrations.
Figure 3.10 also demonstrates the s e n s i t iv i t y  o f the ELISA
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Figure 3.10 Chequerboard ELISA Experiment with S-Antigen and Rat Antiserum
The determination o f a su itable concentration o f S-antigen, 
and d i lu t io n  of ra t polyclonal antiserum, to use in the 
ELISA assays, involved a chequerboard experiment (Section 
3 .8 .4 ,5 ).
The in te n s ity  o f the ELISA reaction (A494 value) decreased 
when the concentration of S-antigen was reduced, and the 
d i lu t io n  o f the ra t polyclonal antiserum remained constant, 
a t 1:200.
The ELISA reaction also decreased when the d i lu t io n  of the 
antiserum was increased, while the antigen concentration 
remained constant, at l j jg /m l. A s im ila r  experiment was 
performed with pre-immune ra t serum. The high t i t r e  of the 
antiserum is  evident, in comparison with the reaction 
obtained with the pre-immune serum. The t i t r e  of th is  
antiserum appeared to be greater than 50,000, ie . generating 
an ELISA reading above that o f the pre-immune serum, at a 
d i lu t io n  o f 1:51,200.
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Lecnrnque, since the 1:200 d i lu t io n  o f antisera was able to detect 
S-antigen in nanogram quan tit ies . The ELISA assay with S-antigen 
was found to give reproducible resu lts .
3.8.6 The ROS ELISA
The ROS employed in the ELISA assay were stored frozen, were lysed 
upon thawing, and were so lub il ised  by means o f mild detergents. 
Thus whole ROS were not applied to the plates. During the 
development o f an ELISA su itable fo r  the ROS antigens, three
d if fe re n t  detergents were investigated, fo r  the s o lu b i l is a t io n  o f
/
the ROS. In add it ion , chequerboards, with and w ithout the 
pre-coating of the ELISA plates with lOjjg/ml po ly lys ine , (Section 
2.1.12) were made.
Volumes of 100^1, o f pe lle ted ROS membranes were so lub il ised  in 
e ith e r 7% Tween 20, T r iton  X-100 or CTAB (Section 2.1.10) in a 
to ta l volume o f 3ml o f PBS (Section 2 .2 .4 .1 ). Even a f te r  vigorous 
s t i r r in g ,  complete so lu b i l is a t io n  o f the ROS membranes was not 
achieved. The membranes apparently became more f u l l y  so lu b il ised  
upon d i lu t io n ,  to give approximately 5^g/ml of p ro te in , fo r  the 
ELISA, in PBS containing 0.05% the appropriate detergent. The Lowry 
assay (Lowry et aJL, 1951) (Section 2.3.3) was employed to give an 
estimate o f the to ta l protein concentration o f the solubiTsed ROS, 
since the detergents in te rfe red  with the Bradford prote in assay 
(Section 2 .3 .2).
Table 3.2 shows the e ffe c ts , on the ELISA reactions, of d i f fe re n t  
detergents used fo r  s o lu b i l is a t io n  o f the ROS, and the e f fe c t  o f 
■^e-treating the plates with po ly lys ine. Tween 20 (Section 2.1.10) 
was found to be unsuitable fo r  th e i r  s o lu b i l is a t io n ,  g iv ing r ise  to
variable readings while the concentrations o f po ly lys ine , antigen
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TABLE 3.2 The e f f ic ie n c y  o f d i f fe re n t  detergents and pre-coating 
o f the ELISA plates in assays invo lv ing ROS* as antigen
ELISA reaction recorded as A492
Anti-ROS 
Serum**
No
Detergent
Tween 20 Triton  X CTAB
+polylysine X 1.563 1.568 1.836 1.776
SD 0.434 0.331 0.013 0.138
-po ly lys ine X 0.797 0.325 0.717 1.624
SD 0.516 0.174 0.101 0.278
Pre-immune
Serum**
+polylysine X 0.057 0.073 0.069 0.100
SD 0.140 0.051 0.009 0.318
-po ly lys ine X 0.055 0.028 0.024 0.030
SD 0.018 0.006 0.005 0.011
* 5pg/ml
* *  D i lu t io n  1:500 
X Mean (8 assays)
SD Standard Deviation (n-1) 
+ Polylysine lOpg/ml 
- No po ly lys ine
and antibody remained constant. The pre-coating of the ELISA plates 
with po ly lys ine , 10jjg/ml in PBS, was found to improve the binding 
of the Tween 20 so lub il ised  ROS. This was indicated by the increase 
in the ELISA reading from 0.3 to 1.5 absorbance un its  at 492nm 
(A492). When no detergent was u t i l is e d  to so lu b il ise  the ROS, 
s im ila r  resu lts  were obtained (Table 3.2).
ELISA p la tes, pre-treated with po ly lysine and coated with the ROS, 
so lub il ised  in CTAB and Triton X-100 (Section 2.1 .10), gave r ise  to 
stronger reactions, with smaller standard deviations compared with 
ROS so lub il ised  in Tween 20. T r iton  X so lub il ised  ROS, gave lower 
readings compared to the CTAB so lub il ised  m ateria l, when po ly lys ine 
was not used.
Pre-treatment o f the plates with po ly lys ine increased the signal to 
noise ra t io ,  ie .  the reactions were increased to a greater extent 
with the antiserum, than with the pre-immune serum (Table 3 .2 ). 
Polylysine was also found to improve re p ro duc ib il ty ,  as shown by 
the smaller standard deviations (Table 3 .2 ), perhaps by
fa c i l i t a t in g  a more even coating o f the ELISA plates with ROS. Thus
polylysine was u t i lse d  in a l l  subsequent ELISA assays invo lv ing 
ROS.
Triton X-100 was selected fo r  the s o lu b i l is a t io n  o f the ROS
membranes, since i t  gave r ise  to more reproducible reactions 
compared to Tween 20 and CTAB. A useful concentration o f ROS
protein fo r  the coating o f the ELISA plates was found to be in the 
region o f 5/jg/ml, as indicated by chequerboard experiments (Section
3.8 .4).
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The preferred wash bu ffer contained 0.05% Tween 20 since the ROS 
tended to be more poorly solublised in th is  bu ffe r compared with 
the same concentration o f T r iton  X-100. Thus, the amount o f antigen 
leaching from the ELISA pla tes, might be reduced when Tween 20 is  
used, rather than Triton  X-100.
In comparison with the S-antigen ELISA, the assay with the ROS 
antigen showed s im ila r  s e n s i t iv i t y  and re p ro d u c ib i l i ty .
3.7 SUMMARY
Bovine re t in a l antigens were u t i l is e d  in th is  study since, they 
were re a d ily  available in large qu an tit ies , and s im i la r i t ie s  of 
certa in  re t in a l antigens between d i f fe re n t  species have been found, 
including opsin (0 'Tousa et a l . , 1985) and S-antigen (Section
1.2 .2 ). Rod outer segment (ROS) membranes were prepared by a 
s im ila r  procedure to tha t of Papermaster and Dreyer (1974) (Section 
3 .6). S-antigen was p u r i f ie d  to give the major band, upon s i lv e r  
s ta in ing (Figure 3 .5 ), by a method modified from tha t o f Borthwick 
and Forrester (1983) (Sections 3.2 to 3.3). The apparent molecular 
weight o f S-antigen was calculated to be 48K from the Pharmacia low 
molecular weight standard protein markers (Figure 6.14), however, 
some va r ia t ion  was observed in the molecular weights calculated 
from gels with d i f fe re n t  percentages o f acrylamide.
A fa in t  reaction was obtained fo r  S-antigen a f te r  the PAS reaction 
fo r  carbohydrates ind ica ting  the presence of a small carbohydrate 
moiety (Figure 3.7a). The S-antigen and ROS antigens were found to 
be h igh ly  antigen ic, inducing high serum t i t r e s  in DA ra ts  
subcutaneously immunised with approximately 5 0 ^  o f prote in in CFA 
(Section 2 .6 .1 ). The DA ra ts , however, remained re fra c to ry  to the
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induction o f EAU under these conditions. The uveitopathogenicity o f 
the S-antigen prepared fo r  th is  study was confirmed upon in jec t io n  
of 50 to lOOjug o f the protein in CFA in to  the hind foo t pads of 
Duncan-Hartley guinea pigs and Lewis rats (Section 6.6).
The optimal concentrations o f antigen and antibody fo r  use in the 
ELISA were determined by means of the chequerboard system (Section
3 .8 .4 ). The ELISA assay systems fo r  both antigens were found to be 
reproducible, generating very s im ila r  readings fo r  the same 
antibodies, both w ith in  one ELISA plate and between plates.
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CHAPTER FOUR
STUDIES ON THE HUMORAL RETINAL AUTOIMMUNITY IN 
RATS AND HUMANS
Chapter 4
STUDIES ON THE HUMORAL RETINAL AUTOIMMUNITY IN RATS AND HUMANS
In th is  chapter the extent of the humoral autoimmune response to 
re t in a l antigens is  examined in  ra ts  and humans. Section 4.1 
presents a detailed serum analysis o f two inbred s tra ins  o f the RCS 
ra t model fo r  human re t in a l degeneration, and three control s tra ins  
o f ra t .  In th is  study i t  was possible to compare gene t ica l ly  
s im ila r  ind iv idua ls , raised under iden tica l conditions. Section 4.2 
describes the resu lts  obtained from a much more l im ited  study of 
the serum antibody responses in human RP and uve it is  pa tien ts , and 
healthy contro ls.
4 .1 STUDIES ON RETINAL AUTQIMMUNITY IN RATS
The potentia l immunopathogenicity o f the rod outer segment 
components has been well established (Section 1.3) (reviewed by 
Faure, 1980). In view o f the accumulation o f the h igh ly  antigenic 
ROS debris in the subretinal space o f rats with inherited  re t in a l 
dystrophy, i t  has been suggested tha t these rats might become 
auto-sensitised to th e i r  re t in a l components (Chant and 
Meyers-El1i o t t ,  1982). C on fl ic t ing  evidence has, however, been 
reported with respect to the con tr ibu tion  o f an autoimmune
component to the degenerative process of the RCS ra t  re t ina  
(Section 1 .5 .6 ).
In an attempt to examine th is  problem fu r th e r ,  experiments were
conducted in order to investigate the extent of au tosens it isa tion
to the re t ina . The study was confined to the humoral immune
response of the dystrophic and control ra ts .
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4 .1 .1  Confirmation of Ocular Histopathology and presence of S-Antigen
Retinal dystrophy o f both s tra ins of RCS ra t employed in th is  
study, was confirmed by a h is to log ica l investiga tion  of pa ra ff in  
embedded sections o f alcohol and gluteraldehyde fixed eyes (Section
2.4 .1 ). Figures 4.1a,b show the histopathology at an advanced stage 
o f the degenerative process, fo r  a 9 week o ld , pigmented Hunter RCS 
ra t .  The section shown in Figure 4.1a was stained with monoclonal 
antibody S2.4.C5 to S-antigen (Chapter 6), in an in d ire c t  
immunoperoxidase procedure (Section 2.4.4) demonstrating the 
presence o f the prote in w ith in  the RCS ra t  photoreceptor ROS. 
S-antigen was apparently absent from the ROS membrane debris ly ing  
between the RPE ce ll  layer and the ROS. Figure 4.1b shows a 
section of RCS ra t  re tina  treated with an ir re le va n t monoclonal 
antibody as a negative con tro l. The nuclei were counterstained with 
haematoxylin.
At the l im i t  of the l ig h t  microscope, the histopathology resembled 
the e a r l ie s t  stages o f experimental autoimmune u ve it is  (EAU). The 
most obvious feature was the advanced d isso lu tion  o f the outer 
nuclear layer (ONL), which had been reduced to a double layer o f 
nuclei from the normal twelve (Figure 4.1b). The photoreceptor 
layer had become homogeneous and eos inoph il ic , in sections stained 
with eosin. Changes in the re t in a l pigment epithelium (RPE) 
included cytoplasmic swelling and an increase in the nuclear 
content. The RPE ce lls  also had attenuated processes containing 
melanosomes (Figure 4.1b). The RPE monolayer remained in ta c t  
suggesting that the blood re t in a l b a rr ie r  was s t i l l  in operation, 
and tha t there had been no major exposure of the antigenic ROS 
debris to the immune system.
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Figure 4.1 Sections of a 9 Week old Hunter RCS Rat Eye showing
cha rac te r is t ic  Retinal Histopathology and the presence of 
S-Antigen w ith in  Rod Photoreceptors
a) Localisation of S-antigen in RCS re tina  with MAb S2.4.C5 
Photographed at Magnification X 100
b) Immunocytochemistry control w ith an i r re le va n t ra t  MAb 
Photographed at Magnification X 400
S-antigen was loca lised in dewaxed sections of 
gluteraldehyde (4%) f ixed Hunter RCS ra t  eye, using an 
in d ire c t  immunoperoxidase technique. The reaction was mainly 
confined to the ROS. The band o f ROS membrane debris 
appeared unstained.
The essential h istopathological features included: a layer
o f ROS debris; reduction in the number o f photoreceptor 
nuc le i; change in nuclear and melanin content of the RPE.
KEY
1. Sclera
2. Choroid (pigmented and vascular)
3. Retinal pigment epithelium
4. Photoreceptor outer segment layer (with ROS debris *)
5. Photoreceptor inner segment layer
6. Photoreceptor nuclei (outer nuclear layer)
7. Outer plexiform layer (synapses)
8. Nuclei o f second order neurons (inner nuclear layer)
9. Inner plexiform layer (synapses)
10. Ganglion ce ll  layer

The RCS ra t was o r ig in a l ly  employed as a model fo r  cataract 
(Bourne et a il. ,  1938). Cataracts were observed in only two animals 
o f the approximately 50 RCS rats involved in th is  study. These 
animals were several months o ld , and most of the other animals were 
sacr if iced  before the cataracts could develop. I t  has been 
suggested tha t the cataracts which occur in the RCS rats may be 
in i t ia te d  by the tox ic  l i p id  peroxidation products, released by the 
degenerating photoreceptor c e l ls ,  which d iffuse  through the 
vitreous to the lens (Z ig le r  and Hess, 1985).
4.1.2 Experimental Approach
4.1.2.1 Animals
Populations o f 10 pigmented Hunter and 10 pink eyed Campbell RCS 
rats were used fo r  the study (Section 2.1.17). Control rats 
included 5 pigmented DA and 5 albino Wistar, as well as 10 ra ts o f 
the PVG s tra in  (Section 2.1.17) from which the Hunter s tra in  o f RCS 
ra t  derives i t s  pigmentation (Yates et aj_., 1974). Pigmented rats 
were included in the study since the presence of melanin w ith in  the 
pigment epithelium is  thought to slow the degenerative process 
(Yates et a l . ,  1974; La Vail and B a t te l le ,  1975). Such a slowing o f 
the process might also be re flec ted  in any concomitant immune
response. The small amount o f pigment in the RPE c e l ls  o f the
Campbell rats has been found to have an in s ign f ican t e f fe c t  in
delaying the disease (La Vail and B a tte l le ,  1975). The eyes o f the 
Campbell ra ts were grossly albino and ind ist ingu ishable  from alb ino 
eyes. Wistar ra ts were included as controls since alb ino animals
are prone to a l ig h t  induced re t in a l degeneration (Noell _et_ a l . ,  
1966; Noell, 1979). Pigmented DA rats were also included as an 
additional normal con tro l.
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Each ra t  was id e n t i f ie d  by a system of ear marking so tha t the 
reaction p ro f i le s  could be monitored at the ind iv idual le ve l.  The 
animals were bled, from the t a i l  a r te ry , at weekly in te rva ls  from 
the age of 3 weeks, the time of weaning, to 10 weeks, by which time 
the RCS ra t  photoreceptors have lo s t  th e ir  outer segments (Dowling 
and Sidman, 1962); the sera were stored at -70°C before use. The 
data presented shows readings fo r  the early  (3 week), middle (6 
week) and la te  (9 week) stages o f the re t ina l degenerative process.
4.1.2.2 Choice of assays
Three s im ila r  types o f assay were employed fo r  the serum study; the
ELISA, immunocytochemistry and immunoblotting. The assays were
s im ila r  in tha t they a l l  involved antigens in the so l id  phase,
which were f i r s t  incubated with the serum, followed by an
incubation with a rabb it a n t i - ra t  IgG(H+L) antibody, peroxidase
conjugated in the case of the ELISA and immunoperoxidase
techniques. The reactions were detected a f te r  incubation with the
125enzyme substrate, or with I protein A, in the case o f the
immunoblots. The IgG(H+L) second antibody detects a l l  ra t  isotypes 
including IgM, due to the l ig h t  chain epitopes. These techniques 
revealed d i f fe re n t  information about the antibodies in question, 
although they varied in th e i r  s e n s i t iv i ty .
The ELISA assay (Section 3.8) was selected because o f i t s  high 
s e n s i t iv i t y  and re p ro d u c ib i l i ty .  This assay was also sparing on 
antigen and allowed the simultaneous screening of large numbers of 
samples over a wide range of d i lu t io n s ,  in duplicate. However, the 
assay does not give biochemical or cyto logica l id e n t i f ic a t io n  of 
the spec if ic  antigenic prote ins.
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The ELISA plates were coated with approximately 5pg/ml of 
so lub il ised ," washed ROS membranes (Section 3.8.6) or lpg/ml of 
p u r i f ie d  bovine S-antigen (Section 3 .8 .5). The optimal
concentrations were determined by the chequerboard system with the 
appropriate antiserum and preimmune serum (Section 3 .8 .4 ). The 
plates were blocked with 50mg/ml o f BSA in order to avoid possible 
nonspecific reaction at the lower serum d i lu t io n s .  A ll serum 
samples were assayed against the same preparations o f S-antigen and 
were subject to iden tica l experimental conditions.
A ll t i t r a t io n s  were made in duplicate to ensure re p ro duc ib li ty . 
V a r ia b i l i t y  between plates fo r  the S-antigen ELISA was assessed by 
using monoclonal antibody S2.4.C5, with s p e c i f ic i t y  to S-antigen 
(Chapter 6), and preimmune serum obtained from a DA ra t ,  as 
pos it ive  and negative controls respective ly. These control 
antibodies were t i t r a te d  on each p la te . V a r ia b i l i t y  between the 
ELISA plates coated with ROS was assessed by the t i t r a t i o n  o f ra t  
anti-ROS serum and preimmune DA serum (pos it ive  and negative 
controls respective ly ). The readings obtained fo r  the omission of 
the primary antibody, gave an ind ica tion  of background. I f  the 
background reaction was over 0.08 absorbance u n its ,  at 492nm 
(A492), then the value was subtracted from a l l  other A492 values 
before the calcu la tions o f means and standard deviations were made 
(Appendix, Tables 4.1 to 4.30). Generally the background reaction 
was in the region o f 0.05 A492, and is  shown as a dotted l in e  in 
Figures 4.2 to 4.3.
Immunocytochemical assays were also performed (Sections 2.4 and 
4 .1 .7 ). These techniques allow the lo ca lisa t io n  of autoantigens
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w ith in  sections o f t issue. They also provide a range o f potentia l 
antigens with which serum antibody might react. However, these 
techniques are much less sensitive  than the ELISA, requ ir ing  lower 
serum d i lu t io n s ,  and generally require antibody of high a v id i ty  
(strength o f binding) and high s p e c i f ic i t y  (Polak and Van Noorden, 
1984).
Serum samples which demonstrated a pos it ive  response in the ELISA 
assay to e ith e r S-antigen or ROS (Section 4.1.5) were tested fo r  
th e ir  re a c t iv i ty  in sections of albino ra t re tina in an in d ire c t  
immunoperoxidase procedure (Section 2 .4 .4 ) , employing 
diaminobenzidine as the peroxidase substrate (Section 2 .2 .8 .4 ) .  
Albino ra t  eyes were u t i l is e d  since the peroxidase reaction product 
may nonspec if ica lly  adhere to the melanin granules present w ith in  
the re t in a l pigment epithelium and choroid. The eyes were f ixed  in 
70% alcohol and processed according to the method o f Sainte-Marie 
(1962) (Section 2 .4 .3 ) , which is  thought to  allow a greater 
preservation o f native antigens than conventional f ix a t io n  and 
embedding techniques.
In d ire c t immunofluorescence (Section 2.4.5) was also employed to 
allow a comparison with the studies made in other labora to ries . In 
these experiments frozen sections of an albino ra t  eye were 
u t i l is e d  (Section 2 .4 .5).
The protein A immunoblotting (Section 2.3.9) technique was u t i l is e d  
in order to assess the s p e c i f ic i t ie s  o f the pos it ive  serum 
responses detected in the ELISA study (Sections 4 .1 .4 -5 ). This 
technique enables the molecular weights o f the resolved antigens to 
be calculated. The immunoblotting procedure has the disadvantage in
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tha t the antigens are denatured. However, th is  can f a c i l i t a t e  the 
id e n t i f ic a t io n  o f relevant epitopes which are not exposed in the 
ELISA or immunocytochemical techniques.
The sera were d ilu ted  1:40 and incubated with the resolved antigens 
on the n itro ce llu lo se  s t r ip s ,  which had previously been blocked 
with 0.5% Tween 20 (Section 2 .2 .6 .2 ). The amount of Tween in the 
wash bu ffe r was reduced to 0.05%, which was thought to reduce the 
leaching of the lower a f f i n i t y  autoantibodies. The prote in A 
detection system was employed, with the intermediate antibody, 
rabb it a n t i - ra t  IgG(H+L) (Sections 2 .3 .9 .4 ,6 ) . Controls consisted 
o f age matched normal ra ts ,  the DA and PVG s tra ins . Age matched RCS 
and Wistar rats which gave no ind ica tion  o f a response in the 
ELISA, were also tested by immunoblotting. The omission of a 
primary antibody provided a control to assess any nonspecific 
in te rac tion  o f the intermediate rabb it antibody with the resolved 
re t in a l antigens, or the Pharmacia low molecular weight standard 
protein markers (Figure 3.9).
4.1.3 Method of ELISA Data Presentation
The responses of sera from populations o f RCS and control rats a t ,
3, 6 and 9 weeks o f age, to bovine solublised rod outer segment
membranes (Section 3.8.6) and p u r i f ie d  S-antigen (Section 3.8.5) in 
ELISA assays are recorded in Tables 4.1 to 4.30 (Appendix). The
resu lts  fo r  the ind iv idual animals are recorded as the mean o f two
assays with standard deviations (S.D.). In add it ion , the mean and
S.D. fo r  each s tra in  are recorded fo r  each time in te rv a l .  The mean 
and S.D. fo r  Campbell s tra in  o f RCS ra t  were calculated with and 
without the apparently pos it ive  sera (Tables 4.1 to 4.6, Appendix), 
since these animals were found to have a s ig n if ic a n t  a f fe c t  on the
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mean fo r  the whole s tra in . The means which do not include the 
pos it ive  Campbell rats are used only in Figures 4.3a,b,c where the 
mean including a l l  of the Campbells is  also shown. Figures 4.3a to 
4.3c, presents the ELISA t i t r e s  of the Campbell ra t  sera, which 
generated reactions to S-antigen and/or ROS above those o f the 
apparently unresponsive l i t te rm a te s . The responses fo r  the ra ts are 
shown at 3, 6 and 9 weeks to both antigens, to allow comparisons to 
be made. The resu lts  are described Section 4.1.5.
In Figures 4.2a to 4.2e, the mean responses of RCS and control ra t 
sera to S-antigen and ROS at 3, 6 and 9 weeks are g raph ica lly
portrayed. Figure 4.2 enables the comparison of the mean responses 
of the d i f fe re n t  s tra ins  of RCS and control rats to the d i f fe re n t  
antigens at the d i f fe re n t  ages (Sections 4.1.4 to 4 .1 .6 ).
Figures 4.4 and 4.5 compare the ELISA responses to both antigens o f 
a l l  the s tra ins of ra t ,  at serum d i lu t io n s  of 1:20 and 1:80, 
respective ly (Sections 4.1.4 to 4 .1 .6 ). The points represent the 
mean of two assays fo r  each ind iv idual ra t .  The mean fo r  each 
s t ra in ,  at each p a r t icu la r  d i lu t io n ,  is  indicated by a bar.
At the 1:20 d i lu t io n ,  the A492 readings are more scattered (Figure
4 .4 ), as well as being higher, than those at the 1:80 d i lu t io n  
(Figure 4.5). The range of scatte r o f the points at the 1:20 
d i lu t io n s ,  was wider fo r  S-antigen than ROS (Figure 4 .4 ). At the 
1:20 d i lu t io n ,  the p o te n t ia l ly  pos it ive  sera were most obvious. The 
1:80 d i lu t io n  was considered to be important fo r  comparison with 
the 1:20 d i lu t io n ,  since responses which were no longer 
s ig n i f ic a n t ly  raised at 1:80, may have generated nonspecific 
reactions at the lower d i lu t io n s .
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4.1.4 Analysis o f the ELISA Results fo r  the Control Rats
The DA and. PVG rats showed no s ig n if ic a n t  change in mean t i t r e  to
e ith e r antigen a t the d i f fe re n t  age in te rva ls  tested (Figures 
4 .2c,d). These rats gave generally lower readings to both antigens
at lower serum d i lu t io n s ,  to both antigens, in comparison with the
RCS and Wistar ra ts (Figures 4 .2a,b ,e). There was no obvious change
in the mean t i t r e s  o f the Wistar rats to e ith e r antigen, although
the mean to S-antigen at 6 weeks was s l ig h t ly  raised at the 1:20 
serum d i lu t io n ,  due to a higher serum response o f two rats (W4 and 
W2) (Figures 4.2e and 4.4b; Table 4.26, Appendix). At the age of 9 
weeks, Wistar ra t W4 also gave a reaction to S-antigen above the 
level of the l i t te rm a te s , at a serum d i lu t io n  of 1:20 ie .  over 0.5
A492, (Table 4.27, Appendix). Although at a d i lu t io n  o f 1:80, the
sera o f these Wistar rats gave readings above those of the
l i t te rm a te s , the reactions were not s t r ik in g .  Immunoblotting 
experiments with the W4 sera gave more information on the
s p e c i f ic i t y  o f the response (Section 4.1 .8; Figure 4.8).
4.1.5 Analysis o f the Responses o f the Campbell RCS Rats
The mean reactions fo r  the Campbell RCS rats to both antigens, at 
low d i lu t io n s ,  at a l l  ages tested (Figure 4.2a), were above those 
of the pigmented sighted control rats (Figures 4 .2c,d). The mean
responses to ROS at 3 and 9 weeks were comparable to those o f the
Wistars (Figure 4.2e). The readings were highest to both antigens 
at 6 weeks (Figure 4.2a).
Four Campbell ra ts were id e n t i f ie d ,  which gave higher ELISA 
readings to re t in a l antigens, than the controls and apparently 
unresponsive l i t te rm a te s , at 6 and/or 9 weeks (Tables 4.2, 4.3, and
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Figure 4.2 Mean ELISA Responses of Sera from 3, 6 and 9 Week old RCS
and Control Rats to S-Antigen and ROS
Sera obtained from 10 Campbell and 10 Hunter RCS ra ts , and 
10 PVG, 5 DA and 5 Wistar control rats ra ts , at the ages of 
3, 6 and 9 weeks, were tested in the ELISA against l^ig/ml
p u r i f ie d  S-antigen and 5jjg/ml ROS. The mean reponses 
obtained fo r  each s tra in  were calculated from the means of 
two readings fo r  the ind iv idual animals. The means and 
standard deviations o f the ind iv idual animals, and fo r  each 
s tra in  as a whole, a t the ages o f 3, 6 and 9 weeks, are also
recorded in Tables 4.1 to 4.30, in the Appendix.
The resu lts  are described in Sections 4.1.4 to 4.1.6.
a) Mean Responses o f Campbell RCS rats to S-antigen and ROS
b) Mean Responses o f Hunter RCS rats to S-antigen and ROS
c) Mean Responses of PVG control rats to S-antigen and ROS
d) Mean Responses of DA control rats to S-antigen and ROS
e) Mean Responses o f Wistar control rats to S-antigen and ROS
KEY
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Figure 4.3 Serum Data from Individual Campbell Rats, giving
Elevated ELISA Responses to Retinal Antigens
Sera obtained from four Campbell RCS rats (C l, C4, C5 and 
C8) generated ELISA responses to S-antigen, s ig n if ic a n t ly  
above those o f the apparently unresponsive l i t te rm a te s . The 
responses o f these pos it ive  sera are compared with the mean 
resu lts  fo r . th e  10 Campbell ra ts ,  and also the mean of the 
s ix unresponsive l i t te rm ates  (see Key below).
At 3 weeks, only ra t  C l ,  indicated a response to S-antigen, 
at a serum d i lu t io n  o f 1:20 only, above the mean fo r  the 
Campbells (a). The responses of rats C l ,  C4 and C8 to ROS at 
the age o f 3 weeks, were not s ig n i f ic a n t ly  raised compared' 
with the mean fo r  the Campbell ra ts at th is  age (a). 
Campbell ra ts C l ,  C4 and C8 appeared to have high responses 
to S-antigen at the age of 6 weeks (b). These ind iv idua ls 
also demonstrated responses to ROS above those of the 
l i t te rm a te s , a lb e i t  lower than the S-antigen response (b). 
At 9 weeks, only ra t  C8, demonstrated a response to 
S-antigen, s ig n i f ic a n t ly  above the level o f the unresponsive 
l i t te rm ates  (c ). However, at th is  time a fo r th  ra t ,  C5, 
indicated a raised response to S-antigen (c ) . At 9 weeks, no 
rats generated a response to ROS s ig n i f ic a n t ly  above the 
mean fo r  10 the Campbell rats (c ) .
The resu lts  are described in Section 4.1.5.
The standard deviations and means o f the ind iv idual animals, 
and fo r  each s tra in  as a whole, at the ages of 3, 6 and 9
weeks, are also recorded in Tables 4.1 to 4.30, in the 
Appendix.
a) Responses o f 3 week old Campbell rats
b) Responses of 6 week old Campbell rats
c) Responses o f 9 week old Campbell rats
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Figure 4 .4  ELISA Readings of RCS and Control Rat Sera d ilu ted  1:20
at 3, 6 and 9 Weeks in Age to S-Antigen and ROS
a) Responses o f 1:20 d i lu t io n  o f RCS and control ra t  sera 
to S-antigen and ROS, at the age o f 3 weeks
b) Responses of 1:20 d i lu t io n  of RCS and control ra t  sera
to S-antigen and ROS, at the age o f 6 weeks
c) Responses of 1:20 d i lu t io n  of RCS and control ra t  sera
to S-antigen and ROS, at the age of 9 weeks
ELISA A492 readings to S-antigen and ROS are shown fo r  the 
1:20 d i lu t io n  o f the sera obtained from 10 Campbell and 10 
Hunter RCS ra ts ,  and 10 PVG, 5 DA and 5 Wistar control rats 
rats at the ages o f (a) 3 (b) 6 and (c) 9 weeks.
The points represent the mean of two assays at the 1:20 
d i lu t io n  (Appendix, Tables 4.1 to 4.30). The bars indicate 
the means obtained fo r  each s tra in  at (a) 3 (b) 6 and (c) 9 
weeks.
The resu lts  are discussed in Sections 4.1.4 to 4.1 .6, in the 
te x t .
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Figure 4.5 ELISA Readings of RCS and Control Rat Sera d ilu ted  1:80
at 3, 6 and 9 Weeks in Age to S-Antigen and ROS
a) Responses of 1:80 d i lu t io n  o f RCS and control ra t  sera 
to S-antigen and ROS, at the age of 3 weeks
b) Responses of 1:80 d i lu t io n  of RCS and control ra t sera
to S-antigen and ROS, at the age of 6 weeks
c) Responses of 1:80 d i lu t io n  of RCS and control ra t  sera
to S-antigen and ROS, at the age of 9 weeks
ELISA A492 readings to S-antigen and ROS are shown fo r  the 
1:80 d i lu t io n  of the sera obtained from 10 Campbell and 10 
Hunter RCS ra ts ,  and 10 PVG, 5 DA and 5 Wistar control rats 
rats at the ages o f (a) 3 (b) 6 and (c) 9 weeks.
The points represent the mean o f two assays at the 1:80 
d i lu t io n  (Appendix, Tables 4.1 to 4.30). The bars ind icate 
the means obtained fo r  each s tra in  at (a) 3 (b) 6 and (c) 9 
weeks.
The resu lts  are discussed in Sections 4.1.4 to 4.1 .6, in the 
te x t .
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4.5). Figures 4.3a,b,c shows the ELISA results  o f these ind iv idua l 
Campbell ra ts ,  Cl, C4, C5 and C8, which demonstrated reactions to 
S-antigen, s ig n i f ic a n t ly  above the controls and above the 
apparently unresponsive l i t te rm a te s , at the age o f 6 weeks. These 
rats also demonstrated raised reactions to ROS, although lower than 
those to S-antigen (Figure 4.3b). Readings are shown fo r  these 
ra ts , to both antigens, at 3, 6 and 9 weeks. The three apparently 
pos it ive  sera, resulted in a raised mean response to S-antigen, fo r  
the Campbell ra t  sera, at 6 weeks (Figures 4.2a and 4.3b). Two 
separate means are included in each of Figures 4 .3a,b ,c . In 
addition to the mean responses to both antigens at each week, fo r  
a l l  10 Campbell ra ts ,  means are shown which do not include the 
resu lts  of the apparently pos it ive  Campbell sera, from rats Cl, C4, 
C5 and C8, since these appear to have a s ig n if ic a n t  e f fe c t  on the 
mean response to S-antigen a t 6 weeks (Figures 4 .3a,b ,c ; Tables 4.1 
to 4 .6).
None of the Campbell RCS rats were s ig n i f ic a n t ly  pos it ive  to e ith e r  
antigen at the age o f 3 weeks (Figure 4.3a). The pos it ive  responses 
o f rats Cl," C4 and C8, evident at 6 weeks, and at both 1:20 and 
1:80 d i lu t io n s  (Figures 4.3b, 4.4b and 4.5b), became less
s ig n if ic a n t  at a d i lu t io n  o f 1:160 (Figure 4.3b). At the age o f 9 
weeks, the responses o f rats Cl and C4, t had fa l le n  to leve ls  
s im ila r  to those of the unresponsive l i t te rm a te s , and only the sera 
of ra t C8 remained raised, a lb e i t  at a lower level (Figures 4.3c, 
4.4c and 4.5c). At the age of 9 weeks, the fourth pos it ive  Campbell 
(C5) serum was detected. At 9 weeks rats C5 and C8 demonstrated 
s im ila r  responses (Figure 4.3c). The serum of ra t  C5, generated a 
higher reaction than tha t of ra t  C8, at a 1:80 d i lu t io n ,  as ra t  C5 
gave an A492 reading of 0.208, and C8 gave a reading of 0.163
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(Figure 4.3c; Table 4.3, Appendix). The resu lts  are discussed in 
Section 4 .1 .9 ).
4.1.6 Analysis o f ELISA Responses of Hunter RCS Rats
The mean responses o f the Hunter RCS ra ts , to S-antigen, a t 3, 6 
and 9 weeks were very close together, suggesting tha t there was no 
s ig n if ic a n t  change in t i t r e  over the period of time studied (Figure 
4.2b). There was also l i t t l e  ind ica tion  of a s ig n if ic a n t  change in 
responses to ROS with time (Figure 4.2b). Overall, the mean 
readings fo r  the Hunter rats appeared s im ila r  to those o f the
Wistars (Figure 4.2e), being lower than those o f the Campbells 
(Figure 4.2a), and higher than those o f the pigmented control rats 
(Figures 4.2c,d).
Generally, the readings given by the ra t  sera, a t the 1:20 d i lu t io n  
(Figure 4 .4 ), to both antigens, demonstrated greater scatte r than 
the readings obtained at the 1:80 d i lu t io n  (Figure 4 .5 ). At the age 
of 3 weeks, however, the readings given by the Hunter ra ts to both 
S-antigen and ROS, were more widespread than those o f the other 
s tra ins , including the Campbells (Figure 4;5a). At 3 weeks, the 
sera (d ilu ted  1:20) o f 3 ra ts ,  HI, H6 and H9, gave ELISA readings
to S-antigen close to 0.5 and 0.6 A492 (Figure 4.4a; Table 4 .7 ).
The readings obtained fo r  the sera o f ra ts H6 and H9, at the 
d i lu t io n  o f 1:80, remained above those o f the apparently
unresponsive l i t te rm ates  ( ie .  close to 0.3 A492) (Figure 4.5a; 
Table 4.7, Appendix). This suggested tha t these ra ts may have had a 
pos it ive  response to S-antigen at 3 weeks. Rat H6 also demonstrated 
a reading to ROS of over 0.3 A492, at a serum d i lu t io n  o f 1:80 
(Figure 4.5a). In add it ion , ra t  H10 at 3 weeks only, ind icated a 
response to ROS of over 0.55 A492, at 1:20 d i lu t io n ,  and over 0.3
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at a 1:80 d i lu t io n  (Figures 4.4a; 4.5a; Table 4.10). Rat H10 was 
not s ig n if ic a n t ly  reactive to S-antigen in the ELISA, at any stage.
At 6 weeks, only one Hunter ra t ,  H8, gave a response to S-antigen 
above those o f the l i t te rm a te s , at the 1:20 d i lu t io n  (Figure 4.4b; 
Table 4.8, Appendix). This response may have indicated the presence 
of very low a f f i n i t y  or cross reacting antibodies, since the serum 
reaction was no longer s ig n i f ic a n t ly  d i f fe re n t  from those of the 
l i t te rm ates  at the 1:80 d i lu t io n  (Figure 4.5b; Table 4 .8 ). At 9 
weeks, ra t  H3 indicated a response to S-antigen of over 0.59 A492, 
at a serum d i lu t io n  of 1:20 (Figure 4.4c). However, th is  may not 
have been a true spec if ic  response since the serum did not ind icate 
a s ig n if ic a n t  reaction at the 1:80 d i lu t io n  (Figure 4.5c). No 
s ig n if ic a n t  reactions with the ROS were observed fo r  the Hunter 
rats at 6 or 9 weeks (Figures 4.4b,c and 4.5b,c).
4.1.7 Reaction of RCS and Control Rat Sera in Tissue Sections
Ind irec t immunofluorescence tests on frozen sections o f ra t  eye 
(Section 2.4.5) were performed on some o f the RCS and PVG control 
sera obtained from animals at the ages o f 3, 6 and 9 weeks. The 
fluorescence resu lts  (Table 4.31) were quantif ied by means o f a 
Le itz  MPV Compact Photometer. The in d ire c t  immunofluorescence te s t 
is  generally considered to be of a lower s e n s i t iv i t y  in comparison 
to the in d ire c t  immunoperoxidase reaction. Undiluted serum was 
applied to the tissue sections in order to increase the binding o f 
spec if ic  antibody which may be present in low concentrations.
The immunofluorescence resu lts  were not found to be very 
reproducible during test ing  of undiluted, p o te n t ia l ly  autoimmune
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Table 4.31 Quantitative IFAT with ra t  sera readings over the
photoreceptor ce ll bodies (ONL)
Relative fluorescence units
Age Age Age
Rat No. 3 Weeks 6 Weeks 9 Weeks
RCS C2 X 1.22 20.66
SD 0.77 4.16 nd
n 2 7
RCS C3 X 6.38 8.4 7.87
SD 0.18 0.81 2.24
n 6 6 7
RCS C4 X 3.03 ROS 5.6 (R]
SD 0.45 nd 7.7
n 5 • 3
RCS C5 X 10.23 10.35
SD 1.32 nd 0.65
n 6 4
PVG2 X 4.67 10.53 33.02
SD 3.2 6.18 6.95
n 6 6 6
PVG3 X 4.57 6.44
SD 2.36 1.15 nd
n 6 6
PVG5 X 0.88 3.94 5.3
SD 0.86 0.38 1.46
n 4 5 6
Controls ROS RIS
S2.4.C5 McAb X 20.45 15.71
to S-antigen SD 1.38 2.07
n 3 6
Irre levan t X 3.31 3.2
McAb (to SD 0.80 0.9
V. cholerae) n 6 6
X : Mean
SD: Standard deviation (n-1) 
n : Number of readings 
nd: Not determined
sera. Intense fluorescence, with a l l  undiluted ra t  sera, was 
obtained in the choroid of the sections of ra t eye. The choroid is  
a h igh ly  vascular t issue , and thus contained a high concentration 
o f ra t  Ig , with which the FITC conjugated rabb it a n t i - ra t  IgG(H+L) 
(Section 2.1.16) could react. Apart from the choroid, the highest 
readings were obtained over the inner nuclear layer ( INL). No 
s ig n if ic a n t  reactions were observed in the photoreceptor ROS layer. 
Table 4.31 shows the readings obtained over the INL, when frozen 
sections o f ra t eye were incubated with Campbell RCS and PVG 
control sera, followed by the FITC conjugate. The highest reading
was obtained fo r  PVG control ra t  2, at the age of 9 weeks. This
animal was not s ig n if ic a n t ly  pos it ive  to S-antigen or ROS in the 
ELISA assays (Tables 4.15 and 4.18).
The use o f undiluted serum, not only increases the chances of the
binding of re la t iv e ly  low a f f i n i t y  autoantibodies, but g rea t ly  
increases the opportunity fo r  nonspecific in te rac tion  of i r re le va n t 
antibodies. The irre levan t antibodies include those directed to 
tissue antigens, which may give r ise  to a background reaction in 
the section. Other unwanted antibody in teractions involve 
crossreactions through the antibody binding s ite s ,  the binding to 
fc  receptors, and nonspecific e le c tro s ta t ic  or hydrophobic 
a ttrac t ions  o f ir re levan t antibodies (Section 8 .4 .1 ) . The high 
reading obtained fo r  PVG ra t 2, at 9 weeks, probably represents a 
nonspecific binding of i r re levan t antibody.
The immunofluorescence technique, however, was found to give 
sa t is fa c to ry  results  with monoclonal antibody S2.4.C5, raised 
against S-antigen (Chapter 6). Table 4.31 also shows the readings 
obtained fo r  th is  monoclonal antibody, and an ir re levan t monoclonal
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Figure 4.6 Detection of Autoantibody to Photoreceptor Antigens
in RCS Rat Sera
a) Immunoperoxidase reaction in the photoreceptor ce ll 
layer, with 1:40 d i lu t io n  of Campbell RCS Rat C4 serum.
b) Absence o f a peroxidase reaction with a 1:40 d i lu t io n  of 
the serum from Campbell RCS Rat Cl.
Ethanol f ixed , dewaxed sections of albino ra t  re tina  were 
u t i l is e d  fo r  the immunoperoxidase experiments. The sera of 
Campbell Rats C4 and Cl were id e n t i f ie d  as pos it ive  to 
S-antigen in the ELISA, but in th is  less sensitive 
immunochemistry te s t ,  only the C4 serum appeared positive 
(a) (Section 4 .1 .7 ). The pattern o f sta in ing produced by the 
C4 serum was s im ila r  to tha t obtained fo r  monoclonal or 
polyclonal a n t i -  S-antigen antibodies, a lb e i t  less intense 
(Figure 7.1).
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2. Photoreceptor inner segment layer
3. Photoreceptor nuclei (outer nuclear layer)
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Photographed at Magnifications X 400

to V ibrio  cholerae LPS used as a con tro l. The antibodies were 
applied in the form of c e l l - f re e  cu ltu re supernatant. These
antibodies §ave more reproducible resu lts  between assays on
d i f fe re n t  sections, compared with the study involv ing undiluted ra t 
sera. This is  probably because there was a much lower concentration 
o f antibody present in the hybridoma supernatant, and also the 
monoclonal antibodies used were very spec if ic  to S-antigen, or to 
the LPS. Also, no other ra t Ig, which might give r ise  to a
nonspecific reaction with the tissue section, was present in the 
supernatant.
In th is  study, the immunoperoxidase technique (Section 4.1 .2 .2)
offered greater s e n s i t iv i t y ,  and re p ro d u c ib i l i ty  in comparison to 
the immunofluorescence procedure. The four Campbell (Cl, C4, C5 and 
C8) and one Wistar (W4) ra t sera which demonstrated pos it ive
reactions to S-antigen in ELISA, at 6 and/or 9 weeks (Sections
4 .1 .4 -5 ), were tested fo r  th e ir  binding in dewaxed sections of 
pa ra ff in  embedded ra t eye in in d ire c t  immunoperoxidase experiments 
(Sections 2.4 .3-4). Only one ra t ,  RCS C4 (6 weeks), gave any 
ind ica tion  o f a reaction at a d i lu t io n  o f 1:40 (Figure 4.6a). The 
ROS and photoreceptor synapses were stained in a s im ila r  pattern to 
tha t obtained with monoclonal antibody S2.4.C5, to S-antigen 
(Figure 7.1a,b). Figure 4.6b shows the lack o f reaction o f 1:40 
d i lu t io n  of serum, from Campbell ra t  Cl. D ilu tions below 1:40
resulted in a general background reaction which rendered
in te rp re ta t ion  o f any spec if ic  s ta in ing impossible.
4.1.8 Immunoblotting Results
The sera of four Campbell RCS (C l, C4, C5 and C8) and one Wistar 
(W4) ra t  which indicated pos it ive  responses to S-antigen in the
143
ELISA at the age o f 6 and/or 9 weeks (Sections 4 .1 .4 -5 ), were 
subjected to immunoblotting experiments (Section 2 .3 .9 ). Two o f the 
four Campbell ra t  sera (C4 and C8) were shown to react with
S-antigen in the immunoblots (Figure 4 .7). The sera of the Campbell 
r a t ,  designated C8, reacted with at least two additional lower 
molecular weight bands present in the crude soluble re t in a l extract 
(Figure 4.7c). The sera of the Campbell ra t  designated C4, 
recognised one of these lower molecular weight bands (Figure 4.7a). 
These bands had molecular weights of approximately 35K and 40K. The 
40K antigen was possibly the same protein recognised by monoclonal 
antibody R l.2 .D2 (Figure 6.8). The 40k antigen was not recognised 
by antibodies to S-antigen. The 35K band could represent a 
breakdown product of the S-antigen, or a subunit of a larger
re t in a l p ro te in , eg. transducin. I t  is  in te re s t in g  tha t Gregerson 
and Abrahams (1983) reported tha t the sera o f some u ve it is  patients 
recognise a 35K antigen. The reaction fo r  the Wistar ra t  (W4)
(Figure 4.8b), appeared s im ila r  to tha t of C4 (Figure 4.7a). The 
sera of rats Cl and C5, did not give r ise  to a s ig n if ic a n t  reaction 
in the immunoblots, at the serum d i lu t io n s  employed during these 
experiments. Figures 4.8c,d show the lack of a reaction fo r  control 
sera obtained from rats W1 and PVG1, which gave no ind ica tion  o f a 
reaction to S-antigen or ROS in the ELISA assays.
The resu lts  obtained fo r  the sera of ra ts C4, C8 and W4 were
demonstrated to be reproducible; identica l patterns o f reaction 
were obtained fo r  three separate immunoblotting experiments subject 
to the same conditions. There was no ind ica tion , in any of the 
immunoblots with the ra t sera, fo r  a reaction with the marker 
proteins.
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Figure 4.7 S p e c if ic i ty  of ELISA Positive RCS Rat Sera in Immunoblots
Immunoblot o f sera from 6 week old Campbell RCS rats C4 and
C8 demonstrating a response to S-antigen. The sera was
d ilu ted  1:80, and incubated with the n itroce llu lo se  s tr ips
1 PSfo r  3 hours. Rabbit a n t i - ra t  IgG(H+L) and I protein A 
were used in the detection o f the reaction.
The two sera s p e c i f ic a l ly  recognised S-antigen and a 40K 
antigen. The 35K antigen recognised by ra t C8, might 
represent a breakdown product of S-antigen (Section 4 .1 .8 ).
a) Autoradiograph o f b lo t with serum from Campbell ra t C4
c) Autoradiograph of b lo t with serum from Campbell ra t C8
b) and d) Amido black stained blots
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Figure 4 .8  Immunoblotting Results fo r  the Sera of two Wistar and one
PVG Rat, against Retinal Antigens
Immunoblot o f sera obtained from a 6 week old Wistar ra t W4, 
demonstrating a response to S-antigen in the ELISA above 
those of the l i t te rm a te s . Blots with sera of Wistar ra t Wl, 
and PVG ra t 1 which gave no ind ica tion  o f a positive  
response to re t in a l antigens, were included as contro ls. The
sera was d ilu ted  1:80 and incubated with the n itroce llu lo se
125s tr ip s  fo r  3 hours. Rabbit a n t i - ra t  IgG(H+L) and I protein 
A were used in the detection o f the reaction.
The sera from ra t  W4, s p e c i f ic a l ly  recognised S-antigen and 
a 40K antigen (Section 4 .1 .8 ). The pattern of response was 
s im ila r  to tha t obtained fo r  the Campbell RCS rats C4 and C8 
(Figure 4.7).
a) Amido black stained b lo t
b) Autoradiograph of b lo t  with Wistar ra t  W4 sera
c) Autoradiograph of b lo t with Wistar ra t  Wl sera
d) Autoradiograph o f b lo t with PVG ra t PVG1 sera
Lanes
1. Low molecular weight markers
2. Purif ied  S-antigen
3. Crude re t in a l extract
4. Bovine ROS
a b c d
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4 .1 .9  Discussion
The data presented above, describes the resu lts  of a study in which 
c irc u la t in g  a n t i - re t in a l  autoantibodies, were sought in  RCS and 
control ra t sera. There was no s ig n if ic a n t  change with time fo r  the
pigmented control rats in the mean ELISA responses to S-antigen and
ROS (Figure 4.2c,d). S ig n if ic a n t ly  raised t i t r e s  to S-antigen or 
ROS were not found in the ind iv idual sera obtained from the 
pigmented control s tra ins of ra t (Section 4 .1 .4 ). Considering the 
mean responses o f the various s tra ins of ra t  to both antigens, 
there was no s tr ik in g  difference between the RCS and control 
s tra ins of ra t .  However, the Campbell rats demonstrated a raised 
mean response to S-antigen, at the age of 6 weeks. This was
a ttr ibu ted  to three Campbell ra ts , Cl, C4 and C8, which were
id e n t i f ie d  as exh ib it ing  a pos it ive  serum response to S-antigen at 
th is  time (Figure 4.3b). Only ra t C8, remained pos it ive  at the age 
of 9 weeks, a lb e i t  at a lower level (Figure 4.3c). A fourth  
Campbell ra t  (C5) demonstrated a reaction above those o f the
li t te rm a te s , at the age of 9 weeks (Figure 4.3c). I t  was
in te res ting  that two Wistar ra ts ,  W2 and W4, also indicated raised 
serum responses to S-antigen at the age o f 6 weeks (Table 4.26, 
Appendix). On d i lu t io n  beyond 1:40, however, many of the Campbell, 
Hunter and Wistar ra t sera which were apparently pos it ive  at a 
d i lu t io n  1:20, gave readings which were no longer s ig n i f ic a n t ly
raised above the unresponsive l i t te rm a te s . However, such sera may 
generate a s ig n if ic a n t  pos it ive  reponse in immunoblots, fo r  
example, ra t W4 (Figure 4.8b). The successful b lo t t in g  o f a serum 
which is  only weakly posit ive  in the ELISA could suggest tha t there 
were s u f f ic ie n t  antibodies of high enough a v id ity ,  which remained 
bound to the antigens during the washing procedures. None o f the 
Wistar rats were s ig n i f ic a n t ly  pos it ive  to the ROS antigen.
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The fa in t  reaction of serum from ra t C4 with the photoreceptor 
synapses, fu r th e r suggests the p o s s ib l i ty  o f the reaction with 
S-antigen, since the protein is  also located in th is  region (Figure 
7.1a,b). The s p e c i f ic i t ie s  o f the serum reactions observed in the 
ELISA to S-antigen, were confirmed in immunoblotting experiments 
fo r  two of the four pos it ive  Campbell sera and Wistar serum (W4). 
Campbell rats C4 and C8, and Wistar ra t ,  W4, s p e c i f ic a l ly  
id e n t i f ie d  S-antigen in prote in A immunoblots, plus a 40K antigen 
w ith in  the crude re t in a l extract (Figures 4.7a,c and 4.8b). 
S-antigen is  known to be h igh ly  antigenic (Wacker et al_., 1977;
Faure, 1980), and i f  the immune system is exposed to the re t in a l 
antigens, the most antigenic components may tend to dominate the 
immune response. The 40K antigen might also be one such antigenic 
component, and may be the same antigen to which monoclonal antibody 
R1.2.D2, has s p e c i f ic i t y  (Section 6.3).
Antibodies spec if ic  to the insoluble ROS prote ins, which consist o f 
85% opsin (Heitzmann, 1972), were less re ad ily  demonstrated in the 
immunoblots. ' The immunoblotting was possibly influenced by the 
amount of prote in in each band. S-antigen and the 40K prote in did 
form two of the main bands on the n itroce llu lo se  s t r ip .  Perhaps at 
higher prote in dens it ies , other relevant auto-antigens could be 
id e n t i f ie d .  The m a jo r ity  o f the RCS ra t  antibodies (from ra ts  Cl, 
C4 and C8), with s p e c i f ic i t y  to the insoluble ROS pro te ins, may be 
directed against conformational determinants which are disrupted in 
SDS-PAGE and binding to the n itro ce llu lo se  paper. Barlow et a l .  
(1986) suggested tha t most antibodies are d irected to 
conformational (or discontinuous) determinants. I t  is  also possible 
tha t the antibodies to the ROS antigens were of lower a f f i n i t y  and
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a v id i ty  than those to S-antigen, and were more eas ily  removed by 
the Tween wash bu ffe r during the immunoblotting procedure. Human 
antibodies to the ROS insoluble antigens were s im i la r ly  d i f f i c u l t  
to demonstrate in immunoblots (Section 4 .2 .7 ).
The pathophysiological changes in the RCS ra t  re t in a ,  which may 
re su lt  in a mild stim ulation o f the immune system, are yet to be 
determined. C learly the autosensitisation to the re t in a l antigens 
was not great, and involved only certa in  ind iv idua ls . Raised levels 
of serum antibody to re t in a l antigens, in p a r t ic u la r  S-antigen, 
could be detected more frequently  in the Campbell than in Hunter 
RCS ra ts . The raised responses detected in two Wistar ra ts ,  were of 
s im ila r  magnitude to those o f the Hunter RCS ra ts .
The pos it ive  responses to S-antigen observed in the sera o f certa in  
Campbell and albino Wistar rats may re f le c t  secondary immunological 
responses occurring a f te r  l ig h t  induced damage w ith in  the albino 
re tinae. The higher responses of the Campbell ra ts over the 
Wistars, might suggest tha t the genetic re t in a l dystrophy 
predisposed the Campbell rats to fu r the r l ig h t  induced damage. I t  
is  possible tha t l ig h t  caused fu r th e r d isruption in the blood 
re t in a l b a rr ie r  in some pink-eyed animals, thus increasing the 
p o s s ib i l i t y  of stimulating the immune system. The l ig h t  absorbing, 
melanin containing pigment granules, protect the eye against excess 
il lum ina t ion . This may explain why the Campbell ra ts showed 
stronger reactions than the Hunter ra ts . Pigmentation has been 
found to delay the progress of degeneration by 7 to 10 days, in the 
posterio r re tina (Yates et a j . ,  1974; La Vail and B a t te l le ,  1975).
The resu lts  obtained fo r  the RCS and control ra t  sera, have
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together helped to bu ild  up a p ic tu re  of the p o te n t ia l ly  autoimmune 
status o f RCS and perhaps albino animals. The ro le o f the immune 
response genes is  an important consideration in studies o f th is  
kind, and genetic factors are l i k e ly  to cause small va r ia tions  in 
the levels of autoantibodies produced by ind iv idua ls  and by 
d i f fe re n t  s tra ins o f ra t  (R o it t  et a j . ,  1985). Since the leve ls of 
autoantibody detected in the RCS ra ts , were re la t iv e ly  low, and 
were found in less than 50% of the animals, the humoral immune 
response at leas t, probably has l i t t l e  e ffe c t on the progress of 
the re t in a l dystrophy. I f ,  however, serum autoantibody was 
sequestered in soluble immune complexes, then possib ly a greater 
proportion o f rats were sensitised than could be detected by serum 
analysis. Hybridoma technology allows the investiga tion  o f B ce l l  
s p e c i f ic i t y ,  in v i t r o ,  where the potentia l complications of immune 
complexes and background reactions may be d i f f i c u l t  e lim inate 
(Section 5.2).
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4.2 STUDIES ON HUMAN RETINAL AUTOIMMUNITY
This section.describes the resu lts  obtained from serological assays 
of sera from RP and uve it is  pa tien ts , and healthy volunteers. The 
sera were screened by the ELISA against S-antigen or so lub il ised  
rod outer segment membranes. The s p e c i f ic i t ie s  of the pos it ive  
responses were fu r th e r assessed in immunoblotting experiments.
This study was undertaken in order to provide information on the 
sera obtained from RP and u ve it is  pa tients , whose peripheral B 
lymphocytes were transformed in re lated study (Section 5 .3). The 
numbers of patients involved were thus small, and a de ta iled
investiga tion  o f the potentia l re t in a l autoimmune responses o f RP 
and u ve it is  was beyond the scope of th is  p ro jec t.
4.2.1 Experimental Approach
4.2.1.1 The subjects o f study
Eleven patients from two heterogeneous groups were investigated 
(Table 4.32). R e t in i t is  pigmentosa patients were selected, since 
there is  evidence that in some sub-groups o f RP, re t in a l
autoimmunity may be detected (Brinkman et a j . ,  1980; Newsome and 
Nussenblatt, 1984; Chant et a j . ,  1985) (Section 1 .4 .4 .3 ). Three of 
the f iv e  RP patients had the autosomal dominant form o f the
disease, and two had advanced disease with no known affected 
re la t ive s .  Patients with u v e i t is ,  a group of inflammatory diseases 
of the re tina  and uveal t ra c t ,  were also studied. There is  a 
growing number o f reports suggesting ocular autoimmunity in u v e it is  
patients (Section 1 .4 .4). Eleven control subjects included healthy 
volunteers, fo r  example unaffected fam ily  members, and laboratory
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Table 4. 32 Details o f the human subjects involved in the serum study
Controls Patients
I n i t i a l Sex Age Transformations * I n i t i a l Disease Sex Age Transformations
AC F 40 - AA ADRP F 50 T
BD M 30 T CM Uveitis F - T
BM M 24 - EN Uveitis F - -
CD M 30 - GA Uveitis M - T
HD M - T GG RP M 70 T
JF M 40 T HM RP M 55 T
KM F 24 T HS Uveitis F 40 T3
LR F 24 - IM ADRP M 40 T
MM M 30 - KM ADRP M 17 T
OM F 40 T MK Uveitis M 15 T -
SG F 26 - UV Uveiti s - - -
* Section 5.2 
T=Transformation 
T3=Three transformations
workers (Table 4.32). The laboratory workers included people 
handling re t in a l antigens in order to ascertain the passive 
sens it isa t ion  to the antigens in question. The approximate ages of 
the subjects were recorded (Table 4.32), since the diseases are 
progressive with time and also, age may play a ro le in the immune 
responsiveness in general.
4.2.1.2 Choice o f assays
The ELISA assay was selected fo r  the same reasons as described fo r  
the assay of the ra t  sera (Section 4 .1 .2 .2 ), and there was no 
a lte ra t io n  in protocol other than the s ta r t ing  d i lu t io n  o f sera, 
and the use o f a rabb it anti-human peroxidase conjugate (Section 
2.1.16). Variation between plates was assessed by control pos it ive  
ra t  antisera and preimmune sera as described in Section 4 .1 .2 .2 , 
and found to be minimal.
The sera obtained from the eleven u ve it is  and RP patients and the 
eleven healthy controls were screened against bovine re t in a l  ROS 
and S-antigen in ELISA (Sections 4.2 .3-5). A ll samples were 
screened against the same preparations of antigens and tested under 
identica l conditions (Section 3.8). Doubling d i lu t io n s  o f the 
serum samples, from 1:10 to 1:1280, were made on the p la te . The 
samples were incubated fo r  4 hours at room temperature to allow 
s u f f ic ie n t  time fo r  the antibodies o f lower a f f i n i t y  and a v id i t y  to 
react with the antigens (Mason and Williams, 1980). The ELISA 
reaction was developed in the usual manner.
Those sera id e n t i f ie d  as pos it ive  to e ith e r or both antigens were 
tested fo r  th e ir  a b i l i t y  to bind to ocular antigens in sections of 
ra t  eye, in immunoperoxidase experiments (Section 2 .4 .4 ) .  The
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in d ire c t  immunofluorescence assay was not used since i t  was found 
to give unre liab le  resu lts  in the study with the ra t sera (Section
4 .1 .7 ).
The s p e c i f ic i t ie s  o f the pos it ive  ELISA t i t r e s  were examined in 
immunoblotting experiments (Sections 2.3.9 and 4 .2 .7 ). Bovine 
re t in a l S-antigen, crude soluble re t in a l antigens, and the ROS 
proteins were e lec tophore tica lly  separated in SDS 10% acrylamide 
gels and transferred to n itroce llu lo se  paper. A fte r blocking, the 
s tr ip s  of n i troce llu lo se  paper were incubated with the human serum 
samples, d ilu ted  1:80 in the same bu ffe r fo r  four hours, to allow 
s u f f ic ie n t  time fo r  the reaction o f antibodies o f lower a f f i n i t y  or
a v id ity  (Mason and Williams, 1980). The reaction was visua lised by
125the I protein A method, with the use o f the intermediate rabb it 
anti-human IgG,M,A (Section 2 .3 .7 .6 ).
4.2.2 Methods of Human ELISA Data presentation
The ELISA resu lts  obtained fo r  the patients and control sera are 
recorded in Tables 4.33 to 4.36, in the Appendix, as the mean o f 
two assays, with ind iv idual standard deviations. The t i t r e s  are 
displayed graph ica lly  in Figures 4.9a,b to 4.12a,b. The figures 
only show the standard deviations fo r  those serum samples which 
demonstrated serum responses s ig n i f ic a n t ly  above the control range.
Table 4.37 examines in three d i f fe re n t  ways, the responses o f human 
subjects, demonstrating s ig n if ic a n t  reactions in the ELISA, to 
re t ina l antigens. The results  fo r  these ind iv idua ls  were compared 
with the pooled resu lts  of the normal control subjects.
4.2.3 Normal Range o f Reactions to S-Antigen and ROS
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Figure 4.9 Data obtained from the ser ia l  d i lu t ion  of Eight Control
Human Sera against S-Antigen and ROS in ELISA Assays
a) Reactions of 8 control sera to S-antigen in ELISA
b) Reaction o f 8 control sera to ROS in ELISA
Serial d i lu t io n s  o f sera obtained from eight healthy 
volunteers were tested in the ELISA assay against (a) lpg/ml 
o f S-antigen, and (b) 5pg/ml ROS. The resu lts  were obtained 
in the form of absorbance readings at A492. The resu lts  are 
recorded as the mean o f two assays. The standard deviations,
together with the means are recorded in Tables 4.33 to 4.36,
in the Appendix.
The range of readings covered by the control sera provided a 
c r i te r ia n ,  fo r  the comparison with the patients sera, above 
which suggested a pos it ive  response.
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The normal range of readings to the antigens was obtained from the
' t i t r e s '  o f the healthy controls (Figures 4.9a,b). The e ight normal
control sera’, obtained from people who were not involved with 
re t ina l antigens, generated readings in the ELISA assays to 
S-antigen and ROS, which were f a i r l y  close together. Sera ly ing  in 
the upper range of the responses against one antigen, tended also 
to l i e  in the upper range o f responses to the other antigen. There 
was a s im ila r ,  but opposite tendency, with the sera ly ing  in the 
lower range o f responses.
For S-antigen, the ELISA readings fo r  the eight control sera ranged 
between 0.21 and 0.45 absorbance un its  at 492nm (A492) at a
d i lu t io n  of 1:10, and decreased to approximately 0.04 to 0.1 A492 
at a d i lu t io n  o f 1:1280 (Figure 4.9a). The responses o f the healthy 
controls to the ROS antigen varied between 0.26 to 0.55 A492 at a 
serum d i lu t io n  of 1:10, to 0.04 to 0.08 A492 a t a d i lu t io n  of 
1:1280 (Figure 4.9b). A template of the normal range of responses 
to each antigen was constructed fo r  overlay on the graphs o f the 
pa tien ts ' serum responses to the re t in a l antigens.
4.2.4 Responses of the f iv e  RP and s ix Uveitis  Patients
The t i t r e s  o f a l l  f iv e  RP patients to both S-antigen and ROS f e l l  
w ith in  the normal range of responses (Figures 4.10a,b). Two out o f 
s ix  patients with u ve it is  (patients HS and UV) demonstrated a 
s ig n if ic a n t  response to S-antigen, th e ir  t i t r e s  fa l l in g  outwith the 
range observed fo r  the healthy controls (Figure 4.11a). Two serum 
samples were taken from pa tien t HS at approximately one year apart. 
The t i t r e s  o f the two samples remained s im ila r ,  with perhaps a 
s l ig h t  change in the response to S-antigen in the second sample. 
The pos it ive  serum reaction observed fo r  th is  pa tien t has been
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Figure 4.10 Data obtained from the serial  d i lu t ion  of Sera from Five
RP Patients against S-Antigen and ROS in ELISA Assays
a) Reactions o f 5 RP sera to S-antigen in ELISA
b) Reaction of 5 RP sera to ROS in ELISA
Serial d i lu t io n s  of sera obtained from f iv e  RP patients were 
tested in the ELISA assay against (a) ljJg/m 1 o f S-antigen 
and (b)p5 g/ml ROS. The resu lts  were obtained in the form of 
absorbance readings at A492. The resu lts  are recorded as the 
mean o f two assays. The standard deviations, together with 
the means, are recorded in Tables 4.33 to 4.36, in the 
Appendix.
The sera from these f iv e  RP patients to (a) S-antigen and 
(b) ROS yielded reactions w ith in  the normal range (Sections 
4.2 .3-4).
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Figure 4.11 Data obtained from the ser ia l  d i lu t io n  of Sera from Six
Uveit is Patients against S-Antigen and ROS in ELISA Assays
a) Reactions of 6 u v e it is  sera to S-antigen in ELISA
b) Reaction of 6 u ve it is  sera to ROS in ELISA
Serial d i lu t io n s  of sera obtained from six u ve it is  patients 
were tested in the ELISA assay against (a) l|ig/ml o f 
S-antigen and (b) 5pg/ml ROS. The resu lts  were obtained in 
the form of absorbance readings at A492. The results  are 
recorded as the mean of two assays (Tables 4.33 to 4.36, 
Appendix). The standard deviations are only shown fo r  the 
pos it ive  sera. The sera from two of the uve it is  patients (HS 
and UV) demonstrated s ig n i f ic a n t ly  raised serum responses to 
(a) S-antigen, compared with the normal range (Figure 4.9a). 
Two d i f fe re n t  serum samples were obtained from patient HS. 
Three u ve it is  patients (EN, GA and MK) indicated raised 
serum antibody to the ROS antigen (b). The resu lts  are 
described in Section 4.2.4.
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confirmed in another laboratory (Forrester, 1986; personal 
communication). Neither o f these two patients gave a response to 
the so lub il ised  bovine ROS in the ELISA (Figure 4.11b). Patient CM 
did not demonstrate a s ig n if ic a n t  response to e ith e r antigen in the 
ELISA. The remaining three o f the u ve it is  patients (EN, GA and MK) 
demonstrated s ig n if ic a n t  t i t r e s  to the bovine ROS (Figure l i b ) .  
These sera were not, however, pos it ive  in the ELISA to S-antigen 
(Figure 11a). The strongest response was indicated by pa tien t EN. 
The t i t r e s  of patients GA and MK, lay close to one another. The 
t i t r e s  of the pos it ive  ind iv idua ls  (Table 4.37), were determined by 
use o f a transparent template o f the normal range o f responses 
(Figures 4.9a,b), layed over the graphs of the pa tien ts ' ELISA 
readings. The t i t r e  was taken to be that d i lu t io n  a t which the 
pa t ie n t 's  response came w ith in  the normal range (Table 4.37). Table 
4.37 also shows the ELISA A492 readings fo r  the pos it ive  
ind iv idua ls  given by serum d i lu t io n s  o f 1:20 and 1:80. The f iv e
patients gave t i t r e s  or readings (at 1:20) to e ith e r S-antigen or
ROS, above the control values, although the rank order o f the 
pa tien ts ' responses varied with each method of presentation (Table
4.37). The responses were less marked at the 1:80 d i lu t io n ,
especia lly  fo r  S-antigen.
Thus, none o f the RP patients tested, showed a s ig n if ic a n t  serum 
response to S-antigen or solublised ROS, and f iv e  o f the s ix  
u ve it is  patients tested, showed a raised response to e ith e r  
antigen, but not to both.
4.2.5 Responses of Laboratory Workers using S-Antigen
The sera of three users of re t in a l antigens were tested fo r  th e i r  
a c t iv i t y  to S-antigen and ROS. One of the three users (LR)
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Table 4.37 ELISA Posit ive Human Serum Responses*
S-antigen ROS
Positive Condition T i t re  A492 A492 T it re  A492 A492
Subjects 1:20 1:80 1:20 1:80
HS1 u ve it is
HS2 u ve it is
UV u ve it is
MK uve it is
EN u ve it is
GA uve it is
LR1 user of
LR2 S-antigen
Mean of 8 controls 
Range of 8 controls
SD (n-1), n = 8
1:80 0.544 0.188
1:160 0.733 0.284
1:160 0.549 0.265
NA 0.235 0.103
NA 0.349 0.221
NA 0.233 0.167
1:120 0.668 0.253
1:320 0.681 0.293
NA 0.303 0.135
NA 0.172 0.072
to to
0.394 0.187
0.076 0.041
NA+ 0.246 0.150
NA 0.310 0.191
NA 0.272 0.163
1:80 0.458 0.163
1:1280 0.876 0.509
1:40 0.426 0.209
1:1280 0.678 0.254
1:1280 0.806 0.386
NA 0.308 0.125
NA 0.398 0.166
to to
0.178 0.076
0.090 0.034
* mean of two assays 
+ NA = not applicable
Figure 4.12 ELISA Reactions of Sera from Three Users of Retinal
Antigens against S-Antigen and ROS in the ELISA
a) Reactions o f the 3 sera to S-antigen in ELISA
b) Reaction o f the 3 sera to ROS in ELISA
Serial d i lu t io n s  of sera obtained from 3 users o f re t ina l 
antigens, were tested in the ELISA assay against (a) ljjg/ml 
o f S-antigen and (b) 5pg/ml ROS. The resu lts  were obtained 
in the form of absorbance readings at A492. The resu lts  are 
recorded as the mean of two assays. The standard deviations 
are only shown fo r  the pos it ive  sera. The standard 
deviations, together with the means, are recorded in Tables 
4.33 to 4.36, in the Appendix. Two samples were obtained 
from subject LR on d i f fe re n t  occasions.
The resu lts  suggest tha t only one user of S-antigen, LR, 
demonstrated a s ig n if ic a n t  response to (a) S-antigen and (b) 
ROS (Section 4 .2 .5 ).
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demonstrated a s ig n i f ic a n t ly  pos it ive  t i t r e  to both antigens, 
whereas the t i t r e s  of the remaining two f e l l  w ith in  the normal 
range (Figure 4.12a,b). Two serum samples were taken from subject 
LR at approximately 18 months apart. The t i t r e s  of both samples to 
each antigen remained s im ila r ,  although the ROS response in the 
second sample (LR2) was s l ig h t ly  increased (Figure 4.12b) (Table
4.37). The responses observed in subject LR, probably resulted from 
a passive sens it isa tion  to these very antigenic substances.
4.2.6 S p e c if ic i ty  o f the Human Reaction to Retinal Antigens
The s p e c i f ic i t ie s  of the pos it ive  reactions observed fo r  the 
pa tien ts ' sera, were indicated in pa rt,  by a reproducible reaction 
to one antigen but not the other (Section 4 .2 .4 ). Two human serum
samples were t i t r e d  against the BSA in order to assess fo r
interference of the blocking agent in  the ELISA assays to re t in a l
antigens. A ll sera were tested at a d i lu t io n  o f 1:10 on plates
treated with the BSA blocking agent only, and the readings a l l  f e l l  
w ith in  a range o f 0.00 to 0.05 A492. There was no ind ica tion  o f a 
reaction fo r  any o f the sera with the BSA. These resu lts  ind ica te  
tha t with the sera o f normal subjects, as well as the pa tien ts , 
there was a greater tendency fo r  reactions with the bovine re t in a l 
antigens than with the BSA, employed as a blocking agent. I t  may be 
worth noting tha t most of the people involved in th is  study had 
been exposed to d ie ta ry  bovine antigens.
4.2.7 S p e c if ic i t ie s  of ELISA Positive Sera in Immunoblotting Experiments 
The s p e c i f ic i t ie s  o f the serum responses, previously demonstrated 
to be pos it ive  to the S-antigen or ROS in ELISA (Sections 4 .2 .4 -5 ) ,  
were determined by protein A immunoblotting experiments (Sections 
2.3.9 and 4 .2 .1 .2 ).
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Figure 4.13 Reaction of Sera from Healthy Subjects in Immunoblots
against Retinal Antigens
Sera from healthy subjects, not demonstrating s ig n if ic a n t 
responses to S-antigen or ROS in the ELISA assays, were used 
as negative contro ls in immunoblotting experiments involving 
human sera. The I^ ^ P ro te in  A detection system was employed., 
with the intermediate incubation with rabb it anti-human IgG+ 
IgM >v+ IgA.
No s ig n if ic a n t  reaction was observed with the resolved 
re t in a l antigens (Section 4 .2 .7 ). Nonspecific reactions were 
obtained with one o f the prote in  standards, and also with 
the dye f ro n t .
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Figure 4.14 S p e c i f ic i ty  in Immunoblots of Sera from Subjects
pos it ive  in the ELISA to Retinal Antigens
The s p e c i f ic i t y  o f sera from subjects demonstrating
s ig n if ic a n t  responses to S-antigen and/or ROS in the ELISA
assays, was investigated in immunoblotting experiments. The 
125I Protein A detection system was employed, with the 
intermediate incubation with rabb it anti-human IgG, IgM and 
IgA.
The pattern o f reaction was s im ila r  in a l l  the immunoblots, 
regardless of the s p e c i f ic i t y  o f the sera in ELISA (Sections
4.2.4 and 4 .2 .7 ).
KEY
a) Reaction of sera from u ve it is  pa tien t EN
b) Reaction o f sera from u ve it is  pa tien t HS
c) Reaction of sera from u ve it is  patient UV
e) Reaction of sera from u ve it is  pa tien t GA
f )  Reaction of sera from u ve it is  patient MK
g) Reaction of sera from subject LR
(user of re t in a l antigens)
d) and h) Amido black stained immunoblots
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There was l i t t l e  ind ica tion  o f a spec if ic  reaction o f the control 
sera to the re t in a l antigens (Figure 4.13). There was a nonspecific 
reaction in the control b lo ts , with one of the low molecular weight 
standard prote ins, and with the dye f ro n t ,  which was a f a i r l y  
common phenomenon in the immunoblots. The human sera, pos it ive  to 
S-antigen and/or ROS in the ELISA, a l l  demonstrated very s im ila r  
patterns o f reactions in the immunoblots (Figure 4.14). In each 
case intense reactions with S-antigen were id e n t i f ie d ,  and also 
less intense reactions a 40K antigen, present w ith in  the crude 
re t in a l ex trac t. In most b lo ts shown in Figure 4.14, a reaction 
with the 30K protein standard can be seen, which ranges from weak 
to strong in the ind iv idual b lo ts .
4.2.8 Immunocytochemical Tests of Human Sera in Sections of Rat Eye
The sera of ind iv idua ls  who displayed a pos it ive  reaction in the 
ELISA to e ith e r S-antigen or ROS (Sections 4.2.4-5) were tested fo r  
r e a c t iv i ty  to the re tina  in sections o f ra t  eye. An in d ire c t  
peroxidase immunocytochemical s ta in ing procedure was employed 
(Section 2 .4 .4).
The sera o f the healthy controls were u t i l is e d  fo r  the assessment 
o f a pos it ive  reaction above the background. The serum samples were 
d ilu ted  1:20, 1:40, and 1:80 and tested in t r ip l i c a te .  At serum
d ilu t io n s  below 1:80 the general high background reaction , which 
could not be eliminated by blocking with undiluted normal ra bb it  
serum, rendered i t  impossible to d is t ingu ish  a spec if ic  reaction 
with the photoreceptors, other re t in a l ce l ls  or the choroid. The 
con tro l,  comprising identica l conditions, except fo r  the omission 
of the primary antibody, indicated tha t the background reaction was
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due to the nonspecific adsorption o f the human immunoglobulins onto 
the tissue sections when low d i lu t io n s  were employed.
At d i lu t io n s  of 1:80, no obvious pos it ive  reactions above the 
reduced background, could be detected in any of the sera previously 
assessed as pos it ive  to e ith e r S-antigen or ROS in the ELISA 
assays. The sera o f only one subject, LR, a user of bovine and ra t 
re t in a l antigens, gave possible pos it ive  sta in ing with the ra t 
photoreceptor ROS, above the general background reaction , at a l l  
d i lu t io n s  tested.
4.2.9 Pi scussion
In th is  l im ited  study, none o f the f iv e  RP patients gave any 
ind ica tion  of a response to S-antigen or to ROS, in the ELISA 
(Figures 4.10a,b). Five of the six u ve it is  patients (Section
4 .2 .4 ) , however, demonstrated a response to e ithe r S-antigen or ROS 
(Figures 11a,b; Table 3.37). The ELISA data obtained fo r  the human 
subjects, provided supplementary information fo r  a re lated study 
(Section 5.3).
RP is a progressive disease. I t  is  possible tha t one or a l l  o f them 
had become sensitised to th e i r  re t in a l antigens in the past, and 
la te r  humoral immune response subsided during the regulation of the 
immune system (R oitt_e t a j . , 1985). I t  is  also possible tha t the 
a n t i - re t in a l  antibodies were unavailable fo r  assay, being 
sequestered in soluble immune complexes with shed antigen. 
A lte rn a t iv e ly ,  the t i t r e s  o f the autoantibodies were too low to 
detect, even in the sensitive ELISA. I t  is  more l i k e ly  tha t the 
fa i lu re  to detect the antibodies in the ELISA, even at only a 1:10 
d i lu t io n ,  was related to the a f f i n i t y  and s p e c i f ic i t y  o f the
156
antibodies. Since the ELISA procedure involves washing steps, with 
a mild detergent, antibodies of low a f f i n i t y  and s p e c i f ic i t y  are 
discouraged from binding. The sera were only screened against 
S-antigen and ROS, and perhaps the sera o f the patients contain 
antibodies to other re t in a l antigens, such as the 40K antigen 
recognised by the sera o f some u ve it is  patients and some Campbell 
ra t  RCS rats in immunoblots (Sections 4.2.7 and 4 .1 .8 , 
respective ly).
I t  is  evident tha t some uve it is  patients may become sensitised to 
th e ir  re t in a l antigens and produce a humoral immune response to 
them. I t  is  of in te re s t tha t the two pa tien ts , UV and HS, generated 
high reactions to S-antigen in the ELISA, but not to ROS, and tha t 
patient EN, p re fe re n t ia l ly  responded to ROS, but not to S-antigen. 
Patients GA and MK, also demonstrated elevated responses to ROS, 
although lower than that of pa tien t EN. Patients GA and MK, were 
apparently unresponsive to S-antigen. Evidently the autoantibodies 
produced by these pa tients , are recognising epitopes o f the bovine 
antigens, which are shared by those of humans. Possibly the sera 
from some of the patients employed in th is  study, were only able to 
recognise human re t in a l antigens. I f  the immune response is  re lated 
to the stage of the disease, i t  may be tha t the i n i t i a l  
sens it isa tion  is  to the most antigenic components, including 
S-antigen. Later antibodies might be produced against the less 
antigenic components, perhaps with the regulation o f the humoral 
immune response to other antigens, l ik e  S-antigen.
The sera demonstrating a pos it ive  response in the ELISA to 
S-antigen and/or ROS, were tested in an immunoperoxidase procedure 
in sections of ra t  eye. No pos it ive  reactions could be detected in
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any of the patients sera tested (Section 4 .2 .8 ). Higher background 
reactions were obtained with the human sera, compared with the ra t 
sera (Section 4 .1 .7 ). The humans were l i k e ly  to have had a more 
complex reperto ire  o f antibodies and possibly autoantibodies, since 
they have been exposed to a much wider range of external antigens. 
The antibodies would d i f f e r  in th e ir  in t r in s ic  a b i l i t ie s  to 
crossreact with ir re levan t antigens in tissue sections. Given the 
re la t iv e  in s e n s i t iv i ty  o f the immunoperoxidase technique, 
especia lly  in comparison with the ELISA (Polak and Van Noorden, 
1984), any spec if ic  antibodies may not have been detected at the 
d i lu t io n s  o f 1:80, or may have been obscured by the high general 
background present a t lower d i lu t io n s .  In add it ion , the reading of 
the ELISA reactions was aided by the use of the T ite r tek  Multiskan 
whereas the immunoperoxidase reactions were in terpreted by eye. 
S im ilar problems were encountered when re t in a l autoimmune responses 
in rats were investigated by th is  technique (Section 4 .1 .7 ) . Human 
re tina  would provide a more su itable set o f antigens than the ra t  
tissue employed in the immunoperoxidase experiments.
The sera ind ica ting  s ig n if ic a n t  responses to the re t in a l antigens 
in the ELISA assays were fu r th e r studied in immunoblots (Section
4 .2 .7 ). An in te res ting  pattern o f responses was obtained with the
pos it ive  human sera. The reactions of a l l  of the u v e it is  pa tien ts ' 
sera tested in the immunoblots, gave s im ila r  resu lts  (Figure 4.14)
irrespective  o f the s p e c i f ic i t ie s  in the ELISA assays (Section
4 .2 .4 ). A ll the sera were capable of recognising S-antigen and an 
antigen with a molecular weight in the region o f 40K. The 40K 
antigen may be the same component recognised by some Campbell ra t  
sera (Section 4 .1 .8 ). The autoantibodies reacting in the ELISA to 
ROS, were not re ad ily  demonstrated in  the immunoblots, presumably
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due to denaturation of the protein epitopes (Section 4 . 1 . 9 ) .
Thus, u v e it is  patients who responded in the ELISA assays, to e ithe r
S-antigen or ROS could be id e n t i f ie d .  Although no pos it ive  serum
responses were detected fo r  the RP pa tien ts , only f iv e  subjects 
were tested, which is  not representative o f th is  heterogeneous
disease. However, the data presented in Section 5.2 suggests tha t 
at least some u ve it is  patients might have become sensitised to
th e ir  re t in a l antigens, although a larger study of contro ls may
indicate tha t perhaps only patients EN and HS were s ig n i f ic a n t ly
pos it ive  to ROS and S-antigen, respective ly. I t  would be of
in te res t to determine the re la tionsh ip  between the immune responses 
and the various subclasses and also stages o f the diseases. Further 
investigations in to  the nature of au to -sens it isa t ion  in these
patients would y ie ld  useful information on the aetio logy o f these 
heterogeneous groups o f diseases.
159
CHAPTER FIVE
STUDIES ON AUTOIMMUNITY TO RETINAL ANTIGENS USING 
TEMPORARILY STABILISED B LYMPHOCYTES IN CULTURE
Chapter 5
STUDIES ON AUTOIMMUNITY TO RETINAL ANTIGENS USING TEMPORARILY 
STABILISED B LYMPHOCYTES IN CULTURE
5.1 INTRODUCTION
This chapter describes the potentia l humoral autoimmune responses 
of the ra t re t in a l dystrophic model and human subjects to re t in a l 
antigens. The investigations involved the use o f techniques 
allowing the long term cu ltu re  o f B lymphocytes, and the tes t ing  o f 
the ce ll cu ltu re  supernatants fo r  the secretion o f spe c if ic  
antibody directed against re t in a l S-antigen or the so lub il ised  rod 
outer segment (ROS) membranes.
The ra t system, described in Section 5.2, involved the temporary 
s ta b i l is a t io n  o f the splenic B lymphocytes, by fusion with a ra t 
myeloma ce ll l in e .  The human transformation system, described in 
Section 5.3, involved the iso la t io n  o f B lymphocytes from 
peripheral blood. These were temporarily s ta b il ise d  by 
transformation with Epstein Barr v irus (EBV). Transformed B ce l ls  
can be fu r th e r s tab il ise d  by fusion with a human lymphoblastoid 
ce ll l in e ,  followed by cloning. The fre sh ly  iso lated human 
peripheral blood B lymphocytes are not generally fused, fo r  
technical reasons (Section 5 .3 .1).
5.2 IMMORTALISATION OF RAT B LYMPHOCYTES
5.2.1 Rationale of Study by Rat Hybridoma Generation
The autoimmune response of the rats with re t in a l degeneration was 
fu r the r investigated by the s ta b i l is a t io n  of th e i r  splenic 
lymphocytes a f te r  fusion with a ra t  myeloma ce ll l in e  (Galfre et
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a l . ,  1979) (Section 2 .6 .6 ). Primary clones o f hybrid ce lls
secreting antibody o f in te re s t ,  can be fu r th e r s ta b i l is e d , or 
immortalised, by cloning (Section 2 .6 .9 ). The immortalised ce lls  
can be grown in d e f in i te ly  in cu ltu re , secreting large amounts of 
monoclonal antibody fo r  experimental purposes. Hybridoma technology 
has been used to generate autoantibodies from non-immunised animals 
with established autoimmune conditions in order to examine fu r the r 
the mechanisms o f autoimmunity (Kani e t_aK , 1985; Lewis et a l . ,  
1981). The potentia l complications of serum studies, where antibody 
may be sequestered as soluble immune complexes, and where 
background reactions are hard to elim inate are thus avoided.
5.2.2 The Hybridoma Study
The rats employed in th is  study, which gave r ise  to successful 
fusions in terms o f the presence of at least 12 primary clones, did 
not demonstrate a s ig n if ic a n t  serum response to S-antigen or ROS in 
the ELISA assays. The rats employed fo r  the hybridoma studies were 
not those u t i l is e d  fo r  the serum studies (Section 4 .1 ), although 
the animals were obtained from the same breeding stocks.
The splenic lymphocytes of four Hunter RCS, three Campbell RCS rats
and three PVG control rats were fused with the ra t  myeloma ce ll
l in e  Y3.Agl.2.3 (Galfre et a } . ,  1979) (Section 2 .1 .18), and the
ce l ls  seeded in to  four 24-well plates per fusion (Section 2 .6 .6 .3 ) .
Of the 96 wells ava ilab le , 4 wells were reserved fo r  the unfused
Y3.Ag l.2.3 and spleen ce ll contro ls . Thus, 92 wells fo r  each fusion
were seeded with the c e l ls ,  and of these wells 0 to over 90%, per
experiment, yielded hybrids a f te r  2 to 3 weeks. Generally, be tte r
fusion frequencies were obtained with Y3 c e l ls ,  grown in a spinner 
f la s k ,  than those grown in p la s t ic  flasks (Section 2.1 .19). I t  was
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also important not to allow the ce l ls  to become crowded, or the 
medium to become too ac id ic ,  in the few days p r io r  to fusion.
5.2.3 Strategy fo r  the Assay of Fusions
The emerging hybrids were fed weekly, and the supernatants were 
assayed when the ce l ls  had became approximately 80% confluent. The 
hybrids were assayed in duplicate. The fusions were screened 
against so lub il ised  bovine ROS and S-antigen on ELISA plates coated 
with the same concentrations of antigen as described fo r  the serum 
study (Section 4 .1 .2 .2 ). The ELISA plates were incubated with the 
ce ll cu ltu re supernatants o f the primary fusion w e lls , fo r  4 hours 
at room temperature or overnight at 4°C. I t  has been suggested tha t 
a longer incubation period may be necessary fo r  antibodies o f lower 
a f f in i t y ,  or when the antibody is  present in very small quantit ies  
(Mason and Williams, 1980).
To avoid the detection o f fa lse  pos it ive  clones, i t  was necessary 
to change the ce ll  cu ltu re  supernatants o f the fusion at least 
twice before, assay. Experience with immunised rats has shown tha t 
the residual unfused spleen ce l ls  are capable of secreting antibody 
in cu ltu re  fo r  several days. Primary growths which were negative, 
were reassayed u n t i l  the wells became overgrown. Those wells 
remaining negative at th is  stage were abandoned.
5.2.4 Choice o f ELISA Categories
The ELISA reactions were categorised in order to c l a r i f y  the 
resu lts  and fa c i l i t a t e  a comparison between fusions. The categories 
were chosen to cover a range of 0.2 absorbance un its  a t 492nm 
(A492). This range was selected in order to allow fo r  the element 
of v a r ia b i l i t y  present when assaying ce ll  cu ltu re supernatants.
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V a r ia b i l i t y  is  ine v itab le , since i t  is  impossible to standardise 
the system, such tha t each primary cu ltu re  has only one ce ll  l in e ,  
i . e .  monoclonal. Each potentia l ce ll l in e  w i l l  grow and secrete 
antibody at a d i f fe re n t  ra te. Furthermore, the ELISA readings fo r  
d i f fe re n t  ce l ls  may be affected, to d i f fe re n t  extents, by d i lu t io n  
of the antibody when the ce l ls  are fed. Even a monoclonal ce l l  l in e  
can produce an ELISA reading of 1.0 A492 on one day and 1.4 A492 on 
the fo llow ing day. Thus, re-assay in addition to assay in 
duplicate , is  important.
The ELISA plates u t i l is e d  fo r  the screening of fusions were coated 
with the same stocks o f S-antigen and ROS, and treated under 
identica l conditions (Section 3.8). Although pos it ive  and negative 
reaction controls were included on the ELISA p la tes, v a r ia b i l i t y  
between plates was not assessed by means of t i t r a t i o n  o f the 
con tro ls , as in the ra t serum studies (Section 4 .1 .2 .2 ) .  The 
re p ro d u c ib i l i ty  o f the ELISA assay systems has been described 
(Sections 3.8.5 and 3.8.6) and, although minor va r ia t ion  between 
plates is  inev itab le , the choice of ELISA categories described 
below were considered to allow fo r  th is .
5.2.5 The ELISA Results
The ELISA absorbance readings at 492nm obtained fo r  the primary 
hybrid cultures to both antigens, are tabulated (Tables 5.1 to
5.8). The data is  presented in terms o f the number o f primary 
hybrid growths fa l l in g  in to  the categories o f absorbance at 492nm. 
The readings obtained from confluent primary hybridomas are 
recorded as the mean o f two assays (Tables 5.1 to 5 .8). The resu lts  
are graph ica lly  displayed in the form of histograms (Figures 5.1 to
5.8).
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TABLE 5.1 ELISA readings o f confluent primary hybridoma clones 
from the fusion fo r  ra t  Hunter 1 
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 60 67.4 84 94.4
2 0.21-0.40 19 21.3 4 4.5
3 0.41-0.60 5 5.6 1 1.1
4 0.61-0.80 2 2.25 0 0
5 0.81-1.00 1 1.1 0 0
6 1.01-1.20 0 0 0 0
7 1.21-0.40 0 0 0 0
8 1.41-1.60 1 1.1 0 0
9 1.61-1.80 1 1.1 0 0
TOTAL 89 100.00 89 100.00
TABLE 5.2 ELISA readings of confluent primary hybridoma clones
from the fusion fo r ra t  Hunter■ 1
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 47 78.33 53 88.33
2 0.21-0.40 11 18.33 7 11.67
3 0.41-0.60 1 1.67 0 0
4 0.61-0.80 1 1.67 0 0
TOTAL 60 100.00 60 100.00
TABLE 5.3 ELISA readings of confluent primary hybridoma clones 
from the fusion fo r  ra t Hunter 3 
Category A492 S-antigen % ROS %
Grouping NO. Wells No. Wells
1 0.00-0.20 24 77.4 26 83.9
2 0.21-0.40 6 19.4 5 16.1
3 0.41-0.60 1 3.2 0 0
TOTAL 31 100.0 31 100.0
TABLE 5.4 ELISA readings of confluent primary hybridoma 
from the fusion fo r  ra t  Hunter 4
clones
Category A492
Grouping
S-antigen 
No. Wells
% ROS 
No. Wells
%
1 0.00-0.20 36 97.3 36 97.3
2 0.21-0.40 1 2.7 1 2.7
TOTAL 37 100.0 37 100.0
TABLE 5.5 ELISA readings o f confluent primary hybridoma clones 
from the fusion fo r  ra t  Campbell 1
Category A492
Grouping
S-antigen 
No. Wells
% ROS 
No. Wells
%
1 0.00-0.20 23 71.9 22 68.75
2 0.21-0.40 8 25.0 8 25.0
3 0.41-0.60 1 3.1 2 6.25
TOTAL 32 100.0 32 100.0
TABLE 5.6 ELISA readings of confluent primary hybridoma clones
from the fusion fo r  ra t  PVG 1
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 28 93.3 30 100.0
2 0.21-0.40 2 6.7 0 0.0
TOTAL 30 100.0 30 100.0
TABLE 5.7 ELISA readings of confluent primary hybridoma clones
from the fusion fo r  ra t  PVG 2
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 10 83.3 8 66.7
2 0.21-0.40 2 16.7 4 33.3
TOTAL 12 100.0 12 100.0
TABLE 5.8 ELISA readings of confluent primary hybridoma clones
from the fusion fo r  ra t  PVG 3
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 19 100.0 19 100.0
TOTAL 19 100.0 19 100.0
TABLE 5.9 Pooled ELISA readings of confluent primary hybridoma
clones from fusions fo r f iv e  RCS and three PVG rats
a) RCS Rats
Category A492
Grouping
S-antigen 
No. Wells
% ROS 
No. Wells
%
1 0.00-0.20 190 76.3 221 88.8
2 0.21-0.40 45 18.1 25 10.0
3 0.41-0.60 8 3.2 3 1.2
4 0.61-0.80 3 1.2 0 0
5 0.81-1.00 1 0.4 0 0
6 1.01-1.20 0 0 0 0
7 1.21-1.40 0 0 0 0
8 1.41-1.60 1 0.4 0 0
9 1.61-1.80 1 0.4 0 0
TOTAL 249 100.0 249 100.0
b) PVG Rats
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.00-0.20 57 93.4 57 93.4
2 0.21-0.40 4 6.6 4 6.6
TOTAL 61 100.0 61 100.0
Figure 5.1 ELISA Assay of Clones from Fusion with Hunter Rat 1
The primary hybridoma clones generated from the fusion of 
RCS ra t  splenic lymphocytes, with ce lls  of the myeloma 
Y3.Agl.2.3 l in e ,  were assayed by ELISA.
The histograms show the re la t iv e  frequencies of confluent 
primary clones, fa l l in g  in to  defined categories of 
absorbance at 492nm (A492), a f te r  assay of the supernatants 
on ELISA plates coated with (a) lyng/ml S-antigen and (b) 
5jjg/ml ROS.
N = number of primary clones assayed
Figure 5.2 ELISA Assay of Clones from Fusion with Hunter Rat 2
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Figure 5.3 ELISA Assay of Clones from Fusion with Hunter Rat 3
The primary hybridoma clones generated from the fusion of 
RCS ra t  splenic lymphocytes, with c e l ls  of the myeloma 
Y3.Agl.2.3 l in e ,  were assayed by ELISA.
The histograms show the re la t iv e  frequencies of confluent 
primary clones, fa l l in g  in to  defined categories of 
absorbance at 492nm (A492), a f te r  assay of the supernatants 
on ELISA plates coated with (a) ljjg/ml S-antigen and (b) 
^jug/ml ROS.
N = number o f primary clones assayed
Figure 5.4 ELISA Assay of Clones from Fusion with Hunter Rat 4
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Figure 5.5 ELISA Assay of Clones from Fusion with Campbell Rat 1
The primary hybridoma clones generated from the fusion of 
ra t  splenic lymphocytes, with ce lls  of the myeloma 
Y3.Ag l.2.3 l in e ,  were assayed by ELISA.
The histograms show the re la t iv e  frequencies of confluent 
primary clones, f a l l in g  in to  defined categories of 
absorbance at 492nm (A492), a f te r  assay o f the supernatants 
on ELISA plates coated with (a) lpg/ml S-antigen and (b) 
5^ig/ml ROS.
N = number of primary clones assayed
Figure 5.6 ELISA Assay of Clones from Fusion with PVG Rat 1
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Figure 5.7 ELISA Assay of Clones from Fusion with PVG Rat 2
The primary hybridoma clones generated from the fusion of 
PVG ra t splenic lymphocytes, with ce l ls  of the myeloma 
Y3.Agl.2.3 l in e ,  were assayed by ELISA.
The histograms show the re la t iv e  frequencies of confluent 
primary clones, f a l l in g  in to  defined categories of 
absorbance at 492nm (A492), a f te r  assay o f the supernatants 
on ELISA plates coated with (a) ljjg/ml S-antigen and (b) 
5jug/ml ROS.
N = number o f primary clones assayed
Figure 5.8 ELISA Assay of Clones from Fusion with PVG Rat 3
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Figure 5.9 Pooled Results from the Assay of primary Clones
derived from Fusions with RCS and PVG Rats
a) Pooled data fo r  RCS rats
b) Pooled data fo r  PVG rats
The primary hybridoma clones generated from fusions of ra t 
splenic lymphocytes, with ce l ls  o f the myeloma Y3.Agl.2.3 
l in e ,  were assayed in ELISA plates coated with (a) ljjg/ml 
S-antigen and (b) 5jug/ml ROS.
The histograms show the re la t iv e  frequencies of confluent 
primary clones, obtained from f iv e  ind iv idual fusions, 
f a l l in g  in to  defined categories of absorbance at 492nm 
(A492), a f te r  assay of the supernatants by ELISA.
N = number of primary clones assayed
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Negative con tro ls , in the form of supernatants o f the unfused Y3 or 
spleen c e l ls ,  gave readings between 0.05 and 0.09 A492 in the ELISA 
assays. Readings below 0.4 A492, may re f le c t  the binding of low 
a f f i n i t y  crossreacting antibody. In fusions derived from an 
immunised animal, a reading o f 0.4 A492 was not considered to be 
s ig n i f ic a n t ly  po s it ive . Readings above 0.4 A492, were considered to 
ind icate a pos it ive  response in fusions derived from p o te n t ia l ly  
autoimmune animals.
Fourteen primary clones, pos it ive  to S-antigen, were detected in 
four out o f f iv e  fusions with the RCS rats (Figures 5.1 to 5 .5). No 
such positives were obtained from the fusions with the healthy PVG 
control rats (Figures 5.6 to 5.8). The fusion designated HI was 
responsible fo r  10 of these pos it ive  primary clones, and generated 
three pos it ive  clones with readings above 0.8 A492 (Figure 5 .1). 
Responses of th is  magnitude would be considered p o s it ive ,  even in a 
fusion from a hyperimmunised animal.
Primary clones, ind ica ting  pos it ive  reponses to the ROS antigen, 
were detected in only two o f the f iv e  RCS ra t fusions. Two o f these 
clones were from a fusion with a Campbell ra t  (Figure 5 .5 ). A th i r d  
clone, pos it ive  to ROS, was derived from the Hunter ra t ,  HI (Figure
5.1). The pos it ive  reactions were not o f a very high magnitude, 
f a l l in g  w ith in  Category 3 (0.4 to 0.6 A492). No pos it ives were
obtained from the PVG control rats (Figures 5.6 to 5 .8).
Established Monoclonal Autoantibodies
Three primary clones, derived from fusions with the splenic 
lymphocytes o f RCS ra ts , were expanded and s ta b i l ise d  by
subcloning, to generate monoclonal antibodies (Kohler and M ils te in , 
1975) (Section 2 .6 .9 ). Two monoclonal autoantibodies were derived 
from the fusion with a nine week old animal designated HI (Figure
5.1). These clones were selected because th e ir  supernatants gave 
the strongest reaction in the ELISA, and the ce l ls  grew a c t iv e ly  in 
f lasks. The th i rd  monoclonal antibody was obtained from a ra t 
sacr if iced  at the age o f 10 weeks (Rat H2) (Figure 5 .2 ), and was 
selected fo r  i t s  in te res ting  cross re a c t iv i ty  with the S-antigen 
and ROS antigens in the ELISA, as well as i t s  good growth ra te . The 
data generated fo r  these monoclonal antibodies is  presented in 
Section 6.3.
The considerable cost involved in the s ta b i l is a t io n  of monoclonal 
antibodies, and the l im i ta t io n  of time, prevented more of the 
clones from being studied fu r the r at th is  time, and several 
p o te n t ia l ly  in te res ting  primary clones remain stored in l iq u id  
nitrogen (Section 2 .6 .8).
5.2.7 Discussion
The re a c t iv i t ie s  to re t in a l antigens in ELISA o f the primary clones 
of hybridomas, obtained from fusions with dystrophic RCS rats and 
PVG contro ls , are summarised in Table 5.9. Fourteen primary growths 
pos it ive  to S-antigen were detected in four RCS rats (fusions with 
Hunter Rats 1, 2 and 3, and Campbell Rat 1) and only three clones 
reactive against ROS were detected, generated in fusions from 
Hunter 1 (HI) and Campbell 1 (C l).
The to ta l number of primary fusion wells with growth is  an
important consideration, when comparing the resu lts  obtained from 
the RCS and control fusions. Fusion HI, which generated three
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pos it ive  potentia l hybridoma ce ll  l in e s ,  reactive with S-antigen in 
the ELISA above 0.8 A492, had yielded a to ta l of 89 wells with 
primary growth (Table 5.1). One of the control fusions produced 
hybridomas in only 12 wells (Table 5.7). C learly , the to ta l number 
o f wells producing hybrids w i l l  a f fe c t  the chances o f detecting 
those ce lls  secreting the antibody o f in te res t.
There appears to have been an in te res ting  difference in the number 
o f pos it ive  clones detected against the two antigens. The apparent 
'dominance' of S-antigen in the a n t i - re t in a l  response is  also 
re flec ted in the ra t  serum studies (Section 4 .1 .3 ). The po ten tia l 
a n t i - re t in a l  autoimmune reponses apparent in some RCS ra ts ,  and the 
possible dominance of S-antigen in the s tim u la tion , are discussed 
in Sections 4.1.9 and 8 .4).
The RCS ra ts , used in the fusion study, did not demonstrate a serum 
response in the ELISA to S-antigen or ROS s ig n i f ic a n t ly  above the 
healthy control PVG and DA ra ts . Perhaps, an RCS ra t  demonstrating 
a s ig n i f ic a n t ly  pos it ive  t i t r e  to e ith e r antigen would y ie ld  a 
greater frequency of pos it ive  clones, although experience here with 
immunised DA rats suggested tha t the detection of the po s it ive  
clones need not re f le c t  the serum t i t r e .  Immunisation, however, 
increases the frequency o f high a f f i n i t y  and high s p e c i f ic i t y  
antibodies, and also increases the chances o f generating IgG 
antibodies, by the matration of the immune response (see R o it t  et 
a l . ,  1985).
Fusions with splenic lymphocytes are thought to involve the 
a c t ive ly  d iv id ing plasma c e l ls .  This may explain why the fusion 
frequencies were re la t iv e ly  poor with some of the ra ts , notably the
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PVG contro ls . This might also ind icate that the RCS ra ts ,  in which 
pos it ive  clones were id e n t i f ie d  (Section 5 .2 .5 ) , were in the 
process of developing a serum response to the re t in a l antigens 
(Section 8 .4 .5 ).
Thus, primary clones pos it ive  to S-antigen could be detected in 
some dystrophic ra ts ,  although the p o s s ib i l i t y  remains that 
positives could be detected in healthy animals, i f  enough fusions 
were undertaken. Immortalised, f u l l y  cloned ra t  hybridomas, 
secreting unlim ited amounts o f monoclonal a n t i - re t in a l  autoantibody 
(Chapter 6), may aid the id e n t i f ic a t io n  and characterisation of 
relevant autoantigens.
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5.3 TEMPORARY STABILISATION OF HUMAN B LYMPHOCYTES
5.3.1 Rationale t o ’ the Transformation Study
The fo llow ing section describes the in v i t ro  responses o f human B 
lymphocytes, transformed by the Epstein-Barr v irus (EBV), to bovine 
re t in a l antigens in ELISA assays. The transformation methodology 
was s im ila r  to tha t o f Kozbor and Roder (1981, 1983). Fusions with 
a human lymphoblastoid ce l l  l in e  (KR-4) were not made with the 
fre sh ly  isolated peripheral blood lymphocytes, since there would be 
only a very small number o f c irc u la t in g  B ce lls  w ith the required 
s p e c i f ic i t y ,  available fo r  fusion. The transformation procedure 
allowed expansion o f the number o f antigen spec if ic  B c e l ls ,  which 
could then be fused. In add it ion , the frequency of fusion between B 
ce lls  and the KR-4 ce lls  is  approximately 10" . Thus i t  would be 
more d i f f i c u l t  to obtain a clone of the required s p e c i f ic i t y  from a 
fusion with non-transformed (and non-expanded B c e l ls ) .  EBV is  
generally considered to be a polyclonal ac t iva to r o f B lymphocytes 
(Rosen £ t  _al_., 1977) and also considerably lengthens th e i r  in v i t r o  
l i f e  span (M il le r  and Lipton, 1973). In th is  way, transformation 
experiments can f a c i l i t a t e  the investiga tion  o f human c irc u la t in g  B 
lymphocyte s p e c i f ic i ty .
This p i lo t  study involved a re la t iv e ly  small number of human 
subjects, and may form a basis fo r  fu ture work.
5.3.2 Human Subjects
Uveitis and RP patients were selected fo r  the transformation 
studies, since there is  evidence tha t patients o f ce r ta in  
sub-groups, are capable o f responding immunologically to re t in a l 
antigens (Section 1.4). Five RP patients (three autosomal dominant
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and two advanced simplex) and three uve it is  patients (with 
associated v a s c u l i t is )  were employed (Table 4.32). Five healthy 
volunteers, ‘ with no known eye disease, were used as controls fo r  
the study (Table 4.32). The sera from a l l  of the people involved in 
the ELISA study were screened against S-antigen and ROS (Section
4.2). Not a l l  o f the people involved in the serum study (Section
4.2) were employed in the transformation experiments.
5.3.3 Choice of Transformation Protocol
I t  is  generally considered preferable to remove or suppress the T 
ce ll  a c t iv i t y  o f in v i t ro  cultured EBV transformed B lymphocytes, 
since the cytotox ic  T lymphocytes are capable of a n t i - v i r a l  
a c t iv i t y ,  especia lly  when the donor has been exposed to the EB 
virus (90% of the adult population) (Campbell, 1984). Even i f  
c l in ic a l  mononucleosis has fa i le d  to develop, the immune system is  
capable of reacting against the v irus .
There are two princ ipa l experimental strategies fo r  the T ce l l  
problem. F i r s t ly ,  the T ce lls  may be removed by rose tt ing  with 
AET-treated sheep red blood c e l ls ,  and separated from the B ce l ls  
on a Percoll gradient (Kaplan and Clark, 1974) (Section 2 .7 .3 .3 ).  
A l te rn a t ive ly ,  the a c t iv i t y  o f the T ce l ls  can be in h ib ite d  by the 
selective action o f the drug, Cyclosporin A (CsA) (Powles et a l . ,  
1980; reviewed by Shevach, 1985) (Section 2 .7 .5 ). CsA has been 
found to markedly f a c i l i t a t e  the growth o f EBV transformed ce l ls  
derived form EBV immune donors (Bird e t _al., 1981). These two
procedures were compared in some of the transformation experiments, 
where the blood samples were divided in to  three portions. The T 
ce lls  of one portion were removed by the rosett ing  method, and 
those o f the second suppressed by CsA. The remaining c e l ls  received
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neither treatment. Thus the re la t ive  merits of the two approaches 
to the solution of the potentia l T ce l l  problem could be assessed 
with respect to th e i r  e f fe c t  on the growth of the transformed ce l ls  
and the a c t iv i t y  o f the transformants in terms of the number of 
positives detected (Section 5 .3 .9).
The transformed ce l ls  were seeded in to  96-well plates (Section 
2 .7 .4 ). Generally the inside 60 wells o f one 96-well p la te , were 
used per 20ml blood sample. The ra t  study employed 24-well plates 
(Section 5 .2 .2 ). The frequency o f ce l l  transformation was always 
very much higher than the frequency of fusion obtained with the ra t 
hybridoma system. Thus the use o f 96-well plates determined tha t 
there were fewer clones o f transformed ce lls  per ce ll  cu ltu re  well 
than there would be i f  24-well plates were used. This is  an 
important consideration in the human transformation, and human and 
mouse hybridoma systems, where the ce l ls  may cease to secrete 
antibody or become overgrown by ce l ls  which do not secrete the 
antibody of in te res t (Campbell, 1984).
5.3.4 Growth of primary Transformed Cells and Strategy fo r  Assay
Transformed ce l ls  could be detected in the 96-well cu ltu re  plates 
18 hours a f te r  in fec t ion  with the EBV. Generally, many human (and 
sometimes sheep) red blood c e l ls  (RBCs) were present among the 
c e l ls ,  due to imperfect separation on the Ficol 1 and Percoll 
gradients (Sections 2.7.2 and 2 .7 .3 .3 ). The wells were usually  
c lear o f the RBCs a f te r  a few days, and the transformed c e l ls  were 
more c le a r ly  v is ib le .  The transformed ce l ls  were gregarious nature 
tending to form c lusters (Figure 2.3).
Three weeks a f te r  transformation, the wells contained numerous
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transformed ce l ls  (transformants), although the number in each well 
varied. The ce l ls  were usually  ready fo r  assay at th is  time. The 
plates were’ screened on ELISA plates coated with S-antigen or ROS 
at lpg and 5pg/ml, respective ly. The small amount o f supernatant 
w ith in  each w e ll,  did not permit the plates to be assayed in 
duplicate in addition to  assay against the two antigens. Only 
approximately 150pl was available fo r  assay against the two 
antigens. Sometimes, i f  two plates o f transformed c e l ls  were 
obtained from one pa tien t, one plate was assayed against S-antigen 
and the other plate assayed against ROS. A few days la te r ,  the 
plates were assayed against the a lte rna t ive  antigen.
Due to the va r ia t ion  in growth between w e lls , i t  was often 
necessary to re-assay the plates. S im ilar problems o f 
standardisation o f the assaying was encountered in the 
transformation system, to those in the ra t hybridoma system 
(Section 5 .2 .4). I f  no fu r th e r  pos it ive  wells could be id e n t i f ie d  
at the second assay, at 4 weeks, the plates were discarded. Those 
wells in which clones had not developed by th is  time, were not 
l i k e ly  to become s u f f ic ie n t ly  established in f lasks , even i f  they 
were pos it ive .
5.3.5 Choice o f ELISA Categories
Smaller categories o f ELISA data were selected fo r  the human 
transformation system, compared with the ra t hybridoma system 
(Section 5 .2 .4). The reason fo r  th is  was tha t the human transformed 
lymphocytes secrete 10 to 100 fo ld  less antibody than do rodent 
hybridomas (Kozbor and Roder, 1983).
In comparison o f ELISA resu lts  obtained from transformations
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performed at in te rva ls  o f several months, there were the inev itab le  
minor varia tions due to the use of d i f fe re n t  batches o f m ic ro t i t re  
plates and rabb it anti-human peroxidase conjugate. Such varia tions 
were unimportant in the screening o f fusions from hyperimmunised 
ra ts , since strongly pos it ive  ELISA readings were expected. The 
readings obtained from fusions with autoimmune ra ts or from 
transformations of human B lymphocytes, were not expected to be so 
high.
ELISA readings of below 0.2 A492 were considered to be
in s ig n i f ic a n t ,  representing non-specific reactions of the primary 
antibody, or of the conjugated second antibody. Readings below 0.3
A492 might also f a l l  in to  th is  category. Reactions above 0.3 A492
were considered to be s ig n i f ic a n t ly  pos it ive  in the human
transformation system. The ELISA readings were categorised in 
in te rva ls  of 0.1 A492 u n its ,  from 0.2 A492. The ELISA resu lts
obtained from the assay of the transformations are presented in 
Tables 5.10 to 5.17. The resu lts  are presented in terms o f the 
number (and percentage) of wells generating ELISA readings, fa l l in g  
in to  the defined categories of A492 values. The resu lts  are 
g raph ica lly  displayed in the form o f histograms (Figures 5.10 to
5.17).
5.3.6 ELISA Reactions of primary Transformed B Lymphocytes from 
Control Subjects
The results  obtained from the assay o f primary growths o f control B 
lymphocytes are given in Tables 5.10a,b,c to 5.11a,b, and Figures 
5.10a,b,c to 5.11a,b. None of the control sera gave s ig n i f ic a n t
responses in the ELISA assays against S-antigen or ROS (Figures 
4.9a,b and 4.12a.b). Only one p o te n t ia l ly  pos it ive  primary clone
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was id e n t i f ie d  in the f iv e  control transformations, g iv ing a value 
between 0.3 and 0.4 A492, in the ELISA against S-antigen (Figure 
5.10). This clone, however, was negative upon reassay a f te r  6 days. 
I t  is  possible tha t th is  apparently weak pos it ive  re su lt  
represented a fa lse reaction, since the assays could not be made in 
duplicate (Section 5 .3 .4 ). Spurious reactions were occasionally 
observed in the ELISA assays where rabb it anti-human peroxidase 
conjugates were involved. Such phenomena were rare in the ra t 
system. These fa lse , weak, pos it ive  reactions might be a property 
of the rabb it anti-human conjugates, since they have been observed 
where complete medium or RPMI was used in place of the ce l l  cu ltu re  
supernatant.
Transformations derived from control subjects, JF and KM were users 
o f S-antigen, and generated a higher proportion o f primary clones, 
fa l l in g  w ith in  the second Category (A492 0.2 to 0.3) (Tables 
5.11a,b and Figures 5.11a,b), compared with the other contol 
transformations. This is  not l i k e ly  to be s ig n i f ic a n t ,  and probably 
re f le c ts  varia tions in the batch o f conjugate, since the 
transformations of JF and KM were performed at the same time, and 
those of the others were performed several months la te r .
5.3.7 ELISA of primary Transformed B Lymphocytes from RP Patients
B ce ll s p e c i f ic i t y  to S-antigen and ROS were investigated in f iv e  
RP patients. Patients IM and KM were fa ther and son, w ith the 
autosomal dominant form of the disease. No pos it ive  reactions were 
detected in the transformation derived from patient IM (Table 5.12a 
and Figure 5.12a). The transformation derived from pa tien t KM, 
however, yielded 2 primary clones reactive in the ELISA assays 
against both S-antigen and ROS, giving readings between 0.3 and 0.4
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TABLE 5.10a ELISA readings of the three week old CsA treated
transformants from control subject BD
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.21 81 95.3 85 100.0
2 0.21-0.30 4 4.7 0 0
TOTAL 85 100.0 85 100.0
TABLE 5.10b* ELISA readings of the three week old CsA treated
transformants fromi control subject HD
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.21 56 93.3 60 100.0
2 0.21-0.30 3 5.0 0 0
3 0.31-0.40 1 1.7 0 0
TOTAL 60 100.0 60 100.0
* Assays repeated 1 week la te r  yielded readings in categor
only.
TABLE 5.10c ELISA readings o f the three week old transformants
from control subject OM
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 64 100 58 90.6
2 0.21-0.30 0 0 6 9.4
TOTAL 64 100.0 64 100.0
Category
from
A492
Grouping
control subject JV: 
S-antigen % 
No. Wells
: user of S-antigen 
ROS % 
No. Wells
1 0.0 -0.20 54 90.0 46 76.7
2 0.21-0.30 6 10.0 14 23.3
TOTAL 60 100.0 60 100.0
TABLE 5. l i b  ELISA readings of the three week old transformants
from control subject KM:: user of S-antigen
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 54 90.0 44 73.3
2 0.21-0.30 6 10.0 16 26.7
TOTAL 60 100.0 60 100.0
TABLE 5. 12a ELISA readings of the three week old transformants
from RP Patient IM
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0‘ -0.20 69 98.6 70 100.0
2 0.21-0.30 1 1.4 0 0
TOTAL 70 100.0 70 100.0
TABLE 5. 12b ELISA readings of the three week old transformants
from RP patient KM
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 78 97.5 76 95.0
2 0.21-0.30 0 0 2 2.5
3 0.31-0.40 2* 2.5 2* 2.5
TOTAL 80 100.0 80 100.0
* Two wells were pos it ive  to both S-antigen and ROS
TABLE 5.13a ELISA readings of the three week old transformants
from RP patient AA 
Category A492 S-antigen % ROS %
Groupi ng No. Wells No. Wells
1 0.0 -0.20 49 81.6 45 75.0
2 0.21-0.30 7 11.7 7 11.7
3 0.31-0.40 2 3.3 2 3.3
4 0.41-0.50 0 0 2 3.3
5 0.51-0.60 1 1.7 3+ 5
6 0.61-0.70 0 0 0 0
7 0.71-0.80 1* 1.7 0 0
8-9 0.81-1.00 0 0 0 0
10 1.01-1.10 0 0 1.7
TOTAL 60 100.0 60 100.0
TABLE 5.13b ELISA readings of the four week old transformants
from RP patient AA
Category A492
Grouping
S-antigen 
No. Wells
% ROS 
No. Wells
%
1 0.0 -0.20 50 83.3 45 75.0
2 0.21-0.30 4 6.7 5 8.3
3 0.31-0.40 4 6.7 6 10.0
4 0.41-0.50 0 0 2 3.3
5 0.51-0.60 0 0 0 0
6 0.61-0.70 0 0 1+ 1.7
7 0.71-0.80 0 0 0 0
8 0.81-0.90 2* 3.3 0 0
9-11 0.91-1.20 0 0 0 0
12 1.21-1.30 0 0 \-k-k 1.7
TOTAL 60 100.0 60 100.0
+ , * , * *  Indicate wells pos it ive  at both 3 and 4 weeks
TABLE 5.14a ELISA readings of the three week old transformants
from RP patient GG 
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 36 90.0 39 97.5
2 0.21-0.30 3 7.5 1 2.5
3 0.31-0.40 0 0 0 0
4 0.41-0.50 1 2.5 0 0
TOTAL 40 100.0 40 100.0
TABLE 5.14b ELISA readings of the three week old CsA treated
transformants from RP patient GG
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 18 75.0 19 79.2
2 0.21-0.30 6 25.0 4 16.7
3 0.31-0.40 0 0 1 4.1
TOTAL 24 100.0 24 100.0
TABLE 5.14c ELISA readings of three week old transformants
from RP patient GG. T Cell a c t iv i t y  not removed
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 17 58.3 19 79.2
2 0.21-0.30 7 29.2 4 16.7
3 0.31-0.40 3 12.5 1 4.1
TOTAL 24 100.0 24 100.0
TABLE 5.15a ELISA readings of the three week old transformants
from RP patient HM 
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 57 95.0 47 78.3
2 0.21-0.30 3 5.0 9 15.0
3 0.31-0.40 0 0 4 6.7
TOTAL 60 100.0 60 100.0
TABLE 5.15b ELISA readings of the three week old CsA treated
transformants from RP patient HM
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 46 76.7 57 95.0
2 0.21-0.30 12 20.0 3 5.0
3 0.31-0.40 2 3.3 0 0
TOTAL 60 100.0 60 100.0
TABLE 5.15c ELISA readings of three week old transformants
from RP patient HM. T Cell a c t iv i t y  not removed
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 39 65.0 40 66.7
2 0.21-0.30 21 35.0 17 28.3
3 0.31-0.40 0 0 3 5.0
TOTAL 60 100.0 60 100.0
Figure 5.10 ELISA Results of primary Clones of Transformed Cells
obtained from three Healthy Controls
The primary clones of transformed c e l ls ,  derived from
transformations o f PBL isolated from healthy control
subjects, were assayed in ELISA plates coated with ljjg/ml
S-antigen and 5/jg/ml ROS.
The histograms show the re la t iv e  frequencies of primary
transformants, fa l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA.
Clones demonstrating reactions in the ELISA below Category 
3, were not taken as pos it ive .
a) ELISA of transformation derived from control subject BD
b) ELISA o f transformation derived from control subject HD
c) ELISA of transformation derived from control subject OM
N = number of primary clones assayed
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Figure 5.11 ELISA Results of primary Clones of Transformed Cells
obtained from two users o f S-Antigen
The primary clones of transformed c e l ls ,  derived from 
transformations o f PBL isolated from subjects who employed 
S-antigen, were assayed in ELISA plates coated with ljjg/ml 
S-antigen and 5jug/ml ROS.
The histograms show the re la t iv e  frequencies of primary 
transformants, fa l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA.
Clones demonstrating reactions in the ELISA below Category 
3, were not taken as pos it ive .
a) ELISA o f transformation derived from subject JF
b) ELISA o f transformation derived from subject KM
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Figure 5.12 ELISA Results of primary Clones of Transformed Cells
obtained from two Related Patients with ADRP
The primary clones of transformed c e l ls ,  derived from 
transformations of PBL isolated from two re lated patients 
with ADRP, were assayed in ELISA plates coated with lpg/ml 
S-antigen and 5jjg/ml ROS.
The histograms show the re la t iv e  frequencies of primary 
transformants, f a l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA.
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos it ives.
No s ig n if ic a n t  pos it ive  clones were id e n t i f ie d  upon assay of 
the transformation derived from pa tien t IM. The 
transformation obtained from patien t KM, however, yielded 2 
clones pos it ive  to both S-antigen and ROS, w ith in  Category 
3.
a) ELISA of transformation derived from pa tien t IM (fa ther)
b) ELISA of transformation derived from patient KM (son)
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Figure 5.13 ELISA Results for  two Assays of primary Clones of
Transformed Cells obtained from ADRP Patient AA
The primary clones o f transformed c e l ls ,  derived from
transformations o f PBL isolated from ADRP patient AA, were 
assayed in ELISA plates coated with tyg/ml S-antigen and 
5jjg/ml ROS. The 96 well p late containing the transformed 
ce lls  was assayed at (a) 3 and (b) 4 weeks post
transformation.
The histograms show the re la t iv e  frequencies of primary
transformants, f a l l in g  in to  defined categories of absorbance
at 492nm (A492), a f te r  assay o f the supernatants by ELISA.
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos itives.
Three of the pos it ive  clones, detected at 3 weeks, with
readings above 0.51 A492, were s t i l l  pos it ive  at 4 weeks
(see Tables 5 .13a,b). At 4 weeks, one additional clone was 
id e n t i f ie d  as re la t iv e ly  s trongly pos it ive  to S-antigen, 
f a l l in g  w ith in  Category 8 (Table 5.13b).
a) ELISA o f transformation a f te r  3 weeks
b) ELISA o f transformation a f te r  4 weeks
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Figure 5.14 ELISA Results for  the Assays of primary Clones of
Transformed Cells obtained from RP Patient GG
The primary clones of transformed c e l ls ,  derived from the 
transformation of PBL isolated from RP (symplex) patient GG, 
were assayed in ELISA plates coated with ljjg/ml S-antigen 
and 5^ug/ml ROS. In th is  transformation, the e ffects  of T 
ce ll  rosett ing  (a) and CsA (b) treatments, on ce ll growth 
and p o s i t iv i t y  in two groups, were compared with ce l ls  
receiving no such treatment (c).
The histograms show the re la t iv e  frequencies of primary 
transformants, fa l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA.
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos itives.
Positive clones, to at least one of the antigens, could be 
detected in a l l  groups of the transformed c e l ls .  No s tr ik in g  
d ifference was observed, in th is  experiment, between the 
three d i f fe re n t  treatments. See also Tables 5.14a,b,c, and 
te x t  (Section 5.3 .9).
a) ELISA of transformation involv ing T ce ll  rosetting
b) ELISA o f transformation invo lv ing the drug CsA
c) ELISA of transformation invo lv ing no such treatments
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Figure 5.15 ELISA Results fo r  the Assays of primary Clones of
Transformed Cells obtained from RP Patient HM
The primary clones o f transformed c e l ls ,  derived from the 
transformation of PBL isolated from RP (symplex) patient HM, 
were assayed in ELISA plates coated with lpg/ml S-antigen 
and 5/jg/ml ROS. In th is  transformation, the e ffects  of T 
ce l l  rosett ing  (a) and CsA (b) treatments, on ce ll growth 
and p o s i t i v i t y  in two groups, were compared with ce lls  
receiving no such treatment (c).
The histograms show the re la t iv e  frequencies of primary 
transformants, f a l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA. 
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos it ives.
Positive clones, to at least one o f the antigens, could be 
detected in a l l  groups of the transformed c e l ls .  No s tr ik in g  
d ifference was observed, in th is  experiment, between the
three d i f fe re n t  treatments. See also Tables 5.15a,b,c, and
te x t  (Section 5 .3 .9).
a) ELISA o f transformation invo lv ing T ce ll  rosetting
b) ELISA o f transformation invo lv ing the drug CsA
c) ELISA o f transformation invo lv ing no such treatments
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A492 (Table 5.12b and Figure 5.12b). These were l i k e ly  to be true 
readings since they were the only 2 s ig n if ic a n t  posit ives out of 80 
w e lls , and were pos it ive  to both antigens. Possibly they were low 
a f f i n i t y  antibodies, crossreacting with S-antigen and a major 
insoluble ROS antigen, such as opsin. A lte rn a t iv e ly ,  there may have 
been two or more clones involved, one secreting antibody to 
S-antigen and one or two other clones secreting antibodies to ROS 
antigens.
These p o te n t ia l ly  very in te res ting  clones were expanded in to  
24-well p la tes, but no fu r th e r  pos it ive  reactions could be obtained 
from them, although the ce l ls  were growing w e ll. This may have been 
the re su lt  of d i lu t io n  of the antibody in the la rger volumes 
involved in the 24-well p la te . The fa i lu re  to detect the antibodies 
could also ind icate tha t the ce l ls  were channelling more energy 
in to  growth than in to  antibody synthesis. Another l i k e ly  
p o s s ib i l i t y  is  the overgrowth by non-secreting c e l ls ,  or ce l ls  
secreting ir re le va n t antibody. Early cloning can prevent th is  
problem in the rodent hybridoma system. However the transformed 
ce l ls  tend not to to le ra te  cloning (Kozbor and Roder, 1982).
The transformation derived from pa tien t AA, generated several 
p o te n t ia l ly  in te res ting  clones (Figures 5.13a,b and Tables 
5.13a,b). A few o f these primary clones, generated reactions 
greater than those o f the transformation obtained from pa tien t KM 
(Table 5.12b). Three clones were id e n t i f ie d  y ie ld ing  readings over 
0.8 A492. These reactions would be considered p o s it ive ,  even in a 
fusion derived from a hyperimmunised ind iv id ua l.  The readings 
obtained from the assay of th is  transformation were not l i k e l y  to 
have resulted from spurious ELISA plate phenomena, since there were
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several pos it ive  wells giv ing stronger reactions than those seen in 
nonspecific reactions occasionally obtained with complete medium 
alone.
Three weeks a f te r  transformation, many of the apparently pos it ive  
c e l ls ,  derived from pa tien t AA, were not ready fo r  expansion. Thus, 
the transformation plates were re-assayed a f te r  a fu r th e r  7 days 
(Table 5.13b and Figure 5.13b). Three o f the re la t iv e ly  strong 
pos it ive  wells remained at s im ila r  A492 leve ls , with one primary 
clone, pos it ive  to ROS, moving from Category 5 to Category 6. Some 
clones, o r ig in a l ly  id e n t i f ie d  as po s it ive , were no longer so, and 
some new positives were obtained. A ll pos it ive  clones were 
expanded. Few primary clones remained pos it ive  in the 25ml f lasks . 
Five clones were expanded in to  250ml flasks and fused with the 
human lymphoblastoid KR-4 ce ll  l in e  (Kozbor jet al_., 1982) (Sections 
2.1.18 and 2.7 .8). The ce ll  cu ltu re  supernatants were no longer
pos it ive  at th is  time, but were fused in the hope o f detecting a 
pos it ive  reaction a f te r  the p a r t ia l  cloning at fusion (Section 
2 .7 .8 .2 ). Assay o f the fused ce l ls  did not suggest tha t there were 
any pos it ive  clones. In view o f the problem of overgrowth by
non-secreter c e l ls ,  subsequent fusions were made with smaller
numbers of c e l ls ,  before the primary clones were expanded from in 
25ml f lasks.
R e la t ive ly  weak positives to S-antigen and ROS (0.31 to 0.40 A492), 
could be detected in transformations derived from RP (advanced 
simplex form) patients GG and HM (Figures 5.14 and 5.15,
respective ly), who did not give any ind ica tion  of s ig n if ic a n t  serum 
responses to these antigens (Figures 4.10a,b). In these two
transformations, the T ce l l  rosett ing  and Cyclosporin A methods
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were compared (Section 5 . 3 . 9 ) .
5.3.8 ELISA Reactions of primary Transformed B Lymphocytes from 
Uveitis  Patients
Transformations were performed with PBL from only three patients 
with u v e it is .  Two o f these patients demonstrated s ig n if ic a n t  serum 
responses to the antigens in question, at the time of 
transformation. Patient MK demonstrated a pos it ive  response to ROS, 
but not to S-antigen (Figure 4.11b), and patient HS indicated a 
pos it ive  serum reponse to S-antigen, but was unreactive to ROS 
(Figure 4.11a,b). No pos it ive  clones could be detected in the 
assays of the transformed PBLs obtained from patien t MK (Figure 
5.16b). Patient CM gave no ind ica tion  of a serum response in the 
ELISA assays (Figures 4.11a,b), and no positives were obtained upon 
transformation o f the PBL (Figure 5.16a). Only pa tien t HS gave r ise  
to primary clones of transformed ce lls  which gave readings above 
0.3 A492 in the ELISA assays to ROS and S-antigen (see also Section
5 .3 .8 .1 ). I t  is  in te re s t in g , tha t although pa tien t HS demonstrated 
a s ig n i f ic a n t ly  pos it ive  serum response to S-antigen, but not to 
ROS, clones pos it ive  to ROS could be id e n t i f ie d  upon transformation 
(Figure 5.17).
5.3.8.1 Comparison of transformations performed at d i f fe re n t  in te rva ls
Three transformations were performed with PBLs iso la ted from 
patient HS (Tables 5.17a,b,c and Figure 5.17a,b,c). The three 
transformations were derived from 40ml blood samples, thus 120 
wells were available fo r  assay a f te r  3 to 4 weeks. Only the 
rosetting  method was employed. The second transformation was 
performed approximately 8 months a f te r  the f i r s t ,  and the th i rd  was 
performed about 12 months a f te r  the f i r s t  transformation. There was
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TABLE 5.16a ELISA readings o f the three week old transformants
from uve it is  patient CM 
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 118 98.3 120 100.0
2 0.21-0.30 2 1.7 0 0
TOTAL 120 100.0 120 100.0
TABLE 5.16b ELISA readings of the three week old transformants
from u ve it is  patient MK
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 59 98.3 60 100.0
2 0.21-0.30 1* 1.7 0 0
TOTAL 60 100.0 60 100.0
* Assays repeated 1 week la te r  yielded the same re su lts ;  the same 
ce lls  gave r ise  to the reading category 2.
TABLE 5.17a ELISA readings of the three week old transformants 
from u ve it is  patient HS; transformation 1 
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 88 73.3 106 88.3
2 0.21-0.30 12 10.0 11 9.2
3 0.31-0.40 11 9.2 2 1.7
4 0.41-0.50 5 4.2 0 0
5 0.51-0.60 2 1.7 0 0 .
6 0.61-0.70 1 0.8 0 0
7 0.71-0.80 0 0 0 0
8 0.81-0.90 1 0.8 0 0
9 0.91-1.00 0 0 1 0.8
TOTAL 120 100.0 120 100.0
TABLE 5.17b* ELISA readings of the three week old transformants
from u ve it is  patient HS; transformation 2
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 118 98.3 119 99.2
2 0.21-0.30 2 1.7 1 0.8
TOTAL 120 100.0 120 100.0
* S imilar resu lts  were obtained upon re-assay a f te r  6 days.
TABLE 5.17c ELISA readings of the three week old transformai
from u ve it is  pa tien t HS; transformation 3
Category A492 S-antigen % ROS %
Grouping No. Wells No. Wells
1 0.0 -0.20 39 65.0 107 89.2
2 0.21-0.30 13 21.6 11 9.2
3 0.31-0.40 4 6.7 0 0
4 0.41-0.50 0 0 1 0.8
5 0.51-0.60 4 6.7 1 0.8
TOTAL 60 100.0  120 100.0
Figure 5.16 ELISA Results for  the Assays of primary Clones of
Transformed Cells obtained from two Uveit is Patients
The primary clones of transformed c e l ls ,  derived from 
transformations o f PBL isolated from two patients with 
u v e i t is ,  were assayed in ELISA plates coated with ljjg/ml
S-antigen and 5jjg/ml ROS.
The histograms show the re la t iv e  frequencies o f primary 
transformants, f a l l in g  in to  defined categories of absorbance 
at 492nm (A492), a f te r  assay of the supernatants by ELISA. 
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos it ives.
No s ig n i f ic a n t ly  pos it ive  clones could be id e n t i f ie d  in the 
transformation derived from pa tien t CM (a). The clone,
ind ica ting  a pos it ive  reaction to S-antigen (Category 3), 
obtained from the transformation o f pa tien t MK, yielded the 
same reading, in the ELISA, one week la te r  (b). No other 
positives could be id e n t i f ie d .
a) ELISA o f transformation derived from patient CM
b) ELISA o f transformation derived from pa tien t MK
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Figure 5.17 ELISA Assays of three separate Transformations derived
from Uveitis  Patient HS
The primary clones of transformed c e l ls ,  derived from the 
transformation o f PBL isolated from u v e it is  pa tien t HS, on 
three d i f fe re n t  occasions, were assayed in ELISA plates 
coated with ljjg/ml S-antigen and Sjjg/ml ROS. Approximately 8 
months a f te r  the f i r s t  transformation (a ), a second 
transformation (b) was performed. The th i rd  transformation 
(c) was performed about 12 months a f te r  the f i r s t  
transformation.
The histograms show the re la t iv e  frequencies o f primary 
transformants, fa l l in g  in to  defined categories o f absorbance 
at 492nm (A492), a f te r  assay o f the supernatants by ELISA. 
Clones demonstrating reactions in the ELISA w ith in  Category 
3 and above, were selected as pos it ives.
Clones pos it ive  to both antigens, could be detected the 
f i r s t  and th i rd  transformations. The frequencies of 
positives obtained to each antigen were s im ila r .  No 
positives were detected in the second transformation, even 
upon re-assay. See also Tables 5.17a,b,c, and tex t (Section
5 .3 .8 .1 ).
a) ELISA of transformation 1
b) ELISA of transformation 2
c) ELISA of transformation 3
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a c lear difference between the number of positives obtained from 
the second transformation, and the two other transformations 
(Tables 5.17a,b,c and Figures 5.17a,b,c). At least three clones, 
obtained from the f i r s t  transformation, generated readings which 
would have been considered pos it ive  in a fusion from a 
hyperimmunised animal (Table 5.17a and Figure 5.17a). In th is  
transformation the m a jo r ity  of the strongest pos it ives were 
reactive in  the ELISA to S-antigen. Two clones were id e n t i f ie d  
which gave reading o f greater than 0.51 A492 in the ELISA against 
ROS (Tables 5.17a,c and Figure 5.17a,c). The clone with strongest 
reaction obtained from transformations derived from pa tien t HS, was 
to ROS, with a reading in the region of 0.91 to 1.0 A492 (Table 
5.17a). This is  in te res ting  since no s ig n if ic a n t  serum reaction to 
ROS, could be detected in the ELISA.
The second transformation did not y ie ld  any s ig n if ic a n t  pos it ives 
to e ith e r antigen. No s ig n if ic a n t  positives were obtained upon 
re-assay o f the transformation, 6 days la te r .  The th i rd  
transformation, performed about one year a f te r  the f i r s t ,  yie lded 8 
positives to S-antigen (out of 60 w e lls ) ,  and 2 posit ives to ROS
(out of 120). The frequency o f posit ives obtained in the assay 
against ROS (Table 5.17c), was s im ila r  to that obtained in the
f i r s t  transformation (Table 5.17a). The frequency o f clones
pos it ive  to S-antigen was also s im ila r  in the f i r s t  and th i rd
transformations, although the proportion o f these clones generating 
readings above 0.5 A492 was greater in the th i rd  transformation. 
The range of pos it ive  reactions obtained in the f i r s t  
transformation was from 0.31 to 1.0 A492 (Table 5.17a), and the 
range in the th i rd  transformation was from 0.31 to 0.6 A492 (Table 
5.17c).
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The larger number o f readings above 0.3 A492, detected in the f i r s t  
and th i rd  transformations, compared to the second transformation, 
is  not l i k e ly  to re f le c t  minor differences in batches of antigen, 
conjugate or ELISA plates.
5.3.9 Comparison of Transformation Procedures
The PBL, isolated from RP patients GG and HM, were divided in to  
three portions in order to assess the e ffe c t o f the T lymphocytes 
on the growth and p o s i t iv i t y  of the EBV transformed c e l ls .  Figures 
5.14a and 5.15a show the resu lts  obtained from the assay o f the 
transformed ce l ls  from which the T c e l ls  were removed by rose tt ing  
(Section 2 .7 .3 .3 ). Figures 5.14b and 5.15b show the ELISA resu lts  
fo r  the transformations treated with CsA, which s p e c i f ic a l ly  
in h ib i ts  the a c t iv i t y  of T ce ll (Powles et al_., 1980; reviewed by 
Shevach, 1985). Figures 5.14c and 5.15c show the resu lts  obtained
from the assay of the transformations in which the T c e l ls  were not
removed or in h ib ite d .
No s ig n if ic a n t  d ifference was observed in the growth rates o f the
ce lls  in the three groups described above, and the resu lts  obtained
fo r  the assay of these three groups were s im ila r .  The
transformation, derived from patient GG, generated 4 primary clones 
positive to S-antigen. Three of these clones were obtained from the 
group of ce l ls  in which the a c t iv i t y  of the T c e l ls  was not
inh ib ited  or removed. (Table 5.14c). The th i rd  pos it ive  clone was 
id e n t i f ie d  w ith in  the group where the T ce lls  were removed by
rosetting (Table 5.14a). The readings obtained from the la t t e r
clone, gave a reaction to S-antigen between 0.41 and 0.50 A492, in 
the ELISA (Table 5.14a). Two primary clones generated readings to
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ROS, in the ELISA, above 0.31 A492 (Table 5.14c).
The transformation derived from pa tien t HM, yielded only 2 clones 
generating readings in the ELISA to S-antigen above 0.31 A492.
These were obtained from the CsA treated transformed c e l ls  (Table 
5.15b). Assay o f the transformation against ROS, indicated that 
there were 7 clones giv ing readings above 0.31 A492 (Tables
5.15a,c). No clones were id e n t i f ie d  in the transformation from 
pa tien t HM, which generated ELISA reactions, to e ith e r antigen, 
above 0.4 A492.
In transformations derived from subjects not described in th is  
study, s im ila r  growth rates were obtained with the rose tt ing  and 
CsA treatments, and poorer growth was apparent a f te r  the f i r s t  week 
in the wells where T ce ll a c t iv i t y  was not removed or in h ib ite d . 
A fte r the th i rd  week, the transformed ce l ls  which received no a n t i -  
T lymphocyte treatment, were growing a c t ive ly .  By th is  time, 
although the T c e l ls  probably inactivated several o f the early  
v i r a l l y  infected c e l ls ,  the remaining transformed ce lls  appeared to 
recover and grow. In conclusion, the subversive influence o f the T 
ce l ls  (cyto tox ic  rather than helper T c e l ls )  was apparent in some 
samples and not in others, probably re f le c t in g  the immunological 
status o f the donor, to EBV or viruses in general, a t the time of 
transformation at least. The drug CsA was found to be as e f fe c t iv e  
in the removal o f T ce l l  a c t iv i t y ,  as the rosetting method, with 
the advantage o f shortening the transformation protocol by about 5 
hours (Sections 2 .7 .5 ). The drug was not found to have any 
detrimental e ffec ts  on ce ll  growth or on the frequency o f pos it ives 
detected, in patients GG and HM, at least.
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5.3.10 Problems in S tab i l isa t ion  of Transformed Lymphocytes
Primary transformed c e l ls  w ith in  the wells o f the 96-well p la tes, 
which generated reactions above 0.3 A492, in th ELISA assays to 
S-antigen and/or ROS, were expanded in to  the wells o f 24-well 
plates. The supernatants o f these expansions were re-assayed a few 
days la te r ,  when the ce l ls  had become established. Often the c e l ls  
seemed to cease to secrete antibody, especia lly  i f  the o r ig ina l 
reaction was in the region o f 0.3 to 0.4 A492. A few expanded 
primary clones remained p o s it ive , a f te r  growth in 25ml f lasks . 
These were the ce l ls  which tended to generate readings in the upper 
range, eg. o f 0.7 A492 and above, in the o r ig ina l assay o f the 
transformation p la te . The readings obtained in subsequent assay 
a f te r  expansion of these ce lls  in the wells of 24-well plates and 
25ml f lasks , were always much lower, eg. 0.3 to 0.5 A492.
Transformed ce l ls  are only temporarily s ta b i l ise d , and although 
some expanded clones could be cultured fo r  over two months, many 
clones a few clones fa i le d  to expand in to  24-well p la tes, and 
others regressed a f te r  expansion in to  25ml flasks.
Two clones, expanded from the f i r s t  transformation derived from 
u ve it is  pa tien t HS, remained pos it ive  (a t 0.4 A492) in the ELISA to 
S-antigen, while growing in 250ml f lasks . These ce l ls  were fused 
with the human lymphoblastoid ce ll l in e ,  KR-4 (Section 2 .7 .8 ) ,  and 
although good growth was obtained, no clones generated a reaction 
above 0.3 A492 in the ELISA assay. Fusions performed with 
transformants grown in 25ml flasks were also unsuccessful . The 
greatest problems encountered in the s ta b i l is a t io n  o f c e l ls  
secreting the required antibody, included the overgrowth by 
non-producers, and the inherent low rate o f antibody production
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(Kozbor and Roder, 1982; Sikora and N ev il le , 1982) (Section 
5.3.10). These factors made i t  d i f f i c u l t  to detect antibody in the 
supernatants of ce l ls  grown in 25ml f lasks. Expansion in to  25ml 
f lasks was required in order to provide s u f f ic ie n t  c e l ls  fo r  the 
purpose of s ta b i l is a t io n  by fusion, and subsequent cloning.
5.3.11 Discussion
Transformations of the PBL, isolated from blood samples obtained 
from certa in patients with RP and u v e i t is ,  demonstrated pos it ive  
clones in ELISA assays against S-antigen and ROS. One apparent 
weak, pos it ive  primary clone, was id e n t i f ie d  in one of the f iv e  
control transformations (Figure 5.10b). However, th is  clone was not 
pos it ive  upon re-assay, and the o r ig ina l re su lt  might have arisen 
from a spurious ELISA plate reaction.
I t  is  possible tha t s ig n i f ic a n t ly  pos it ive  clones of transformed B 
lymphocytes, could be detected in transformations derived from 
healthy ind iv id ua ls , i f  a larger number of experiments were 
performed. I t  is  the re la t iv e  frequencies of such clones, in 
transformations from healthy con tro ls , which should be compared 
with those from patients with ocular disease. However, Winger et 
a l . (1983) have shown that without p r io r  immunisation o f the 
subject, i t  is  possible to id e n t i fy  primary clones o f transformed 
human B lymphocytes, with s p e c i f ic i t ie s  to a va r ie ty  o f antigens.
The removal o f the T ce l ls  by rose tt ing  or th e ir  suppression by CsA 
in the transformations derived from RP patients G6 and HM, did not 
give r ise  to an improved growth or an increase in the number o f 
pos it ive  primary clones (Section 5 .3 .9 ). The removal or suppression
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of the T c e l ls ,  in transformations not described in th is  study, has 
resulted in improved growth. Bird et^ aj_. (1981), demonstrated that 
the addition of CsA to EBV infected B lymphocytes, enhanced th e ir  
growth. The e f fe c t  o f the T ce l ls  on the transformed B lymphocytes 
is  l i k e ly  to vary with the immunological status o f the pa tien t to 
EBV and to viruses in general.
The m a jo r ity  of c irc u la t in g  B c e l ls  are thought to be memory ce l ls  
(R o it t  et a j . ,  1985). I t  has been suggested tha t the m a jo r ity  o f B 
ce l ls  involved in transformation, are the memory ce l ls  (Volkman and 
Weetman, 1986). Thus, the detection of spec if ic  clones, using th is  
methodology, may suggest tha t the patients who did not give any 
ind ica tion  fo r  a pos it ive  serum response to the re t in a l antigens in 
the ELISA, might have become sensitised to them in the past. The 
most obvious example in th is  study, is  given by the ADRP pa tien t AA 
(Section 5 .3 .7). Conversely, recent evidence suggests tha t EBV may 
se le c t ive ly  transform B lymphocytes which have already begun to 
secrete immunoglobulin in v ivo, but which have not yet developed 
in to  plasma ce lls  (Steel et a j . ,  1986). Perhaps, during a certa in  
phase of the progressive re t in a l disease, the b lood-re tina l b a r r ie r  
was disrupted, and the immune system of the pa tien t became exposed 
to the re t in a l antigens. Newly stimulated antigen spe c if ic  B c e l ls ,  
which are ju s t  beginning to secrete antibody, become ava ilab le  fo r  
transformation by EBV (Steel et_ _al_*» 1986). S im i la r ly ,  u v e it is  
diseases might also undergo phases of a c t iv i t y  and regression. This 
could be re flected in immunological assays, where immunological 
factors are involved in the disease. The ocular inflammation 
observed in u v e i t is ,  might occasionally give r ise  to the sp e c if ic  
sens it isa t ion  of the immune system to certa in ocular antigens, at 
the more acute phases of the disease.
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Uveitis  patient HS demonstrated a re la t iv e ly  strong response to 
S-antigen in the ELISA, but the response to ROS was w ith in  the 
normal range. Several primary clones, generating pos it ive  reactions 
with both antigens, could be id e n t i f ie d  in two o f the three 
transformations (Figures 5.17a,c). This may ind icate tha t the 
pa tien t was in the process of developing a humoral immune response 
to ROS insoluble antigens. The second o f the three transformations 
derived from pa tien t HS, did not generate any s ig n i f ic a n t ly  
pos it ive  primary clones to S-antigen or ROS, in the ELISA assay 
(Figure 5.17b). I f  memory ce lls  are involved in the 
transformations, then positives would be expected from the second 
transformation, since they were obtained in the f i r s t  
transformation. However, i f  i t  is  the newly stimulated B ce l ls  
which are transformed, then the detection of pos it ive  clones w i l l  
probably depend on the present phase o f the disease, and the 
physiological state of the pa tien t. There may also be a sampling 
e rro r ,  in a s ta t is t ic a l  sense, and tha t fewer B lymphocytes, 
spec if ic  to re t in a l antigens, or transformable by EBV (Steel el: 
a j . ,  1986) were present w ith in  tha t p a r t icu la r  40ml blood sample.
In th is  study, only antibodies spec if ic  to S-antigen and ROS 
insoluble antigens, were sought. There is  no reason to believe tha t 
no other re t in a l proteins are involved; indeed the immunoblotting 
experiments with certa in patients sera suggest tha t a 40K antigen 
may be important (Section 4 .2 .7 ). The possible involvement o f the T 
lymphocytes was not investigated in th is  study. T ce l l  mediated 
immune reactions may be of importance in certa in  groups of patients  
with RP and u ve it is  (Sections 1 .4 .3 .5 , and 1 .4 .4 .4 ). The presence 
of humoral antibody may merely represent a by-product of the T
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lymphocyte mediated responses, which might be pa tho log ica lly  more 
s ig n if ic a n t .
Thus, c ircu la t in g  B lymphocytes, with s p e c i f ic i t y  to re t in a l 
antigens, could be id e n t i f ie d  in certa in  u ve it is  and RP patients by 
transformation technology. However, the stage of maturation o f 
those B lymphocytes with s p e c i f ic i t y  fo r  re t in a l antigens, which 
are transformable by EBV, remains to be determined.
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CHAPTER SIX
ESTABLISHMENT AND CHARACTERISATION OF 
MONOCLONAL ANTIBODIES
Chapter 6
ESTABLISHMENT AND CHARACTERISATION OF MONOCLONAL ANTIBODIES
The development and characterisation o f monoclonal antibodies 
derived from fusions with hyperimmunised and p o te n t ia l ly  autoimmune 
rats are described in th is  chapter. The s p e c i f ic i t ie s  and 
immunoglobulin classes o f a panel of f iv e  monoclonal antibodies are 
summarised in Table 6.1.
6.1 THE ESTABLISHMENT OF MONOCLONAL ANTIBODIES
6.1.1 Frequency of Positive Clones
The fusions were screened against lpg/ml of S-antigen and 5pg/ml of 
so lub il ised  rod outer segment membranes in ELISA assays (Section 
3 .8 .3-6). Absorbance readings of 0.8 or greater, at 492nm were 
taken to ind icate a s ig n if ic a n t  pos it ive  reaction o f hybridoma 
supernatants, from an immunised animal. The frequency o f pos it ive  
primary clones obtained from fusions with rats hyperimmunised with
S-antigen or ROS antigen ranged from 0 to close to 100%.
The resu lts  fo r  the screening of fusions with the p o te n t ia l ly  
autoiummune RCS rats are described in Section 5.2.5. For these 
fusions, readings of 0.4 and greater were taken as s ig n i f ic a n t ly  
pos it ive  (Section 5 .2 .5).
6.1.2 Expansion and selection o f Positive Hybrids
Primary fusion wells id e n t i f ie d  as pos it ive  in the ELISA to e ith e r
S-antigen or ROS, were expanded in to  25ml f lasks , when the wells 
had become confluent. The growth rate and general appearance o f the 
hybrids varied considerably between fusions, and even w ith in  one
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fusion p la te . Some primary clones would grow rap id ly  and expand 
re ad ily  in f lasks . Such ce l ls  tended to have smooth membranes. 
Clones e x ib it in g  poorer growth, generally had less smooth 
membranes. These ce lls  tended to regress a f te r  th e i r  i n i t i a l  
appearance, although a f te r  feeding with spleen c e l ls  from 
non-immunised rats (Section 2.6 .9.1) in complete medium, some such 
clones would improve dramatically. Only those potentia l clones 
demonstrating stable growth and antibody production were selected 
fo r  fu r th e r characterisation.
Due to the considerable cost involved in the establishment o f 
monoclonal antibodies, i t  was necessary to id e n t i fy  those 
antibodies with the greatest p o te n t ia l ,  by prelim inary experiments 
with the supernatants from the expanded, but as yet uncloned 
hybridomas, fo r  example, immunoblotting (Section 2.3.9) and 
immunocytochemistry (Section 2.4). The primary uncloned c e l ls ,  not 
selected fo r  the present study, were stored frozen in l iq u id  
nitrogen (Section 2 .6 .8).
6.1.3 Subcloning to achieve Monoclonality
The hybrids were subcloned by l im i t in g  d i lu t io n ,  as described in 
Section 2.6.9. Generally, less than 100% growth was obtained when 
the ce l ls  were cloned at one ce ll  per w e ll;  s im i la r ly ,  less than 
50% and less than 25% of wells had hybrids growing in them a f te r  
subcloning at 0.5 and 0.25 ce l ls  per w e l l ,  respective ly . At the 
f i r s t  subcloning, not a l l  o f the supernatants from wells w ith 
growth were pos it ive  in the ELISA, especia lly  when the o r ig in a l 
fusion had been h ighly successful in terms of the number o f wells 
with growth. In these cases, there was probably an i r re le v a n t clone 
sharing the same well as the clone of in te re s t .  Positive clones
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were expanded from the wells seeded at 0.25 ce lls  per w e l l ,  since 
these wells were more l i k e ly  to contain the o ffspring  descended 
from a single c e l l .  A ll subsequent subcloning gave r ise  to 100% of 
pos it ive  clones. Often i t  was only necessary to assay those wells 
with ce l ls  cloned at 0.25 and 0.5 ce l ls  per w e ll.  A fte r subcloning 
three times at 0.25 ce l ls  per w e l l ,  the hybrids were considered to 
be monoclonal, and could be grown in bulk cu ltu re  fo r  the 
production of large quantit ies of antibody fo r  experimental 
purposes (Section 2.6.10).
6.1.4 Established Monoclonal Antibodies
Two monoclonal antibodies were established from hyperimmunised DA 
rats (Table 6.1). Monoclonal antibody S2.4 .C5, detected against 
bovine S-antigen in ELISA, was obtained from a fusion with a ra t 
immunised with th is  prote in . Antibody R1.2.D2, detected in  the 
ELISA against ROS, was derived from a ra t immunised against bovine 
rod outer segment membranes (Section 2 .6 .1 ). Time did not permit 
the antibody. R1.2.D2, to be cloned more than once. Thus R1.2.D2 is  
not referred to as a monoclonal antibody, although i t  could have 
been regarded as one under less s tr ingen t c r i te r ia .
Three monoclonal autoantibodies were s tab il ised  from fusions with 
the splenic lymphocytes of RCS rats (Table 6.1). Two monoclonal 
antibodies were derived from the nine week old animal designated 
H9; monoclonal antibody, H9.1.C2 was reactive against S-antigen, 
and antibody H9.5.A4 was reactive to ROS in ELISA. The th i rd  
monoclonal antibody H10.1.D2,was obtained from a ra t sac r if ice d  at 
the age of 10 weeks (H10), and was reactive against both S-antigen 
and ROS.
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TABLE 6.1 Class and s p e c i f ic i t y  of monoclonal antibodies
Monoclonal Parent Immunising Class . S p e c if ic i ty  
Antibody Rat Strain Antigen
S2.4.C5 DA S-antigen IgGl S-antigen
R1.2D2 DA ROS IgM 39K
H9.1.C2 RCS Hunter - IgM S-antigen
H9.5.A4 RCS Hunter - IgM ROS protein
H10.1.D3 RCS Hunter - IgM Opsin/S-ag
6.2 ISOTYPE OF MONOCLONAL ANTIBODIES
Tenfold concentrates of the monoclonal antibodies, ammonium 
sulphate p rec ip ita ted from ce ll free cu ltu re supernatant and 
dialysed against PBS (Section 2 .2 .4 .1 ) ,  were assayed with isotype 
spec if ic  rabb it antisera in Ouchterlony immunodiffusion experiments 
(Section 2.6.11). Immune complexes p rec ip ita ted where the 
monoclonal antibody came in contact with the appropriate isotype 
spec if ic  anti sera (Section 2.1.16). An immunoprecipitate formed 
when ra t monoclonal antibody S2.4.C5, with s p e c i f ic i t y  to 
S-antigen, reacted with rabb it a n t i - ra t  IgG (gamma chain) and sheep 
a n t i - ra t  IgGl. This monoclonal antibody did not form a p re c ip i t in  
band with rabb it a n t i - ra t  IgM, goat a n t i - ra t  IgG 2a or 2c, or 
rabb it a n t i - ra t  IgG 2b. Monoclonal antibody R1.2.D2 with 
s p e c i f ic i t y  to ROS, and also the three autoantibodies (Section 
6.1.4) formed p re c ip i t in  bands with rabb it a n t i - ra t  IgM, but not 
with rabb it a n t i - ra t  IgG (gamma chain) or any of the other antisera 
to ra t  IgG subclasses. Table 6.1 shows the classes o f the 
monoclonal antibodies obtained during the course of th is  work.
6.3 SPECIFICITY OF MONOCLONAL ANTIBODIES
6.3.1 ELISA T itres  of Monoclonal Antibodies
The s p e c i f ic i t ie s  of the monoclonal antibodies in ELISA were 
determined by t i t r a t in g  o f the ce ll cu ltu re  supernatants against 
the S-antigen and washed ROS antigen (Figures 6.1 to 6 .6 ). Assay 
controls included the t i t r a t io n  o f the monoclonal antibodies on 
plates coated with BSA only, and also the t i t r a t io n  o f i r re le v a n t  
IgG and IgM monoclonal antibodies on plates coated with the two 
antigens.
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6.3.1.1 T i t ra t io n  o f monoclonals from immunised rats
Monoclonal antibody S2.4.C5, demonstrated a t i t r e  to S-antigen of 
more than 1000, which suggested that i t  might be used at high 
d i lu t io n s  in certa in experiments. Figure 6.1 shows the t i t r e s  given 
by monoclonal antibody S2.4.C5, to S-antigen, at time in te rva ls  
from 30 seconds to 4 hours. The short period required fo r  binding, 
suggests tha t the antibody is  l i k e ly  to be of re la t iv e ly  high 
a f f i n i t y  (Mason and Williams, 1980). Figure 6.2 shows the decrease 
in the ELISA readings when the concentration of e ith e r S-antigen or
S2.4.C5 was reduced, while the other parameter remained constant.
Antibody R1.2.D2, demonstrated a t i t r e  to bovine ROS in the ELISA 
assay (Figure 6.3). The antibody was unreactive to S-antigen and 
BSA in the ELISA, generating readings s im ila r to tha t of the 
background reaction given by the omission of the primary antibody 
step, shown by the dotted l in e  in Figure 6.3.
6.3.1.2 T i t ra t io n  of monoclonal autoantibodies
The RCS ra t monoclonal autoantibodies were of apparently low 
a f f in i t y ,  with the reaction fa l l in g  ra p id ly  even at low d i lu t io n s .  
A higher antibody concentration was apparently required to drive 
the reaction forward, in comparison with the apparently high 
a f f i n i t y  IgG monoclonal antibody S2.4.C5 (Figure 6 .1). Monoclonal 
antibody H9.1.C2 exhibited a low t i t r e  to S-antigen and was 
unreactive against the washed ROS (Figure 6.4). Monoclonal antibody 
H9.5.A4 reacted with ROS in ELISA, but not with S-antigen, and also 
demonstrated a re la t iv e ly  low t i t r e  (Figure 6.5). The th i rd  
monoclonal autoantibody, H10.1.D3, showed a weak response to both 
antigens, although at a level above the background and above the 
reading given by the omission of the primary antibody (Figure 6 .6 ).
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Figure 6.1 Reactions of ser ia l  d i lu t ions of MAb S2.4.C5
against lpg/ml o f S-Antigen in the ELISA
The monoclonal antibody, in the form of hybridoma 
supernatant, was t i t r a te d  on the ELISA plate at d i f fe re n t  
time in te rva ls ,  in order to measure the e f fe c t  o f d i lu t io n  
and incubation time on the reaction. The re su lt  fo r  the 4 
hour incubation is  the mean of 5 assays. The readings fo r  
a l l  other periods o f MAb incubation were obtained from 
single assays.
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Figure 6.2 Chequerboard Experiment with MAb S2.4.C5 and S-Antigen
The effec ts  on the ELISA reaction of va r ia t ion  in 
concentration o f MAb S2.4.C5, in the form o f hybridoma 
supernatant, and S-antigen, was determined by means of a 
chequerboard experiment (Section 3 .8 .4 ). The incubation time 
with the monoclonal antibody was 2 hours.
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Figure 6.3 Reaction of Antibody R1.2.D2 to Retinal Antigens in ELISA
The antibody was applied to ELISA plates coated with 5ug/ml 
o f ROS, as c e l l - f r e e  hybridoma supernatant. The t i t r a t io n  
against ROS was the mean o f 5 assays. The incubation time 
fo r  the primary antibody was 4 hours.
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Figure 6.4 Reaction of RCS Rat MAb H9.1.C2 to S-Antigen in ELISA
MAb H9.1.C2 was applied to the ELISA plates as hybridoma 
supernatant, from which seria l d i lu t io n s  were made. A 10 
fo ld  ammonium sulphate concentrate of the antibody was also 
applied to the p la te. The incubation time fo r  the monoclonal 
antibody was 4 hours.
The monoclonal autoantibody was reactive to bovine S-antigen 
( l j jg /m l) but was unreactive to ROS (5jjg/ml). Only a small 
increase in the in te n s ity  o f reaction was obtained with the 
10 fo ld  concentrate of antibody.
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Figure 6.5 Reaction of RCS Rat MAb H9.5.A4 to ROS Antigens in ELISA
MAb H9.5.A4 was applied to the ELISA plates as hybridoma 
supernatant, from which seria l d i lu t io n s  were made. A 10 
fo ld  ammonium sulphate concentrate o f the antibody was also 
applied to the p la te . The incubation time fo r  the monoclonal 
antibody was 4 hours.
The monoclonal autoantibody was reactive to bovine ROS 
(5pg/ml) but was unreactive to S-antigen ( lpg /m l). Only a 
small increase in the in te n s ity  of reaction was obtained 
with the 10 fo ld  concentrate o f antibody.
KEY
□ t i t r a t io n  of H9.5.A4 against ROS 
■ t i t r a t io n  of H9.5.A4 against S-antigen
1.1
1.0
0.9
1:2 1:4 1:161:81x10 1 : 1
Dilution of supernatant
Figure 6 .6  Reaction of RCS Rat MAb H10.1.D3 Retinal Antigens in ELISA
MAb H10.1.D3 was applied to the ELISA plates as hybridoma 
supernatant, from which seria l d i lu t io n s  were made. A 10 
fo ld  ammonium sulphate concentrate o f the antibody was also 
applied to the p la te . The incubation time fo r  the monoclonal 
antibody was 4 hours.
The monoclonal autoantibody demonstrated a re la t iv e ly  weak 
t i t r e  to bovine S-antigen (l j jg /m l) and ROS (5jjg/ml). Only a 
small increase in the in te n s ity  of reaction was obtained 
with the 10 fo ld  concentrate o f antibody.
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Figures 6.4 to 6.6 include the reactions of the monoclonal 
autoantibodies in the form of 10 fo ld  concentrates o f the hybridoma 
supernatant.’ The tenfo ld increase in the concentration o f the 
antibodies H9.1.C2 and H10.1.D3, resulted in only a re la t iv e ly  
small r ise  in the ELISA reaction (Figures 6.4 and 6.6, 
respective ly). A tenfo ld concentration of monoclonal antibody 
R1.2.D2, resulted in a more s ig n if ic a n t  increase in the ELISA 
reading.
6.3.2 S p e c if ic i ty  of the Monoclonal Antibodies in Immunoblots
6.3.2.1 High t i t r e  monoclonal antibodies
The s p e c i f ic i t y  of the monoclonal antibodies was investigated in
immunoblotting experiments (Batte iger et a l . ,  1982) (Section
2.3 .9 ). When antibody S2.4.C5, from a hyperimmunised animal
1(Section 2.6.1) was tested in I protein A b lo ts , against 
e le c trop ho re t ica l ly  resolved proteins from complex prote in mixtures 
in addition to p u r if ie d  S-antigen and crude re t in a l antigens, i t  
was found to be very spec if ic  to S-antigen (Figures 6.7 and 
6 .11a,b).
Figure 6.8b shows a peroxidase enzyme b lo t  (Sections 2 .3 .9 .6 ,7 ) fo r  
antibody R1.2.D2. The antibody reacted against a band of apparent 
molecular weight 37K to 39K, present w ith in  the crude extract of 
the re t ina . In th is  experiment there was a re la t iv e ly  high 
background reaction with the other proteins on the n itro ce l lu lo se  
s t r ip .  The antibody was apparently unreactive against the opsin 
protein of the ROS track , and unreactive to the S-antigen. The 
antibody d id , however, react with a band in the region of 39K, in 
the crude re t in a l ex trac t. The intense reaction with the 30K 
protein standard (carbonic anhydrase) which represented the
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Figure 6.7 S p e c i f ic i ty  of MAb S2.4.C5 in Immunoblots against
Retinal Antigens 
125The I protein A detection system was employed with the 
omission o f the intermediate rabb it a n t i - ra t  IgG, since the 
protein A was capable of binding to th is  ra t  IgGl MAb. The 
MAb was applied as the hybridoma supernatant.
a) Amido Black stained b lo t
b) Autoradiograph of b lo t  with S2.4.C5
LANES
1. Pharmacia low molecular weight standard proteins
2. Bovine S-antigen
3. Crude re t in a l extract
4. Bovine ROS membrane proteins
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Figure 6 .8  S p e c i f ic i ty  of Antibody R1.2.D2 in Immunoblots against
Retinal Antigens
The enzyme detection system was employed with the peroxidase 
conjugated rabb it a n t i - ra t  IgG(H+L), and o-d ian is id ine as a 
substrate. The antibody was applied as the hybridoma 
supernatant. An enzyme b lo t of MAb S2.4.C5 was included fo r  
comparison.
There was a re la t iv e ly  high background with the re t ina l 
antigens, although the R1.2.D2 antibody appeared to id e n t i fy  
with a 39K antigen in the crude re t in a l ex trac t. The 
reaction with the 30K standard protein was a common feature 
in the immunoblots, and was a tt r ibu ted  to a nonspecific 
binding of the rabb it a n t i - ra t  antibody.
a) Amido Black stained n itroce llu lo se  s t r ip
b) Enzyme b lo t with R1.2.D2
c) Enzyme b lo t with S2.4.C5
LANES
1. Pharmacia low molecular weight standard proteins
2. Bovine S-antigen
3. Crude re t in a l extract
4. Bovine ROS membrane proteins
a b c
30K
1 2  3 4 4 3 2 1 2
Figure 6.9 S p e c i f ic i ty  of RCS Rat MAbs in Immunoblots with Retinal
Antigens
The I prote in A detection system was employed with the 
use o f the intermediate rabb it a n t i - ra t  IgG(H+L), since the 
protein A did not re ad ily  bind to ra t  IgM. The MAbs were 
applied as hybridoma supernatants. MAb H10.1.D3 appeared to 
react against S-antigen and opsin. MAb H9.5.A4 was reactive 
against S-antigen only.
a) Amido Black stained transfe r
b) Autoradiograph of b lo t  with H10.1.D3
c) Autoradiograph o f b lo t  with H9.1.C2
LANES
1. Pharmacia low molecular weight standard proteins
2. Bovine S-antigen
3. Bovine ROS membrane proteins
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nonspecific reaction of the rabb it a n t i - ra t  sera with th is  pro te in , 
was a re la t iv e ly  common feature in the enzyme and protein A b lo ts .
Figure 6.8c shows the intense reaction o f monoclonal antibody
S2.4.C5, with S-antigen, fo r  comparison with the enzyme b lo t  with 
antibody R1.2.D2. The stained bands below and above the S-antigen 
band, almost c e r ta in ly  represent breakdown products o f S-antigen 
and micro-aggregates of S-antigen and i t s  breakdown products. These 
reactive bands were not detected in the Amido black (Section 
2.3.9.2) stained n itroce llu lo se  s t r ip s ,  due to the re la t iv e  
in s e n s i t iv i ty  of th is  s ta in .
6.3.2.2 Monoclonal autoantibodies
125The reactions of the monoclonal autoantibodies in I prote in  A 
immunoblotting experiments (Sections 2 .3 .9 .6 ,7) were not as intense 
as tha t of the S2.4.C5 antibody. Antibody H9.1.C2 appeared to 
id e n t i fy  S-antigen (Figure 6.9c) and antibody H10.1.D2 
cross-blotted with both opsin and S-antigen (Figure 6.9b). The 
observed c ro ss re a c t iv ity  may have arisen from the presence o f 
s im ila r carbohydrate residues on S-antigen and opsin, and the 
epitope recognised by the antibody may have been carbohydrate 
(Section 8 .4 .5 ). H10.1.D2 also recognised a higher molecular weight 
band in the ROS which probably represented an aggregate o f opsin. 
Monoclonal antibody H9.5.A4 did not react with any o f the material 
on the n itroce llu lo se  paper. Presumably the relevant epitopes were 
denatured upon SDS-PA6E (Section 2.4.2) and binding to the 
n itroce llu lo se  paper.
6.3.3 Immunoblotting Controls
125The omission controls fo r  the I protein A b lo ts of re t in a l
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antigens, are described in 'Section 3.8.1 (Figure 3.9, Legend). The 
negative control immunoblots were exposed to X-ray f i lm  fo r  the 
same length 6f time as the b lo ts  with the monoclonals. Normal ra t 
serum used as a negative con tro l,  resulted in a neg lig ib le  
reaction. Irre levan t monoclonal antibodies, also employed as 
negative contro ls , did not give r ise  to a detectable reaction. In 
some enzyme and protein A b lo ts , a nonspecific reaction with the 
30K (carbonic anhydrase), and occasionally the 14.4K 
(a -lacta lbum in), molecular weight standard was observed (Figures 
6.8b and 4.13, respective ly ). This could be a tt r ib u te d  to the 
nonspecific reaction o f the second antibody, when the primary 
antibody was omitted.
6.3.3.1 Irre levan t antigens
In addition to being tested against crude re t in a l antigens, the
antisera and monoclonal antibodies, with the only exception being
antibody R1.2.D2, were immunoblotted against soluble extracts from
various ra t tissues (prepared as fo r  the crude re t in a l e x tra c t;
Section 3 .2 .1). This experiment provided a va r ie ty  of proteins and
other antigens fo r  the investiga tion  of the s p e c i f ic i t y  o f the
antibodies. The samples were not treated with mercaptoethanol in
the sample bu ffer (Section 2.2 .5.5) in order to reduce d isruption
125of native epitopes. The I prote in A detection system was used 
(Section 2 .3 .9 .6 ,7 ) .
Figure 6.10 shows a Coomassie Blue stained gel of the resolved ra t  
tissue antigens used in the s p e c i f ic i t y  tes ts . A ll o f the 
monoclonal antibodies and antisera immunoblotted against these 
ir re levan t antigens appeared to give r ise  to intense reactions with 
certa in high molecular weight components. Figure 6.11a shows th is
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Figure 6.10 Coomassie Blue stained SDS Gel of Soluble Extracts
obtained from several Rat Tissues
Soluble extracts were taken from several ra t tissues in 
order to provide a wide va r ie ty  o f i r re le va n t antigens to 
tes t the s p e c i f ic i t y  o f the monoclonal antibodies in 
immunoblots (Figures 6.11a,b). The samples were not treated 
with mercaptoethanol, in order to preserve a greater number 
o f native eptitopes.
LANES
1. Crude soluble extract o f brain
2. Crude soluble extract of heart
3. Crude soluble extract o f lung
4. Crude soluble extract o f l i v e r
5. Pharmacia low molecular weight standards
6. Crude soluble extract of muscle
7. Crude soluble extract of spleen
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reaction fo r  an immunoblot with antibody S2.4.C5. The apparent
crossreactions observed were a t tr ibu ted  to the reaction o f the 
second antibody, rabb it a n t i - ra t  IgG(H+L) (Section 2 .1 .16), with 
the ra t  immunoglobulins present in the crude tissue extracts . This 
was shown by the omission of the primary antibody (Figure 6.11b). 
The protein A did not s ig n i f ic a n t ly  react with th is  ra t  tissue 
immunoglobulin, although i t  is  able to bind to the ra t  IgG
subclasses, with varying e f f ic ie n cy  (Rousseaux et al_., 1981;
Nilsson et a j . ,  1982). I t  was possible to use the I prote in A 
b lo t t in g  technique, with the ra t IgGl monoclonal antibody, S2.4.C5, 
without the aid o f the rabb it a n t i - ra t  second antibody (Figure 
6 .7).
No reactions, other than those obtained when only the rabb it
a n t i - ra t  IgG was used, were obtained with any of the monoclonal or 
polyclonal antibodies tested.
The s p e c i f ic i t y  of monoclonal antibody S2.4.C5 to 3-antigen, was 
fu r th e r demonstrated when i t  was immunoblotted against a 
so lub il ised  extract of eye melanoma, Hela chromatin and V ibrio  
cholerae LPS. In th is  experiment, invo lv ing labelled prote in A, the 
rabb it a n t i - ra t  IgG(H+L) antibody was not used. Monoclonal antibody
S2.4.C5, gave r ise  to no nonspecific reaction with these ir re le v a n t  
antigens.
Thus, the monoclonal antibodies produced during the course o f th is  
work were not found to crossreact with any of the ir re le v a n t  
antigens tested.
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Figure 6.11a S p e c i f ic i ty  of MAb S2.4.C5 in Immunoblots against
i r re le va n t Rat Antigens
The MAb, in the form of hybridoma supernatant, was incubated 
with n itro ce llu lo se  s tr ip s  bearing resolved crude antigens 
extracted from several ra t  t issues, which had not been 
treated with mercaptoethanol. The - ^ 1  protein A detection 
system was employed, with the inclusion of the intermediate 
rabb it a n t i - ra t  IgG(H+L).
Intense reactions were observed with certa in  high molecular 
weight bands, which did not form major bands in the 
Coomassie Blue stained gel (Figure 6.10). These reactions 
were a t tr ibu ted  to the reaction of the rabb it a n t i - ra t  
IgG(H+L) with the endogenous ra t  immunoglobulin (Figure 
6.11b). No additional reactions were obtained.
LANES
1. Purif ied  bovine S-antigen
2. Crude soluble extrac t o f brain
3. Crude soluble ex trac t of heart
4. Crude soluble extrac t of lung
5. Low molecular weight standards
6. Crude soluble extrac t o f l i v e r
7. Crude soluble extrac t o f spleen
8. Crude soluble ex trac t o f muscle
9. Crude soluble ex trac t of muscle
S -a n t ig e n —
Figure 6.11b React iv i ty  of Rabbit A n t i - r a t  IgG(H+L) in Protein A
Immunoblots against complex Mixtures o f Rat Antigens
The rabb it a n t i - ra t  IgG(H+L) was incubated with 
n itro ce llu lo se  s tr ip s  bearing resolved crude antigens 
extracted from several ra t  t issues, which had not been 
treated with mercaptoethanol.
Intense reactions were observed with the same high molecular 
weight bands, as observed in immunoblots with the monoclonal 
antibodies (Figure 6.11a). These reactions were a tt r ibu ted  
to the reaction o f the rabb it a n t i - ra t  IgG(H+L) with the 
endogenous ra t  immunoglobulin. No additional reactions were 
obtained.
LANES
1. Crude soluble extract of brain
2. Crude soluble extrac t of heart
3. Crude soluble extrac t o f l i v e r
4. Crude soluble extract o f spleen
5. Crude soluble extrac t o f lung
6. Crude soluble extrac t o f muscle
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IMMUNOBLOTTING OF S-ANTIGEN FRAGMENTS WITH MONOCLONAL ANTIBODY
S2.4.C5
Immunoblotting experiments were performed with S2.4.C5 against 
enzymatic digests of S-antigen in order to id e n t i fy  the smallest
fragment bearing the S2.4.C5 epitope. Enzymatic digestion was
carried out according to the procedure of Cleveland et al_. (1977) 
(Section 2 .3 .8 ). The enzymes employed included tryp s in ,  
chymotrypsin and Staphylococcus aureus V8 protease (Section 2 .1 .6 ). 
Trypsin cleaves peptides on the carboxyl side o f lys ine or 
arg in ine, and chymotrypsin cleaves on the carboxyl side of aromatic 
amino acids (eg. tryptophan). Staphylococcus V8 protease cleaves 
s p e c i f ic a l ly  glutamyl, and sometimes aspartyl peptide bonds.
The resolved fragments of S-antigen were e le c tro p h o re t ica l ly
transferred to n itroce llu lo se  paper and immunoblotted with
125monoclonal antibody S2.4.C5 and I labe lled protein A (Batte iger 
et a j . ,  1982) (Section 2 .3 .9 ). Although the n itro ce llu lo se  s tr ip s  
containing the resolved fragments of S-antigen were blocked with
0.5% Tween 20 in the Tris  bu ffe r (Section 2 .3 .9 .6 ),  the detergent 
in the wash bu ffer was reduced to 0.05% in order to reduce the 
leaching of protein from the n itroce llu lo se  paper. The loss o f 
p ro te in , in the presence of high Tween concentrations, was shown 
by the amido black sta in ing o f n i t ro ce llu lo se  s tr ip s  (Section 
2 .3 .9 .2 ) ,  washed with e ithe r 0.5% and 0.05% Tween.
The protein A detection system was selected, since by increasing 
the exposure time of the b lo t to f i lm ,  those fragments present in 
smaller concentrations could be more re a d ily  v isua lised. The denser 
bands required shorter periods of exposure.
6.4.1  Molecular Weights of S i lver  stained Peptides of S-Antigen
Figures 6.12A,B show two s i lv e r  stains of the peptide map obtained 
fo r  the digestion of S-antigen with tryp s in , chymotrypsin and V8 
protease. The sta in ing method of Wray et cQ. (1981) was employed, 
with 5 minutes longer allowed fo r  the incubation with the s i lv e r  
sta in fo r  th is  15% gel (Section 2 .3 .6 .2 ). The Cleveland method of 
digestion with the three enzymes (Section 2 .3 .8 ) , was found to 
generate reproducible patterns o f bands and was not s ig n i f ic a n t ly  
affected by the enzyme concentration or time allowed fo r  the 
digestion. In some gels, a few of the bands or part of the bands 
were apparently missing (Figures 6.12A,B). This represents an 
a r t i f a c t  o f s i lv e r  s ta in ing.
6.4.2 Molecular Weights of the smallest Fragments bearing the S2.4.C5 
Epitope
Reproducible patterns of bands were obtained on the autoradiographs 
125of the Cleveland I protein A b lo ts fo r  monoclonal antibody
S2.4.C5 (Figure 6.13A). Inspection o f several experimental resu lts  
indicated that a l l  detectable bands bore the S2.4.C5 epitope; no 
unreactive bands could be id e n t i f ie d .
The Rf values were calculated fo r  the Pharmacia low molecular 
weight standard protein markers, from the gel shown in Figure 
6.12A, and a standard curve o f molecular weight versus m o b i l i ty ,  
was p lo tted (Figure 6.14). The pattern of bands on the 
autoradiographs, obtained from the 125 i protein A b lo ts  w ith 
monoclonal antibody S2.4.C5, were compared with those on the 
o r ig ina l b lo t ,  stained with Amido black (Figures 6.13A,B). A ll 
bands v is ib le  on the n itroce llu lo se  paper corresponded to a band on
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Figure 6.12 S ilve r stained SDS 15% Acr.ylamide Gel o f Enzymatic 
Digests o f S-Antigen
Fragments o f S-antigen were generated by digestion in SDS 
acrylamide gels with tryp s in , chymotrypsin and V8 protease
employing the method of Cleveland et a ] . ,  (1977), and
subjected to sensitive s i lv e r  s ta in ing. Two gels (A and B)
are shown since there was an a r t i fa c tu a l absence of sta in ing
in some regions of the gel.
A wide range of peptides were obtained, the smallest of which 
were approximately 9.2K to 9.4K.
LANES
V8: Digest with V8 protease (LHS: 50ng enzyme;
RHS: 5ng enzyme)
T: Trypsin (LHS: 50ng enzyme; RHS: 5n enzyme)
Ch: Chymotrypsin (LHS: 50ng enzyme; RHS: 5ng enzyme)
LMW: Pharmacia low molecular weight standards
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Figure 6.13 Immunoblot of MAb S2.4.C5 against S-Antigen Fragments
A) Autoradiograph of prote in A immunoblot w ith MAb S2.4.C5
B) Amido black sta in of the immunoblot
Fragments o f S-antigen were generated by digestion in SDS
acrylamide gels with tryp s in , chymotrypsin and V8 protease
employing the method of Cleveland et a l . ,  (1977). The
peptides were e le c trop ho re t ica l ly  transferred to
n itroce llu lo se  paper and subsequently immunoblotted with MAb
125S2.4.C5, using the I protein A technique.
The MAb appeared to react with a l l  fragments of S-antigen 
detected on the n itroce llu lo se  paper, the smallest of which 
were approximately 9 .OK to 9.4K (arrows).
LANES
V8: Digest with V8 protease (LHS: 50ng enzyme;
RHS: 5ng enzyme)
T: Trypsin (LHS: 50ng enzyme; RHS: 5n enzyme)
Ch: Chymotrypsin (LHS: 50ng enzyme; RHS: 5ng enzyme)
LMW: Pharmacia low molecular weight standards
Smallest peptides obtained; reactive with MAb S2.4.C5.
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the autoradiograph. The bands v is ib le  on the n itro ce llu lo se  paper 
were compared with those of the s i lv e r  stained Cleveland gels 
(Figures 6.12A,B). From th is  comparison, i t  was possible to 
id e n t i fy  the smallest detectable fragments bearing the S2.4.C5 
epitope, obtained by th is  method. The comparison also suggested 
that there were no obvious unreactive bands.
The smallest fragments of S-antigen, produced by digestion with the 
three enzymes, which gave detectable reactions in the b lo ts  with
52.4.C5, are indicated by arrows in Figure 6.13A,B. The apparent 
molecular weight of the smallest fragment bearing the S2.4.C5 
epitope, in the tryps in  d igest, was calculated using the standard 
curve shown in Figure 6.14, to be approximately 9.3K (Figures 6.12, 
6.13). The smallest fragment produced by digestion with V8 protease 
was apparently 9.2K to 9.4K (Figures 6.12, 6.13 and 6.14). The 
smallest peptide o f S-antigen shown in the chymotrypsin digest in 
Figure 6.12, had a molecular weight in the region of 9.6K. However, 
in the Cleveland b lo t ,  a fragment of less than 9K could be detected 
in the chymotrypsin digest. Fragments smaller than these could not 
be detected in the s i lv e r  stained gels, and could not be generated 
upon increasing the concentration of the enzymes, or by increasing 
the time or temperature fo r  the digestion. Smaller fragments could 
not be produced by the digestion of S-antigen with mixtures o f the 
three enzymes, in every combination.
The apparent absence o f unreactive bands might imply tha t the
52.4.C5 epitope was unaffected by cleavage by the enzymes, and tha t 
the cleavage s ites did not form a s ig n if ic a n t  part of the S2.4.C5 
epitope. However, a peptide of 9K indicates the presence of about 
50 amino acids. I t  seems u n l ik e ly  tha t the cleavage s ites  fo r  the
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Figure 6.14 Standard Curve fo r  Molecular Weight determination of the
smallest S-Antigen Fragments bearing the S2.4.C5 Epitope
The molecular weights of the smallest epitopes bearing the
S2.4.C5 epitope were estimated from a standard curve of the 
m o b il i ty  versus molecular weight o f the Pharmacia low 
molecular prote in markers. Since the smallest marker protein 
was 14K, the curve was lengthened by extrapolation.
The molecular weights o f the smallest S-antigen peptides 
obtained by enzymatic d igestion, were in the region of 9.4K 
to 9.2K, and are indicated by c irc le s  on the standard curve. 
The molecular weight of S-antigen was also determined by 
th is  method; giving a molecular weight o f 48K (indicated by 
a c i r c le  on the standard curve).
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three enzymes were absent in th is  region. I t  is  possible tha t 
smaller peptides trave lled  past the end of the gel during 
electrophoresis. In add it ion , the very small peptides are l i k e ly  to 
travel through the n itro ce llu lo se  paper during e le c tro - tra n s fe r .  I t  
is also possible tha t complete digestion was not obtained w ith in  
the ge l, under the conditions employed fo r  the digestion (Section 
2 . 3 .8 . 2 ).
6.4.3 Comparison with Rat Polyclonal Antisera
Three ra t polyclonal antisera were b lo tted against the S-antigen
fragments fo r  a comparison with the monoclonal antibody (Figures
6.15a,b,c). The smallest bands giving r ise  to a detectable reaction 
125in the I prote in A blots were apparently of a larger molecular 
weight than those id e n t i f ie d  in the blots with monoclonal antibody,
S2.4.C5 (Section 6 .4 .2 ). Although the antisera employed may not 
have recognised the epitope presented on the 9.2K to 9.7K 
fragments, i t  is  possible tha t th is  was a re f le c t io n  o f the 
d i lu t io n  (1:200) o f the antisera.
Cleveland b lo t t in g  experiments with anti sera can y ie ld  useful 
information, which cannot be obtained from a monoclonal antibody 
alone. Anti sera from d i f fe re n t  ind iv idua ls  contain th e i r  own 
reperto ire  of antibodies, with d i f fe r in g  isotypes, s p e c i f ic i t ie s  
and a f f in i t i e s .  The use of polyclonal antisera could aid the 
id e n t i f ic a t io n  o f peptides containing the dominant antigenic 
determinants. Antisera raised in d i f fe re n t  species are l i k e l y  to 
recognise a d i f fe re n t  pattern of determinants. Cleveland b lo t t in g  
experiments with the ra t  and human autoimmune sera could y ie ld  
important information on the epitopes o f S-antigen involved in the 
induction of the humoral immune respone observed in certa in
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Figure 6.15 Reaction of Rat Polyclonal Anti sera to S-Antigen in
Cleveland Blots
a) Autoradiograph of immunoblot with ra t  anti serum SI
b) Autoradiograph o f immunoblot with ra t  anti serum S2
c) Autoradiograph o f immunoblot with ra t  antiserum S3
Three ra t polyclonal antisera raised against S-antigen were 
tested fo r  th e ir  re a c t iv i ty  in Cleveland immunoblots, with 
fragments o f S-antigen generated by digestion in SDS 
acrylamide gels with 50ng of tryp s in , chymotrypsin and V8 
protease. The 125 j protein A detection system was employed 
with the second antibody, rabb it a n t i - ra t  IgG(H+L).
The polyclonal antisera, at a 1:400 d i lu t io n ,  appeared to 
react with a l l  fragments of S-antigen, v is ib le  on the 
n itroce llu lo se  paper, the smallest of which was 
approximately 9.2K to 9.7K.
LANES
V8: Digest with V8 protease (50ng enzyme)
T: Trypsin (50ng enzyme)
Ch: Chymotrypsin (50ng enzyme)

ind iv idua ls  (Chapter 4). In add it ion , certa in  autoantibodies may be 
found to id e n t i fy  minor epitopes of antigens not 'seen' by 
hyperimmune sera, where the antibodies tend to react w ith the 
dominant determinants.
6-5 PURIFICATION OF MONOCLONAL ANTIBODY S2.4.C5
Purif ied  ra t  IgGl monoclonal antibody S2.4.C5 was required fo r  
experiments investiga ting  i t s  e f fe c t  on the experimental autoimmune 
u ve it is  (EAU) in rodents (Section 6.6).
6.5.1 Production of Monoclonal Antibody S2.4.C5 in Serum-free Media
The hybrids secreting monoclonal antibody S2.4.C5 were grown in 
complete medium containing 20% foetal c a l f  serum (FCS), and were 
weaned through 10% to 5% FCS (Section 2 .2 .7 .1 ). A volume of 600ml 
containing 10 to 10 ce l ls  per ml, was centrifuged at 200g to 
p e l le t  the c e l ls .  The ce ll pe lle ts  were resuspended and pooled 
before washing twice with RPMI (Section 2.1.20). F in a l ly ,  the c e i ls  
were resupended in RPMI and placed in a spinner cu ltu re  f la sk  
(Section 2.6.10) in a to ta l volume of 300 ml of RPMI, supplemented 
with glutamine (Section 2.1.20). The volume of RPMI was h a lf  tha t 
of the o r ig ina l volume since the hybrids secrete much lower 
quantit ies of antibody in the absence of FCS, and the c e l ls  could 
only be grown in RPMI without FCS fo r  short periods of time.
A fte r 48 hours, the ce ll cu ltu re  supernatant was harvested and the 
antibody prec ip ita ted by the addition of ammonium sulphate 
(adjusted to pH 7.2 with ammonia), and dialysed against PBS 
(Section 2.2.4.1) using a s im ila r  method fo r  the p re c ip i ta t io n  of 
the soluble re t in a l proteins (Section 3 .2 .1 ). Only a minute p e l le t
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Figure 6.16 S i lve r  stained SDS Gel of a Preparation of MAb S2.4.C5
from Serum-Free RPMI
MAb S2.4.C5 was produced by hybrids grown in serum free 
RPMI, ammonium sulphate concentrated, dialysed, and subject 
to SDS-PAGE with s i lv e r  sta in ing as a c r i te r io n  fo r  p u r i ty .
The resu lts  ind icate that the monoclonal antibody produced 
by th is  method was not pure. Some o f the contaminating bands 
may represent p a r t ia l l y  re-associated immunoglobulin chains 
(Section 6.5). The bands which are l i k e ly  represent the 
heavy and l ig h t  chains are indicated with H (molecular 
weights o f 47.8K and 55K) and L (27K), respective ly. There 
may be more than one var ia t ion  of each chain (Section 6.5).
LANES
1. Pharmacia low molecular weight standards
2. MAb S2.4.C5, produced in RPMI
3. BSA
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of prec ip ita ted protein was obtained when compared with tha t 
obtained fo r  monoclonal antibody produced in the presence of FCS. 
The vast m a jo r ity  of p rec ip ita ted prote in obtained from the la t te r  
procedure was derived from the FCS.
Figure 6.16 shows a s i lv e r  stained SDS polyacrylamide gel of RPMI 
produced S2.4.C5. Although the m a jo r ity  o f the BSA from the FCS, 
was absent, there was a large number of contaminating bands. Some 
of these may represent proteins released by dying hybrids, although 
others could represent the p a r t ia l ly  re-associated heavy and l ig h t  
IgG monoclonal antibody. At least two bands, one o f 47.8K and 
another o f 55K, could represent the heavy chain of the ra t  IgGl, 
each expressing a d i f fe r in g  extent of g lycosyla tion. Only one band 
was v is ib le  in the region of 27K, ind ica ting  tha t there may be only
one l ig h t  chain type. The presence of the large number of
contaminating bands indicated th a t,  although th is  method o f
obtaining BSA free antibody may be suitable fo r  some purposes, the 
preparation was unsuitable fo r  the in vivo studies (Section 6 .6 ).
6.5.2 P u r if ica t io n  of S2.4.C5 by Ion-exchange Chromatography
The QAE-Sephadex anion exchanger (Section 2 .1 .3 ) , frequently  
u t i l is e d  fo r  the p u r i f ic a t io n  of serum IgG, was employed.
Monoclonal antibody S2.4.C5, was produced in medium in which the 
FCS was reduced to 5%. The column gel was equ il ib ra ted with 0.1M 
Tris /HCl, pH 6.5, and the concentrated antibody was dialysed 
against the same bu ffe r. At th is  pH, the BSA bound to the gel and
the IgG monoclonal passed through. The e lu tion  of the monoclonal
antibody was followed by measuring the to ta l protein of the column
fractions by reading the absorbance at 280nm and by assay in ELISA
plates coated with lpg/ml of S-antigen (Sections 2.3.1 and 3.8.3)
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Figure 6.17 Pur i f ica t ion  of MAb S2.4.C5 on QAE-Sephadex
MAb S2.4.C5 was p u r i f ie d  by ion exchange chromatography on a 
QAE-Sephadex column (Section 6 .5 .2 ). The absorbance of the 
column frac tions  were measured at 280nm, to give an 
ind ica tion  o f prote in concentration. The column frac tions 
were assayed in the ELISA against lyg/ml S-antigen.
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(Figure 6.17). The p u r i ty  of the frac tions  and the re la t ive  
concentration of monoclonal antibody and other proteins was 
assessed by SDS-PAGE followed by s i lv e r  sta in ing (Sections 2.3 .4,6) 
(Figure 6.18).
From the e lu tion  p ro f i le  fo r  the p u r i f ic a t io n  o f th is  monoclonal 
antibody, i t  can be seen that no sharp peak was obtained fo r
S2.4.C5 (Figure 6.17). The antibody could be detected throughout 
the column frac tions  both in the ELISA (Figure 6.17) and upon 
s i lv e r  sta in ing of SDS gels of samples of the frac t ions  (Figure 
6.18). Two bands were id e n t i f ie d ,  one of 50K and the other, 55K. 
E ither, or both bands may represent the IgGl heavy (gamma) chain; 
the second band possessing a d i f fe re n t  amount of carbohydrate. A 
single band in the region of 29K was l i k e ly  to represent the l ig h t  
chain. Very l i t t l e  BSA could be detected in the column frac tions  in 
the s i lv e r  stained gel. The major contaminants consisted o f a 105K 
and a 148K band. The 105K band could represent two re-associated 
heavy chains, and the 148K band might be the whole IgG monoclonal 
antibody (Figure 6.18). Although 2-mercaptoethanol was present in 
the sample bu ffer (Section 2 .2 .5 .5 ) ,  and the samples were bo iled, 
immunoglobulins are prone to re-association upon cooling, even in 
the presence of the mercaptoethanol.
Pooled column frac tions were solvent p rec ip ita ted  with 66.6% (v/v)
ethanol, and the protein pe lle ts  were collected by cen tr ifuga tion  
a f te r  an incubation at -20°C, fo r  48 hours. The prote in  was 
lyop h il ised , dissolved in the T ris  bu ffe r , pH 6.5, and re -p u r i f ie d  
through a smaller QAE column in order to remove most o f the 
remaining BSA. The monoclonal antibody was again concentrated and 
lyoph il ised  before f i n a l l y  being dissolved in d is t i l l e d  water, to
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Figure 6.18 S i lve r  stained SDS Gel of MAb, S2.4.C5, Puri f ied  on a
QAE-Sephadex Column
MAb S2.4.C5 was concentrated from hybridoma supernatant 
containing FCS dialysed, and p u r i f ie d  on a QAE-Sephadex 
column. The column frac tions  were subjected to SDS-PAGE, 
with s i lv e r  s ta in ing as a c r i te r ia n  fo r  p u r i ty .
The resu lts  ind icate that the monoclonal antibody produced 
by th is  method was not pure. Some of the contaminating bands 
might represent p a r t ia l ly  re-associated immunoglobulin 
chains (Section 6.5). The bands which are l i k e ly  represent 
the heavy and l ig h t  chains are indicated with an H 
(molecular weight of 50K and 55K) and L (29K), respective ly. 
There may be more than one va r ia t ion  o f each chain (Section 
6.5).
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Figure 6.19 S i lve r  stained SDS Gel of concentrated Puri f ied S2.4.C5
Pooled frac tions  containing MAb S2.4.C5, a f te r  ion-exchange 
chromatography on a QAE-Sephadex column, were lyoph il ised 
and subjected to SDS-PAGE with s i lv e r  s ta in ing.
The band in the region of 50K is  l i k e ly  to represent the 
heavy (H) chain. Bands which may be l ig h t  (L) chain are 
indicated in the region of 18K. There may be more than one 
va r ia t ion  of each chain (Section 6.5).
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give a f in a l  protein concentration o f lmg/ml. The antibody was 
dialysed against d is t i l l e d  water, mixed 1:1 with glycerol and 
stored at -20°C before i t s  in je c t io n  in to  experimental animals.
Figure 6.19 shows a s i lv e r  stained SDS polyacrylamide gel of 
QAE-Sephadex p u r i f ie d ,  and lyoph il ised  S2.4.C5. The streaking o f 
the bands in the gel probably resulted from the presence o f a large 
amount of Tr is  a f te r  ly o p h i l is a t io n  and before i t s  removal by 
d ia ly s is .  BSA was v i r t u a l l y  absent, and the major contaminating 
bands were at 72K and 100K. The 72K band could represent an 
associated heavy and l ig h t  chain, and the 100K band could ind ica te 
the presence of two associated heavy chains (Figure 6.19). In 
add it ion , there appeared to be a single heavy chain, w ith an 
apparent molecular weight of 48K. There were two bands, one at 17K 
and the other at approximately 18K, which are u n l ike ly  to be l ig h t  
chains, since l ig h t  chains usually have molecular weight in the 
region o f 25K.
There appeared to be two heavy chains in some preparations of the 
antibody (Figure 6.16 and 6.18) and possibly only one in others 
(Figure 6.19). The second apparent band of the heavy chain could 
represent contaminating proteins in the preparation. The absence o f 
a second band, in some gels, might ind icate tha t the two forms of 
the heavy chain, exh ib it ing  d i f fe r in g  e lu t ion  properties during the 
p u r i f ic a t io n .  A lte rn a t ive ly ,  i t  may represent an a r t i f a c t  o f the 
s i lv e r  s ta in ing . Internal la b e l l in g  of the monoclonal antibody with 
35S methionine followed by immunoprecipitation, might have helped 
to answer th is  question.
Figure 6.20 shows a chequerboard experiment (Section 3.8.4) w ith
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Figure 6.20 Chequerboard Experiment with Puri f ied MAb S2.4.C5
and S-Antigen
The e ffec ts  o f va r ia t ion  in concentration of MAb S2.4.C5, 
p u r i f ie d  on a QAE-Sephadex column, and S-antigen, in the 
ELISA reaction was determined by means of a chequerboard 
experiment (Section 3 .8 .4 ). The incubation time fo r  the 
monoclonal antibody was 4 hours.
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the p u r i f ie d  monoclonal antibody S2.4.C5, and S-antigen. The 
re la t iv e ly  high ELISA reaction of the antibody, present in
microgram qu an tit ies , suggests tha t there was no serious loss o f 
a c t iv i t y  a f te r  the p u r i f ic a t io n  and concentration procedures.
EFFECT OF MONOCLONAL ANTIBODY S2.4.C5 ON EAU
Preliminary studies were made on the e f fe c t  of monoclonal antibody
S2.4.C5, on the development o f S-antigen induced experimental 
autoimmune u v e o re t in i t is  (EAU) in guinea pigs and ra ts . Nine 
Duncan-Hartley guinea pigs were in jected subcutaneously, w ith lOOpg 
of S-antigen, p u r if ie d  on a DEAE-Sephacel column (Section 3 .2 ), 
mixed 1:1 with complete Freund's adjuvant (Section 2 .6 .1 ) . Each 
animal was in jected in both hind foo t pads. Five of the guinea pigs 
received an in traperitoneal boost of lmg o f the monoclonal
antibody, p u r i f ie d  as described in Section 6.5.2. Six Lewis ra ts 
were in jected with 50pg of S-antigen in the foo t pads. Three o f 
these animals simultaneously received an in traperitoneal in je c t io n  
o f lmg o f monoclonal antibody S2.4.C5. Two o f the s ix  ra ts received 
an in traperitoneal in jec t io n  of lmg of a f f i n i t y  p u r i f ie d  ra t  IgG, 
in addition to the foo t pad in je c t io n  o f S-antigen, and served as 
contro ls . The remaining two animals which received only the
S-antigen, also served as contro ls.
The progress of the ocular inflammation was assessed by
ophthalmoscopical examination of the eyes. U1 tra s tru c tu ra l  
investigations of the ocular histopathology were to be carr ied out 
at a la te r  date.
Ophthalmoscopical examination revealed tha t a l l  f iv e  guinea pigs, 
in jected the monoclonal antibody simultaneously with S-antigen,
developed more severe inflammation in comparison with the guinea 
pigs in jected with S-antigen alone. In contrast, the disease in the 
rats appeared to be inh ib ited  by the monoclonal antibody. The rats 
receiving S-antigen alone, developed extensive inflammation a f te r  
13 to 18 days. The control rats receiving ra t IgG and S-antigen 
appeared to develop even more severe disease. However, one o f the 
rats which received the monoclonal antibody and S-antigen, did not 
develop c l in ic a l  EAU, and the remaining two exhibited a delayed 
onset of the inflammation, appearing a f te r  13 to 18 days, and the 
inflammation was markedly attenuated and the eyes recovered 
spontaneously.
Further work is  required to establish these f ind ings , and to 
determine the mechanisms by which monoclonal antibody S2.4.C5 
exascerbates or in h ib i ts  EAU in d i f fe re n t  species o f laboratory 
animals (see Section 8 .2 .2 ). These studies are presently in 
progress.
DISCUSSION .
The s p e c i f ic i t ie s  and classes of f iv e  monoclonal antibodies to 
re t in a l antigens are summarised in Table 6.1. Two monoclonal 
antibodies derived from hyperimmunised rats have been 
characterised. In add it ion , three monoclonal autoantibodies were 
derived from two RCS ra ts .
Monoclonal antibody S2.4.C5, an IgGl, derived from a hyperimmunised 
ra t ,  was spec if ic  fo r  S-antigen in the ELISA (Figure 6.1) and 
immunoblots (Figures 6.7 and 6.11a,b) when tested against a v a r ie ty  
of ir re le va n t antigens. The apparently high a f f i n i t y  and a v id i t y  of 
antibody S2.4.C5, indicated by i t s  behaviour in the ELISA (Figures
6.1 and 6 .2 ), was probably re lated to the class o f the monoclonal. 
IgG antibodies tend be of higher a f f i n i t y  than those o f the IgM 
class, occurring at a la te r  stage in the maturation of the immune 
response (R o it t  et a l . ,  1985).
The smallest fragment of S-antigen bearing the S2.4.C5 epitope, 
detectable in Cleveland b lo ts ,  was id e n t i f ie d  in the region of 
9 -9 .4K (Section 6 .4 .2 ). The monoclonal antibody was probably
capable of recognising the epitope in smaller fragments o f
S-antigen, however, smaller fragments could not be generated in the 
Cleveland experiments. The epitope recognised by antibody S2.4.C5, 
is u n l ik e ly  to have a three dimensional conformation, since no 
unreactive bands could be detected in the Cleveland b lo ts . Three 
dimensional determinants, espec ia lly  in the smaller peptide 
fragments, would probably be denatured under the conditions of 
SDS-PAGE and binding to the n itro ce llu lo se  paper.
The apparent high s p e c i f ic i t y  and a f f i n i t y  of monoclonal antibody
S2.4.C5, suggested tha t i t  might be su itab le  fo r  the 
immunocytochemical lo ca lisa t io n  o f S-antigen at the electron 
microscopical level (Polak and Van Noorden, 1984) (Section 7 .6 ).
Monoclonal antibody S2.4.C5, was p u r i f ie d  by ion exchange
chromatography on a QAE-Sephadex column (Section 6.5.2) in order to 
obtain a re la t iv e ly  pure preparation to in je c t  in to  guinea pigs. 
The p u r i f ic a t io n  method was not found to be ideal fo r  th is  
monoclonal antibody. Monoclonal antibodies have unique properties , 
and there is no standard p u r i f ic a t io n  method suitable fo r  a l l .  The 
preparation of antibody S2.4.C5 was at least 50% pure, and some of 
the contaminating bands, evident a f te r  SDS-PAGE (Figures 6.18 and
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6.19), may represent p a r t ia l l y  re-associated heavy and l ig h t  
chains. The c l in ic a l  resu lts  o f pre lim inary experiments 
investiga ting  the e f fe c t  of the monoclonal antibody on S-antigen 
induced EAU, suggest tha t S2.4.C5 exacerbates the inflammation in 
guinea pigs, and v i r t u a l l y  prevents the disease in rats (Section
6.6 ). Further work is  required in order to confirm these f ind ings , 
and to uncover the mechanisms by which the monoclonal antibody 
a ffec ts  the disease progress (Section 8 .2 .2 ).
R1.2.D2, an IgM monoclonal antibody, was reactive against ROS in 
ELISA assays (Figure 6 .3 ), and in immunoblots against an antigen 
present in the crude re t in a l ex trac t,  with an apparent molecular 
weight of 37K to 39K (Figure 6 .8). The antibody did not demonstrate 
a spec if ic  reaction with opsin, and may have s p e c i f ic i t y  fo r  a 
subunit o f transducin (Shichi et a l . ,  1984) or an ROS rim protein 
(Molday et a j . , 1986).
The three IgM monoclonal autoantibodies derived from RCS rats 
(Section 5.16), demonsrated lower t i t r e s  compared with antibodies 
obtained from immunised rats (Section 6 .3 .1 ). Antibody H9.1.C2 was 
reactive to S-antigen in ELISA (Figure 6.4) and immunoblots (Figure 
6.9c). Antibody H9.5.A4 was reactive with the ROS antigen in the 
ELISA (Figure 6 .5 ), but was unreactive in immunoblots. The th i rd  
monoclonal autoantibody H10.1.D3, was crossreactive against the ROS 
and the S-antigen in both the ELISA assays (Figure 6.6) and in 
immunoblots (Figure 6.9b) ra is ing  the p o s s ib i l i t y  o f shared 
carbohydrate or prote in sequences between S-antigen and opsin. The 
c ro ss re a c t iv ity  may also re su lt  form dual s e c i f i c i t y  o f the 
monoclonal antibody (Ghosh and Campbell, 1986) (Section 8 .4 .5 ) .
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The protein A b lo ts with the three monoclonal autoantibodies, 
required a longer exposure time of the b lo t to the X-ray f i lm ,  
compared with antibody S2.4.C5. This probably indicates tha t there 
was a greater proportion of bound antibody in the b lo ts with 
antibody S2.4.C5, compared with the autoantibodies. There may have 
been less autoantibody bound, due to th e ir  lower re la t iv e  a f f in i t y .  
The autoantibodies were probably raised to more native forms o f the 
antigens, whereas the monoclonal antibody S2.4.C5 was raised in a 
ra t  hyperimmunised with S-antigen denatured w ith in  the complete 
Freund's adjuvant. Thus the monoclonal autoantibodies derived from 
the RCS rats possibly demonstrated a reduced a f f i n i t y  fo r  the 
denatured antigens.
The lack of re a c t iv i ty  with monoclonal antibody H9.5.A4 in the 
immunoblots, and the re la t iv e ly  weak re a c t iv i ty  shown by the other 
two autoantibodies, may also be an ind ica tion  of the re la t iv e ly  low 
a f f i n i t y  o f the antibodies fo r  the appropriate antigenic 
determinants.
The monoclonal antibodies described in th is  chapter, provide useful 
too ls in the study of the nature and physiology of re t in a l 
antigens. Monoclonal antibody S2.4.C5, was useful in the 
lo c a l is t io n  of S-antigen at the u l t ra s tru c tu ra l level (Sectoin
7 .6 ), and antibody R1.2.D2 was used to loca lise  the 39K antigen at 
the electron microscopical level (Section 7.7). Further work is  
required in order to id e n t i fy  the physiological ro le  of th is  
antigen.
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CHAPTER SEVEN
LIGHT AND ELECTRON IMMUNOCYTOCHEMICAL LOCALISATION OF 
RETINAL ANTIGENS BY MEANS OF MONOCLONAL ANTIBODIES
Chapter 7
LIGHT AND ELECTRON IMMUNOCYTOCHEMICAL LOCALISATION OF 
RETINAL ANTIGENS WITH MONOCLONAL ANTIBODY REAGENTS
INTRODUCTION
In th is  chapter, the subcellu lar lo ca lisa t io n  o f re t in a l S-antigen 
and a 39K photoreceptor antigen, by means of spec if ic  monoclonal 
antibodies (Chapter 6) is  described.
Retinal S-antigen has been loca lised at the 1igh t microscopical 
level using conventional polyclonal antisera and mouse monoclonal 
antibodies (reviewed in Chapter 1). The protein has also been 
localised electron m icroscopically in Lowicryl embedded tissue using 
polyclonal antisera (McKechnie et a l . ,  1986).
In th is  study re t in a l S-antigen was loca lised at the u lt ra s tru c tu ra l 
level in the photoreceptor rod ce l ls  o f Lowicryl embedded sections 
o f human and swine re tinae , and also in LR White embedded human 
re t ina . The electron immunocytochemical lo ca lisa t io n  o f the prote in 
involved the spec if ic  ra t IgGl monoclonal antibody, S2.4.C5, 
produced during the course o f th is  work (Chapter 6). The detection 
o f S-antigen by the monoclonal antibody was visualised by means of 
electron-dense gold probes. Results fo r  the detection o f S-antigen 
by means of ra t  anti sera to the p ro te in , are included fo r  
comparison.
An additional re t in a l antigen, of apparent molecular weight 39K 
(Figure 6.8) was also loca lised a t the electron microscopical le v e l,  
using the IgM monoclonal antibody R1.2.D2. The antigen was loca lised
in the human and pig re tinae , employing the same techniques as fo r  
the lo ca lisa t io n  of the S-antigen.
7.2 LOCALISATION OF S-ANTIGEN AND THE 39K ANTIGEN AT THE LIGHT 
MICROSCOPICAL LEVEL
7.2.1 Localisation o f S-Antigen in Rat Retina
7.2.1.1 Effect o f method o f f ix a t io n
The photoreceptors of ra t  re tina  mainly consist of rods, since the 
ra t  is  a nocturnal animal. Thus, although the photoreceptor ce ll  
layer appeared grossly stained by l ig h t  microscopy, and the rods 
were c le a r ly  involved, i t  was not possible to ascertain whether the 
cone ce l ls  were also stained.
Monoclonal antibody S2.4.C5 reacted in tensely with the photoreceptor 
ce l l  layer o f ra t re t in a , f ixed in 70% ethanol (Section 2.4.1) 
(Figure 7.1a). The d is t r ib u t io n  of sta in ing was s im ila r  to tha t o f 
the ra t  polyclonal antisera, raised against S-antigen (Section
2.6.1) (Figure 7.1b). The monoclonal antibody offered the advantage 
of greater s p e c i f ic i t y  and the absence o f a background reaction with 
other re t in a l c e l ls ,  compared with the polyclonal antisera (Figures 
7.1a,b). Although the en tire  photoreceptor ce ll was lab e lled , the 
in te n s i ty  of reaction, in the ethanol-fixed t issue , was greater in 
the ROS than in the inner segments. The reaction in the perinuclear 
region was of comparable in te n s i ty  to tha t of the ROS. In these 
sections, the reaction in  the photoreceptor synapses appeared more 
intense than the sta in ing in the ROS. While these resu lts  ind icate 
the presence o f S-antigen throughout the photoreceptor c e l l ,  th is  
pattern was thought to arise p a r t ia l l y  from the method of t issue 
f ix a t io n ,  since gluteraldehyde f ixed sections demonstrate a 
d i f fe re n t  pa ttern, under iden tica l experimental conditions (Figure
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Figure 7.1 Localisation of S-Antigen with in Rod Photoreceptors
a) Localisation with Rat MAb S2.4.C5
b) Localisation with ra t  polyclonal antisera
S-antigen was loca lised in dewaxed sections of alcohol fixed 
ra t  eye, using an immunoperoxidase technique. The reaction 
was present throughout the photoreceptor ce l l  layer, which 
consists almost e n t i re ly  o f rods in the ra t .  The inner 
segment regions were less in tensely stained compared to the 
rest o f the c e l l .  The pattern of la b e l l in g  was s im ila r  fo r  
the MAb and the anti sera, although the anti sera gave r ise  to 
some background reaction with other re t in a l neurons.
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2. Retinal pigment epithelium
3. Photoreceptor outer segment layer
4. Photoreceptor inner segment layer
5. Photoreceptor nuclei (outer nuclear layer)
6. Outer plexiform layer (synapses)
7. Nuclei of second order neurons (inner nuclear layer)
8. Inner plexiform layer (synapses)
Photographed at magnification x 400

Figure 7.2 Immunoperoxidase Localisation of S-Antigen in dewaxed
Sections of Rat Eye fixed in 4% Gluteraldehyde
S-antigen was loca lised , by means of MAb S2.4.C5 and an 
immunoperoxidase procedure, in dewaxed sections of 
gluteraldehyde (4%) f ixed ra t eye. The reaction was mainly 
confined to the ROS, with a l ig h t  sta in ing of the apical 
regions of the inner segments. Staining was also present 
around the nuclei and in the photorecptor synapses. There 
was a l ig h t  background reaction with other re t ina l neurons.
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Photographed at  magnif ication x 400
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7 .2 ) .
In the gluteraldehyde fixed re tina  (Section 2 .4 .1 ) ,  the ROS were 
in tensely stained with monoclonal antibody S2.4.C5. The e l l ip s o id  
region o f the inner segments, immediately below the ROS, appeared 
l i g h t l y  stained. Staining was also present w ith in  the perinuclear 
area and in the region o f the photoreceptor synapses. In the 
gluteraldehyde f ixed sections, there was a s l ig h t  background 
reaction with some of the nuclei o f the inner nuclear layer (INL) 
and of the photoreceptors. There may also be some nonspecific 
deposition o f the peroxidase substrate (DAB, Section 2.4.4) in the 
region o f the melanin pigment w ith in  the choroid. The reaction of 
the monoclonal antibody in gluteraldehyde fixed re t ina  could not be 
compared with polyclonal antiserum since sera gave r ise  to a high 
background reaction over the en tire  section, due to the presence of 
a large number o f antibodies of d i f fe r in g  s p e c i f ic i t ie s .
That monoclonal antibody S2.4.C5, was capable o f reacting in 
sections fixed in 4% gluteraldehyde (Figure 7 .2 ), suggested tha t the 
antibody may be suitable fo r  electron immunocytochemistry (Section
7.6), where there may be a ltered a n t ig e n ic i ty  due to f ix a t io n  and EM 
processing.
7.2.1.2 Localisation in l ig h t  and dark adapted ra t  retinae
Preliminary studies on the l ig h t  versus dark lo c a lis a t io n  of 
S-antigen at the l ig h t  microscopical le v e l,  in ethanol f ixed  ra t  
eyes (Section 2 .4 .1 ) , ind icate tha t there may be a d ifference in the 
'  in te n s i ty  of s ta in ing in the rod outer and inner segments (Figures 
7.3a,b). In immunoperoxidase experiments with monoclonal antibody
S2.4.C5 and polyclonal antisera to S-antigen, on sections o f (a t
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Figure 7.3 Localisation of the S2.4.C5 Epitope of S-Antigen under
conditions o f L ight and Dark Adaptation
a) Immunolocalisation with S2.4.C5 in l ig h t  adapted re tina
b) Immunolocalisation with S2.4.C5 in dark adapted re tina
Light and dark adapted, ethanol f ixed , dewaxed sections of 
albino ra t eyes were treated with MAb S2.4.C5 in an 
immunoperoxidase technique.
In the l ig h t  adapted ra t re tina  (a ), the epitope of 
S-antigen recognised by MAb S2.4.C5 appeared to be localised 
p r im a r i ly  in the ROS, with a l ig h t  reaction around the 
nuclei and in the synapses. The inner segment regions were 
less in tensely stained compared to the rest of the c e l l .
The S2.4.C5 epitope in the dark adapted re tina  (b) appeared 
to be d is tr ib u te d  throughout photoreceptor c e l l ,  where the 
reaction was o f f a i r l y  uniform in te n s ity .
KEY
1. Photoreceptor outer segment layer
2. Photoreceptor inner segment layer
3. Photoreceptor nuclei (outer nuclear layer)
4. Outer plexiform layer (synapses)
5. Nuclei of second order neurons (inner nuclear layer)
Photographed at magnification x 400
*  i
I #
* f  •  *  * m 0  " *
*  * v *■ H .1 44 v
I f
least 2 hours) l ig h t  adapted ra t  re t in a ,  the pattern o f sta in ing 
(Figure 7.3a) was s im ila r  to tha t seen in Figures 7.1a,b. The 
pattern o f ’ s ta in ing o f l ig h t  adapted retinae was found to be 
consistent in a l l  specimens examined.
In the dark adapted specimen (12 hours darkness, with d issection and 
f ix a t io n  procedures carried out in dim red l i g h t ) ,  the reaction was 
much more intense in the inner segments (Figure 7.3b), than in the 
l ig h t  adapted specimens (Figure 7.3a). The reaction was, perhaps, 
stronger in the inner segments than in the outer segments, in the 
dark adapted re tina  (Figure 7.3b). These i n i t i a l  observations 
require confirmation in additional specimens o f dark adapted 
re tinae. I t  would be useful to compare these resu lts  w ith s im ila r  
experiments on gluteraldehyde fixed t issue , in view o f the e f fe c t  of 
f ix a t io n  method (Section 7 .2 .1 .1 ).
7.2.2 Localisation o f the 39K Antigen at the L ight Microscope level
The ra t  IgM antibody R1.2.D2, obtained from a fusion with a ra t 
immunised with bovine ROS (Section 2 .6 .1 ) ,  was tested at the l ig h t  
microscopical level in sections o f alcohol fixed ra t  eye (Section
2 .4 .1 ) , in an immunoperoxidase procedure (Section 2 .4 .4 ) . The 
antibody reacted in tensely with the photoreceptor outer segments, 
sparing the rest o f the ce ll (Figure 7.4) and a l l  other c e l ls  of the 
re t ina . The reaction c e r ta in ly  involved the rod photoreceptors 
(Section 7 .2 .1 .1 ) ,  although i t  was not possible to determine 
sta in ing of the cones at the level of the l ig h t  microscope. The 
pattern of reaction was s im ila r  to tha t given by polyclonal antisera 
raised in rats against bovine ROS (Figure 7.5) (Section 2 .6 .1 ) . This 
antisera reacted with bovine opsin in immunoblots (Section 2 .3 .9 .6 ) .  
The antibody R1.2.D2, applied as hybridoma supernatant, did not
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Figure 7.4 Immunoperoxidase Localisation of a 39K Retinal Antigen
w ith in  Rod Photoreceptors by means o f a Rat MAb
The 39K antigen was loca lised with MAb R1.2.D2, in dewaxed 
sections o f ethanol f ixed ra t  eye, using an immunoperoxidase 
technique. The antigen appeared to be confined to the 
photoreceptor outer segments. Photographed at magnification 
x 400
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Figure 7.5 Immunoperoxidase Localisation of Opsin with 
Polyclonal Antiserum
Opsin was loca lised in ra t photoreceptors of ethanol f ixed 
t issue , using anti serum raised in rats against bovine ROS 
membrane prote ins. The peroxidase reaction was mainly 
confined to the ROS, with a fa in t  reaction in other regions 
o f the re t in a ,  which may be nonspecific. This pattern of 
s ta in ing provided a useful comparison fo r  the R1.2.D2 MAb 
' (Figure 7.4). Photographed at magnification x 400
8
Figure 7.6 Immunoperoxidase Experimental Control
Lack of peroxidase reaction in dewaxed sections of ethanol 
f ixed ra t  eye, when an ir re le va n t ra t  IgG MAb is  used in 
place of ra t a n t i - re t in a l  antibody.
KEY
1. Choroid (pigmented and vascular)
2. Retinal pigment epithelium
3. Photoreceptor outer and inner segments
4. Photoreceptor nuclei (outer nuclear layer)
5. Outer plexiform layer (synapses)
6. Nuclei of second order neurons (inner nuclear layer)
Photographed at magnification x 400

present any s ig n if ic a n t  background reaction (Figure 7.4). The 
antisera , however, gave r ise  to some background reaction with the 
inner (IPL) and outer plexiform layers (OPL) (Figure 7.5). This may 
be due to the presence of antibodies to contaminating re t in a l 
antigens w ith in  the immunising ROS antigen, or to the crossreaction 
o f low a f f i n i t y  antibodies.
Immunoperoxidase experiments with antibody R1.2.D2, in l ig h t  and 
dark adapted re tinae , gave r ise  to s im ila r  sta in ing reactions, 
ind ica ting  that the epitope recognised by th is  antibody was not 
d i f f e r e n t ia l l y  loca lised or exposed in the presence or absence of 
l ig h t ,  under the conditions employed. This antibody was not tested 
on gluteraldehyde fixed pa ra ff in  embedded sections.
7.2.3 Immunoperoxidase Experimental Control
A negative con tro l,  fo r  the immunoperoxidase reaction, invo lv ing the 
use of an ir re le va n t ra t IgG monoclonal antibody to V ibrio  cholerae, 
is shown in Figure 7.6. The control shows tha t there was l i t t l e  
tendency fo r  the peroxidase conjugated rabb it a n t i - ra t  IgG(H+L) to 
bind non -spec if ica l ly  with the t issue. The control also showed tha t 
the peroxidase DAB substrate (Section 2 .4 .4 ) , which has the 
potentia l to become deposited on the melanin granules, did not 
in te r fe re  with the lo ca lisa t io n  of the antigens.
7.3 PREPARATION OF TISSUE SPECIMENS
7.3.1 Embedding Media
Three d i f fe re n t  embedding media were investigated. A ra ld ite  resin 
was investigated since i t  o ffe rs  a greater morphological 
preservation, and therefore the presence o f plasma membrane s ta in ing 
might be more read ily  determined. L ig h t ly  f ixed (Section 2 .5 .1 .1)
211
specimens of ra t  re tina  were embedded in A ra ld ite  (Section 2 .5 .1 .3 ). 
The immunostaining of the a ra ld ite  embedded sections was too l ig h t  
fo r  meaningful in te rp re ta t io n ,  probably p a r t ia l ly  due to antigen 
masking w ith in  th is  hydrophobic resin .
Lowicryl K4M and LR White (Section 2.1 .8.3) resins are more 
frequently  u t i l is e d  fo r  electron immunocytochemistry, because of 
th e i r  hydrophilic  nature.
7.3.2 Lowicryl Embedded Material
The Lowicryl K4M (Section 2.1.8.3) embedded specimens o f human and 
swine retinae were the generous g i f t  o f Dr N. McKechnie, In s t i tu te  
o f Ophthalmology, London. The human tissue was obtained from the eye 
of a 50 year old male whose eye was enucleated as part o f an 
exenteration procedure fo r  sebaceous carcinoma of the eyelids and 
conjunctiva. The globe was not affected by the tumour. The eye was 
immediately dissected and small pieces o f re tina were removed and 
fixed in 1% gluteraldehyde (Section 2.1 .8.1) in PBS, pH7.2 (Section
2.2.4.1) fo r  one hour. The pig re tina  was fixed in the same manner.
The fixed tissues were dehydrated through a graded series of 
dimethyl formaldehyde and water at -4°C, and in f i l t r a te d  with the 
Lowicryl resin at the same temperature. Polymerisation was achieved 
by exposure to long wavelength u l t r a v io le t  l ig h t  Sylvana (F475/BLB 
or Ph il ips TDL/6W/05), as described by Ambruster et aK (1982), w ith 
minor modifications.
7.3.3 LR White Embedded Human Retina
Human re tina  was also processed fo r  EM histochemistry. Blocks of
chorio re tina l tissue were excised from the posterio r pole of the eye
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of a 71 year old female, removed due to the presence o f a malignant 
melanoma of the an te r io r choroid. The tissue was f ixed in 1% 
gluteraldehyde in cacodylate bu ffe r (Section 2.2.8.2) fo r  2 hours at 
room temperature, washed with PBS and ammonium ch lo r ide , dehydrated 
in 70% ethanol and embedded in LR White, hard grade (Section
2 .1 .8 .3 ). Paraffin  embedded sections o f the same area o f tissue 
u t i l is e d  fo r  immuno-electron microscopy, showed no s ig n if ic a n t  
abnormality.
7.4 MORPHOLOGICAL PRESERVATION OF TISSUE SPECIMENS
The preservation o f u l t ra s tru c tu re  was s im ila r in the Lowicryl and 
LR White embedded specimens. The u l t ra s tru c tu ra l preservation of the 
outer segment disc membranes was sa t is fa c to ry , although those of the 
pig and LR White embedded human retinae appeared somewhat 
disorganised, presumably due to a less immediate f ix a t io n .  The 
id e n t i f ic a t io n  o f the in t ra c e l lu la r  structures o f the inner segments 
were, less ce rta in , although mitochondrial c r is ta e , endoplasmic 
reticulum, cen tr io les , synaptic vesicles and ce ll  junctions could 
often be distinguished. The layer of re t in a l pigment e p ith e l ia l  
ce l ls  (the RPE) was retained in the LR White embedded human re t in a ,  
which allowed the id e n t i f ic a t io n  of S-antigen w ith in  the phagosomes 
o f the RPE c e l ls  (Section 7.6.3) (Figures 7.15 and 7.16).
7.5 STAINING METHODS
The v isua lisa tion  o f the reaction of the antibodies with S-antigen 
was achieved by two methods; gold adsorbed protein A and gold 
adsorbed goat or rabb it a n t i - ra t  IgG(H+L) were employed (Section
2 . 5 . 3 ) .  The protein A technique was esse n tia l ly  tha t o f Roth 
(1974), and the immunogold lo ca lisa t io n  method was s im ila r  to the 
method of De May (1963). Both commercial (Janssen) goat a n t i - r a t
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IgG-gold and protein A-gold (lOnm and 5nm gold p a r t ic le  size) 
(Section 2.1 .16), and the rabb it a n t i - ra t  IgG conjugated to lOnm 
gold p a rt ic les  by the method of Roth fo r  the conjugation of protein 
A with gold (Roth, 1974) were u t i l is e d  (Section 2 .5 .2 ). There was 
some va r ia t ion  in the background reactions between preparations of 
the gold reagent. In the protein A-gold technique, best resu lts  were 
obtained when a second antibody, rabb it a n t i - ra t  IgG(H+L) was used, 
although protein A does bind to the S2.4.C5 antibody as demonstrated 
in immunoblots (Figure 6.7). The immunogold sta in ing experiments 
were selected fo r  the qu an tif ica t ion  of the la b e ll in g  of S-antigen.
7.6 ULTRASTRUCTURAL LOCALISATION OF S-ANTIGEN
7.6.1 Specific la b e l l in g  o f the Rod Cell
The d is t r ib u t io n  of S-antigen at the electron microscopical level 
was s im ila r  to tha t observed in l ig h t  microscopy, where the prote in 
was loca lised throughout the photoreceptor ce l ls  in ra t  re tina  
(Figures 7.1a,b). The immunostaining methods invo lv ing gold 
conjugated protein A or immunogold gave r ise  to s im ila r  re su lts .  The 
Lowicryl embedded sections o f human and pig tissue, were stained 
with immunogold, and the LR White embedded sections o f human re tina 
were treated with prote in A-gold.
Monoclonal antibody S2.4.C5, and antiserum raised in rats against 
bovine S-antigen, labelled the rod outer segment disc membranes of 
human (Figures 7.7, 7.8a and 7.9) and porcine retinae (Figure 7.11). 
Irre levan t ra t IgG and IgM monoclonal antibodies, employed as 
negative controls did not give r ise  to any s ig n if ic a n t  s ta in ing (eg. 
Figures 7.10 and 7.12). There was no ind ica tion  o f spec if ic  
la b e ll in g  of the rod ce ll membrane in e ith e r the Lowicryl or LR 
White embedded tissue , even in regions where the plasma membrane
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Figure 7.7 Electron Microscopical Localisation of S-Antigen with in a
Human Rod Photoreceptor Cell
Electron micrograph o f a rod ce ll  in a Lowicryl embedded
section o f human re tina  treated with MAb S2.4.C5, in an 
immunogold cytochemistry experiment.
The disc membranes of the rod ce ll  were s p e c if ic a l ly
decorated. The connecting c il ium  was also labe lled . The
la b e l l in g  in the inner segment was less intense, re la t iv e  to
the disc membranes. Gold label tended not to be present on
the mitochondria or the Lowicryl resin .
KEY
ROS: Photoreceptor rod outer segment
RIS: Photoreceptor rod inner segment
cc: Region of connecting c il ium
m: Mitochondrion in e l l ip s o id  region o f inner segment 
■*- ROS disc membranes
Magnification x 34,000

Figure 7.8 U1trastructural Localisation of S-Antigen within Lowicryl
embedded Sections of Human Rod Cells by means of MAb
S2.4.C5 and a Gold Probe
a) Electron micrograph o f an immunostained rod outer 
segment, showing spec if ic  decoration of the disc membranes. 
Labelling o f the ROS plasma membrane was less read ily  
determined.
Magnification x 43,000 
KEY
m: Mitochondrion in e l l ip s o id  region of inner segment 
ROS disc membranes
b) Electron micrograph of an immunostained rod inner 
segment. The inner segment was less in tensely labelled than 
the ROS. Gold label tended not to be present on the 
mitochondria.
Magnification x 44,000
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Figure 7.9 Localisation o f S-Antigen on the ROS Disc 
Membranes o f LR White embedded Human Retina
Electron micrograph o f an apical region o f human ROS, proximal to the 
RPE, showing spec if ic  rod disc membrane decoration, a f te r  
immunocytochemistry with MAb S2.4.C5 and the protein A-gold probe. The 
plasma membrane o f th is  ROS appeared unlabelled.
Magnification x 43,000
Figure 7.10 Immunocytochemical Negative Control on LR White 
embedded Human Retina
Electron micrograph showing the absence o f sta in ing on an LR 
White embedded section o f an apical region of human ROS, 
proximal to the RPE, treated with an ir re levan t ra t IgG MAb 
and protein A-gold.
Magnification x 31,000

Figure 7.11 Immunocytochemical Localisation of S-Antigen within
Lowicryl embedded Sections of Pig Retina by means o f MAb
52.4.C5 and a Gold Probe
Electron micrograph of a porcine rod outer segment, double 
immunostained, fo r  S-antigen and opsin. Gold p a r t ic le s ,  5nm 
in diameter ind icate the lo ca lisa t io n  o f S-antigen with MAb
52.4.C5, and the lOnm p a rt ic le s  ind icate the la b e l l in g  of 
opsin by means of polyclonal anti serum, raised in rats 
against bovine ROS membrane pro te in . Both sizes o f gold 
pa rt ic les  were loca lised on the disc membranes
Magnification x 76,000
Figure 7.12 Negative Control fo r  Electron immunocytochemistry
Absence of gold label on a section of Lowicryl embedded 
porcine ROS, in an immunogold cytochemistry procedure 
involv ing an i r re le va n t ra t IgG MAb.
Magnification x 43,000

Figure 7.13 U1trastructural Localisation of S-Antigen within
the Perinuclear region of the Rod Cell
a) Electron micrograph o f the inner nuclear region of LR 
White embedded human re t in a , treated with MAb S2.4.C5 and 
protein A-gold. The section demonstrates spec if ic  la b e ll in g  
o f the perinuclear region, where the S-antigen is  l i k e ly  to 
be synthesised.
Magnification x 53,000 
KEY
Rn: Photoreceptor rod nucleus 
Cn: Photoreceptor cone ce ll  nucleus
b) Electron micrograph of the inner nuclear region of LR 
White embedded human re t in a ,  treated with MAb S2.4.C5 and 
protein A-gold. The perinuclear region o f the rod c e l l ,  but 
not the cone, was labe lled . The background reaction apparent 
on the rod nucleus, might have resulted from the d if fu s ion  
o f S-antigen from the s i te  o f synthesis, due to the delay 
before tissue f ix a t io n .
Magnification x 53,000
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appeared well preserved (Figures 7.7 and 7.8a). The inner segments 
in both cases were also stained, although less in tensely (Figures
7.7 and 7.8b). Gold label was also demonstrated in the connecting 
c il ium  (Figure 7.7). In the LR White embedded tissue , there was also 
intense la b e l l in g  in the rod perinuclear region (Figures 7.13a,b), 
suggesting that th is  is  l i k e ly  to be the s i te  o f S-antigen 
synthesis. This was not c lear in the Lowicryl embedded re tinae. 
There appeared to be fewer non -spec if ica l ly  adsorbed gold pa rt ic le s  
on the cone ce ll  nuc le i, than on the rod ce ll  nuclei (Figures 
7.13a,b). This presumably resulted from the d if fu s io n  of S-antigen, 
from the s i te  of synthesis, to the rod nuc le i, during tissue 
preparation fo r  electron microscopy, and perhaps during the delay 
before f ix a t io n .
7.6.2 Reaction fo r  the Cone Cells
The cone photoreceptor ce l ls  o f the human and pig specimens were 
labelled only at background levels (Figures 7.14a,b, Table 7 .1 ), 
when incubated with antibody S2.4.C5 or spec if ic  antisera to 
S-antigen. The cone ce lls  were, however, l i g h t l y  labelled when the 
grids were treated with certa in  ra t  anti-bovine ROS sera since the 
immunising antigen contained material from the cones in addition to 
the ROS.
7.6.3 S-Antigen Immunoreactivity w ith in  RPE Cells
Figure 7.15 shows a section o f an LR White embedded human RPE c e l l ,  
with the c lose ly  associated ROS. Phagosomes containing ROS membranes 
at various stages of digestion were observed. The ROS and some of 
the phagocytosed ROS debris were stained with monoclonal antibody
S2.4.C5, and prote in A-gold (Figure 7.15). Numerous l ip o fu sc in  
deposits were apparent w ith in  the cytoplasm, due to the accumulation
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Figure 7.14 Absence of Immunolabel1ing for  S-Antigen within a Human
Photoreceptor Cone Cell
Electron micrographs o f a Lowicryl embedded cone outer 
segment (a) and inner segment (b ), presenting sta in ing at 
only background levels a f te r  treatment with MAb S2.4.C5 and 
the immunogold probe.
KEY
COS: Photoreceptor cone outer segment 
CIS: Photoreceptor cone inner segment 
m: Mitochondrion in e l l ip s o id  region of inner segment
a) Magnification x 45,000
b) Magnification x 58,000

Figure 7.15 Electron Immunocytochemical Localisation of S-Antigen
w ith in  RQS Membrane Material Phagocytosed by the RPE
Electron micrograph of LR White embedded human re t in a , 
showing a portion of pigment ep ith ia l  ce l l  embedded in LR 
White. The section shows the t ip s  o f the ROS surrounded by 
sheaths or m ic r o v i l l i ,  from the RPE. The section was stained 
with MAb S2.4.C5 and protein A-goTd.
KEY
cy: RPE ce ll cytoplasm 
N: RPE nucleus 
I f :  Lipofuscin deposits 
RPE apical m ic ro v i l l i
i )  and i i )  ind icate phagosomes shown at higher 
magnification in Figures 7.16a,b respective ly, 
i i i )  indicates ROS shown in Figure 7.16c
Magnification x 8,200

Figure 7.16 U1trastructural Localisation of S-Antigen in Phagocytosed
ROS at  various Stages of Digestion with in RPE
a) Electron micrograph o f phagosome w ith in  an RPE c e l l .  The 
epitope o f S-antigen recognised by MAb S2.4.C5 could no 
longer be labe lled , probably due to enzymatic degradation.
Magnification x 30,000
b) Electron micrograph showing newly phagocytosed ROS 
membranes labelled fo r  S-antigen with MAb S2.4.C5 and 
protein A-gold.
Magnification x 16,000
c) Electron micrograph of LR White embedded human re t in a , 
showing the t ip  of an ROS embedded w ith in  the RPE c e l l .  The 
ROS disc membranes were labe lled fo r  S-antigen with MAb
S2.4.C5 and prote in A-gold. There was no ind ica tion  fo r  
spec if ic  s ta in ing o f the RPE sheath surrounding the ROS t ip .
Magnification x 30,000
KEY
cy: RPE ce ll  cytoplasm 
I f :  Lipofuscin deposits 
i ,  i i  and i i i  are also 
shown in Figure 7.15

accumulation and condensation of undigestable ROS material and old 
melanin granules, w ith in  the aging RPE ce lls  (Figures 7.15 and 
7.16a,b).
Figure 7.16 presents enlargements of three regions of the area of 
RPE shown in Figure 7.15. Phagosomes containing newly phagocytosed 
ROS membranes were labelled with the S2.4.C5 monoclonal antibody 
(Figure 7.16b). Stained and unstained regions w ith in  a phagosome 
could be id e n t i f ie d .  Unstained phagocytosed m ateria l, presumably at 
more advanced stages of digestion were also observed (Figure 7.16a). 
No spec if ic  s ta in ing was id e n t i f ie d  w ith in  the RPE cytoplasm, 
Bruch's membrane or the choroid.
7.7 ULTRASTRUCTURAL LOCALISATION OF A 39K RETINAL PROTEIN
7.7.1 Localisation w ith in  Rod Photoreceptors
The pattern o f sta in ing fo r  the R1.2.D2 IgM ra t monoclonal antibody 
was s im ila r  at both l ig h t  (Figure 7.4) and electron microscopical 
leve ls . The pattern o f re a c t iv i ty  contrasted to tha t fo r  S-antigen 
(Section 7 .2 . i  and 7.6). The antibody reacted in tensely along the 
length o f the ROS disc membranes (Figures 7.17a,b and 7.18a). 
Neglig ib le sta in ing was present w ith in  the rod inner segments and 
very l i t t l e  label was observed in the region o f the connecting 
c il ium  (Figure 7.17b and 7.18a). There was perhaps an increase in 
sta in ing around the nuclei o f the rods where the antigen is  l i k e l y  
to be synthesised.
The sta in ing with antibody R1.2.D2, was apparent as fa r  as the rims 
of the discs, and the gold label could also be detected on the rod 
plasma membrane. The th in  cytoplasmic extensions of the inner
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Figure 7.17 U1trastructural Localisation of the 39K Antigen within
Lowicryl embedded Human Rod Photoreceptors
a) Electron micrograph showing the lo ca lisa t io n  of a 39K 
antigen recognised by the ra t  IgM MAb R1.2.D2. The 
immunogold label was s p e c i f ic a l ly  associated with the ROS 
disc membranes.
Magnification x 42,000
KEY
cc: Connecting c il ium
b) Electron micrograph showing the region o f the connecting
c il ium  of a human rod c e l l .  Although the ROS disc membranes
were in tensely labe lled , there were very few gold pa rt ic les
w ith in  the connecting c il ium  or the inner segment.
A
Magnification x 42,000

Figure 7.18 Electron Immunocytochemical Local isat ion of the 39K
Antigen with in Lowicryl embedded Human Rod Photoreceptors
a) Electron micrograph showing the loca lisa t io n  o f a 39K 
antigen recognised by the ra t  Ig'M MAb R1.2.D2. The 
immunogold label was s p e c i f ic a l ly  associated with the ROS 
disc membranes. There was only a s l ig h t  sta in ing in the 
region of the connecting c i l iu m , and even less in the inner 
segments of the rod c e l ls .
Magnification x 44,000 
KEY
m: Mitochondrion
Cytoplasmic extension
b) Electron micrograph showing the fa in t  s ta in ing of a rod 
inner segment, with MAb R1.2.D2 and immunogold.
Magnification x 46,000

Figure 7.19 Localisation of the 39K Antigen in the region of the
Rod Cell Plasma Membrane
a) Electron micrograph of a Lowicryl embedded human ROS,
labelled with MAb R1.2.D2 and immunogold. In th is  rod ce ll
the rims of the discs and the plasma membrane appeared to be
p re fe re n t ia l ly  labelled.
Magnification x 90,000 
KEY
ROS: Rod outer segment
RIS: Rod inner segment
b) Electron micrograph showing la b e l l in g  o f a rod inner
segment plasma membrane with MAb R1.2.D2 and immunogold. Few
gold pa rt ic les  were id e n t i f ie d  w ith in  the cytoplasm of the
inner segment.
Magnification x 90,000

Figure 7.20 Absence of Immunogold labe l l ing  fo r  the 39K Antigen in
Lowicryl embedded Human Cone Cells
a) Electron micrograph showing a low power view of a human 
cone outer and inner segment. There was no ind ica tion  fo r  
any spec if ic  sta in ing with MAb R1.2.D2 and the immunogold 
probe.
Magnification x 24,000 
KEY
COS: Cone outer segment 
CIS: Cone inner segment 
m: Mitochondrion
b) Electron micrograph of a human cone outer segment, 
treated with MAb R1.2.D2 and immunogold. The gold pa rt ic les  
were present at only background leve ls .
Magnification x 70,000
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segments which surround the lower regions of the ROS were labelled 
(Figure 7.18a), ind ica ting  fu r the r tha t the antigen may be present 
on the R0S‘ plasma membrane. Specific decoration o f the membrane 
surrounding the ROS was d i f f i c u l t  to discern, however, due to the 
poor preservation o f the plasma membrane. I t  is  also possible tha t 
the antigen was subject to leaching o f f  the plasma membrane during 
the tissue processing. In some rods, the plasma membrane o f the 
outer and inner segments appeared labe lled , although the cytoplasm 
of the inner segment was unstained (Figure 7.19a,b). A few rods were 
found in one section, which were labelled p re fe re n t ia l ly  at the 
periphery o f the ROS, apparently s ta in ing the rims o f the discs 
and/or the ROS plasma membrane (Figure 7.19a). The phenonemon may 
have been a s ta in ing a r t i f a c t ,  and was not seen in the sections 
labelled with the S2.4.C5 monoclonal antibody to S-antigen.
7.7.2 Reaction with Cone Photoreceptors
Antibody R1.2.D2, was unreactive with the cones of human (Figure 
7.20a,b) and pig re t ina .
7.8 SPECIFICITY CONTROLS FOR IMMUNOCYTOCHEMICAL LOCALISATION
7.8.1 S p e c if ic i ty  of Antibodies
The s p e c i f ic i t y  of la b e ll in g  was ind icated, in pa rt,  by the absence 
of label on ir re le va n t structures in the section, such as the 
photoreceptor nucle i. The s p e c i f ic i t ie s  of the monoclonal 
antibodies, and of the antisera were also established in 
immunoblotting experiments (Sections 6.3.2 and 3 .8 .1 , re spec tive ly ). 
Antibody S2.4.C5 was apparently t o t a l l y  spec if ic  fo r  S-antigen 
(Figure 6 .7 ), ind ica ting  tha t the lo ca lisa t io n  was unambiguous. 
S im ila r ly ,  the s p e c i f ic i t y  of monoclonal antibody R1.2.D2, was shown 
in immunoblotting experiments (Figure 6.8b).
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7.8.2 Comparison With conventional Polyclonal Antisera
Rat antiserum against S-antigen served as a useful comparison fo r  
the reac tion ’with monoclonal antibody S2.4.C5, and also provided a 
pos it ive  sta in ing con tro l. The antisera gave r ise  to a s im ila r 
sta in ing pattern to tha t o f the monoclonal antibody, p r im a r i ly  
la b e ll in g  the ROS disc membranes. In th is  study, an ti-ops in  sera was 
also used. Rhodopsin (and opsin) are known to be loca lised in the 
disc membranes, and thus antisera to th is  prote in provided a useful 
disc s ta in ing con tro l,  and labelled the ROS disc membranes v i r t u a l l y  
exc lus ive ly  (see double immunolabel1ing fo r  opsin and S-antigen in 
Figure 7.11).
7.8.3 Negative Controls
The omission o f the primary antibody provided one negative con tro l,  
ensuring the s p e c i f ic i t y  o f the gold probes. The use of a negative 
antibody con tro l,  however, is very important. In th is  study, 
preimmune ra t  serum provided a negative control fo r  the te s t  
antisera, and was used at the same or lower d i lu t io n s .  This gave an 
ind ica tion  o f the possible nonspecific reactions with polyclonal 
antisera (Table 7.1). An ir re le va n t monoclonal ra t  IgG, to V ibrio  
cholerae, was employed as a negative control fo r  the monoclonal 
antibodies (Figures 7.10 and 7.12). The control monoclonal antibody 
was used as the ce ll free cu ltu re  supernatant or as a 10 fo ld  
concentrate in PBS (Table 7.1).
7.9 QUANTIFICATION OF STAINING
The in te n s i ty  of la b e ll in g  with the immunogold probe was assessed by 
counting the number of gold pa rt ic les  per square micron, w ith the 
aid o f a template la id  over the electron micrographs. The resu lts
fo r  the quantita tion  of la b e l l in g  of S-antigen are shown in Table
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Table 7.1 Estimation o f spec if ic  la b e l l in g  of disc membranes by
monoclonal antibody S2.4.C5
Density o f Gold Label*
Rod Rod Rod
Outer Segments Inner Segments Nuclei
Human Retina --------- -----------------------------------------------------------
S2.4.C5 x 1/2 40 + /-0 .6  
n=6
15.5 + / -2 .96 
n=4
0.45 +/-0.50 
n= ll
Anti-S x 1/200 44.3 + /-8 .8  
n=6
17.3 +/-6.9 
n=9
4.0 +/-1.76 
n=9
Anti-Opsin x 1/200 20.3 +/-6.1 
n=4
6.5 +/-3.0 
n=4
2.0 +/-1.58 
n=4
MAb to V.cholerae xlO 1.0 + /-  1.2 
n=6
0.8 +/-0.75 
n=5
n/d
Preimmune x 1/100 0.75 + /-0 .8  
n=4
1.25 +/-0.97 
n=8
3.33 +/-0.47 
n=3
Preadsorption * * 1.09 +/-1 .2  
n= ll
2.0 +/-0.89 
n=5
0.8 +/-0.75 
n=5
Ab blank n/d 0.5 +/-0.5 
n=4
0.5 +/-0.87 
n=4
Pig Retina
S2.4.C5 x 1/2 62 +/-21.4 
n= ll
27.7 +/-4.5 
n=6
3.83 +/-1.34 
n=6
Anti-S x 1/200 36.6 + /-9 .0  
n=12
23.5 + / -1 .5 
n=2
5.0 +/-1.22 
n=4
Anti-Opsin x 1/200 76.4 +/-12.5 
n=7
n/d n/d
MAb to V.cholerae xlO 0.86 +/-0.64 
n=7
0.67 + /-0 .5  
n=3
n/d
Preimmune x 1/200 3.86 + /-1 .8  
n=4
n/d n/d
Ab blank 3.83 + /-1 .3  
n=6
n/d 2.7 +/-1.09 
n=4
Pig Cone 
Outer segment
Pig Cone 
Inner Segment
S2.4.C5 2.33 +/-0.47 
n=3
3.25 + / -1 .71 
n=8
* Expressed as mean pa rt ic les  per square micron + /-  standard dev ia tion .
* *  lOOpg/ml S-antigen 1:1 S2.4.C5
7.1. Only the resu lts  obtained with the immunogold detection method 
were quantif ied .
Due to the hydrophilic  nature of the Lowicryl and LR White resins, 
gold pa rt ic le s  tended not to adhere non-spec if ica lly  to i t ,  and only 
ra re ly  was gold observed on the resin . Thus, the resin could not 
provide a true ind ica tion  o f background reaction. Background
stain ing was indicated by the deposition o f gold p a rt ic le s  on
irre levan t structures such as the photoreceptor nucle i. The number 
of gold pa rt ic les  on the photoreceptor rod ce ll nuclei was always 
larger than the number present on other re t ina l nuc le i, fo r  example, 
those o f the inner nuclear layer. This phenomenon may re s u lt  from 
the d if fu s io n  of S-antigen during tissue preparation fo r  electron 
microscopy, from the perinuclear area, where the prote in is  probably 
synthesised (Section 7 .6 .1).
Nonspecific reactions with ir re le va n t s tructures, and general
background sta in ing tended to be greater with the control pos it ive  
and negative sera than with the monoclonal antibody S2.4.C5. 
S im ila r ly ,  background was v i r t u a l l y  absent when an ir re le v a n t ra t  
IgG monoclonal antibody was used as a negative con tro l,  ra ther than 
pre-immune ra t serum (Table 7.1). Omission of the primary antibody 
also resulted in neg lig ib le  s ta in ing.
7.10 Discussion
This study has revealed fu r th e r information on the nature and 
physiology of photoreceptor antigens.
The electron immunocytochemistry resu lts  invo lv ing the spec if ic  
monoclonal antibody S2.4.C5 to S-antigen, indicated tha t the prote in
219
was located w ith in  the rod, but not the cone photoreceptors (Figures
7.7 and 7.14, respective ly). The pattern of la b e l l in g  w ith in  the
rods suggested tha t th is  protein was synthesised in the perinuclear 
region o f the rods (Figure 7.13), where the sta in ing was more 
intense than in the inner segment (Figure 7.8b). I t  is  in th is  
region of the photoreceptor c e l l ,  tha t the rough endoplasmic 
reticulm  and Golgi apparatus are located, although these membranous 
structures were not eas ily  id e n t i f ie d  in the Lowicryl and LR White 
embedded re tinae. S-antigen is  probably transported from the
perinuclear area to the apical region of the inner segment fo r  i t s
incorporation in to  the ROS. S-antigen was loca lised s p e c i f ic a l ly  on 
the disc membranes, and the gold label could also be id e n t i f ie d  
w ith in  the region of the connecting c il ium  (Figures 7 .7). This was 
in agreement with a previous study using polyclonal antiserum and 
s im ila r techniques (McKechnie _et al_., 1985). Specific  la b e l l in g  of 
the ROS plasma membrane was less re ad ily  determined, due to the 
poorer preservation during tissue processing fo r  electron 
microscopy.
At the level o f the l ig h t  microscope, S-antigen could be detected 
throughout the en t ire  photoreceptor c e l l ,  including the synapses 
(Figure 7.2). I t  is  not yet known whether S-antigen has a 
physiological ro le in th is  region o f the c e l l .  There is  evidence 
tha t the prote in may be involved in the control o f the visual cycle 
(Section 1 .2 .3 ), however, S-antigen does seen to d is tr ib u te d  in the 
rod c e l l ,  in a d i f fe re n t  pattern to tha t of opsin. A pre lim inary 
study at the l ig h t  microscopical le ve l,  has suggested tha t S-antigen 
may be d is tr ibu ted  in a d i f fe re n t  pattern under conditions o f dark 
adaptation (Figures 7.3a,b; Section 7 .2 .1 .2 ). I f  th is  is  shown to be
reproducible, s im ila r  experiments at the level o f the e lectron
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microscope would allow the pattern of s ta in ing to be more prec ise ly  
determined, and also enable quantita tion  of la b e l l in g .
At the electron microscopical level S-antigen could also be detected
in the newly phagocytosed ROS, but was apparently absent in some
phagosomes which were presumably at more advanced stages of
digestion (Figures 7.15 and 7.16). S-antigen was not loca lised
w ith in  the RPE cytoplasm, the basement membrane or the choriod.
The 39K protein was loca lised on the rod disc membranes using the 
monoclonal antibody R l.2 .D2 (Figure 7.17 and 7.18). Very l ig h t
la b e l l in g  was obtained fo r  the epitope recognised by R1.2.D2, in the 
rod inner segments and connecting c il ium  (Figures 7.17b and 7.18a),
which contrasted to tha t observed fo r  S-antigen (Figure 7 .7). This
pattern o f s ta in ing was also observed at the l ig h t  microscopical 
level (Figure 7.4). The plasma membrane around the inner segment
appeared labelled in some sections. The id e n t i ty  o f the 39K antigen 
is yet to be determined, and i t  may be a subunit o f one o f the
larger ROS prote ins, eg. transducin (Section 8.6).
The epitope o f bovine S-antigen recognised by the monoclonal 
antibody S2.4.C5, was shared by the p ig , human and ra t .  S im i la r ly ,  
antibody R1.2.D2 was raised against bovine antigen, and is  capable
of recognising the human, ra t  and pig form of the antigen. This
provides fu r th e r evidence fo r  the conserved nature o f photoreceptor 
spec if ic  antigens.
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CHAPTER EIGHT
GENERAL DISCUSSION
Chapter 8
GENERAL DISCUSSION
8.1 OVERVIEW
This study has investigated the question of whether humoral 
autoimmunity to re t in a l antigens is  expressed in human r e t i n i t i s  
pigmentosa and u v e i t is ,  and the re t in a l dystrophic RCS ra t  model. 
Specific serum antibody was sought to p u r if ied  S-antigen, crude 
re t in a l extract and ROS membranes (Chapter 4). Human and ra t  B 
lymphocytes were modified, to allow long term cu ltu re enabling the 
potentia l a n t i - re t in a l  immune response to be fu r th e r  studied 
(Chapter 5). In th is  study, the frequency of pos it ive  serum 
responses to re t in a l antigens, and the frequency of clones 
secreting antibody to S-antigen or ROS, was greater in the re t in a l 
dystrophic rats than in the control ra ts , and greater in the 
u ve it is  patients than in the RP patients or in the healthy 
controls.
The second aspect of th is  thesis involved the characterisation of 
ra t monoclonal antibodies to p u r i f ie d  S-antigen and a rod outer 
segment membrane prote in . An IgG monoclonal antibody was raised 
against bovine S-antigen, and an IgM monoclonal antibody was 
produced to a rod disc membrane protein with an apparent molecular 
weight of 39K (Chapter 6). Both of these antibodies, derived from 
hyperimmunised DA rats were used to loca lise  the respective 
antigens at the electron microscopical level on human and pig 
photoreceptor rod disc membranes (Chapter 7). The a f fe c t  of one 
monoclonal antibody, on S-antigen induced EAU was also
investigated.
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8.2 PROPERTIES OF RETINAL S-ANTIGEN
8.2.1 Presence o f Carbohydrate on S-Antigen
S-antigen has been tested fo r  the presence of a carbohydrate group 
by means of the periodic acid S c h if f 's  (PAS) reaction. A fa in t  
pos it ive  PAS reaction was obtained fo r  the S-antigen prepared fo r  
th is  study, suggesting the presence of a re la t iv e ly  small 
carbohydrate moiety, which is  perhaps eas ily  lo s t  during the 
p u r i f ic a t io n  procedures. Both pos it ive  and negative reactions have 
been reported (Borthwick and Forrester, 1983; Wacker e t ^ l . ,  1977, 
respective ly). B lo tt ing  of S-antigen transferred to n itro ce l lu lo se  
paper from SDS polyacrylamide gels, with rad io - labe lled  le c t in s  
could y ie ld  useful information on the nature of th is  carbohydrate 
moiety. This technique o ffe rs  a greater s e n s i t iv i t y  than does the 
PAS reaction.
8.2.2 Uveitopathogenic capacity of S-Antigen and the e f fe c t  of 
Monoclonal Antibody S2.4.C5 in EAU
Duncan-Hartley guinea pigs, in jected in the hind foo t pad w ith a 
single dose of 50pg of S-antigen mixed 1:1 with CFA, developed 
severe c l in ic a l  u ve it is  w ith in  17 days a f te r  the in je c t io n .  
Histopathological examination revealed tha t the morphology o f the 
EAU was s im ila r  to tha t described by Forrester e t a l . (1985). The 
in traperitonea l in je c t io n  o f lmg o f the ra t IgGl monoclonal 
antibody S2.4.C5, with s p e c i f ic i t y  to S-antigen (Section 6 .3 ), 
simultaneously with the foo t pad in je c t io n  of S-antigen in  CFA, 
resulted in an exacerbation of the c l in ic a l  and histopatholog ical 
features of EAU. This is  in contrast to the s itua t ion  in s im ila r  
experiments with Lewis ra ts ,  were monoclonal antibody S2.4.C5
prevented the development of the disease (Section 6.6).
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The resu lts  with the Lewis rats are s im ila r to the find ings of de 
Kozak et a j .  (1985) and Merryman et a]_. (1986), who found tha t 
th e ir  mouse monoclonal antibodies to S-antigen prevented the 
induction of EAU in ra ts . In such experiments, i t  is  u n l ik e ly  tha t 
a n t i - id io ty p ic  antibodies to the monoclonal antibodies are 
involved, e ith e r in the suppression of EAU by inducing T
suppressive a n t i- id io typ e s , as suggested by de Kozak et a}. (1985), 
or in the exacerbation of the disease by acting as surrogate 
antigen. Experience has shown that the production of a n t i- id io types  
is  d i f f i c u l t  to achieve, and requires in je c t io n  with large 
quantit ies of the monoclonal antibody (Ghosh and Campbell,
unpublished observations). I t  is  u n l ike ly  tha t many a n t i - id io ty p ic  
antibodies, which t ru e ly  resemble the o r ig ina l antigen, could be 
generated in the short period of time, (w ith in  two weeks) a f te r  
in je c t io n .  In experiments with ra ts , the monoclonal antibodies may 
fa c i l i t a t e  the removal of S-antigen, reducing i t s  exposure to the 
immune system. In the guinea pigs, the foreign ra t  monoclonal 
antibody might have resulted in the boosting of the immune response 
in general, perhaps involv ing immune complexes with the ra t  
monoclonal antibody, and guinea pig a n t i - ra t  antibodies. The 
resu lts  are however, d i f f i c u l t  to f u l l y  explain u n t i l  the 
experiments are repeated, with additional tes ts . Further work is  
required in order to monitor of the animals' responses to the
injected antibody, eg. assay fo r  a n t i - id io ty p ic  antibody to
S2.4.C5, and the determination of the e f fe c t  of the monoclonal 
antibody acting alone, in the induction of EAU. Important contro ls 
fo r  such experiments include the in je c t io n  of ir re le v e n t antigen 
with the monoclonal antibody, and also the in je c t io n  o f an 
ir re levan t monoclonal antibody with S-antigen.
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De Kozak et a l . (1985) reported that the disease was only inh ib ited  
i f  the antibody was administered at the time o f in je c t io n  of 
S-antigen, and not a f te r  7 or 14 days. Since the level of
c irc u la t in g  monoclonal antibody, measured by ELISA, did not pe rs is t 
at high levels a f te r  7 days (de Kozak et a j . ,  1985), i t  may have 
complexed with autologous antigen released from the re t in a , or with 
a n t i - id io ty p ic  antibodies. I t  seems more l i k e ly ,  however, tha t the 
mouse antibody was removed by the ra t immune system, as foreign 
pro te in , since the damage to the re tina was u n l ik e ly  to occur
during the f i r s t  week a f te r  immunisation.
In contrast to the present study and tha t of de Kozak et a l .
(1985), Merryman et a l.  (1986) in jected th e ir  experimental ra ts 
with preformed immune complexes of S-antigen with two mouse 
monoclonal antibodies to S-antigen. One of the monoclonals did not 
have any e f fe c t  on the EAU, and the second antibody was capable of 
preventing EAU in 85% of the animals, when 200pg o f complexes were
in jected. The remaining 15% had a delayed onset o f the disease. At
higher doses, 300pg of complexes, a l l  animals developed c l in ic a l  
disease although i t  was delayed in onset. Merryman et a j .  (1986) 
suggested tha t th e ir  second monoclonal antibody modified the 
S-antigen in a way in which the f i r s t  antibody did not, and tha t 
immune complexes may play a ro le in the regulation of th is  T ce l l  
mediated experimental disease. I t  seems l i k e ly ,  however, tha t the 
immunising complexes would be broken up and processed f a i r l y  
ra p id ly  w ith in  the ra ts , both components of the complexes being 
foreign prote in . In th is  respect, the complexes may have been 
rap id ly  cleared, thus reducing the chances of developing spe c if ic  
ce ll mediated immune mechanisms. Perhaps the in e ffe c t ive  antibody
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of Merryman et aK (1986) was of a lower a f f in i t y ,  and did not 
re ad ily  remain complexed in v iv o , and thus the S-antigen could 
pe rs is t longer and evoke the ce ll  mediated responses which are 
responsible fo r  the development of EAU. Furthermore, i t  is  not 
possible to obtain true complexes o f monoclonal antibody and 
antigen, since by nature monoclonal antibodies usually  only 
recognise one epitope. Thus the ra t io  of antibody to antigen is  
only 1:1, or possibly 1:2, with an IgG monoclonal monoclonal 
antibody. Antigen complexes with IgM monoclonal antibodies can be 
la rge r, since they are polyvalent, but these w i l l  be very much 
smaller than than those which can be obtained with polyclonal 
anti sera.
The ac tiva tion  or suppression of S-antigen induced EAU, by 
monoclonal antibodies, is  l i k e ly  to depend on many fa c to rs , 
including the re la t iv e  doses of antigen and antibody, routes and 
time of in je c t io n ,  the a f f i n i t y  and isotype of the antibody, the 
nature o f the appropriate epitope on S-antigen, and the species or 
s tra in  of experimental animal. This is  a new area o f research in to  
EAU, and may provide fu r th e r information in to  the mechanisms o f the 
induction of the disease.
Although the DA rats employed fo r  the production of monoclonal 
antibodies were immunised with 2 to 3 in jec t ions  o f doses up to 
twice that required fo r  the induction of EAU in guinea p igs, none 
of the animals examined demonstrated any s ig n i f ic a n t  ocular 
pathological changes. DA ra ts were u t i l is e d  because o f th e i r  
a b i l i t y  to produce good immune responses to in jected antigens. 
A fte r a s ingle in je c t io n ,  the DA rats were capable o f developing 
t i t r e s  of several thousand. These rats received subcutaneous
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in jec t ions  in the thigh and neck, in contrast to the animals 
involved in most EAU studies, where the animals were in jected in 
the foo t pad. I t  is  thought tha t in je c t io n  in to  the foo t pad is 
more e f f ic ie n t  in the induction of a ce l l  mediated immune response, 
through the recruitment of lymphocytes to the draining lymph nodes, 
and EAU is  thought to be la rge ly  ce ll mediated (Section 1 .3 .5 ). I t  
is  possible tha t the induction o f spec if ic  suppressor T ce l ls  
reduced the T ce ll  mediated damage. The pathological changes which 
occur in EAU tend to be focal in d is t r ib u t io n  (Forrester et a l . ,  
1985). Perhaps, the sections o f S-antigen immunised DA ra t  eyes 
which were examined represented the healthy regions o f re tina  and 
choroid.
8.2.3 Fragments of S-Antigen Retain Immunological A c t iv i ty
I t  has recently  been suggested that a 40K antigen, iso la ted from 
ROS, contains most, i f  not a l l  of the antigenic determinants of 
S-antigen (Gregerson and Putterman, 1984). This 40K antigen might 
be a precursor or breakdown product o f S-antigen. However, th is  
information was based on an immunoprecipitation experiment 
involv ing polyclonal antiserum to S-antigen. In the present study 
there was no strong evidence to support th is  hypothesis, since in 
immunoblots against crude re t in a l antigens, where a 40K band could 
be id e n t i f ie d ,  both ra t antisera and monoclonal antibody S2.4.C5, 
reacted only with S-antigen.
Partia l p ro teo ly t ic  digestion of S-antigen in Cleveland gels, 
followed by immunoblotting with monoclonal antibody S2.4.C5, 
indicated that a l l  fragments produced, contained the S2.4.C5 
antigenic determinant. The smallest fragment obtained under these 
conditions was approximately 9.0 to 9.4K (Section 6 .4 .2 ) ,  which
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would contain in the region of 50 amino acids. Although smaller 
fragments could not be generated using th is  technique, cleavage 
with cyanogen bromide (CNBr) can produce smaller fragments 
(Gregerson and Putterman, 1984). I t  would be in te res ting  to 
id e n t i fy  and p u r i fy  the smallest fragment of S-antigen, bearing 
the S2.4.C5 epitope, and investigate i t s  ro le in EAU. Perhaps the 
CNBr digestion technique of Gregerson and Putterman (1984) could be 
used in combination with immunoblotting. S im ila r ly ,  i t  would be 
useful to id e n t i fy  and characterise the epitopes recognised by 
na tu ra l ly  occurring a n t i -  S-antigen antibodies, from rats and 
humans (Chapter 4).
Gregerson and Putterman (1984) produced 7 major fragments with 
molecular weights ranging from 18 to 199 amino acids in length. Of 
these 7 fragments, 6 were p u r if ie d  and th e i r  amino acid sequences 
determined. In add it ion , a minor fragment was s im i la r ly  
characterised. A ll of these fragments were reactive in the ELISA 
with polyclonal antiserum, but th e ir  uveitopathogenic capacity has 
not yet been reported. In a short communication Stein (1984), 
presented evidence tha t a mixture of S-antigen fragments, mainly of 
10 to 30K, was capable of inducing EAU in about 50% of Lewis ra ts . 
However, the successful induction o f EAU with a mixture of 
fragments is  not surpris ing , since the development o f EAU is 
thought to involve T ce lls  (Section 1 .3 .5 ), sensitised by small 
fragments of antigen processed and presented on the surfaces of 
antigen presenting c e l ls ,  such as macrophages, in association with 
Class I I  h is tocom patability  antigens. More information is  to be 
gained from experiments invo lv ing the induction of EAU with 
p u r i f ie d  fragments of S-antigen. Kamada et a l . (1985) produced 3 
peptides of S-antigen by digestion with a-chymotrypsin. Only the
228
24K peptide and not those o f 16 and 12K, reacted with the rabb it 
polyclonal antisera in the ELISA. However, the re a c t iv i ty  o f the 
antisera with S-antigen in the ELISA is  dependent on the c o l le c t iv e  
a f f in i t i e s  of the polyclonal antibodies, and on the d i lu t io n  used. 
This was also seen in the Cleveland b lo t experiments invo lv ing 3 
d i f fe re n t  anti sera shown in Figure 6.15. The smallest fragment 
detected in th is  experiment was 9.7K. These sera were used at 1:400 
d i lu t io n ,  and i t  is  possible tha t at a 1:200 d i lu t io n ,  the 9.2 and 
9.4K bands would also be detected. The 24K fragment id e n t i f ie d  by 
Kamada et a l .  (1985) was uveitopathogenic, but th is  is  a re la t iv e ly  
large fragment (50% of the o r ig ina l p ro te in ). I t  is  quite probable 
tha t there are several regions o f the molecule which are capable of 
inducing the disease, and together they have a synerg is tic  e f fe c t ,  
since they w i l l  activa te  separate clones of T ce l ls  w ith d i f fe re n t  
s p e c i f ic i t ie s .
Together, polyclonal and monoclonal antibodies w i l l  aid the 
id e n t i f ic a t io n  of the major antigenic determinants o f S-antigen. I t  
is  quite possible tha t d i f fe re n t  epitopes o f S-antigen might be 
antigen ic, or uveitopathogenic in some species, but not others. 
Therefore antibodies from d i f fe re n t  species, in addition to 
d i f fe re n t  ind iv idua ls , should be investigated. Recently i t  has been 
suggested tha t the m a jo r ity  of antigenic determinants are 
conformational, rather than l in e a r (Tainer et a } . ,  1985; Barlow et 
a l . ,  1986). However, the epitope recognised by S2.4.C5 is  more 
l i k e ly  to be l in e a r in nature since i t  has survived treatments 
l i k e ly  to be detrimental to many conformational determinants, ie .  
enzymatic digestion followed by SDS-PAGE and binding to 
n itroce llu lo se  paper, and f ix a t io n  in 4% gluteraldehyde (Figure 
7 .2 ), processing fo r  electron microscopy.
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8.3 EXTENT OF AUTOIMMUNITY IN UVEITIS AND RP PATIENTS
In recent years, there have been numerous studies inves tiga ting  the 
immune mechanisms of RP and u ve it is  pa tien ts , as well as other 
occular patients (Section 1.4). However, the data supporting the 
view of associated autoimmunity, with many o f these diseases, is  
la rg e ly  unconvincing, and often contrad ictory. The contrad ictions 
between groups probably a r ise , in pa rt,  from the differences in the 
s e n s i t iv i t ie s  of the techniques employed, the low numbers of
patients and contro ls investigated and also the in te rp re ta t io n  o f 
the data. Often the resu lts  fo r  the various immunological tests
suggests tha t the m a jo r ity  o f the patients responses l i e  w ith in  the 
normal range. However, two or three ind iv idual patients generating 
high readings, raise the mean response of the whole group s l ig h t ly ,  
but s t a t i s t i c a l l y  s ig n i f ic a n t ly ,  above the mean o f the contro ls 
(eg. Nussenblatt e t cQ., 1980; Nussenblatt et a l . ,  1983; and
Gregerson et al_., 1981).
8.3.1 Estimation of Serum A n t i- re t in a l  Immune Responses of RP 
and Uveitis  Patients
The pre lim inary study described in Section 5.3, sought to 
investigate the re la t iv e  frequencies o f c irc u la t in g  B lymphocytes 
in RP and u ve it is  pa tien ts , which were capable o f secreting 
antibody against S-antigen or ROS a f te r  ac t iva tion  by EBV. The 
pa tien ts ' serum t i t r e s  to these antigens, were also recorded 
(Section 4.2.4) so tha t comparisons could be made. In th is  l im ite d  
study, only one of the 11 control sera, gave an ind ica tion  o f a 
pos it ive  t i t r e  to S-antigen and ROS in the ELISA (Figures 4.12a,b),
and was obtained from a user o f the antigens, who probably became
passively sensitised through contact (Section 4 .2 .5 ) . Only 5 RP,
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and 6 u ve it is  patients were tested in serum study. I t  is
in te res ting  tha t although none of the RP patients generated 
pos it ive  serum t i t r e s  to e ith e r antigen (Figures 4.10a,b), f iv e  of 
the s ix  u v e it is  patients tested e ith e r responded to S-antigen or to 
ROS, but not both (Figures 4.11a,b) (Sections 4 .2 .5 ) . I t  is  also 
in te res ting  tha t a l l  o f the pos it ive  human sera id e n t i f ie d  
S-antigen and the 40K antigen in immunoblots, regardless o f the 
ELISA s p e c i f ic i t ie s  (Figure 4.14). These two components were also 
recognised by the pos it ive  RCS and Wistar ra t sera (Figures 4.7 and 
4.8) (Sections 4 .1 .8 -9). The resu lts  with the human sera suggest 
tha t there were determinants on S-antigen which were exposed in the 
immunoblotting technique, but were not re ad ily  detected in the
ELISA. Conversely, human (and ra t)  autoantibody to the ROS
insoluble prote ins, such as opsin, were not re ad ily  detected by
th is  method, probably due to the denaturation o f the re levant 
epitopes. I t  is  also possible tha t the re la t iv e  low a f f i n i t y  and/or 
a v id i ty  of the antibodies resulted in the fa i lu re  to demonstrate 
autoantibody to opsin in the immunoblots.
The 40K antigen, present in the crude re t in a l ex trac t
(predominantly soluble antigens), was not seen in the S-antigen and
ROS preparations in s ig n if ic a n t  quan t it ie s , and therefore was 
probably not re ad ily  detected in the ELISA assay systems employed.
The 40K antigen was thought not to be a breakdown product o f
S-antigen, since ra t monoclonal antibody S2.4.C5, sp e c if ic  fo r  
S-antigen, did not recognise i t  (Figure 6 .7). The re tention o f the
S2.4.C5 epitope in fragments of S-antigen is  fu r th e r exemplified by 
the Cleveland b lo t t in g  experiments (Figure 6.13).
I t  is  in te res ting  tha t S-antigen and the 40K antigen appeared to
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dominate the autoimmune response in both the pos it ive  ra t  and human 
sera. Perhaps th is  is  a re f le c t io n  of the high a n t ig e n ic i ty  of 
these ROS components, compared with the other re t in a l antigens. The 
high s o lu b i l i t y  of S-antigen, and perhaps also o f the 40K antigen, 
might f a c i l i t a t e  th e i r  leakage from the photoreceptors, during 
degeneration or inflammation, and the s tim ula tion o f 
immunocompetent c e l ls .
However, u n t i l  a larger scale study is  completed, i t  is  not 
possible to draw any conclusions on the s ign if icance of the 
pa tien ts ' responses, shown in the ELISA assays and immunoblots. 
Others have found that there is  l i t t l e  d ifference in the serum 
antibody response to S-antigen in the ELISA of u v e it is  pa tients and 
controls (Forrester, personal communication, 1986). Further studies 
are required in order to determine the immunological importance o f 
the 40K antigen.
8.3.2 Presence of Anti-Retinal B Lymphocytes in Uveitis  and RP
In the transformation study (Sections 5.3.6-11), only one o f the 5 
control samples generated a possible pos it ive  clone (Section
5.3 .6 ). I t  i s ,  of course possible, tha t in a la rger study, a 
greater proportion of pos it ive  serum responses, or pos it ive  clones 
would be detected. The transformation resu lts  did not f u l l y  
correspond to the patients t i t r e s .  One u ve it is  pa tien t w ith a 
re la t iv e ly  high t i t r e  to ROS, did not generate any pos it ives upon 
transformation (Sections 5.3.8 and 5.3.11). Another p a t ie n t ,  with 
RP, who did not demonstrate a s ig n if ic a n t  serum response to  e ith e r 
antigen in the ELISA, generated several clones pos it ive  to both 
antigens upon transformation o f the peripheral B lymphocytes 
(Section 5.3.7 and 5.3.11). These find ings might be an ind ica t ion
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of the nature of the B ce l ls  which were transformed. I t  is  not yet 
known whether EBV invades primary small B lymphocytes, memory ce l ls  
or more mature B lymphocytes. The v irus may in fe c t  B lymphocytes at 
more than one stage of maturation, and yet be se lective as to the 
nature o f the surface receptors on the B c e l ls ,  perhaps including 
the antigen s p e c i f ic i t y ,  and th is  could vary between ind iv idua ls . 
There is  evidence tha t EBV may se le c t ive ly  transform B c e l ls  which 
are ju s t  beginning to secrete antibody, but not mature plasma ce lls  
(Steel et a ] . ,  1986).
Three samples obtained from one u ve it is  pa t ien t,  on separate 
occasions, generated almost iden tica l serum t i t r e s  to S-antigen 
(Figure 4.11a), yet the transformation of the B c e l ls  yielded 
d i f fe r in g  frequencies of clones pos it ive  to S-antigen and ROS 
(Figures 5.17) (Sections 5.3.8.1 and 5.3.11). This might be a 
re f le c t io n  o f the d i f fe re n t  phases in the regulation o f the immune 
system. There are, however, many other factors which might have an 
e f fe c t  on the number of clones obtained, including the 
physiological state o f the pa tien t and recent in fe c t ions . Even the 
time of day at which blood samples are taken can a f fe c t  the number 
of lymphocytes obtained, i f  the c irc u la t in g  ce l ls  fo l low  a 
circadian rhythm. L i t t l e  is  known of the physiological va r ia tions  
which occur in the immune system, perhaps on a d a i ly  basis. Others 
have reported varia tions in the production o f IL-2 and a - in te r fe ro n  
by lymphocytes iso lated from the same ind iv idua ls  on d i f fe re n t  days 
(BenEzra et aj_., 1984; Hendricks and Fishman, 1986) (Section
1 .4 .3 .6 ). C learly , a detailed long itud ina l inves tiga tion  o f the 
c ircu la t in g  immunoglobulins and ce l ls  o f the immune system, in 
healthy ind iv id ua ls , would provide a valuable reference fo r  a l l  
studies involv ing tests of immune function .
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The involvement of the immune system is  even less certa in  in RP 
than in u v e i t is ,  and no obvious inflammation has been found in RP, 
although the presence of ce l ls  in the vitreous is  a constant 
feature of RP (Marmor et a j . ,  1983). Undoubtedly the immune system 
is  involved in u v e i t is ,  since i t  is  the ce l ls  of the immune system 
which i n f i l t r a t e  in to  the uveal tissues and vitreous (Section
1 .4 .4 .1 ). However, the s p e c i f ic i t y  of th is  inflammatory response is  
yet to be accurately determined. I t  is  possible tha t increased 
vascular permeability or changes in the pigment epithelium 
occurring in some pa tien ts , gives the p o te n t ia l ly  autoreactive 
antibodies or T c e l ls ,  the opportunity to loca lise  w ith in  the 
vitreous or uveal tissues. I t  is also possible tha t in u v e it is  
disease there is  a malfunction in the regulation o f the immune 
system, such tha t the normally present low a f f i n i t y  autoantibodies 
or antibodies, which crossreact with s e l f  antigens, eg. re t in a l 
prote ins, could take on a pathogenic ro le . S im ilar antibodies in 
healthy subjects, are re la t iv e ly  harmless. I t  has been suggested 
tha t a n t i - id io ty p ic  antibodies could have a protective ro le ,  since 
re t in a l v a s c u l i t is  patients with high levels of c irc u la t in g  immune 
complexes, tended to have less severe disease (Drumonde et al^., 
1982).
Much of the published work cannot be v e r i f ie d  u n t i l  a large, 
perhaps double masked, study is  undertaken, preferably funded by a 
relevant body and monitored by a s c ie n t i f ic  committee, as 
recommended by BenEzra et a j .  (1984). The RP and u v e it is  patients 
should be c le a r ly  c la s s i f ie d ,  as fa r  as possible, and numerous age 
matched controls included, since age is  a relevant fac to r  in the 
consideration of autoimmunity.
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Should a f u l l  evaluation of the responses of human transformed B 
lymphocytes reveal no s ig n if ic a n t  d ifference between the patients 
and con tro ls , the value o f the transformation technique remains as 
a step towards the development of human monoclonal antibodies. A 
human monoclonal antibody, derived from an ind iv idua l not 
a r t i f i c i a l l y  immunised, may id e n t i fy  an in te res ting  epitope o f an 
antigen, not re ad ily  detected in hyperimmune animal serum. I t  may 
be tha t patients with u ve it is  disease produce spec if ic  antibody, or 
antibody which crossreacts with S-antigen, recognising a certa in  
group o f antigenic determinants, which are not recognised by the 
sera of healthy con tro ls , although the control sera may id e n t i fy  
other, perhaps less pathogenic epitopes.
8.4 HUMORAL AUTOIMMUNITY IN RCS RATS
8.4.1 Immunocytochemistry with RCS Rat Sera
Previous reports regarding humoral autoimmunity in the re t in a l
dystrophic RCS ra t  u t i l is e d  the re la t iv e ly  insens it ive  
immunofluorescence technique and unspecified numbers o f animals 
(Brinkman and Broekhuyse, 1981; Chant and Meyers-El1i o t t ,  1982). 
These studies employed undiluted sera, or very low serum d i lu t io n .  
Under such conditions, the chances of nonspecific binding o f
antibody due to charge a tt rac t ions  ( ion ic  and Van der Waals forces) 
as well as physical in te ractions with the tissue section are
maximised. In add it ion , many ce l ls  have fc  receptors to which serum
immunoglobulin w i l l  bind in immunocytochemisty. Furthermore, low 
serum d i lu t io n s  enhance the in te rac tion  of low concentrations of 
autoantibodies to non-tissue spec if ic  antigens such as c o n tra c t i le  
prote ins, nuclear and mitochondrial antigens (Spalton e t a j . ,  
1978b; Murray, 1986). In th is  study, the immunofluorescence
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technique was found to be unre liab le  when neat serum was used on 
the frozen sections of ra t  eye, since the resu lts  were poorly 
reproducible, and that s im ila r  frequencies of apparent (or fa lse ) 
positives were detected in RCS dystrophic ra t sera and PVG control 
sera (Table 4.31). C learly section thickness and a d i f fe re n t ia l  
washing between sections could also a f fe c t  the in te n s i ty  o f an 
apparent spec if ic  reaction. The choroid usually demonstrated 
intense fluorescence, presumably due to the endogenous ra t 
immunoglobulin in th is  h igh ly  vascular tissue. Where fluorescence 
was observed w ith in  the re t in a ,  the reaction tended to be located 
in the photoreceptor ce ll bodies ra ther than the ROS, s im ila r  to 
the observation o f  Chant and Meyers-El 1 io t  (1982). Id e a l ly ,  a wide 
range of serum d ilu t io n s  should be tested, and a large number of 
rats tested, including d i f fe re n t  s tra in s , the immune response genes 
may lead to considerable differences between stra ins (Ruscetti et 
c il. ,  1975; see also R o itt  et aj_., 1985).
The present study also u t i l is e d  the more sensitive in d ire c t
peroxidase immunocytochemistry procedure, the e xq u is ite ly  sens it ive  
ELISA and a sensitive immunoblotting technique' (Section 4 .1 .2 .2 ) .  
In the immunoperoxidase cytochemistry assay, only one Campbell ra t  
serum sample, at a d i lu t io n  of 1:80, was found to give a fa in t  
pos it ive  reaction with the photoreceptor outer segments. At
d i lu t io n s  lower than 1:80, there was a higher proportion o f weak,
perhaps normally present autoantibodies reacting with the
non-tissue spec if ic  antigens, however the general background 
reaction present at lower d i lu t io n s  was too high. In a fu r th e r  
study, i t  would be useful to investigate the reaction o f RCS ra t  
sera in tissue sections using the peroxidase anti-peroxidase (PAP) 
technique, which offe rs  s e n s i t iv i t y  at least 100 fo ld  greater than
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tha t of the in d ire c t  peroxidase procedure (see Polakand Van 
Norden, 1984).
Immunocytochemical assays are often used to tes t fo r  autoantibody, 
since they o f fe r  a wide va r ie ty  of tissue antigens. In add it ion , 
the antigens are often considered to be close to th e ir  native form, 
especia lly  in unfixed frozen sections. However, the antigens of 
e ithe r frozen or dewaxed pa ra ff in  sections o f t issue , such as 
re t in a , w i l l  be d i f f e r e n t ia l l y  exposed and also e x is t at d i f fe re n t  
concentrations. Under the conditions of assay, soluble antigens 
l ik e  S-antigen, are eas ily  washed away. Therefore l ig h t  f ix a t io n  is 
necessary. Cross-linking f ix a t iv e s  such as formaldehyde (usua lly  as 
formalin) and gluteraldehyde were not used to f i x  tissue to be used 
fo r  the assay of p o te n t ia l ly  autoimmune sera, since the relevant 
epitopes are l i k e ly  to be a lte red , and also at the low d i lu t io n s  
necessary to detect the autoantibodies, the background reaction 
would be very intense. Thus 95% ethanol or acetone was u t i l is e d  to 
in so lu b i l ise  the normally soluble proteins. Therefore, in 
immunocytochemical assays the antigens are not in the native form.
8.4.2 Id e n t i f ic a t io n  o f Autoimmune Rat Sera in the ELISA
Sera from 3 o f the 10 Campbell RCS rats at the age o f 6 weeks, 
demonstrated responses to S-antigen in the ELISA, s ig n i f ic a n t ly  
above those of the apparently unresponsive l i t te rm a te s  (Figure 
4.3b) (Sections 4.1.5 and 4 .1 .9 ). S im ilar responses were not 
detected at the age of 3 weeks (Figure 4.3a). Only one o f the three 
rats retained a detectable pos it ive  response at the age o f 9 weeks, 
at which time a fourth Campbell ra t  became seropositive (Figure 
4.3c). Two o f the RCS ra t sera, reactive with S-antigen, also 
recognised ROS antigen(s), a lb e i t  at lower t i t r e s  (Figure 4.3b).
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The lower magnitude of responses to the ROS antigen, was not 
thought to be a re f le c t io n  of a lower s e n s i t iv i t y  o f the assay 
compared to the S-antigen ELISA system. I t  is  possible tha t the 
relevant epitopes o f opsin, which accounts fo r  most of the ROS 
membrane pro te in , are denatured upon binding to the p la s t ic  
m ic ro t i t re  plates (Berkowitz and Webert, 1981). In order to 
p a r t ia l ly  compensate fo r  th is ,  the ELISA plates were coated with 
ROS at a greater protein density (5pg/ml) compared w ith S-antigen 
( lpg /m l). The amount o f antigen adsorption probably varies with the 
nature o f the antigen, and i t  was not possible to determine the 
re la t ive  binding of the two antigens in the ELISA. This would be 
possible in a radioimmunoassay system, where binding could be more 
re ad ily  assessed by rad io labe ll ing  the antigen. However, the 
e ff ic ie n c y  o f la b e l l in g  o f the d i f fe re n t  antigens would provide 
another variab le .
The reason fo r  the drop in t i t r e s  at the age of 9 weeks, o f the two 
of the Campbell rats seropositive at 6 weeks, fo r  S-antigen, might 
re f le c t  a minor reduction in the secretion of autoantibody to 
S-antigen, such tha t the antibodies could no longer be detected in 
the ELISA. I t  is  possible tha t in these animals a suppressor T ce l l  
response modified the spec if ic  a n t i -  S-antigen response. The 
development of s e l f  tolerance usually occurs in neonatal l i f e ,  but 
may continue fo r  a few weeks. The animals used in th is  study were 
re la t iv e ly  young, from 3 to 9 weeks in age, and might s t i l l  have 
been susceptible to the induction o f tolerance. The production of 
a n t i - id io ty p ic  antibodies during the control o f the immune response 
might be responsible fo r  sequestering the autoreactive antibodies, 
or perhaps more l i k e ly ,  minute quantit ies of antigens released from 
the degenerating ROS, was enough to sequester the small
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concentration of autoantibody present. Further work, however, is  
required to v e r i f y  th is  postu la t ion , perhaps involv ing assays fo r  
soluble immune complexes.
No s im ila r  pos it ive  t i t r e s  to S-antigen were detected w ith in  the 10 
Hunter RCS rats tested (Section 4 .1 .6 ). I t  is  in te res ting  tha t 1 of 
the 5 Wistar control ra ts , but none of the 15 pigmented con tro ls , 
was id e n t i f ie d  as pos it ive  to S-antigen (at 6 weeks only) (Section 
4 .1 .4 ). Thus, the pos it ive  serum responses were detected 
predominantly in the pink-eyed s tra in  o f dystrophic ra t ,  and also 
in one albino Wistar ra t .  This raises the p o s s ib i l i t y  tha t the 
apparent sens it isa t ion  of the animals to re t in a l antigens, 
S-antigen in p a r t ic u la r ,  arises from l ig h t  induced damage to the 
re t in a , rather than from the genetic degenerative process. Indeed 
the presence o f pigment w ith in  the RPE and choroid has been found 
to slow the degenerative processes by about a week (Yates et a j . ,  
1974; La Vail and B a tte l le ,  1975). The phenomenon o f l ig h t  induced 
re t in a l damage has been well documentd since i t s  f i r s t  report in 
albino rats by Noell et a l . ,  in 1966. High l ig h t  in te n s i t ie s  and 
long exposures re su lt  in the to ta l d isruption of photoreceptor
u lt ra s tru c tu re ,  beginning with the ROS, and resu lt ing  in the
eventual loss of visual ce l ls  (La V a i l ,  1976c; Duncan and O'Steen, 
1985). Perhaps the degeneration of the RCS ra t  re tina  increases the 
s u s c e p t ib i l i ty  o f the Campbell s tra in  to l ig h t  induced damage, 
which results  in the exposure o f the immune system, in some
animals, to previously hidden re t in a l antigens. Previous reports on 
the reaction o f dystrophic ra t  sera with re t in a l antigens in 
sections (Brinkman and Broekhuyse, 1981; Chant and Meyers-El1i o t t ,  
1982), only examined the pink-eyed s tra in .  Where pos it ive  reactions 
were detected, the p o s s ib i l i t y  of a l ig h t  induced exposure o f the
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immune system to re t in a l antigens was not considered (Chant and 
Meyers-El1i o t t , 1982).
I t  would be in te res ting  to id e n t i fy  the class o f autoantibodies in 
the RCS rats using spec if ic  probes. The weak pos it ive  responses 
could e ith e r be due to the presence of low a f f i n i t y  antibody, 
probably IgM, or a very small amount of higher a f f i n i t y  IgG.
Thus, the humoral autoimmune response in the RCS rats does not 
appear to be general, since the m a jo r ity  o f animals did not 
demonstrate a detectable response. In th is  study, the sera o f 10 
Campbell RCS rats were tested at three d i f fe re n t  time in te rva ls .  I f  
fewer animals were tested, and i f  only one time in te rva l was
chosen, i t  would have been possible to miss the pos it ive  sera. 
Previous reports studying the potentia l a n t i - re t in a l  autoimmune 
response o f RCS rats did not state the number o f ra ts involved in
the study. Further work is  required to acsertain the frequency of
pos it ive  t i t r e s  among the RCS rats to the 4GK antigen.
8.4.3 Certain RCS Rat Sera id e n t i fy  S-Antigen and a 40K Antigen
The s p e c i f ic i t y  o f the a n t i-  S-antigen immune response observed in 
the four Campbell and one Wistar pos it ive  sera was assessed in 
immunoblots against crude re t in a l ex trac t,  so lub il ised  ROS
membranes and p u r i f ie d  S-antigen (Sections 4.1.8 and 4 .1 .9 ) .  The 
Wistar and two of the four Campbell sera, pos it ive  to S-antigen in 
the ELISA, also demonstrated a reaction with the prote in  in 
immunoblots (Figures 4.7 and 4 .8). Some of the RCS ra t  
autoantibodies may have been directed against epitopes on the 
native S-antigen, which became denatured a f te r  SDS-PAGE and binding 
to n itroce llu lo se  paper, since the sera of two Campbell ra ts ,
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pos it ive  in ELISA, were unreactive in immunoblots. A lte rn a t iv e ly ,  
the re la t iv e  a f f in i t i e s  of some of the autoantibodies may have been 
too low to detect under the conditions employed in immunoblots. 
Evidently some autoantibodies produced by the rats were of high 
enough a f f i n i t y  and present in s u f f ic ie n t  quantity  fo r  detection, 
and directed to epitopes which survived the conditions of 
immmunoblotting. The two RCS and the one Wistar ra t  sera also 
recognised a 40K antigen in the crude re t in a l ex trac t,  and one of 
the RCS rats also weakly reacted with a 35K antigen. The 40K 
antigen is  probably the same band seen in the b lo ts with the human 
pa tien ts ' sera, and the 35K antigen may be a breakdown product of 
S-antigen. Again, s im ila r  to the s itu a t io n  with the human sera, 
autoantibodies were not detected to opsin in th is  technique 
(Section 8 .3 .1 ) .
I t  should be remembered tha t both the ELISA and espec ia lly  the 
immunoblotting techniques involve several washing steps. During the 
washing procedure, antibodies of lower a f f i n i t y  a n d s p e c if ic i ty  may 
be leached from the plate or n itro ce llu lo se  paper. These techniques 
tend to be selective fo r  high a f f i n i t y  antibodies, which may be 
used at low concentrations. However, autoimmune serum, espec ia lly  
when the degree o f spec if ic  sens it isa t ion  is  not great, contains 
antibodies of re la t iv e ly  low a f f i n i t y  and a v id ity .  Such antibodies 
might take longer to bind to the relevant antigens in the 
immunoassays (Mason and Wiliams, 1980) and i f  the antibodies are o f 
low a v id i ty ,  they may eas ily  be washed o f f .  Also i f  the association 
and d issocia tion of the antibody with the antigen is  rap id , the 
antibodies would ea s ily  leach from the immobilised antigen.
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8 .4 .4  Id e n t i f ic a t io n  of RCS Splenic B Cell Clones with S p e c i f ic i ty
to S-Antigen and ROS
The hybridoma study was somewhat d i f fe re n t  from in the serum study, 
since i t  was not possible to control the number of tests (clones) 
per animal. Although numerous clones secreting antibody reactive 
with S-antigen and ROS were detected in the ELISA, the m a jo r ity  o f
these were obtained from one RCS ra t  fusion (Table 5 .1). This
fusion was derived from a Hunter ra t ,  yet in the serum study,
responses as high as those seen in Campbell ra ts ,  were not found.
In the hybridoma study, only one fusion with a Campbell ra t
generated viable ce l ls  (Table 5.5). S im ila r ly ,  re la t iv e ly  few 
primary clones were obtained in fusions with PVG lymphocytes. The 
reason fo r  the poor fusion frequency obtained in many amimals in
th is  study may be due in pa rt,  to the d i f fe re n t ia l  response o f the 
newly fused ce lls  to minor varia tions in tissue cu ltu re  conditions. 
However, the reason probably l ie s  with the splenic B lymphocytes. 
Generally, hybridoma technology and the generation of monoclonal 
antibodies, involves the in traperitonea l boosting of the immune
system with small doses o f the immunogen, 3 to 4 days p r io r  to
fusion (see Campbell, 1984). This stimulates blastogenesis o f the 
antigen spec if ic  clones. Cells in the b lasto id  stage have been
found to be the optimal fusion partners fo r  the myeloma ce ll  l in e s ,  
not because fusion frequency is  greater, by because the nuclei o f 
the two ce ll types are l i k e ly  to enter m ito t ic  d iv is ion  a t the same 
time (Ltfvborg, 1982).
However, in sp ite  of the above d i f f i c u l t i e s ,  the fa c t remains tha t 
one ra t ,  at lea s t,  generated a fusion frequency and a frequency o f 
pos it ive  clones, comparable to a fusion derived form an immunised
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ra t .  This indicates that several B ce l l  clones were undergoing 
d iv is ion  at the time o f s a c r if ice  fo r  fusion. Since several clones 
were pos it ive  to re t in a l antigens, the ind iv idual may have become 
autosensitised to the degenerating re t ina . However, cloning of 
three of these primary growths, and fu r th e r characterisation o f the 
monoclonal autoantibodies, indicated tha t they were o f r e la t iv e ly  
low a f f i n i t y  compared to the monoclonal antibodies obtained from 
hyperimmunised animals (Section 6 .3 .1 .1 ). The r e la t iv e ly  low 
a f f i n i t y  o f the RCS ra t monoclonal autoantibodies, might be a 
re f le c t io n  o f th e i r  class, which was IgM. Thus, the ra ts  were 
probably in the early  stage o f an immune reponse to the re t in a l 
antigens, which may have matured to give higher a f f i n i t y  antibodies 
should the rats have been spared.
Although the Campbell s tra in  generated a higher frequency of 
positives in the serum study, the ind iv idua ls  u t i l is e d  in the 
hybridoma study, yielded few or no clones (Table 5 .5 ). This have 
been an ind ica tion  tha t few B ce l ls  in these ind iv idua ls  were 
undergoing blastogenesis in response to re t ina l or other antigens. 
S im ila r ly ,  the PVG control fusions did not y ie ld  high fusion 
frequencies (Tables 5.6-8).
Until more successful fusions are obtained with the control ra ts ,  
i t  is  not possible to conclude tha t re t in a l autoreactive B c e l ls  
can only be derived from re t in a l dystrophic ra ts . However, i t  seems 
u n l ike ly  tha t such a high frequency of pos it ive  clones to re t in a l 
antigens would be obtained from a healthy ra t ,  as tha t found with 
Hunter ra t  1 (Table 5.1).
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8.4.5 Possible Dual S p e c if ic i ty  of Monoclonal Autoantibody H10.1.D2
The three monoclonal autoantibodies derived from two Hunter RCS 
ra ts ,  H9.1.C2, H9.5.A4 and H10.1.D3, respective ly recognised
S-antigen, opsin and crossreacted with S-antigen and opsin 
(Sections 6.3.1.2 and 6 .3 .2 .2 ). The in te res ting  c ro ss re a c t iv ity  o f 
antibody H10.1.D3, is  perhaps more l i k e ly  to re f le c t  dual 
s p e c i f ic i t y  o f the antibody, than to suggest shared carbohydrate 
residues or amino acid sequences. In th is  s itua t ion  the antibody 
binding region has the capacity to react with more than one 
epitope, which may be unrelated and located on d i f fe re n t  antigens 
(Ghosh and Campbell, 1986). Such phenonema are more common in IgM 
than IgG antibodies (reviewed by Ghosh and Campbell, 1986). 
However, many of IgM antibodies, derived from hyperimmunised 
animals, do e x ib i t  good s p e c i f ic i t y  and a f f in i t y .
The monoclonal autoantibodies produced in th is  study, might 
recognise epitopes which are not 'seen' by hyperimmune serum, which 
tends to recognise the dominant determinants. Further studies, 
involv ing su ita b ly  modified Cleveland b lo ts , with concentrated 
antibody, could generate some in te res ting  data.
8.4.6 Significance o f the A n ti-  S-Antigen Response in Albino RCS and 
Wistar Rats
The s ign if icance of the low pos it ive  t i t r e s  to S-antigen, found in 
40% of the Campbell s t ra in ,  and the high frequency o f pos it ive  
clones from a Hunter ra t fus ion, is  d i f f i c u l t  to evaluate. Since 
the genetic defect in the ra t re t in a l dystrophy is  known to be 
expressed in the RPE ce lls  (Section 1.5.4) an autoimmune response 
to the re tina is  u n l ik e ly  to be responsible fo r  the in i t i a t io n  o f
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the disease. A sens it isa t ion  to the re t in a l antigens, secondary to 
the primary defect in the RPE, may occur in some animals, 
p a r t ic u la r ly  in the pink-eyed Campbell s t ra in ,  where the l ig h t  
induced re t in a l damage can exacerbate the condition.
There is  evidence tha t in the RCS ra t ,  there is  a breakdown, and 
decrease in number, of the ce l l  junctiona l complexes which normally 
form a b e l t - l ik e  arrangement around the RPE c e l ls ,  thus forming the 
ba rr ie r  between the c h o r io ca p i l la r is  and the re tina  (Caldwell and 
McLaughlin, 1984; Caldwell■ et a l . , 1984). In the albino RCS ra t ,
these junctions become abnormally permeable to tracer substances
a f te r  3 weeks. These changes are not apparent in the pigmented RCS 
rats u n t i l  the age of 6 weeks (Caldwell and McLagchlin, 1983). 
Furthermore, there are several reports o f degenerative changes in 
albino ra t  RPE c e l ls ,  p r io r  to or concomitant w ith l ig h t  induced 
photoreceptor ce ll degeneration (see Semple-Rowland and Dawson 
(1986). There is  also evidence tha t the albino RPE is  also
fu n c t io n a l ly  a ltered a f te r  exposure to extremely low l ig h t  
in te n s it ie s  (Semple-Rowland and Dawson, 1986). Although the ra ts
employed in the present study were not exposed'to extremes o f l ig h t
in te n s i ty ,  i t  is  possible tha t in some ind iv id ua ls , changes did
occur in the RPE, resu lt ing  in a breach of the b lood-re t ina l 
b a rr ie r .  Thus the c irc u la t in g  components of the immune system could 
be exposed to previously hidden antigens. Minute amounts o f the 
h igh ly immunogenic photoreceptor antigens may d if fuse  through the 
RPE layer to the c h o r io c a p i l la r is ,  or perhaps the incoming 
macrophages which phagocytose the ROS membrane debris , present the 
antigenic debris to the T c e l ls .
In view of the very small size of the re tina  re la t iv e  to the whole
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body, and the microscopic regions where there may be a breach in 
the b lood-re tina l b a r r ie r ,  i t  may be unreasonable to expect a 
strong stim ula tion of the immune system. Immunised animals, 
producing high t i t r e s  are usually  in jected with 30 to lOOpg of 
S-antigen, or ten fo ld  greater concentrations fo r  other re t in a l 
antigens (Section 1 .3 ), mixed 1:1 with CFA which nonspec if ica lly  
activates the immune system, thus fa c i l i t a t in g  a strong response to 
the immunogen. Linder these conditions the antigens are slowly 
released, providing exposure o f the immune system to the antigen 
over a period o f time, thus aiding the maturation o f the immune 
response.
The fa c t  tha t hyperimmunised DA rats u t i l is e d  fo r  monoclonal 
antibody generation, did not develop EAU, would suggest tha t a low 
t i t r e ,  such as those demonstrated by the 4 Campbell and one Wistar 
ra t ,  is not l i k e ly  to be immunopathogenic. However, the RCS rats 
may develop a breached b lood-re tina l b a rr ie r  (Caldwell and 
McLaughlin, 1984), which would in i  t a l l y  re su lt  in  the 
autosensitisa.tion, whereas the experimentally induced immune
response in the DA rats would have to cause a breach in th is
b a rr ie r  in order to in i t i a t e  EAU.
I f  a humoral immune response against the re tina was an important 
secondary development in the RCS ra t ,  i t  might be expected tha t the 
response would be more re ad ily  detectable, and the antibodies to be 
of higher a f f i n i t y  and present in a l l  ind iv idua ls  of every s tra in  
of the dystrophic ra t .
F in a l ly ,  i t  should be noted tha t heterologous (bovine) antigens
were used to screen the ra t  and human sera, and ce l l  cu ltu re
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supernatants, in the ELISA assays. Although strong evidence exists 
fo r  the conservation of S-antigen and opsin (Section 1.2.2) 
(O'Tousa et a K ,  1985), and probably other photoreceptor spec if ic  
antigens, the p o s s ib l i ty  remains tha t some antibodies recognised 
epitopes spec if ic  to the homologous antigen ( ie .  ra t  or human). 
This would re su lt  in a lower serum t i t r e  and also a decrease in the 
detected frequency o f pos it ive  primary immortalised B ce ll  clones.
IMMUNOCYTOCHEMICAL LOCALISATION WITH MONOCLONAL ANTIBODIES 
Lampson and Fisher (1985) recommend tha t in s itua tions  where a 
monoclonal antibody is  to be used to locate an antigen in a tissue 
sample, the homogenised tissue be f i r s t  immunoblotted to ensure 
that no crossreactive material is  present. The immunoblot o f the 
monoclonal antibody S2.4.C5 indicates high s p e c i f ic i t y  fo r  
S-antigen so tha t the immunocytochemical lo c a lis a t io n  is  
unambiguous. In addition to crude re t in a l extract and ROS, the 
antibody was tested against soluble extracts of several ra t  tissues 
and found negative in a l l  cases (Section 6 .3 .2 .1 ). The apparent 
high a f f i n i t y  of monoclonal antibody S2.4.C5, as suggested by i t s  
rapid reaction in the ELISA (Figure 6 .1 ), fu r th e r emphasised the 
s u i t a b i l i t y  of th is  antibody fo r  immunocytochemistry, at both l ig h t  
and electron microscopical levels (Polak and Van Noorden, 1984).
In addition to s p e c i f ic i t y ,  monoclonal antibodies o f fe r  a reduction 
of the background signal in e v ita b ly  present in polyclonal serum so 
tha t there is  no non-specific reaction outwith the main antigenic 
s ites . This study confirms such observations, since the 
lo ca lisa t io n  is very much be tte r defined with the monoclonal 
antibody in comparison to conventional antisera (Figure 7.1a,b; 7.4
and 7 .5 ) .
Monoclonal antibodies are generally assumed to be superior reagents 
fo r  immunocytochemical lo ca lisa t io n  of antigens because o f th e ir  
f ine  s p e c i f ic i ty .  However, even with these probes, unexpected 
immunocytochemical crossreactions are occasionally observed. A high 
a f f i n i t y  IgG antibody generally displays high s p e c i f ic i t y  and gives 
good lo c a lis a t io n ,  whereas IgM monoclonal antibodies sometimes 
generate ambivalent data (reviewed by Ghosh and Campbell, 1986). 
Consequently, the IgG class o f the S2.4.C5 antibody employed fo r
the lo ca lisa t io n  of S-antigen was a relevant con tr ibu to ry  fac to r  to 
the favourable signal to noise ra t io .  Such advantages were probably
also shared by the mouse IgG monoclonal antibodies o f Faure et a l . ,
1984; Mirshahi et a l . ,  1984; Mirshahi et a l . ,  1985 (Section 1 .2 .2 ). 
However, most IgM monoclonal antibodies probably do not crossreact, 
and many h igh ly  spec if ic  IgM antibodies have been generated. 
Antibody R1.2.D2 was an IgM antibody, which demonstrated spe c if ic  
c e l lu la r  lo ca lisa t io n  (Figures 7.4 and 7.17).
In a l l  immunohistochemical studies, s tr ingent contro ls are
essentia l, including a negative antibody con tro l. The most 
appropriate control fo r  a monoclonal antibody consists of an 
ir re le va n t monoclonal antibody, raised in the same species, o f the 
same class and used at the same concentration. Supernatants 
(concentrated or otherwise) or ascites from the hybridoma parent 
ce ll l in e  (eg. NS1 fo r  the mouse system or Y3-Ag.1.2.3 fo r  the ra t  
system) are inappropriate, since such ce l ls  are e ith e r  
non-secretors (NS1) or secrete only the immunoglobulin l i g h t  chain 
(Y3-Ag.1 .2 .3 ) . Thus, such samples do not provide the same amount o f 
antibody as do the experimental monoclonal antibodies.
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I t  is  often stated tha t immunohistochemistry requires a compromise 
between preservation of a n t ig e n ic i ty  and u ltra s tru c tu re  (Polak and 
Van Noorden, 1984). Frozen sections and techniques may re su lt  in a 
greater proportion o f native antigens. However, th is  is  not without 
considerable sa c r if ic e  in terms of u l t ra s tru c tu ra l preservation of 
membranes and organelles. L ight f ix a t io n  and low temperature 
embedding techniques fo r  electron immunocytochemistry, such as 
those employed by McKechnie et a K ,  (1986) and in the present 
study, gave r ise  to sa t is fa c to ry  preservation o f u l t ra s tru c tu re .  
The a n t ig e n ic i ty  o f S-antigen was also adequately maintained, as 
indicated by successful s ta in ing with a monoclonal antibody as well 
as with antiserum.
8.5.1 D is tr ibu t ion  of S-Antigen at the Light Microscopical level
S-antigen, extractable from mammalian photoreceptor rod outer 
segments, has been loca lised throughout the photoreceptor rod ce l ls  
by l ig h t  microscopy in an immunofluorescence procedure, using 
guinea pig antiserum to p u r i f ie d  S-antigen (Wacker et a l.. ,  1977).
The recent development of monoclonal antibodies to S-antigen has 
made more de fina tive  immunocytochemical lo ca lisa t io n  o f the protein 
possible. In th is  study, S-antigen was loca lised throughout the 
photoreceptor ce ll laye r, using monoclonal antibody S2.4.C5 (Figure
7.1) in a pattern s im ila r  to tha t observed by Wacker (1981). In 
addition to the re t in a ,  S-antigen has also been id e n t i f ie d  in the 
mammalian pineal gland, using s im ila r  techniques (Kalsow and 
Wacker, 1977; Korf et a l . ,  1985).
Monoclonal antibody technology has enabled the phylogenic 
d is t r ib u t io n  of d is t in c t  epitopes to be studied (Faure et a l . ,
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1984; Mirshahi et a l . ,  1984; Mirshahi et a l . ,  1985). These authors 
have detected epitopes of S-antigen in the photoreceptors and 
pinealocytes o f species from every class o f vertebrates, and in the 
photoreceptors o f certa in  invertebrates, using mouse IgG monoclonal 
antibodies and ra t  polyclonal antisera to S-antigen, in 
immunofluorescence techniques (Section 1 .2 .2). The ra t  monoclonal 
antibody S2.4.C5, u t i l is e d  in the present study, was raised and 
detected against bovine S-antigen, although the antibody appeared 
to recognise human, pig and ra t S-antigens equally w e ll .  I t  would 
be in te res ting  to fu r th e r  study the phylogenic d is t r ib u t io n  o f the
S2.4.C5 epitope.
I t  would be valuable to compare immunoblots o f extracts of 
photoreceptor c e l ls ,  and pineal organs, with the monoclonal 
antibodies o f Mirshahi et a l .  (1985). This would give information 
about the molecular weights of the re lated S-antigens, as well as 
ascertaining the s p e c i f ic i t y  of the monoclonals fo r  S-antigen. 
Cleveland mapping o f the d i f fe re n t  S-antigens, together with 
Cleveland b lo t t in g ,  would y ie ld  very in te res ting  information with 
respect to the extent of conservation of the S-antigen epitopes. I t  
is  possible tha t the proteins recognised by these mouse monoclonal 
antibodies were recognising epitopes on one or more re lated 
prote ins, which have a s im ila r  function to tha t o f S-antigen.
8.5.2 Effect o f F ixation Method
The present study, described in Section 7.1, has shown tha t 
d i f fe re n t  patterns o f sta in ing can be obtained fo r  S-antigen, with 
monoclonal antibody S2.4.C5, depending on the f ix a t iv e  employed. 
When the tissue was fixed in 70% alcohol, the prote in was loca lised 
throughout the en tire  photoreceptor c e l l ,  the peroxidase reaction
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appearing most intense w ith in  the ROS and the rod synapses (Figure 
7.1a,b). This is  s im ila r  to the d is t r ib u t io n  observed by Wacker et 
a l . (1977) and Wacker (1981) on unfixed frozen sections, with
antiserum in an immunofluorescence technique. However, in 
gluteraldehyde fixed tissue , S-antigen appeared to be la rg e ly  
confined to the ROS layer, with only a fa in t  reaction in the inner 
segments and synapses (Figure 7.2). The area around the 
photoreceptor ce l l  nuclei also appeared stained, although less 
in tensely than the ROS. Such a f ix a t iv e  e f fe c t ,  apparent at the 
electron microscopical level has been reported by others. 
Broekhuyse et a ] . ,  (1985b) suggested that S-antigen e a s i ly  moves
from i t s  s itua t ion  in the ROS, to the inner segment plasma 
membrane, during f ix a t io n  by immersion. I f  the antigen is  capable 
of th is  s h i f t  p r io r  to immobilisation by the f ix a t iv e ,  then i t  
might be capable of such a s h i f t ,  during dark adaptation in vivo 
(Section 8 .5 .3 ).
8.6.3 Localisation of S-Antigen under conditions o f L ight and Dark 
Adaptation
At the l ig h t  microscopical le v e l,  S-antigen in l ig h t  adapted, 
alcohol f ixed eyes was loca lised throughout the photoreceptor c e l l ,  
using both monoclonal and polyclonal antibodies (Section 7 .2 .1 .2 ) .  
The reaction in the ROS was more intense than in the inner segments
in a l l  specimens examined. However, in a 16 hour dark adapted
specimen (Section 7 .2 .1 .2 ), the immunoperoxidase reaction obtained 
in the inner segment appeared as intense as that in the ROS (Figure 
7.3b). These observations are very s im ila r  to those of Broekhuyse 
et a j.  (1985b), who used polyclonal antisera and immunofluorescence 
to loca lise  S-antigen in l ig h t  and dark adapted ra t  re tinae . I f  in
the dissected eye, S-antigen is  capable of d if fu s in g  from the ROS
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through the connecting c il ium  to the inner segment in the
re la t iv e ly  short time p r io r  to f ix a t io n  (Broekhuyse, et al_.,
1985b), the prote in might conceivably undergo such a migration 
under conditions o f long term dark adaptation (overn ight). This is  
in keeping with the theory tha t S-antigen becomes c lose ly  
associated with the disc membranes upon i l lu m in a t io n , and tha t the 
protein is  more eas ily  extractable from the ROS membranes in the 
absence o f l ig h t  (P f is te r  et a l . ,  1984; P f is te r  et a l . ,  1985).
In the context o f lo ca lisa t io n  in l ig h t  versus dark adapted
specimens of re tinae , i t  is  in te res ting  that Balkema and Drager
(1985) report a mouse monoclonal antibody which reacts w ith ROS in 
dark adapted, but not in l ig h t  adapted specimens. The antigen had 
not yet been id e n t i f ie d ,  but i t  was thought not to be rhodopsin. I t  
is also in te res ting  tha t two mouse monoclonal antibodies reactive 
against a h igh ly phosphorylated neurofilament subunit, reacted with 
l ig h t ,  but not dark adapted ROS (Balkema and Drager, 1985). These 
antibodies reacted with the amacrine, horizontal and ganglion ce l ls  
of the neural re t in a ,  irrespective  o f i l lu m in a t io n . At leas t one of 
the antibodies was found to crossreact with rhodopsin, presumably 
at the phosphorylation s ites (Balkema and Drager, 1985).
8.5.4 U1trastructural Localisation o f Retinal S-Antigen w ith in  the 
Rod Photoreceptor Cell '
Information concerning the d is t r ib u t io n  and precise lo c a l is a t io n  o f 
S-antigen w ith in  the photoreceptor ce l l  w i l l  aid the e luc ida tion  o f 
i t s  physiological ro le . Section 7.6 describes the electron 
immunocytochemical lo ca lisa t io n  of S-antigen on the ROS disc 
membranes of human and pig photoreceptors by means o f the h igh ly  
spec if ic  ra t IgG monoclonal antibody, raised to bovine S-antigen.
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Electron m icroscopica lly , i t  was possible to discern tha t the cone 
photoreceptors laked S-antigen (Figures 7.14a,b). This was in
agreement with the f ind ings of McKechnie et al.. (1986). At the 
u l t ra s tru c tu ra l le v e l,  monoclonal antibody S2.4 .C5, revealed tha t 
S-antigen was located throughout the photoreceptor c e l l ,  from the 
outer segment to the rod spherule, with the m a jo r ity  of the gold 
label concentrated on the rod disc membranes (Figures 7.7 and 
7.8a). Staining of the inner segments was less intense (Figure
7.8b). The perinuclear region was also f a i r l y  in tense ly  stained 
(Figure 7.13). The pattern o f sta in ing was consistent w ith the 
in te n s i ty  o f reaction of the monoclonal antibody in 
immunoperoxidase experiments at the l ig h t  microscopical le v e l.  This 
d is t r ib u t io n  is  not, perhaps, unexpected since the prote in  is
l i k e ly  to be synthesised in the perinuclear area, where the Golgi 
apparatus and rough endoplasmic reticulum are located, and 
transported through the inner segment, before i t s  incorporation 
in to  the outer segment. There is  biochemical evidence tha t the 
outer segment proteins are synthesised in the inner segment and 
transported to the base of the ROS fo r  th e i r  incorporation (Hall et 
a l . ,  1969; Young, 1971, 1974).
The protein has been loca lised at the electron microscopical le v e l,  
on ra t ROS disc membranes o f f ixed , frozen tissue (Broekhuyse et 
a l . ,  1985a) and on the ROS disc membranes o f f ixed  human re t ina  
(McKechnie et a l . ,  1986) using rabb it polyclonal antisera with 
prote in A-gold immunocytochemical techniques. Yajima et a j .  (1983) 
and Uusitalo et a_l. (1985) obtained sta in ing o f f ixed  rodent rod 
outer segment plasma and disc membranes, using conventional 
antisera and d ire c t  immunoperoxidase and peroxidase anti-peroxidase
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sta in ing procedures respective ly. In these studies, the la b e ll in g  
of the inner segments was less intense, in comparison with the ROS. 
The find ings were s im ila r  to those with the monoclonal antibody
S2.4.C5. The peroxidase techniques do not o f fe r  the advantage of 
re la t iv e  quantita t ion  which is possible with the immunogold and 
protein A-gold techniques. In add it ion , the peroxidase reaction 
product tends to obsure the underlying u lt ra s tru c tu re .  Yajima et 
a l . (1983) and Uusitalo et a l .  (1985) did not present any evidence
that the protein which they loca lised was, in fa c t ,  the S-antigen 
o r ig in a l ly  id e n t i f ie d  by Wacker (1973).
The method of pre-embedding immunoperoxidase sta in ing of tissue 
blocks, employed by Uusitalo et a l .  (1985), has the disadvantage of 
only a l im ited  penetration of the reagents, and the pattern of 
s ta in ing was very variab le . However, these authors were able to 
id e n t i fy  an intense reaction on the disc membranes. The choroid and 
RPE apparently remained unstained. The find ings were generally in 
agreement with the observations in th is  study, with the exception 
of the absence of a reaction in the cytoplasm of the outer nuclear 
layer, although the plasma membrane in th is  region was stained. 
This discrepancy might have resulted from the penetration problem 
experienced with the pre-embedding s ta in ing technique.
In the present study, there was no evidence of spe c if ic  la b e l l in g  
of the photoreceptor plasma membrane, in agreement w ith the 
observations of Broekhuyse et al.., (1985a) and McKechnie et a l . ,
(1986). The membrane around the photoreceptor ROS, however, was not 
as c le a r ly  preserved as the disc membranes. The absence o f plasma 
membrane decoration could be a r t i fa c tu a l ,  resu lt ing  from the 
deleterious e ffec ts  of tissue preparation, whether frozen or f ixed .
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The frozen section of a rod c e l l ,  stained with rabb it antiserum to 
S-antigen and prote in A-gold, presented by Broekhuyse et a l.  
(1985a) as showing l ig h t  plasma membrane stain ing in addition to 
predominant disc la b e l l in g ,  demonstrated poorer membrane 
preservation compared with the Lowicryl embedded tissue of 
McKechnie et a l .  (1986), also used in the present study. The 
in te rp re ta t io n  of a reaction in th is  area is  probably subjective. 
Possibly soluble membrane associated proteins l ik e  S-antigen, were 
more eas ily  leached from the plasma membrane p r io r  to complete 
f ix a t io n .
The reason fo r  the presence o f S-antigen throughout the 
photoreceptor c e l l ,  remains to be discovered. Some o f the S-antigen 
loca lised w ith in  the inner segment might be the re su lt  o f d if fu s io n  
from the outer segment before f ix a t io n ,  as suggested by Broekhuyse 
et a l-  (1985b). A l te rn a t iv e ly ,  i t  may re f le c t  a d i f fe re n t  mechanism 
of transport o f th is  soluble pro te in , compared to the insoluble 
prote ins, eg. rhodopsin, o f which l i t t l e  is detected w ith in  the 
inner segment using monoclonal antibodies (Hicks and Molday, 1986). 
I t  is also possible tha t the observed pattern of s ta in ing  is  
re lated to the rate of synthesis of S-antigen. Perhaps the answer 
l ie s  with more than one of these explanations. The presence of 
S-antigen w ith in  the photoreceptor synapses is  more d i f f i c u l t  to 
explain. I t  may have some, as yet un iden tif ied  function in th is  
area, or indeed w ith in  the inner segment also. Perhaps S-antigen is  
also involved in neurological s ign a ll ing  in photoreceptor rod 
c e l ls .  Further research in to  the physiological ro le  or roles o f 
th is  protein are required to answer these questions.
A ll previous studies on the lo ca lisa t io n  of S-antigen a t the
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u ltra s tru c tu ra l level have employed polyclonal antisera. The 
present work employed a monospecific monoclonal antibody, which
allowed the id e n t i f ic a t io n  of S-antigen w ith in  the photoreceptor
ce ll  and the RPE with greater ce r ta in ty .
8.6.5 Pattern of sta in ing w ith in  the ROS
The epitopes o f S-antigen recognised by the monoclonal antibody
S2.4.C5 and the polyclonal antisera , were apparently uniform ly 
exposed along the length of the ROS in human and pig specimens, as 
quantita tive  studies gave l i t t l e  ind ica tion  fo r  a graded la b e l l in g  
(Section 7.6). McKechnie et al_., (1986) observed d i f fe re n t ia l
la b e ll in g  of the proximal and apical regions o f the ROS. Such a
manifestation could also be an a r t i f a c t  of f ix a t io n  or serum
d i lu t io n .  S-antigen could leach from the ROS p r io r  to f ix a t io n ,  
resu lt ing  in a lower concentration of the p ro te in , perhaps 
especia lly  in the apical regions since in th is  tissue the RPE was 
not retained. This d i f fe re n t ia l  concentration, whether as a re su lt  
o f leaching of the soluble antigen, or a true property o f the ROS, 
might only be detected at certa in  d i lu t io n s  of the antiserum or 
monoclonal antibody. Perhaps in th is  study, the antibody was used 
at saturating conditions, and a lower concentration of the antibody 
might have given s im ila r  resu lts  as observed by McKechnie et a l .
(1986).
D if fe re n t ia l  expression o f the epitopes of S-antigen have been 
implicated at the l ig h t  microscopical le v e l,  using mouse monoclonal 
antibodies with immunofluorescence (Mirshahi et a l . . , 1985) and
radioimmunocytochemistry (Das et a l . ,  1984). Both these 
immunocytochemical techniques give r ise  to d i f f i c u l t i e s  w ith 
reso lu tion , making i t  d i f f i c u l t  to d is tingu ish  la b e l l in g  o f the
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plasma membrane from tha t of the ce l l  in te r io r ,  in a narrow ce ll 
l ik e  the photoreceptor. D if fe re n t ia l  long itud ina l expression is ,  
however, easier to discern.
Of the two monoclonal antibodies of Das et a l .  (1984), RSA1/83
apparently recognised an epitope o f S-antigen which is  d is tr ib u te d  
throughout the photoreceptor c e l ls .  The other monoclonal antibody, 
RSA2/83, p re fe re n t ia l ly  labelled the apical region o f the ROS. The 
monoclonal antibodies were applied as ascites f l u id ,  which 
generally contain high concentrations o f monoclonal antibody 
(Campbell, 1984). The control consisted of non-secreting NS1 
myeloma ascites. The radioimmunocytochemical technique appeared to 
give a very poor reso lu tion and a very high background with the NS1 
ascites con tro l,  which was v i r t u a l l y  ind is tingu ishable  from the 
reaction given by antibody RSA1/83. Apart from the d i f f i c u l t y  in 
the determination of the s p e c i f ic i t y  o f the reactions, a fu r th e r  
problem with these experiments was the use of bovine re t in a ,  w ith 
ascites f lu id  which could contain mouse antibody to the foeta l c a l f  
serum antigens, and thus could cause unwanted reactions.
In agreement with the observations presented in Section 7 .6 .1 , fo r  
monoclonal antibody S2.4 .C5, Mirshahi et a j . ,  (1985) found tha t in 
an in d ire c t  fluorescence technique, four of th e ir  monoclonal 
antibodies to S-antigen outlined the en tire  photoreceptor c e l l ,  
excluding the nucleus. A f i f t h  monoclonal antibody predominantly 
labelled the perinuclear area. The authors suggested tha t th is  
antibody was recognising an epitope of the native prote in  which 
became masked upon fu r th e r processing. A l te rn a t iv e ly ,  the antibody 
may have recognised a precursor molecule. Ir re leva n t monoclonal 
antibodies were employed as negative controls in th e i r  study.
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I t  is  also possible, however, tha t epitopes o f S-antigen are 
exposed d i f f e r e n t ia l l y  in d i f fe re n t  regions of the photoreceptor 
c e l l ,  eg. at the s i te  o f manufacture, or transport. The antigenic 
determinants of S-antigen may be d i f f e r e n t ia l l y  exposed along the 
ROS, perhaps as the discs age, or in preparation fo r  phagocytosis. 
McKechnie et a j . (1986), suggest tha t longitud inal d ifferences in 
antigenic expression may account fo r  some o f the morphological 
differences in EAU reported by d i f fe re n t  groups. I t  is  also 
possible tha t a binding protein is involved in the transport o f the 
protein from i t s  s i te  o f synthesis to the ROS base.
8.5.6 Fate of S-antigen w ith in  the RPE
In th is  study, S-antigen was also loca lised in the ROS phagosomes 
of the human pigment epithelium, but was absent in the other 
re t ina l ce l ls  and in the choroid. The presence o f gold s ta in ing
with monoclonal antibody S2.4.C5, in the phagosomes o f the pigment
epithelium, indicates that the epitope is  conserved a f te r  i n i t i a l  
phagocytosis (Figures 7. and 7 .a ,b ,c ) .  The survival o f the epitope 
recognised by antibody S2.4.C5 is  not surpris ing , in view o f the 
Cleveland b lo t t in g  resu lts  described in Section 6.4, where 
re a c t iv i ty  was detected a f te r  considerable digestion.
A recent study using rabb it polyclonal antisera w ith an 
immunoperoxidase sta in ing method, has suggested tha t S-antigen may 
be taken up by the RPE m ic ro v i l l i  during phagocytosis, and 
transported through the cytoplasm and the basal in fo ld ings o f the
RPE, across Bruch's membrane, to the endothelium o f the
ch o r io ca p il la r is  a f te r  a period o f 30 hours exposure to l ig h t  
(Yajima et a l . ,  1985). The re t in a l tissues used in the present
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study would have been l ig h t  adapted due to the il lum inated 
environment of d issection. S-antigen was not be detected in the 
region of Bruch's membrane or the c h o r io c a p i l la r is ,  and the 
immunogold sta in was confined to the phagocytosed membrane 
m ateria l, where i t  was apparently f u l l y  degraded. The retinae 
studied by Yajima et aK (1985) were derived from albino rabb its . A 
period o f 30 hours l ig h t  adaptation is  perhaps a l i t t l e  severe, 
especia lly  to the albino eye. I t  probably would be more re levant to 
fo llow  the fa te  of S-antigen w ith in  pigmented re t inae , w ith an 
immunogold rather than a peroxidase technique, to avoid a 
nonspecific deposition of the peroxidase substrate on the melanin, 
and to allow re la t iv e  quantita tion  of s ta in ing to be made w ith in  
each experiment.
8.6 LOCALISATION OF THE R1.2.D2 EPITOPE
The ra t IgM antibody, derived from an animal immunised w ith bovine 
ROS membranes, reacted with a protein with an apparent molecular 
weight of 37 to 39K in immunoblots, a f te r  SDS-PAGE (Figure 6 .8 ). I t  
is  possible tha t the antigen recognised by R1.2.D2 is  the alpha or 
beta subunit o f transducin, the photoreceptor G-protein. These 
subunits have molecular weights of approximately 39K and 36K, 
respective ly (see Shichi et a l.., 1984).
At the l ig h t  and electron microscopical leve ls , antibody R1.2.D2 
reacted with a s im ila r  pattern to tha t given by the ra t  an ti sera 
raised against ROS membranes. At the level o f the l ig h t  microscope, 
the photoreceptor ROS were in tensely stained, while the inner 
segment was v i r t u a l ly  devoid of the peroxidase reaction product
259
(Figure 7.4). In contrast to the lo ca lisa t io n  of S-antigen (Section 
8 .6 .3 ) , the pattern of s ta in ing appeared independent of 
i l lum ina t ion . Likewise, the lo ca lisa t io n  of opsin, using polyclonal 
ra t anti-ROS sera did not appear re lated to i l lu m in a t io n , in 
agreement with Broekhuyse et a l .  (1985b). Fekete and Barnstable
(1983) describe a mouse monoclonal antibody (Ret P2) which reacts 
p re fe re n t ia l ly  with the ROS in tissue sections, and with a 38K 
antigen in immunoblots, and was unreactive with opsin. Thus, the 
epitopes recognised by antibodies R1.2.D2 and Ret P2 might be 
presented on the same antigen.
Electron m icroscopica lly, the R1.2.D2 epitope was s im i la r ly  
d is tr ib u te d , with intense spec if ic  decoration of the disc membranes 
and very l i t t l e  label in the connecting c il ium  or inner segment 
(Figures 7.17b). This pattern of s ta in ing is  very s im ila r  to tha t 
reported fo r  rhodopsin, using a panel of mouse monoclonal 
antibodies (Hicks and Molday, 1986). However, no spec if ic  reaction 
was obtained with antibody R1.2.D2 in immunoblots against 
rhodopsin. The rod outer and inner segment plasma membrane might 
also have been labelled (Figures 7.19a,b). The pattern o f s ta in ing 
contrasted with tha t obtained fo r  S-antigen, where the e n t ire  rod 
photoreceptor was stained (Figure 7.7). There was no reaction with 
the R1.2.D2 antibody and the cone photoreceptors (Figures 7.20a,b).
At the electron microscopical le v e l,  some rods stained w ith R1.2.D2 
and immunogold, appeared s p e c i f ic a l ly  labelled at the edges o f the 
rods, perhaps reacting with the disc rims and/or the plasma 
membrane (Figures 7.19a,b). Further studies are required to 
determine the importance of th is  reaction, which may depend on the 
d i lu t io n  of the antibody. The re su lt  suggested, however, tha t there
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might be a re la tionsh ip  between the R1.2.D2 antigen and the 35K 
subunit of peripherin , a recently  described disc rim protein 
(Molday et a j . ,  1986). However, monoclonal antibodies to peripherin 
tend not to react with the lamellar regions of the discs (Molday et 
a l . ,  1986), and antibody R1.2.D2 c le a r ly  reacted in th is  region in 
most cases (Figures 7.17a,b and 7.18a).
8.7 FUTURE WORK
The ro le o f re t in a l antigens such as S-antigen in the development 
of human u v e i t is ,  RP or other ocular conditions of unknown 
aetio logy, remains to be established. A large well defined, double 
b l ind , longitud ina l study is  required. This should include numerous 
cases of well c la ss if ie d  u v e i t is ,  RP and possibly other conditions, 
and at least an equal number of contro ls . I t  would also be useful 
to include patients with established autoimmune disease, such as 
rheumatoid a r t h r i t i s .  A va r ie ty  of assays fo r  humoral and ce ll  
mediated assays should be used, with standardised and con tro lled  
conditions. I t  would be important to take blood samples from the 
subjects on d i f fe re n t  days and perhaps also at d i f fe re n t  times of 
the day, since the population of c irc u la t in g  ce l ls  seem to vary 
(BenEzra et a l . ,  1984; Hendricks and Fishman, 1986). The resu lts  
should be confirmed in separate labora tories. BenEzra et a l .  (1984) 
recommended that such a study be sponsored by a re levant 
organisation, fo r  example the RP Foundation, and monitored by a 
s c ie n t i f ic  body.
Although the investiga tion  suggested above is  the more important, 
i t  may be useful to fu r the r study the ro le  of the immune system in 
animal models of re t in a l dystrophy, especia lly  where n a tu ra l ly
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occurring, since i f  certa in  groups of ocular conditions, l ik e  RP, 
are found to involve abnormalities in the immune system, animals 
demonstrating s im ila r  immune responses, might provide suitable 
models.
Should spec if ic  re t in a l or choroidal autoimmune mechanisms be found 
to be important in certa in  subgroups o f RP or u v e i t is ,  then the 
human monoclonal antibody system might provide a useful tool fo r  
investiga ting  the ro le of humoral antibody, and in the 
id e n t i f ic a t io n  of the relevant antigens and th e i r  important 
epitopes. However, such a study might best be postponed u n t i l  the 
human monoclonal antibody technology has fu r th e r advanced. I t  may 
be possible to generate monoclonal autoantibodies from other 
s tra ins o f re t in a l dystrophic ra t ,  and mice, should they be found 
to demonstrate s ig n if ic a n t  re t in a l autoimmunity. The RCS ra t  
monoclonal antibodies generated in th is  study might recognise 
epitopes relevant in the human response. Further characterisation 
of these monoclonal autoantibodies, in th is  context, may prove to 
be of value.
I t  seems l i k e ly  tha t S-antigen is  in fa c t the ' 48K1 protein o f the 
re t in a , and binds to photoactivated disc membranes (P f is te r  et a l . ,  
1984; P f is te r  et a j . ,  1985). I t  is  possible tha t the p ro te in ,
S-antigen, is  no longer associated with the disc membranes in the 
absence of l ig h t  (P f is te r  _et aj . ,  1984; P f is te r  et al_., 1985). 
Future investigations using monoclonal antibody S2.4.C5 and 
immunogold, comparing the d is t r ib u t io n  of S-antigen under various 
degrees of l ig h t  and dark adapted re tinae , o f laboratory animals, 
might v e r i f y  th is  hypothesis at the electron microscopical le ve l.  
I f  S-antigen in te racts  with photoactivated rhodopsin, i t  would be
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in te res ting  to determine whether or not certa in anti-rhodopsin, or 
anti-transducin  antibodies might demonstrate a l ig h t  dependent 
reaction due e ith e r to a shared binding s i te  with S-antigen, or to 
s te r ic  hindrance caused by tha t prote in .
I t  would be in te res ting  to investigate the phylogenic d is t r ib u t io n  
of the epitopes o f monoclonal antibodies S2.4.C5 and R1.2.D2, in 
the various photoreceptor types and pineal s tructures. Studies, 
invo lv ing the lo ca lisa t io n  o f S-antigen and the 39K prote in  in  the 
developing photoreceptors, might also prove valuable. Such studies 
may be useful in fu r th e r determining the physiological ro le  of 
S-antigen and the 39K antigen, and may give some clues as to i t s  
lo ca lisa t io n  o f S-antigen w ith in  the rod synapse.
Studies are presently in progress, fu r the r inves tiga ting  the 
e ffec ts  o f monoclonal antibody S2.4.C5, in S-antigen induced EAU in 
rats and guinea pigs. The antibody has been found to exacerbate the 
disease in guinea pigs, but in ra ts , the development o f EAU was was 
in h ib ite d . The e f fe c t  o f antibody dose in EAU w i l l  be determined, 
in addition ‘ to the e f fe c t  of the time o f i t s  adm in is tra tion . I t  
w i l l  also be important to determine the effec ts  o f the monoclonal 
antibody alone, since i t  may be capable o f inducing EAU. Control 
experiments with ir re le va n t monoclonal antibodies should also be 
undertaken. I t  may be useful to id e n t i fy  and p u r i fy  the smallest 
fragment o f S-antigen, bearing the S2.4.C5 epitope, and investiga te  
i t s  ro le in EAU, probably a f te r  coupling to a c a r r ie r  p ro te in .
Further characterisation of the R1.2.D2 antibody, and the 
id e n t i f ic a t io n  o f the 39K antigen is  required. I t  might be possible 
to p u r i fy  the R1.2.D2 antigen using an a f f i n i t y  column with the
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monoclonal antibody. The p u r i f ie d  antigen could then be fu r the r 
characterised. S im ilar EAU studies w i l l  be possible with monoclonal 
antibody R1.2.D2, and the crude, or p u r if ie d  antigen.
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E P ILO ftllE
To me, we have been as M lth en ,
Ploying on the scn-shoro, 
a%nd diverting ourselves in  now and then 
Finding a smoother pebble or prettier shed than ordtnarg, 
W hilst the great ocean oj tru th  lag undiscovered bejore us.
Sir Isaac Newton 
1642-1727
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Table 4.1 ELISA Responses fo r Individual Campbell Rats
to S-Antigen, a t the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.112
0.473
0.035
0.140
0.013
0.113
0.001
0.103
0.021
0.020
0.014
0.035
0.008
0.049
0.001
0.029
0.010
0.066
Rat 2 SD 
Mean
0.018
0.095
0.009
0.061
0.013
0.039
0.001
0.034
0.008
0.068
0.001
0.050
0.001
0.065
0.008
0.071
0.000
0.097
Rat 3 SD 
Mean
0.005
0.291
0.010
0.114
0.001
0.087
0.056
0.066
0.012
0.025
0.002
0.001
0.004
0.011
0.008
0.034
0.005
0.033
Rat 4 SD 
Mean
0.014
0.254
0.019
0.154
0.006
0.100
0.003
0.100
0.019
0.100
0.033
0.115
0.007
0.045
0.005
0.050
0.007
0.086
Rat 5 SD 
Mean
0.020
0.289
0.004
0.182
0.006
0.058
0.029
0.068
0.021
0.059
0.000
0.031
0.025
0.068
0.020
0.083
0.011
0.076
Rat 6 SD 
Mean
0.020
0.296
0.010
0.114
0.001
0.074
0.001
0.053
0.028
0.031
0.011
0.018
0.013
0.009
0.011
0.013
0.006
0.016
Rat 7 SD 
Mean
0.024
0.505
0.008
0.217
0.003
0.122
0.011
0.057
0.030
0.044
0.011
0.051
0.013
0.056
0.022
0.039
0.025
0.045
Rat 8 SD 
Mean
0.002
0.121
0.024
0.041
0.009
0.015
0.013
0.009
0.007
0.019
0.006
0.018
0.014
0.014
0.001
0.021
0.008
0.026
Rat 9 SD 
Mean
0.012
0.145
0.011
0.049
0.024
0.018
0.009
0.031
0.000
0.027
0.009
0.034
0.044
0.086
0.009
0.048
0.004
0.043
Rat 10 SD 
Mean
0.026
0.399
0.016
0.152
0.012
0.052
0.007
0.024
0.000
0.000
0.013
0.009
0.008
0.008
0.010
0.007
0.011
0.022
Mean 0.287 0.122 0.068 0.054 0.039 0.036 0.041 0.040 0.051
SD 0.141 0.058 0.038 0.031 0.029 0.032 0.029 0.024 0.029
Range 0.095
0.505
0.041
0.217
0.015
0.122
0.009
0.103
0.000
0.100
0.001
0.115
0.008
0.086
0.007
0.083
0.016
0.097
Results for apparently unresponsive Rats 2 ,3 ,6 ,7 ,9  & 10
Mean 0.289 0.118 0.065 0.044 0.033 0.027 0.039 0.035 0.043
SD 0.153 0.062 0.037 0.017 0.023 0.021 0.034 0.023 0.029
Range 0.095
0.505
0.049
0.217
0.018
0.122
0.024
0.066
0.000
0.068
0.001
0.051
0.008
0.086
0.007
0.071
0.016
0.097
Table 4.2 ELISA Responses for Individual Campbell Rats
to S-antigen, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.123
1.594
0.057
0.570
0.011
0.255
0.018
0.158
0.007
0.103
0.035
0.103
0.026
0.109
0.033
0.114
0.030
0.114
Rat 2 SD 
Mean
0.083
0.220
0.005
0.072
0.006
0.049
0.006
0.040
0.017
0.043
0.006
0.035
0.002
0.028
0.013
0.033
0.009
0.069
Rat 3 SD 
Mean
0.003
0.376
0.010
0.133
0.020
0.105
0.016
0.092
0.030
0.082
0.010
0.080
0.027
0.083
0.018
0.133
0.013
0.061
Rat 4 SD 
Mean
0.013
1.444
0.018
0.894
0.040
0.551
0.006
0.261
0.076
0.122
0.033
0.071
0.018
0.065
0.023
0.056
0.016
0.047
Rat 5 SD 
Mean
0.016
0.250
0.008
0.163
0.019
0.144
0.005
0.120
0.012
0.128
0.012
0.123
0.008
0.135
0.001
0.043
0.003
0.084
Rat 6 SD 
Mean
0.072
0.518
0.004
0.232
0.012
0.129
0.002
0.042
0.025
0.072
0.016
0.031
0.008
0.018
0.011
0.028
0.016
0.020
Rat 7 SD 
Mean
0.015
0.450
0.017
0.165
0.054
0.076
0.010
0.007
0.001
0.008
0.028
0.039
0.030
0.026
0.003
0.020
0.016
0.016
Rat 8 SD 
Mean
0.021
1.553
0.189
0.769
0.048
0.311
0.008
0.109
0.016
0.033
0.004
0.029
0.013
0.009
0.018
0.023
0.016
0.011
Rat 9 SD 
Mean
0.088
0.532
0.062
0.155
0.053
0.052
0.033
0.024
0.029
0.020
0.045
0.032
0.042
0.030
0.058
0.042
0.064
0.057
Rat 10 SD 
Mean
0.054
0.204
0.031
0.097
0.019
0.031
0.016
0.012
0.018
0.013
0.000
0.000
0.000
0.000
0.002
0.001
0.006
0.004
Mean 0.714 0.325 0.170 0.086 0.063 0.054 0.050 0.049 0.048
SD 0.576 0.302 0.162 0.080 0.045 0.038 0.046 0.042 0.036
Range 0.204
1.594
0.072
0.894
0.031
0.551
0.007
0.261
0.008
0.128
0.000
0.123
0.000
0.135
0.001
0.133
0.004
0.114
Results for apparently unresponsive Rats 2 ,3 ,6 ,7 ,9  & 10
Mean 0.383 0.142 0.074 0.036 0.040 0.036 0.031 0.043 0.038
SD 0.144 0.056 0.037 0.031 0.031 0.026 0.028 0.046 0.028
»
Range 0.204
0.532
0.072
0.232
0.031
0.129
0.007
0.092
0.008
0.082
0.000
0.080
0.000
0.083
0.001
0.133
0.004
0.069
Table 4.3 ELISA Responses for Individual Campbell Rats
to S-Antigen, at the Age of 9 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.007
0.323
0.002
0.108
0.006
0.076
0.003
0.059
0.024
0.063
0.016
0.082
0.007
0.104
0.012
0.020
0.027
0.035
Rat 2 SD 
Mean
0.008
0.338
0.082
0.169
0.049
0.096
0.029
0.053
0.004
0.076
0.004
0.069
0.012
0.025
0.008
0.063
0.000
0.081
Rat 3 SD 
Mean
0.031
0.285
0.037
0.163
0.006
0.118
0.033
0.099
0.022
0.083
0.031
0.095
0.037
0.112
0.015
0.028
0.008
0.053
Rat 4 SD 
Mean
0.037
0.262
0.024
0.144
0.024
0.075
0.010
0.068
0.013
0.019
0.001
0.013
0.008
0.025
0.005
0.031
0.037
0.063
Rat 5 SD 
Mean
0.025
0.753
0.027
0.457
0.042
0.208
0.019
0.079
0.004
0.042
0.011
0.029
0.013
0.028
0.004
0.039
0.015
0.053
Rat 6 SD 
Mean
0.043
0.304
0.062
0.146
0.052
0.082
0.043
0.042
0.022
0.033
0.015
0.015
0.008
0.033
0.011
0.058
0.010
0.036
Rat 7 SD 
Mean
0.023
0.218
0.010
0.047
0.013
0.010
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 8 SD 
Mean
0.008
0.844
0.026
0.382
0.025
0.163
0.006
0.070
0.017
0.023
0.012
0.008
0.017
0.012
0.018
0.023
0.016
0.011
Rat 9 SD 
Mean
0.016
0.417
0.013
0.139
0.011
0.050
0.005
0.036
0.000
0.020
0.006
0.013
0.008
0.055
0.005
0.031
0.001
0.050
Rat 10 SD 
Mean
0.040
0.361
0.008
0.108
0.016
0.035
0.011
0.008
0.006
0.007
0.003
0.004
0.000
0.000
0.004
0.005
0.014
0.010
Mean 0.411 0.186 0.091 0.051 0.037 0.033 0.039 0.030 0.039
SD 0.213 0.129 0.059 0.031 0.029 0.035 0.040 0.020 0.026
Range 0.218
0.844
0.047
0.457
0.010
0.208
0.000
0.099
0.000
0.083
0.000
0.095
0.000
0.112
0.000
0.063
0.000
0.081
Results for apparently unresponsive Rats 2 ,3 , 6',7,9 & 10
Mean 0.321 0.129 0.065 0.040 0.037 0.033 0.038 0.031 0.038
SD 0.068 0.045 0.041 0.035 0.035 0.039 0.042 0.026 0.030
Range 0.218
0.417
0.047
0.169
0.010
0.118
0.000
0.099
0.000
0.083
0.000
0.095
0.000
0.112
0.000
0.063
0.000
0.081
Table 4.4 ELISA Responses for Individual Campbell Rats
to ROS, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.065
0.206
0.001
0.171
0.029
0.182
0.004
0.244
0.032
0.148
0.002
0.094
0.015
0.099
0.018
0.141
0.000
0.058
Rat 2 SD 
Mean
0.020
0.186
0.047
0.202
0.016
0.180
0.020
0.077
0.004
0.074
0.005
0.082
0.001
0.078
0.062
0.048
0.005
0.058
Rat 3 SD 
Mean
0.004
0.297
0.001
0.280
0.008
0.163
0.002
0.138
0.025
0.119
0.006
0.074
0.006
0.065
0.004
0.079
0.001
0.064
Rat 4 SD 
. Mean
0.037
0.290
0.032
0.227
0.020
0.153
0.008
0.129
0.006
0.084
0.003
0.037
0.049
0.061
0.027
0.077
0.002
0.077
Rat 5 SD 
Mean
0.020
0.266
0.040
0.194
0.016
0.133
0.000
0.121
0.001
0.094
0.016
0.087
0.006
0.087
0.052
0.059
0.007
0.014
Rat 6 SD 
Mean
0.006
0.295
0.005
0.127
0.025
0.086
0.043
0.068
0.010
0.049
0.007
0.051
0.017
0.079
0.016
0.054
0.016
0.073
Rat 7 SD 
Mean
0.001
0.226
0.002
0.145
0.027
0.127
0.002
0.103
0.007
0.068
0.011
0.045
0.000
0.098
0.030
0.061
0.010
0.051
Rat 8 SD 
Mean
0.014
0.232
0.006
0.243
0.001
0.190
0.002
0.195
0.019
0.117
0.017
0.053
0.011
0.058
0.008
0.031
0.003
0.030
Rat 9 SD 
Mean
0.027
0.235
0.035
0.224
0.027
0.133
0.003
0.117
0.001
0.082
0.028
0.066
0.044
0.055
0.006
0.037
0.013
0.015
Rat 10 SD 
Mean
0.001
0.450
0.017
0.279
0.005
0.167
0.013
0.088
0.010
0.057
0.004
0.021
0.000
0.001
0.007
0.005
0.004
0.015
Mean 0.268 0.209 0.151 0.128 0.089 0.061 0.068 0.059 0.045
SD 0.074 0.052 0.032 0.054 0.031 0.024 0.028 0.036 0.025
Range 0.186
0.450
0.127
0.280
0.086
0.190
0.068
0.244
0.049
0.148
0.021
0.094
0.001
0.099
0.005
0.141
0.014
0.077
Results for apparently unresponsive Rats 2,3 , 6,7 ,9 & 10
Mean 0.282 0.210 0.143 0.099 0.075 0.057 0.063 0.047 0.046
SD 0.093 0.065 0.034 0.026 0.025 0.022 0.034 0.025 0.025
Range 0.186
0.450
0.127
0.280
0.086
0.180
0.068
0.138
0.049
0.119
0.021
0.082
0.001
0.098
0.005
0.079
0.015
0.073
Table 4.5 ELISA Responses for Individual Campbell Rats
to ROS, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.033
0.753
0.009
0.480
0.018
0.274
0.055
0.260
0.004
0.233
0.018
0.163
0.030
0.146
0.043
0.065
0.003
0.078
Rat 2 SD 
Mean
0.006
0.314
0.001
0.157
0.006
0.106
0.003
0.066
0.003
0.045
0.021
0.082
0.006
0.041
0.001
0.068
0.018
0.030
Rat 3 SD 
Mean
0.045
0.454
0.046
0.287
0.056
0.256
0.015
0.170
0.001
0.082
0.031
0.054
0.049
0.113
0.001
0.083
0.001
0.094
Rat 4 SD 
Mean
0.049
0.840
0.010
0.615
0.001
0.422
0.016
0.488
0.019
0.263
0.010
0.134
0.002
0.148
0.001
0.068
0.020
0.050
Rat 5 SD 
Mean
0.032
0.369
0.035
0.154
0.016
0.149
0.005
0.087
0.004
0.084
0.006
0.057
0.004
0.149
0.002
0.062
0.002
0.076
Rat 6 SD 
Mean
0.029
0.227
0.008
0.137
0.058
0.167
0.032
0.149
0.007
0.059
0.013
0.080
0.003
0.044
0.001
0.041
0.016
0.052
Rat 7 SD 
Mean
0.013
0.328
0.028
0.161
0.011
0.138
0.010
0.126
0.002
0.111
0.001
0.104
0.006
0.087
0.008
0.089
0.008
0.082
Rat 8 SD 
Mean
0.005
0.353
0.016
0.277
0.133
0.256
0.004
0.165
0.004
0.104
0.045
0.045
0.017
0.058
0.033
0.076
0.001
0.097
Rat 9 SD 
Mean
0.011
0.455
0.031
0.269
0.030
0.210
0.015
0.134
0.011
0.043
0.004
0.054
0.005
0.028
0.047
0.065
0.001
0.077
Rat 10 SD 
Mean
0.003
0.258
0.048
0.118
0.042
0.058
0.043
0.033
0.057
0.040
0.000
0.000
0.000
0.000
0.000
0.000
0.010
0.007
Mean 0.435 0.266 0.204 0.168 0.106 0.077 0.081 0.062 0.064
SD 0.205 0.164 0.104 0.129 0.079 0.047 0.055 0.025 0.029
Range 0.227
0.840
0.118
0.615
0.058
0.422
0.033
0.488
0.400
0.263
0.000
0.163
0.000
0.149
0.000
0.089
0.007
0.097
Results for apparently unresponsive Rats 2 ,3 ,6 ,7 ,9  & 10
Mean 0.339 0.188 0.156 0.113 0.063 0.062 0.052 0.058 0.057
SD 0.096 0.071 0.071 0.052 0.028 0.036 0.041 0.033 0.034
Range 0.227
0.455
0.118
0.287
0.058
0.256
0.033
0.170
0.040
0.111
0.000
0.104
0.000
0.113
0.000
0.089
0.007
0.094
Table 4.6 ELISA Responses for Individual Campbell Rats
to ROS, at the Age of 9 Weeks 
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.028
0.274
0.005
0.294
0.060
0.253
0.020
0.178
0.037
0.155
0.024
0.074
0.005
0.065
0.019
0.061
0.002
0.048
Rat 2 SD 
Mean
0.018
0.205
0.065
0.153
0.010
0.090
0.011
0.084
0.004
0.084
0.010
0.080
0.023
0.055
0.007
0.052
0.006
0.046
Rat 3 SD 
Mean
0.019
0.272
0.022
0.220
0.016
0.170
0.016
0.113
0.009
0.056-
0.011
0.065
0.004
0.033
0.002
0.037
0.018
0.045
Rat 4 SD 
Mean
0.005
0.267
0.011
0.122
0.001
0.092
0.006
0.082
0.025
0.070
0.001
0.071
0.011
0.045
0.015
0.045
0.009
0.042
Rat 5 SD 
Mean
0.017
0.291
0.052
0.237
0.024
0.134
0.012
0.119
0.004
0.056
0.013
0.084
0.011
0.079
0.015
0.045
0.011
0.059
Rat 6 SD 
Mean
0.013
0.226
0.018
0.170
0.008
0.086
0.011
0.090
0.012
0.079
0.002
0.087
0.005
0.082.
0.002
0.086
0.036
0.061
Rat 7 SD 
Mean
0.019
0.316
0.044
0.246
0.006
0.105
0.000
0.082
0.003
0.043
0.003
0.040
0.008
0.042
0.007
0.045
0.035
0.071
Rat 8 SD 
Mean
0.035
0.244
0.004
0.185
0.004
0.066
0.001
0.088
0.012
0.068
0.001
0.085
0.026
0.062
0.028
0.056
0.000
0.044
Rat 9 SD 
Mean
0.183
0.348
0.039
0.133
0.003
0.055
0.016
0.073
0.028
0.052
0.001
0.052
0.004
0.079
0.002
0.089
0.003
0.032
Rat 10 SD 
Mean
0.001
0.477
0.001
0.200
0.004
0.124
0.011
0.079
0.006
0.043
0.004
0.022
0.004
0.013
0.000
0.000
0.008
0.005
Mean 0.292 0.196 0.118 0.099 0.071 0.066 0.056' 0.052 0.045
SD 0.077 0.054 0.058 0.031 0.033 0.022 0.022 0.025 0.018
Range 0.205
0.477
0.122
0.294
0.055
0.253
0.073
0.178
0.043
0.155
0.022
0.087
0.013
0.082
0.000
0.089
0.005
0.071
Results for apparently unresponsive Rats 2 ,3 ,6 ,7 ,9  & 10
Mean 0.307 0.187 0.105 0.087 0.060 0.058 0.051 0.052 0.043
SD 0.099 0.043 0.039 0.014 0.018 0.025 0.027 0.033 0.023
Range 0.205
0.477
0.133
0.246
0.055
0.170
0.073
0.113
0.043
0.084
0.022
0.087
0.013
0.082
0.000
0.089
0.005
0.071
Table 4.7 ELISA Responses for Individual Hunter Rats
to S-Antigen, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.018
0.511
0.004
0.205
0.014
0.163
0.001
0.092
0.006
0.038
0.008
0.017
0.026
0.061
0.019
0.079
0.005
0.083
Rat 2 SD 
Mean
0.010
0.197
0.007
0.170
0.010
0.184
0.012
0.063
0.030
0.049
0.010
0.061
0.001
0.069
0.006
0.069
0.017
0.075
Rat 3 SD 
Mean
0.007
0.139
0.009
0.046
0.018
0.018
0.018
0.013
0.001
0.014
0.010
0.014
0.004
0.009
0.011
0.014
0.006
0.009
Rat 4 SD 
Mean
0.023
0.402
0.034
0.210
0.030
0.109
0.007
0.061
0.011
0.046
0.006
0.050
0.023
0.047
0.002
0.080
0.008
0.035
Rat 5 SD 
Mean
0.011
0.161
0.006
0.104
0.018
0.043
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.001
0.006
Rat 6 SD 
Mean
0.132
0.619
0.037
0.328
0.052
0.275
0.055
0.184
0.031
0.152
0.030
0.127
0.006
0.122
0.022
0.092
0.041
0.044
Rat 7 SD 
Mean
0.004
0.177
0.007
0.124
0.008
0.082
0.006
0.013
0.008
0.006
0.006
0.004
0.000
0.000
0.001
0.001
0.003
0.008
Rat 8 SD 
Mean
0.004
0.199
0.014
0.120
0.009
0.126
0.018
0.115
0.005
0.094
0.011
0.013
0.014
0.032
0.000
0.094
0.004
0.024
Rat 9 SD 
Mean
0.028
0.453
0.013
0.215
0.018
0.121
0.040
0.068
0.001
0.048
0.002
0.042
0.008
0.011
0.007
0.005
0.000
0.000
Rat 10 SD 
Mean
0.004
0.168
0.014
0.086
0.013
0.064
0.000
0.037
0.010
0.057
0.009
0.083
0.002
0.056
0.004
0.063
0.011
0.059
Mean 0.303 0.161 0.119 0.065 0.050 0.041 0.041 0.050 0.034
SD 0.176 0.082 0.075 0.056 0.045 0.041 0.039 0.040 0.030
Range 0.139
0.619
0.046
0.328
0.018
0.275
0.000
0.184
0.000
0.152
0.000
0.127
0.000
0.122
0.000
0.094
0.000
0.083
Table 4.8 ELISA Responses for Individual Hunter Rats
to S-Antigen, at the Age of 6 Weeks
20 40
Serum Dilution 
80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.016
0.284
0.018
0.177
0.011
0.153
0.048
0.095
0.004
0.056
0.029
0.053
0.025
0.018
0.019
0.070
0.052
0.059
Rat 2 SD 
Mean
0.001
0.219
0.003
0.167
0.023
0.106
0.022
0.095
0.035
0.027
0.008
0.045
0.058
0.041
0.020
0.035
0.032
0.022
Rat 3 SD 
Mean
0.069
0.496
0.025
0.151
0.022
0.093
0.007
0.034
0.002
0.013
0.009
0.031
0.023
0.033
0.011
0.040
0.013
0.039
Rat 4 SD 
Mean
0.018
0.136
0.033
0.052
0.000
0.042
0.007
0.015
0.018
0.033
0.021
0.024
0.006
0.044
0.033
0.046
0.004
0.054
Rat 5 SD 
Mean
0.029
0.144
0.049
0.087
0.045
0.034
0.019
0.014
0.013
0.009
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.014
0.332
0.006
0.225
0.040
0.176
0.039
0.141
0.044
0.148
0.035
0.151
0.005
0.094
0.000
0.084
0.008
0.071
Rat 7 SD 
Mean
0.015
0.148
0.006
0.037
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 8 SD 
Mean
0.056
0.924
0.004
0.278
0.001
0.173
0.012
0.176
0.016
0.042
0.011
0.049
0.001
0.045
0.013
0.050
0.023
0.065
Rat 9 SD 
Mean
0.042
0.307
0.016
0.180
0.026
0.093
0.021
0.073
0.008
0.052
0.023
0.016
0.007
0.021
0.000
0.000
0.000
0.000
Rat 10 SD 
Mean
0.008
0.079
0.000
0.065
0.001
0.013
0.053
0.041
0.016
0.049
0.021
0.059
0.008
0.053
0.036
0.037
0.012
0.045
Mean 0.307 0.142 0.088 0.068 0.043 0.043 0.035 0.036 0.036
SD 0.249 0.079 0.065 0.058 0.042 0.043 0.028 0.029 0.028
Range 0.079
0.924
0.037
0.278
0.000
0.176
0.000
0.176
0.000
0.148
0.000
0.151
0.000
0.094
0.000
0.084
0.000
0.071
Table 4.9 ELISA Responses for Individual Hunter Rats
to S-Antigen, at the Age of 9 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.023
0.395
0.028
0.167
0.010
0.128
0.014
0.176
0.004
0.090
0.013
0.065
0.023
0.090
0.015
0.056
0.004
0.039
Rat 2 SD 
Mean
0.004
0.106
0.022
0.065
0.002
0.081
0.017
0.056
0.022
0.103
0.003
0.122
0.018
0.071
0.002
0.087
0.007
0.077
Rat 3 SD 
Mean
0.004
0.596
0.030
0.202
0.037
0.113
0.020
0.068
0.015
0.048
0.009
0.031
0.023
0.033
0.011
0.040
0.007
0.035
Rat 4 SD 
Mean
0.054
0.395
0.011
0.168
0.013
0.080
0.010
0.061
0.038
0.093
0.067
0.071
0.041
0.086
0.007
0.062
0.023
0.073
Rat 5 SD 
Mean
0.000
0.165
0.000
0.121
0.000
0.066
0.000
0.027
0.000
0.018
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.006
Rat 6 SD 
Mean
0.000
0.124
0.000
0.052
0.000
0.003
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 7 SD 
Mean
0.000
0.439
0.000
0.255
0.000
0.171
0.000
0.168
0.000
0.171
0.000
0.149
0.000
0.039
0.000
0.122
0.000
0.083
Rat 8 SD 
Mean
0.000
0.475
0.000
0.364
0.000
0.209
0.000
0.202
0.000
0.166
0.000
0.149
0.000
0.086
0.000
0.051
0.000
0.064
Rat 9 SD 
Mean
0.000
0.050
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.004
0.000
0.000
0.000
0.000
0.000
0.000
Rat 10 SD 
Mean
0.000
0.044
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.001
0.000
0.000
0.000
0.000
0.000
0.002
0.000
0.002
Mean 0.279 0.139 0.085 0.076 0.069 0.059 0.041 0.042 0.038
SD 0.202 0.116 0.072 0.078 0.066 0.062 0.040 0.042 0.034
Range 0.044
0.056
0.000
0.364
0.000
0.209
0.000
0.202
0.000
0.171
0.000
0.149
0.000
0.090
0.000
0.122
0.000
0.083
Table 4.10 ELISA Responses fo r Individual Hunter Rats
to ROS, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.024
0.383
0.005
0.247
0.006
0.253
0.012
0.122
0.005
0.128
0.002
0.103
0.011
0.080
0.001
0.071
0.028
0.037
Rat 2 SD 
Mean
0.053
0.409
0.003
0.301
0.029
0.250
0.019
0.170
0.002
0.168
0.028
0.042
0.001
0.055
0.028
0.050
0.009
0.088
Rat 3 SD 
Mean
0.021
0.261
0.001
0.173
0.013
0.133
0.001
0.108
0.011
0.076
0.002
0.087
0.020
0.048
0.018
0.063
0.004
0.053
Rat 4 SD 
Mean
0.059
0.439
0.027
0.324
0.004
0.269
0.042
0.136
0.035
0.125
0.010
0.086
0.018
0.034
0.001
0.071
0.028
0.068
Rat 5 SD 
Mean
0.016
0.108
0.001
0.050
0.013
0.015
0.004
0.006
0.000
0.000
0.006
0.004
0.000
0.000
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.011
0.557
0.021
0.491
0.000
0.346
0.013
0.271
0.006
0.189
0.006
0.153
0.014
0.145
0.011
0.016
0.016
0.024
Rat 7 SD 
Mean
0.007
0.355
0.011
0.214
0.009
0.108
0.000
0.054
0.012
0.013
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 8 SD 
Mean
0.008
0.089
0.014
0.089
0.022
0.106
0.018
0.094
0.027
0.113
0.008
0.136
0.007
0.068
0.003
0.022
0.007
0.061
Rat 9 SD 
Mean
0.028
0.415
0.034
0.389
0.031
0.249
0.007
0.168
0.028
0.150
0.016
0.095
0.001
0.084
0.004
0.015
0.018
0.066
Rat 10 SD 
Mean
0.051
0.576
0.029
0.404
0.177
0.381
0.040
0.150
0.001
0.065
0.016
0.060
0.033
0.065
0.035
0.061
0.031
0.065
Mean 0.359 0.268 0.211 0.128 0.103 0.077 0.058 0.037 0.046
SD 0.165 0.141 0.116 0.072 0.063 0.051 0.043 0.029 0.030
Range 0.089
0.576
0.050
0.491
0.015
0.381
0.006
0.271
0.000
0.189
0.000
0.153
0.000
0.145
0.000
0.071
0.000
0.088
Table 4.11 ELISA Responses for Individual Hunter Rats
to ROS, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.036
0.253
0.029
0.153
0.018
0.187
0.006
0.094
0.002
0.064
0.008
0.067
0.016
0.088
0.008
0.060
0.006
0.026
Rat 2 SD 
Mean
0.005
0.275
0.013
0.175
0.040
0.167
0.006
0.095
0.001
0.088
0.028
0.059
0.006
0.070
0.011
0.051
0.016
0.059
Rat 3 SD 
Mean
0.031
0.236
0.023
0.134
0.015
0.095
0.016
0.076
0.033
0.093
0.017
0.062
0.007
0.093
0.004
0.071
0.019
0.081
Rat 4 SD 
Mean
0.013
0.302
0.013
0.217
0.008
0.183
0.003
0.165
0.004
0.079
0.008
0.071
0.011
0.053
0.001
0.058
0.004
0.059
Rat 5 SD 
Mean
0.028
0.033
0.008
0.006
0.004
0.002
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.011
0.230
0.014
0.178
0.049
0.160
0.018
0.076
0.018
0.066
0.011
0.061
0.002
0.048
0.005
0.048
0.004
0.018
Rat 7 SD 
Mean
0.008
0.035
0.001
0.019
0.000
0.003
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 8 SD 
Mean
0.015
0.273
0.007
0.214
0.018
0.164
0.000
0.117
0.016
0.045
0.017
0.037
0.004
0.031
0.011
0.034
0.019
0.026
Rat 9 SD 
Mean
0.033
0.279
0.005
0.151
0.008
0.184
0.034
0.066
0.033
0.055
0.006
0.061
0.001
0.095
0.011
0.076
0.004
0.022
Rat 10 SD 
Mean
0.016
0.317
0.020
0.267
0.024
0.154
0.028
0.140
0.002
0.083
0.023
0.046
0.004
0.063
0.027
0.065
0.016
0.047
Mean 0.223 0.151 0.130 0.083 0.057 0.047 0.054 0.046 0.034
SD 0.103 0.083 0.072 0.053 0.034 0.026 0.035 0.027 0.027
Range 0.033
0.317
0.006
0.267
0.002
0.187
0.000
0.165
0.000
0.093
0.000
0.071
0.000
0.095
0.000
0.076
0.000
0.081
Table 4.12 ELISA Responses for Individual Hunter Rats
to ROS, at the Age of 9 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.018
0.280
0.010
0.170
0.005
0.194
0.008
0.077
0.015
0.066
0.006
0.065
0.006
0.028
0.006
0.024
0.001
0.019
Rat 2 SD 
Mean
0.039
0.277
0.006
0.215
0.011
0.114
0.023
0.065
0.003
0.039
0.003
0.052
0.008
0.090
0.011
0.018
0.023
0.049
Rat 3 SD 
Mean
0.018
0.255
0.003
0.157
0.000
0.146
0.032
0.119
0.006
0.099
0.013
0.083
0.001
0.065
0.008
0.077
0.018
0.052
Rat 4 SD 
Mean
0.014
0.383
0.005
0.277
0.025
0.182
0.013
0.153
0.006
0.091
0.016
0.075
0.013
0.075
0.017
0.084
0.025
0.054
Rat 5 SD 
Mean
0.016
0.108
0.001
0.050
0.013
0.015
0.004
0.006
0.000
0.000
0.006
0.004
0.000
0.000
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.011
0.358
0.049
0.241
0.004
0.143
0.013
0.071
0.006
0.089
0.006
0.053
0.014
0.045
0.011
0.016
0.002
0.034
Rat 7 SD 
Mean
0.013
0.095
0.011
0.033
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 8 SD 
Mean
0.001
0.301
0.003
0.195
0.027
0.125
0.013
0.064
0.006
0.040
0.012
0.021
0.001
0.014
0.002
0.037
0.009
0.022
Rat 9 SD 
Mean
0.008
0.266
0.009
0.215
0.027
0.148
0.007
0.104
0.022
0.077
0.009
0.093
0.004
0.093
0.025
0.071
0.017
0.079
Rat 10 SD 
Mean
0.004
0.310
0.030
0.237
0.013
0.176
0.011
0.086
0.000
0.080
0.006
0.054
0.011
0.081
0.006
0.071
0.002
0.058
Mean 0.263 0.179 0.124 0.075 0.058 0.050 0.049 0.040 0.037
SD 0.094 0.081 0.066 0.047 0.037 0.032 0.036 0.033 0.026
Range 0.095
0.383
0.033
0.277
0.000
0.194
0.000
0.153
0.000
0.099
0.000
0.093
0.000
0.093
0.000
0.084
0.000
0.079
Table 4.13 ELISA Responses for Individual PVG Rats
to S-Antigen, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.004
0.100
0.009
0.037
0.009
0.015
0.011
0.035
0.013
0.031
0.021
0.039
0.010
0.051
0.041
0.054
0.002
0.071
Rat 2 SD 
Mean
0.006
0.129
0.028
0.078
0.002
0.024
0.009
0.006
0.001
0.001
0.001
0.001
0.000
0.000
0.000
0.000
0.000
0.000
Rat 3 SD 
Mean
0.006
0.357
0.015
0.197
0.088
0.099
0.006
0.124
0.005
0.071
0.001
0.065
0.034
0.072
0.012
0.050
0.003
0.066
Rat 4 SD 
Mean
0.004
0.198
0.037
0.126
0.004
0.065
0.004
0.065
0.005
0.061
0.017
0.063
0.008
0.018
0.006
0.058
0.002
0.041
Rat 5 SD 
Mean
0.024
0.258
0.004
0.149
0.030
0.121
0.006
0.054
0.006
0.004
0.006
0.004
0.002
0.001
0.003
0.002
0.004
0.003
Rat 6 SD 
Mean
0.017
0.183
0.001
0.111
0.004
0.074
0.042
0.040
0.001
0.001
0.000
0.000
0.000
0.000
0.000
0.000
0.001
0.001
Rat 7 SD 
Mean
0.008
0.284
0.001
0.137
0.007
0.094
0.011
0.037
0.006
0.049
0.001
0.024
0.001
0.092
0.003
0.057
0.018
0.042
Rat 8 SD 
Mean
0.019
0.267
0.015
0.138
0.001
0.053
0.018
0.034
0.016
0.033
0.004
0.008
0.008
0.006
0.001
0.006
0.006
0.015
Rat 9 SD 
Mean
0.017
0.156
0.001
0.071
0.009
0.037
0.011
0.027
0.018
0.016
0.010
0.014
0.004
0.014
0.016
0.016
0.009
0.010
Rat 10 SD 
Mean
0.006
0.282
0.027
0.156
0.029
0.163
0.004
0.124
0.009
0.024
0.002
0.013
0.040
0.028
0.003
0.020
0.020
0.014
Mean 0.222 0.120 0.075 0.055 0.029 0.023 0.028 0.026 0.026
SD 0.081 0.047 0.046 0.040 0.025 0.024 0.033 0.025 0.027
Range 0.100
0.357
0.037
0.197
0.015
0.163
0.006
0.124
0.001
0.071
0.000
0.065
0.000
0.092
0.000
0.058
0.000
0.071
Table 4.14 ELISA Responses for Individual PVG Rats
to S-Antigen, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.004
0.111
0.017
0.068
0.002
0.039
0.009
0.034
0.000
0.044
0.001
0.068
0.012
0.071
0.004
0.023
0.001
0.022
Rat 2 SD 
Mean
0.013
0.082
0.002
0.045
0.030
0.031
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 3 SD 
Mean
0.028
0.171
0.008
0.058
0.030
0.057
0.047
0.061
0.019
0.022
0.008
0.047
0.009
0.075
0.002
0.060
0.002
0.045
Rat 4 SD 
Mean
0.002
0.154
0.004
0.057
0.003
0.038
0.006
0.033
0.004
0.028
0.004
0.011
0.026
0.046
0.006
0.058
0.029
0.068
Rat 5 SD 
Mean
0.001
0.023
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.005
0.003
0.001
0.001
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.013
0.016
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 7 SD 
Mean
0.022
0.299
0.009
0.180
0.015
0.058
0.007
0.066
0.006
0.094
0.003
0.043
0.004
0.045
0.007
0.031
0.001
0.005
Rat 8 SD 
Mean
0.004
0.090
0.016
0.049
0.004
0.020
0.008
0.005
0.000
0.000
0.000
0.000
0.004
0.003
0.000
0.000
0.000
0.000
Rat 9 SD 
Mean
0.002
0.109
0.001
0.052
0.001
0.034
0.002
0.016
0.003
0.002
0.001
0.001
0.004
0.007
0.004
0.004
0.007
0.005
Rat 10 SD 
Mean
0.002
0.165
0.065
0.069
0.044
0.053
0.047
0.048
0.035
0.063
0.035
0.025
0.000
0.000
0.030
0.022
0.007
0.074
Mean 0.122 0.058 0.033 0.026 0.025 0.020 0.025 0.020 0.022
SD 0.082 0.050 0.021 0.026 0.033 0.025 0.031 0.024 0.029
Range 0.016
0.299
0.000
0.180
0.000
0.058
0.000
0.066
0.000
0.094
0.000
0.068
0.000
0.075
0.000
0.060
0.000
0.074
Table 4.15 ELISA Responses for Individual PVG Rats
to S-Antigen, at the Age of 9 Weeks .
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.054
0.166
0.044
0.109
0.039
0.062
0.030
0.051
0.047
0.065
0.037
0.068
0.015
0.082
0.022
0.084
0.001
0.071
Rat 2 SD 
Mean
0.029
0.158
0.013
0.065
0.011
0.042
0.011
0.008
0.022
0.016
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 3 SD 
Mean
0.016
0.282
0.026
0.257
0.008
0.161
0.018
0.075
0.004
0.112
0.007
0.087
0.008
0.095
0.045
0.063
0.007
0.067
Rat 4 SD 
Mean
0.007
0.178
0.013
0.082
0.013
0.072
0.000
0.038
0.001
0.055
0.008
0.075
0.008
0.089
0.001
0.084
0.008
0.087
Rat 5 SD 
Mean
0.010
0.051
0.008
0.059
0.000
0.000
0.025
0.018
0.021
0.015
0.006
0.004
0.000
0.000
0.000
0.000
0.000
0.000
Rat 6 SD 
Mean
0.020
0.014
0.071
0.050
0.040
0.029
0.018
0.013
0.019
0.014
0.021
0.015
0.006
0.007
0.007
0.006
0.014
0.010
Rat 7 SD 
Mean
0.008
0.326
0.007
0.190
0.000
0.115
0.001
0.081
0.001
0.082
0.012
0.076
0.007
0.079
0.016
0.058
0.009
0.076
Rat 8 SD 
Mean
0.028
0.203
0.028
0.118
0.003
0.098
0.048
0.034
0.028
0.020
0.023
0.016
0.013
0.009
0.028
0.020
0.035
0.025
Rat 9 SD 
Mean
0.019
0.144
0.021
0.075
0.016
0.058
0.020
0.027
0.019
0.014
0.006
0.017
0.016
0.028
0.005
0.020
0.003
0.004
Rat 10 SD 
Mean
0.028
0.583
0.033
0.299
0.042
0.116
0.054
0.038
0.006
0.058
0.006
0.074
0.000
0.000
0.000
0.000
0.016
0.011
Mean 0.211 0.130 0.075 0.038 0.045 0.043 0.039 0.033 0.035
SD 0.161 0.088 0.048 0.025 0.035 0.035 0.042 0.035 0.036
Range 0.014
0.583
0.050
0.299
0.000
0.161
0.008
0.081
0.014
0.112
0.000
0.087
0.000
0.095
0.000
0.084
0.000
0.087
Table 4.16 ELISA Responses for Individual PVG Rats
to ROS, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.013
0.205
0.024
0.200
0.002
0.193
0.011
0.127
0.001
0.096
0.001
0.090
0.006
0.061
0.045
0.066
0.008
0.032
Rat 2 SD 
Mean
0.016
0.294
0.021
0.160
0.001
0.110
0.010
0.092
0.001
0.094
0.001
0.071
0.023
0.073
0.018
0.076
0.044
0.057
Rat 3 SD 
Mean
0.041
0.228
0.036
0.069
0.015
0.050
0.004
0.085
0.013
0.071
0.022
0.065
0.000
0.088
0.000
0.098
0.004
0.041
Rat 4 SD 
Mean
0.030
0.224
0.006
0.193
0.004
0.061
0.010
0.059
0.030
0.071
0.039
0.056
0.004
0.024
0.002
0.082
0.013
0.039
Rat 5 SD 
Mean
0.013
0.215
0.013
0.109
0.003
0.073
0.001
0.093
0.001
0.087
0.002
0.092
0.024
0.055
0.004
0.042
0.011
0.067
Rat 6 SD 
Mean
0.023
0.224
0.021
0.163
0.004
0.072
0.006
0.047
0.017
0.079
0.001
0.093
0.015
0.062
0.016
0.026
0.023
0.046
Rat 7 SD 
Mean
0.006
0.215
0.017
0.124
0.011
0.102
0.012
0.087
0.028
0.052
0.011
0.055
0.004
0.035
0.028
0.061
0.039
0.056
Rat 8 SD 
Mean
0.016
0.259
0.025
0.160
0.004
0.108
0.008
0.063
0.004
0.041
0.002
0.062
0.035
0.056
0.004
0.039
0.002
0.054
Rat 9 SD 
Mean
0.022
0.190
0.016
0.151
0.007
0.110
0.028
0.070
0.011
0.070
0.036
0.062
0.025
0.069
0.021
0.053
0.028
0.066
Rat 10 SD 
Mean
0.012
0.182
0.012
0.160
0.020
0.128
0.000
0.107
0.008
0.074
0.007
0.078
0.002
0.087
0.001
0.064
0.003
0.037
Mean 0.224 0.149 0.101 0.083 0.074 0.072 0.061 0.061 0.050
SD 0.033 0.039 0.041 0.024 0.017 0.015 0.020 0.022 0.012
Range 0.182
0.294
0.069
0.200
0.05
0.193
0.047
0.127
0.041
0.096
0.055
0.093
0.024
0.088
0.026
0.098
0.032
0.067
Table 4.17 ELISA Responses for Individual PV6 Rats
to ROS, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.029
0.285
0.036
0.144
0.000
0.098
0.003
0.091
0.004
0.086
0.004
0.086
0.011
0.061
0.021
0.050
0.004
0.036
Rat 2 SD 
Mean
0.008
0.208
0.019
0.134
0.004
0.090
0.003
0.082
0.021
0.063
0.018
0.080
0.023
0.070
0.030
0.037
0.016
0.072
Rat 3 SD 
Mean
0.019
0.161
0.008
0.148
0.000
0.106
0.003
0.093
0.004
0.079
0.008
0.072
0.003
0.086
0.023
0.037
0.001
0.036
Rat 4 SD 
Mean
0.018
0.155
0.006
0.104
0.004
0.093
0.004
0.071
0.006
0.077
0.005
0.070
0.007
0.070
0.003
0.069
0.005
0.065
Rat 5 SD 
Mean
0.014
0.184
0.002
0.069
0.004
0.060
0.006
0.063
0.032
0.071
0.009
0.082
0.001
0.005
0.006
0.007
0.001
0.050
Rat 6 SD 
Mean
0.008
0.209
0.023
0.143
0.018
0.082
0.006
0.095
0.008
0.049
0.012
0.056
0.032
0.068
0.018
0.056
0.007
0.033
Rat 7 SD 
Mean
0.010
0.250
0.007
0.163
0.008
0.107
0.006
0.088
0.019
0.071
0.021
0.068
0.018
0.068
0.011
0.024
0.006
0.024
Rat 8 SD 
Mean
0.008
0.173
0.015
0.151
0.004
0.109
0.010
0.090
0.001
0.083
0.016
0.056
0.019
0.057
0.018
0.048
0.033
0.055
Rat 9 SD 
Mean
0.007
0.238
0.000
0.195
0.008
0.084
0.003
0.090
0.006
0.085
0.018
0.084
0.003
0.042
0.008
0.072
0.002
0.048
Rat 10 SD 
Mean
0.037
0.168
0.016
0.138
0.001
0.103
0.005
0.092
0.014
0.088
0.001
0.039
0.012
0.073
0.004
0.074
0.032
0.061
Mean 0.203 0.139 0.093 0.086 0.075 0.069 0.060 0.047 0.048
SD 0.043 0.034 0.015 0.010 0.012 0.015 0.022 0.022 0.016
Range 0.155
0.285
0.069
0.195
0.060
0.109
0.063
0.095
0.049
0.088
0.039
0.086
0.005
0.086
0.007
0.074
0.024
0.072
Table 4.18 ELISA Responses for Individual PVG Rats
to ROS, at the Age of 9 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 ' 5120
Rat 1 SD 
Mean
0.010
0.249
0.001
0.156
0.002
0.104
0.006
0.086
0.013
0.085
0.010
0.074
0.002
0.022
0.022
0.081
0.006
0.021
Rat 2 SD 
Mean
0.018
0.185
0.035
0.159
0.000
0.052
0.027
0.065
0.008
0.074
0.001
0.075
0.019
0.057
0.006
0.087
0.001
0.005
Rat 3 SD 
Mean
0.000
0.184
0.005
0.108
0.004
0.092
0.011
0.078
0.004
0.084
0.009
0.082
0.018
0.045
0.028
0.079
0.008
0.047
Rat 4 SD 
Mean
0.062
0.183
0.007
0.163
0.001
0.104
0.006
0.087
0.004
0.082
0.010
0.051
0.007
0.068
0.019
0.050
0.020
0.039
Rat 5 SD 
Mean
0.010
0.185
0.001
0.171
0.004
0.169
0.004
0.106
0.023
0.078
0.012
0.068
0.006
0.079
0.004
0.094
0.012
0.084
Rat 6 SD 
Mean
0.023
0.257
0.002
0.168
0.013
0.070
0.001
0.097
0.006
0.061
0.002
0.058
0.003
0.060
0.009
0.061
0.008
0.052
Rat 7 SD 
Mean
0.033
0.266
0.006
0.116
0.006
0.080
0.019
0.068
0.001
0.083
0.009
0.087
0.004
0.068
0.020
0.059
0.006
0.076
Rat 8 SD 
Mean
0.011
0.242
0.021
0.128
0.030
0.073
0.006
0.088
0.019
0.081
0.013
0.049
0.031
0.046
0.003
0.064
0.015
0.042
Rat 9 SD 
Mean
0.021
0.217
0.013
0.112
0.001
0.099
0.016
0.082
0.008
0.077
0.013
0.062
0.003
0.065
0.042
0.065
0.042
0.066
Rat 10 SD 
Mean
0.045
0.247
0.001
0.193
0.021
0.082
0.000
0.065
0.009
0.058
0.008
0.074
0.001
0.049
0.004
0.046
0.013
0.050
Mean 0.222 0.147 0.092 0.082 0.076 0.068 0.056 0.069 0.048
SD 0.034 0.029 0.032 0.014 0.009 0.013 0.016 0.016 0.024
Range 0.183
0.266
0.108
0.193
0.052
0.169
0.065
0.106
0.058
0.085
0.049
0.087
0.022
0.079
0.046
0.094
0.005
0.084
laDie q . iy  tLi^M Kesponses Tor mcnviauai um Kats
to S-Antigen, at the Age of 3 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.013
0.045
0.011
0.008
0.019
0.014
0.025
0.018
0.011
0.020
0.008
0.020
0.001
0.008
0.006
0.031
0.004
0.039
Rat 2 SD 
Mean
0.000
0.105
0.000
0.049
0.000
0.031
0.000
0.023
0.000
0.019
0.000
0.014
0.000
0.018
0.000
0.011
0.000
0.011
Rat 3 SD 
Mean
0.033
0.160
0.003
0.070
0.009
0.083
0.022
0.072
0.016
0.076
0.001
0.098
0.021
0.059
0.018
0.060
0.002
0.053
Rat 4 SD 
Mean
0.069
0.056
0.004
0.050
0.021
0.050
0.005
0.040
0.025
0.018
0.033
0.028
0.011
0.029
0.004
0.037
0.008
0.044
Rat 5 SD 
Mean
0.018
0.148
0.009
0.092
0.007
0.049
0.001
0.048
0.016
0.043
0.001
0.053
0.003
0.051
0.010
0.034
0.008
0.054
Mean 0.103 0.054 0.045 0.040 0.035 0.043 0.033 0.035 0.040
SD 0.052 0.031 0.026 0.022 0.025 0.035 0.022 0.017 0.017
Range 0.045
0.160
0.008
0.092
0.014
0.083
0.018
0.072
0.018
0.076
0.014
0.098
0.008
0.059
0.011
0.060
0.011
0.054
Table 4.20 ELISA Responses for Individual DA Rats
to S-Antigen, at the Age of 6 Weeks
Serum Dilution
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.018
0.136
0.021
0.072
0.006
0.029
0.004
0.020
0.008
0.025
0.001
0.022
0.015
0.028
0.016
0.038
0.016
0.040
Rat 2 SD 
Mean
0.000
0.160
0.000
0.089
0.000
0.041
0.000
0.011
0.000
0.012
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Rat 3 SD 
Mean
0.047
0.270
0.004
0.124
0.006
0.126
0.032
0.053
0.005
0.007
0.026
0.018
0.000
0.000
0.025
0.018
0.016
0.030
Rat 4 SD 
Mean
0.031
0.244
0.005
0.134
0.025
0.081
0.010
0.090
0.026
0.063
0.011
0.064
0.002
0.083
0.018
0.077
0.038
0.070
Rat 5 SD 
Mean
0.006
0.173
0.002
0.103
0.001
0.093
0.008
0.082
0.021
0.050
0.005
0.081
0.001
0.081
0.005
0.047
0.001
0.031
Mean 0.197 0.104 0.074 0.051 0.031 0.037 0.038 0.036 0.034
SD 0.057 0.025 0.039 0.036 0.024 0.034 0.041 0.029 0.025
Range 0.136
0.270
0.072
0.134
0.029
0.126
0.011
0.090
0.007
0.063
0.000
0.081
0.000
0.083
0.000
0.077
0.000
0.070
Table 4.21 ELISA Responses fo r Individual DA Rats
to S-Antigen, at the Age of 9 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.000
0.171
0.000
0.110
0.000
0.107
0.000
0.082
0.000
0.116
0.000
0.114
0.000
0.027
0.000
0.033
0.000
0.029
Rat 2 SD 
Mean
0.029
0.121
0.004
0.061
0.035
0.039
0.001
0.028
0.021
0.015
0.010
0.029
0.006
0.021
0.009
0.050
0.021
0.026
Rat 3 SD 
Mean
0.059
0.183
0.000
0.100
0.017
0.072
0.013
0.054
0.003
0.055
0.025
0.066
0.007
0.053
0.003
0.055
0.013
0.053
Rat 4 SD 
Mean
0.027
0.247
0.040
0.170
0.006
0.086
0.014
0.048
0.006
0.039
0.006
0.086
0.013
0.049
0.014
0.065
0.028
0.050
Mean 0.181 0.110 0.076 0.053 0.056 0.074 0.038 0.051 0.040
SD 0.052 0.045 0.029 0.022 0.043 0.036 0.016 0.013 0.014
Range 0.121
0.247
0.061
0.170
0.039
0.107
0.028
0.082
0.015
0.116
0.029
0.114
0.021
0.053
0.033
0.065
0.026
0.053
Table 4.22 ELISA Responses fo r Individual DA Rats
to ROS, at the Age of 3 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.010
0.090
0.008
0.095
0.001
0.090
0.006
0.081
0.011
0.071
0.006
0.067
0.009
0.043
0.006
0.055
0.018
0.053
Rat 2 SD 
Mean
0.005
0.108
0.025
0.104
0.013
0.081
0.012
0.068
0.037
0.066
0.010
0.053
0.011
0.062
0.000
0.068
0.000
0.055
Rat 3 SD 
Mean
0.003
0.119
0.007
0.123
0.001
0.105
0.033
0.067
0.023
0.050
0.001
0.047
0.004
0.048
0.015
0.056
0.028
0.060
Rat 4 SD 
Mean
0.004
0.138
0.004
0.115
0.013
0.064
0.011
0.065
0.018
0.048
0.000
0.055
0.028
0.079
0.028
0.063
0.006
0.072
Rat 5 SD 
Mean
0.011
0.141
0.018
0.053
0.011
0.051
0.013
0.081
0.023
0.079
0.008
0.053
0.011
0.062
0.033
0.063
0.008
0.056
Mean 0.119 0.098 0.078 0.073 0.063 0.055 0.059 0.061 0.059
SD 0.022 0.028 0.021 0.008 0.013 0.008 0.014 0.005 0.008
Range 0.090
0.141
0.053
0.123
0.051
0.105
0.065
0.081
0.048
0.079
0.047
0.067
0.043
0.079
0.055
0.068
0.053
0.072
Table 4.23 ELISA Responses for Individual DA Rats
to ROS, at the Age of 6 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.004
0.118
0.008
0.109
0.013
0.094
0.006
0.089
0.006
0.090
0.010
0.077
0.003
0.071
0.007
0.064
0.006
0.068
Rat 2 SD 
Mean
0.001
0.187
0.015
0.088
0.014
0.078
0.016
0.071
0.014
0.070
0.015
0.061
0.006
0.046
0.001
0.075
0.025
0.051
Rat 3 SD 
Mean
0.021
0.151
0.001
0.090
0.014
0.065
0.025
0.069
0.019
0.063
0.018
0.056
0.019
0.053
0.021
0.080
0.006
0.028
Rat 4 SD 
Mean
0.017
0.092
0.010
0.098
0.011
0.086
0.005
0.061
0.028
0.064
0.023
0.052
0.014
0.048
0.006
0.070
0.015
0.045
Rat 5 SD 
Mean
0.002
0.126
0.004
0.103
0.016
0.088
0.010
0.075
0.013
0.076
0.030
0.066
0.019
0.063
0.027
0.050
0.021
0.054
Mean 0.135 0.098 0.822 0.073 0.073 0.062 0.056 0.068 0.050
SD 0.036 0.009 0.011 0.010 0.011 0.010 0.011 0.012 0.015
Range 0.092
0.187
0.088
0.109
0.065
0.094
0.061
0.089
0.063
0.090
0.052
0.077
0.046
0.071
0.050
0.080
0.028
0.068
Table 4.24 ELISA Responses for Individual DA Rats
to ROS, at the Age of 9 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.000
0.133
0.000
0.108
0.004
0.098
0.012
0.082
0.010
0.069
0.008
0.054
0.005
0.076
0.021
0.073
0.004
0.068
Rat 2 SD 
Mean
0.025
0.144
0.001
0.198
0.007
0.083
0.008
0.076
0.005
0.077
0.019
0.085
0.019
0.056
0.007
0.071
0.020
0.047
Rat 3 SD 
Mean
0.004
0.164
0.008
0.103
0.007
0.089
0.007
0.060
0.008
0.089
0.018
0.061
0.013
0.065
0.008
0.059
0.002
0.065
Rat 4 SD 
Mean
0.009
0.119
0.001
0.103
0.004
0.095
0.020
0.068
0.008
0.060
0.029
0.065
0.019
0.063
0.023
0.052
0.021
0.054
Mean 0.140 0.128 0.091 0.071 0.074 0.067 0.065 0.064 0.058
SD 0.019 0.047 0.006 0.009 0.012 0.013 0.009 0.010 0.009
Range 0.119
0.164
0.103
0.198
0.083
0.098
0.060
0.082
0.060
0.089
0.054
0.085
0.056
0.076
0.052
0.073
0.047
0.068
Table 4.25 ELISA Responses for Individual Wistar Rats
to S-Antigen, at the Age of 3 Weeks
Serum D ilu t ion
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.048
0.060
0.020
0.030
0.004
0.046
0.000
0.036
0.020
0.041
0.014
0.051
0.013
0.050
0.008
0.057
0.005
0.071
Rat 2 SD 
Mean
0.045
0.287
0.003
0.144
0.013
0.087
0.016
0.044
0.029
0.031
0.033
0.037
0.028
0.024
0.010
0.047
0.021
0.034
Rat 3 SD 
Mean
0.000
0.316
0.000
0.086
0.000
0.044
0.000
0.017
0.000
0.032
0.000
0.017
0.000
0.020
0.000
0.036
0.000
0.003
Rat 4 SD 
Mean
0.062
0.318
0.004
0.156
0.014
0.100
0.017
0.072
0.004
0.062
0.011
0.075
0.004
0.074
0.011
0.072
0.009
0.078
Mean 0.245 0.104 0.070 0.042 0.042 0.045 0.042 0.053 0.046
SD 0.124 0.058 0.028 0.023 0.015 0.024 0.025 0.015 0.035
Range 0.060
0.318
0.030
0.156
0.044
0.100
0.017
0.072
0.031
0.062
0.017
0.075
0.020
0.074
0.036
0.072
0.003
0.078
Table 4.26 ELISA Responses for Individual Wistar Rats
to S-Antigen, at the Age of 6 Weeks
Serum D ilu t ion
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.023
0.133
0.044
0.066
0.045
0.045
0.008
0.019
0.013
0.034
0.011
0.037
0.007
0.063
0.009
0.076
0.007
0.072
Rat 2 SD 
Mean
0.018
0.556
0.009
0.304
0.054
0.178
0.048
0.137
0.013
0.107
0.001
0.084
0.012
0.057
0.022
0.066
0.012
0.082
Rat 3 SD 
Mean
0.000
0.273
0.000
0.164
0.000
0.055
0.000
0.045
0.000
0.040
0.000
0.020
0.000
0.029
0.000
0.039
0.000
0.020
Rat 4 SD 
Mean
0.034
0.594
0.006
0.274
0.006
0.117
0.003
0.066
0.015
0.035
0.023
0.026
0.004
0.037
0.002
0.031
0.029
0.048
Rat 5 SD 
Mean
0.043
0.470
0.047
0.158
0.021
0.107
0.004
0.078
0.051
0.068
0.011
0.051
0.035
0.063
0.004
0.071
0.026
0.062
Mean 0.405 0.193 0.100 0.069 0.057 0.044 0.050 0.057 0.057
SD 0.196 0.096 0.054 0.044 0.031 0.026 0.016 0.020 0.024
Range 0.133
0.594
0.066
0.304
0.045
0.178
0.019
0.137
0.034
0.107
0.020
0.084
0.029
0.063
0.031
0.076
0.020
0.082
Table 4.27 ELISA Responses for Individual Wistar Rats
to S-Antigen, at the Age of 9 Weeks
Serum D ilu tion
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.038
0.176
0.004
0.066
0.010
0.087
0.000
0.049
0.018
0.056
0.006
0.062
0.030
0.068
0.006
0.066
0.017
0.083
Rat 2 SD 
Mean
0.000
0.046
0.000
0.089
0.001
0.100
0.000
0.105
0.025
0.082
0.033
0.060
0.001
0.039
0.022
0.066
0.016
0.062
Rat 3 SD 
Mean
0.016
0.274
0.001
0.134
0.002
0.087
0.003
0.050
0.009
0.061
0.006
0.043
0.009
0.064
0.001
0.081
0.001
0.049
Rat 4 SD 
Mean
0.044
0.696
0.038
0.213
0.006
0.125
0.031
0.064
0.020
0.038
0.007
0.048
0.001
0.056
0.025
0.038
0.009
0.056
Mean 0.298 0.126 0.100 0.067 0.059 0.053 0.057 0.063 0.063
SD 0.281 0.065 0.018 0.026 0.018 0.009 0.013 0.018 0.015
Range 0.046
0.696
0.066
0.213
0.087
0.125
0.049
0.105
0.038
0.082
0.043
0.062
0.039
0.068
0.038
0.081
0.049
0.083
Table 4.28 ELISA Responses for Individual Wistar Rats
to ROS, at the Age of 3 Weeks
Serum D ilu t ion
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.011
0.197
0.004
0.095
0.007
0.087
0.004
0.086
0.015
0.073
0.004
0.086
0.013
0.056
0.000
0.086
0.008
0.091
Rat 2 SD 
Mean
0.008
0.267
0.023
0.192
0.004
0.104
0.021
0.084
0.001
0.082
0.001
0.087
0.010
0.065
0.013
0.075
0.004
0.078
Rat 3 SD 
Mean
0.006
0.237
0.028
0.204
0.012
0.160
0.001
0.104
0.008
0.089
0.018
0.087
0.008
0.087
0.020
0.080
0.003
0.077
Rat 4 SD 
Mean
0.003
0.277
0.040
0.260
0.014
0.213
0.006
0.177
0.040
0.080
0.016
0.097
0.006
0.076
0.008
0.071
0.004
0.063
Rat 5 SD 
Mean
0.012
0.262
0.013
0.163
0.001
0.108
0.004
0.061
0.010
0.043
0.001
0.043
0.004
0.043
0.000
0.085
0.000
0.074
Mean 0.248 0.182 0.134 0.103 0.073 0.080 0.066 0.079 0.077
SD 0.032 0.060 0.052 0.045 0.018 0.021 0.017 0.007 0.010
Range 0.197
0.277
0.095
0.260
0.087
0.213
0.061
0.177
0.043
0.089
0.043
0.097
0.043
0.087
0.071
0.086
0.063
0.091
Table 4.29 ELISA Responses for Individual Wistar Rats
to ROS, at the Age of 6 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.007
0.282
0.021
0.237
0.022
0.178
0.001
0.126
0.006
0.110
0.014
0.122
0.021
0.079
0.011
0.081
0.005
0.072
Rat 2 SD 
Mean
0.037
0.284
0.010
0.201
0.025
0.126
0.018
0.085
0.016
0.075
0.008
0.086
0.033
0.058
0.008
0.060
0.004
0.053
Rat 3 SD 
Mean
0.018
0.271
0.023
0.183
0.001
0.155
0.012
0.122
0.017
0.044
0.021
0.058
0.039
0.065
0.010
0.081
0.021
0.084
Rat 4 SD 
Mean
0.021
0.356
0.002
0.250
0.005
0.128
0.005
0.092
0.017
0.066
0.030
0.065
0.013
0.068
0.011
0.040
0.014
0.012
Rat 5 SD 
Mean
0.033
0.245
0.007
0.226
0.037
0.148
0.000
0.123
0.003
0.092
0.002
0.078
0.028
0.073
0.002
0.045
0.005
0.036
Mean 0.288 0.219 0.147 0.110 0.077 0.082 0.069 0.061 0.051
SD 0.041 0.027 0.021 0.019 0.025 0.025 0.008 0.019 0.029
Range 0.245
0.356
0.183
0.250
0.126
0.178
0.085
0.126
0.044
0.110
0.058
0.122
0.058
0.079
0.040
0.081
0.012
0.084
Table 4.30 ELISA Responses for Individual Wistars Rats
to ROS, at the Age of 9 Weeks
Serum D ilu t io n
20 40 80 160 320 640 1280 2560 5120
Rat 1 SD 
Mean
0.025
0.280
0.013
0.176
0.021
0.153
0.015
0.063
0.010
0.078
0.014
0.077
0.008
0.041
0.026
0.043
0.023
0.061
Rat 2 SD 
Mean
0.004
0.274
0.001
0.221
0.027
0.143
0.011
0.086
0.004
0.089
0.010
0.085
0.008
0.070
0.039
0.060
0.018
0.076
Rat 3 SD 
Mean
0.041
0.244
0.002
0.183
0.004
0.145
0.006
0.097
0.013
0.077
0.010
0.074
0.014
0.063
0.018
0.055
0.027
0.078
Rat 4 SD 
Mean
0.011
0.230
0.035
0.173
0.002
0.108
0.013
0.071
0.026
0.062
0.029
0.064
0.014
0.041
0.012
0.068
0.022
0.035
Rat 5 SD 
Mean
0.017
0.170
0.000
0.137
0.000
0.102
0.013
0.087
0.009
0.080
0.007
0.071
0.037
0.066
0.018
0.045
0.007
0.054
Mean 0.240 0.178 0.130 0.081 0.077 0.074 0.056 0.054 0.061
SD 0.044 0.030 0.023 0.014 0.010 0.008 0.014 0.010 0.018
Range 0.170
0.280
0.137
0.221
0.102
0.153
0.063
0.097
0.062
0.089
0.064
0.085
0.041
0.070
0.043
0.068
0.035
0.078
Table 4.36 ELISA Responses of RP and Uveitis  Patients to ROS
Subject 10 20 40
Serum D ilu t ion  
80 160 320 640 1280
A A* X 0.389 0.255 0.150 0.111 0.093 0.043 0.045 0.058
SD 0.042 0.004 0.008 0.021 0.009 0.006 0.001 0.004
CM+ X 0.321 0.204 0.122 0.073 0.057 0.036 0.068 0.079
SD 0.010 0.011 0.007 0.001 0.007 0.006 0.020 0.002
EN+ X 0.946 0.876 0.679 0.509 0.351 0.218 0.139 0.083
SD 0.015 0.062 0.003^ 0.007 0.023 0.023 0.010 0.004
GA* X 0.766 0.426 0.298 0.210 0.174 0.136 0.070 0.048
SD : 0.027 0.021 0.004 0.018 0.008 0.062 0.008 0.004
GG* X 0.273 0.179 0.108 0.047 0.064 0.051 0.054 0.051
SD 0.030 0.013 0.009 0.010 0.078 0.002 0.008 0.004
HM* X 0.317 0.164 0.120 0.074 0.062 0.052 0.045 0.038
SD 0.040 0.001 0.031 0.001 0.005 0.006 0.003 0.005
HS1+ X 0.400 0.246 0.211 0.150 0.136 0.094 0.091 0.085
SD 0.076 0.008 0.002 0.010 0.017 0.015 0.011 0.007
HS2+ X 0.424 0.310 0.238 0.191 0.167 0.104 - -
SD 0.023 0.022 0.004 0.006 0.010 0.002 - -
IM* X 0.450 0.331 0.186 0.121 0.093 0.058 0.046 0.050
SD 0.008 0.009 0.034 0.011 0.004 0.005 0.042 0.001
KM* X 0.216 0.185 0.082 0.042 0.060 0.022 0.024 0.042
SD 0.035 0.009 0.017 0.007 0.021 0.015 0.003 0.013
MK+ X 0.679 0.458 0.284 0.163 0.159 0.108 0.076 0.061
SD 0.046 0.011 0.017 0.010 0.005 0.015 0.004 0.023
UV+ X 0.035 0.272 0.189 0.168 0.140 0.078 0.065 0.054
SD 0.023 0.005 0.018 0.011 0.004 0.003 0.012 0.001
X = Mean o f 2 assays
SD = Standard deviation (n-1)
*  = Patient has RP 
+ = Patient has u v e it is
Table 4.33 ELISA Responses of Control Human Subjects to S-Antigen
Subject 10 20
(
40
Serum D ilu t ion  
80 160 320 640 1280
AC X 0.417 0.394 0.253 0.140 0.065 0.051 0.046 0.037
SD 0.004 0.016 0.019 0.035 0.029 0.003 0.004 0.016
BD X 0.409 0.331 0.213 0.187 0.157 0.121 0.105 0.102
SD 0.047 0.007 0.007 0.023 0.019 0.011 0.006 0.013
BM X 0.425 0.367 0.208 0.153 0.106 0.095 0.067 0.041
SD 0.013 0.002 0.006 0.019 0.057 0.011 0.036 0.0
CD X 0.345 0.225 0.138 0.089 0.069 0.068 0.061 0.048
SD 0.134 0.006 0.013 0.015 0.013 0.005 0.006 0.006
HD X 0.211 0.172 0.119 0.072 0.072 0.065 0.063 0.057
SD 0.002 0.002 0.012 0.006 0.011 0.001 0.003 0.003
JF* X 0.274 0.195 0.129 0.097 0.093 0.061 0.048 0.0
SD 0.013 0.007 0.011 0.013 0.002 0.0 0.014 0.0
KM* X 0.257 0.223 0.116 0.065 0.057 0.044 0.042 0.041
SD 0.256 0.040 0.006 0.004 0.002 0.008 0.003 0.006
LR1* X 0.925 0.668 0.423 0.253 0.135 0.089 0.078 0.050
SD 0.010 0.035 0.012 0.013 0.006 0.021 0.020 0.010
LR2* X 0.891 0.681 0.533 0.293 0.183 0.138 0.070 0.064
SD 0.055 0.012 0.046 0.006 0.023 0.020 0.014 0.007
MM X 0.424 0.282 0.191 0.119 0.093 0.078 0.067 0.060
SD 0.018 0.003 0.014 0.023 0.013 0.007 0.003 0.006
OM X 0.381 0.293 0.222 0.180 0.152 0.110 0.082 0.090
SD 0.032 0.008 0.017 0.007 0.023 0.014 0.012 0.016
SG X 0.452 0.360 0.227 0.143 0.093 0.072 0.050 0.045
SD 0.011 0.004 0.021 0.001 0.001 0.006 0.0 0.008
X = Mean of 2 assays
SD = Standard deviation (n-1)
*  = Users of re t in a l antigens
Table 4.34 ELISA Responses of RP and Uveitis  Patients to S-Antigen
Subject 10 20
Serum D ilu tion  
40 80 160 320 640 1280
AA* X 0.356 0.282 0.181 0.179 0.117 0.098 0.103 0.062
SD 0.013 0.010 0.006 0.023 0.009 0.001 0.009 0.015
CM+ X 0.335 0.229 0.128 0.063 0.054 0.042 0.039 0.049
SD 0.005 0.004 0.014 0.009 0.013 0.006 0.013 0.006
EN+# X 0.411 0.349 0.275 0.221 0.181 0.110 0.085 0.032
SD - - - - - - - -
GA* X 0.414 0.233 0.186 0.167 0.137 0.099 0.104 0.053
SD 0.047 0.075 0.022 0.007 0.011 0.010 0.002 0.0
GG* X 0.413 0.251 0.150 0.096 0.086 0.079 0.047 0.076
SD 0.008 0.011 0.004 0.006 0.018 0.099 0.009 0.0
HM* X 0.334 0.253 0.162 0.100 0.063 0.049 0.049 0.036
SD 0.016 0.017 0.010 0.007 0.001 0.013 0.008 0.0
HS1+ X 0.811 0.544 0.340 0.188 0.136 0.082 0.063 0.0
SD 0.035 0.024 0.011 0.008 0.018 0.021 0.015 0.0
HS2+ X 0.808 0.733 0.491 0.284 0.157 0.078 0.076 0.017
SD 0.054 0.028 0.024 0.007 0.014 0.007 0.013 0.006
IM* X 0.405 0.294 0.186 0.146 0.097 0.088 0.094 0.093
SD 0.002 0.004 0.010 0.005 0.006 0.007 0.009 0.007
KM* X 0.314 0.214 0.130 0.097 0.085 0.061 0.059 0.059
SD 0.010 0.011 0.017 0.008 0.010 0.002 0.020 0.009
MK+ X 0.390 0.234 0.165 0.103 0.098 0.045 0.034 0.055
SD 0.018 0.006 0.020 0.021 0.020 0.004 0.008 0.006
UV+ X 0.694 0.549 0.346 0.265 0.163 0.120 0.104 0.064
SD 0.014 0.020 0.014 0.018 0.009 0.001 0.001 0.008
X = Mean o f 2 assays *  = Patient has RP
SD = Standard deviation (n-1) + = Patient has u v e it is
# = Results of single assay
Table 4.35 ELISA Responses of Control Human Subjects to ROS
Subject 10 20 40
Serum D ilu t ion  
80 160 320 640 1280
AC X 0.502 0.398 0.268 0.161 0.123 0.095 0.084 0.081
SD 0.009 0.009 0.018 0.001 0.006 0.018 0.007 0.007
BD X 0.478 0.396 0.241 0.166 0.146 0.101 0.073 0.035
SD 0.040 0.005 0.0 0.113 0.156 0.002 0.001 0.008
BM X 0.354 0.323 0.207 0.125 0.082 0.079 0.065 0.064
SD 0.002 0.019 0.006 0.013 0.001 0.003 0.002 0.0
CD X 0.302 0.178 0.135 0.088 0.087 0.082 0.072 0.048
SD . 0.008 0.004 0.025 0.001 0.002 0.004 0.019 0.004
HD X 0.323 0.235 0.150 0.076 0.079 0.060 0.080 0.060
SD 0.005 0.0 0.006 0.004 0.016 0.003 0.038 0.006
JF* X 0.339 0.210 0.193 0.153 0.138 0.108 0.071 0.045
SD 0.054 0.025 0.046 0.033 0.042 0.026 - -
KM* X 0.218 0.119 0.092 0.051 0.069 0.046 0.044 0.033
SD 0.019 0.016 0.006 0.026 0.011 0.004 0.007 0.001
LR1* X 0.907 0.678 0.463 0.254 0.215 0.135 0.091 0.056
SD 0.043 0.011 0.004 0.004 0.006 0.003 0.004 0.005
LR2* X 1.029 0.806 0.570 0.386 0.277 0.180 0.114 0.080
SD 0.023 0.022 0.037 0.304 0.023 0.005 0.002 0.0
MM X 0.337 0.332 0.238 0.150 0.080 0.071 0.050 0.051
SD 0.051 0.032 0.016 0.006 0.026 0.006 0.011 0.0
OM X 0.258 0.207 0.128 0.098 0.064 0.053 0.042 0.046
SD 0.067 0.008 0.005 0.006 0.003 0.011 0.005 0.006
SG X 0.553 0.397 0.254 0.139 0.112 0.065 0.068 0.084
SD 0.098 0.006 0.020 0.013 0.018 0.001 0.001 0.005
X = Mean o f 2 assays
SD = Standard deviation (n-1)
*  = Users o f re t in a l antigens
